1	OPEN	NN	MISC	open	nn	3	SENT_1	[p1l187t137r269b160],
2	8	CD	NUMBER	8	num	3	SENT_1	[p1l279t118r311b169],
3	ACCESS	NNP	O	ACCESS	_	0	SENT_1	[p1l319t137r431b161],
4	Freely	RB	O	freely	advmod	5	SENT_1	[p1l447t136r536b168],
5	available	JJ	O	available	amod	3	SENT_1	[p1l544t136r677b161],
6	online	NN	O	online	prep	3	SENT_1	[p1l685t136r777b161],
7	P	NN	O	p	dep	6	SENT_1	[p1l1981t118r2095b161],
8	?	.	O	?	_	0	SENT_1	[p1l1981t118r2095b161],

1	PATHOGENS	NNS	O	pathogen	_	0	SENT_2	[p1l2106t138r2286b161],

1	ART	NN	O	art	nsubj	2	SENT_3	[p1l190t218r359b289],
2	Suppresses	VBZ	O	suppress	_	0	SENT_3	[p1l398t218r877b310],
3	Plasma	NN	O	plasma	nn	5	SENT_3	[p1l924t215r1216b290],
4	HIV-1	NN	O	hiv-1	nn	5	SENT_3	[p1l1265t219r1473b289],
5	RNA	NN	O	rna	dobj	2	SENT_3	[p1l1535t218r1713b289],
6	to	TO	O	to	_	0	SENT_3	[p1l1752t227r1838b290],
7	a	DT	O	a	det	8	SENT_3	[p1l1880t237r1920b290],
8	Stable	JJ	O	stable	prep_to	5	SENT_3	[p1l1965t215r2227b290],

1	Set	NN	O	set	nn	2	SENT_4	[p1l192t342r322b414],
2	Point	NN	O	point	nsubj	3	SENT_4	[p1l367t342r585b414],
3	Predicted	VBN	O	predict	_	0	SENT_4	[p1l630t339r1029b414],
4	by	IN	O	by	_	0	SENT_4	[p1l1078t339r1179b436],
5	Pretherapy	NNP	PERSON	Pretherapy	nn	6	SENT_4	[p1l1221t339r1689b436],
6	Viremia	NNP	PERSON	Viremia	prep_by	3	SENT_4	[p1l1724t342r2045b414],

1	Frank	NNP	PERSON	Frank	nn	2	SENT_5	[p1l190t486r286b514],
2	Maldarelli	NNP	PERSON	Maldarelli	nsubj	19	SENT_5	[p1l300t475r510b518],
3	"	``	O	"	punct	9	SENT_5	[p1l300t475r510b518],
4	,	,	O	,	_	0	SENT_5	[p1l300t475r510b518],
5	Sarah	NNP	PERSON	Sarah	nn	6	SENT_5	[p1l526t486r620b514],
6	Palmerl	NNP	PERSON	Palmerl	dep	9	SENT_5	[p1l637t476r781b518],
7	,	,	O	,	_	0	SENT_5	[p1l637t476r781b518],
8	Martin	NNP	PERSON	Martin	nn	9	SENT_5	[p1l797t486r906b514],
9	S.	NNP	PERSON	S.	dep	2	SENT_5	[p1l923t487r951b513],
10	Kingz	NNP	PERSON	Kingz	dep	9	SENT_5	[p1l967t475r1069b521],
11	,	,	O	,	_	0	SENT_5	[p1l967t475r1069b521],
12	Ann	NNP	PERSON	Ann	nn	14	SENT_5	[p1l1084t487r1151b513],
13	Wiegand	NNP	PERSON	Wiegand	nn	14	SENT_5	[p1l1166t476r1344b521],
14	‘	NNP	O	‘	appos	9	SENT_5	[p1l1166t476r1344b521],
15	,	,	O	,	_	0	SENT_5	[p1l1166t476r1344b521],
16	Michael	NNP	PERSON	Michael	nn	18	SENT_5	[p1l1359t486r1488b514],
17	A.	NNP	PERSON	A.	nn	18	SENT_5	[p1l1504t487r1537b513],
18	Po	NNP	PERSON	Po	appos	14	SENT_5	[p1l1553t475r1658b518],
19	|	VBD	O	|	_	0	SENT_5	[p1l1553t475r1658b518],
20	is3	NN	O	is3	dep	19	SENT_5	[p1l1553t475r1658b518],
21	,	,	O	,	_	0	SENT_5	[p1l1553t475r1658b518],
22	JoAnn	NNP	PERSON	JoAnn	nn	23	SENT_5	[p1l1672t487r1777b514],
23	Mican3	NNP	PERSON	Mican3	appos	20	SENT_5	[p1l1794t475r1920b518],
24	,	,	O	,	_	0	SENT_5	[p1l1794t475r1920b518],
25	Joseph	NNP	PERSON	Joseph	nn	27	SENT_5	[p1l1934t486r2051b521],
26	A.	NNP	PERSON	A.	nn	27	SENT_5	[p1l2067t487r2100b513],
27	Kovacs4	NNP	PERSON	Kovacs4	appos	20	SENT_5	[p1l2117t476r2260b518],
28	,	,	O	,	_	0	SENT_5	[p1l2117t476r2260b518],
29	Richard	NNP	PERSON	Richard	nn	31	SENT_5	[p1l190t544r315b572],
30	T.	NNP	PERSON	T.	nn	31	SENT_5	[p1l330t545r360b571],
31	Davey3	NNP	PERSON	Davey3	appos	20	SENT_5	[p1l376t533r507b579],
32	,	,	O	,	_	0	SENT_5	[p1l376t533r507b579],
33	Diane	NNP	PERSON	Diane	nn	34	SENT_5	[p1l523t544r620b571],
34	Rock-Kress3	NNP	PERSON	Rock-Kress3	appos	20	SENT_5	[p1l636t533r846b576],
35	,	,	O	,	_	0	SENT_5	[p1l636t533r846b576],
36	Robin	NNP	PERSON	Robin	nn	37	SENT_5	[p1l862t544r957b572],
37	Dewars	NNP	PERSON	Dewars	appos	20	SENT_5	[p1l975t534r1109b576],
38	,	,	O	,	_	0	SENT_5	[p1l975t534r1109b576],
39	Shuying	NNP	PERSON	Shuying	nn	40	SENT_5	[p1l1125t544r1261b579],
40	Liu3	NNP	O	Liu3	appos	20	SENT_5	[p1l1278t533r1354b576],
41	,	,	O	,	_	0	SENT_5	[p1l1278t533r1354b576],
42	Julia	NNP	PERSON	Julia	nn	46	SENT_5	[p1l1368t544r1444b572],
43	A.	NNP	PERSON	A.	nn	46	SENT_5	[p1l1460t545r1493b571],
44	Metca	NNP	PERSON	Metca	nn	46	SENT_5	[p1l1509t533r1661b576],
45	|	NN	O	|	nn	46	SENT_5	[p1l1509t533r1661b576],
46	f3	NN	O	f3	appos	20	SENT_5	[p1l1509t533r1661b576],
47	,	,	O	,	_	0	SENT_5	[p1l1509t533r1661b576],
48	Catherine	NNP	PERSON	Catherine	nn	49	SENT_5	[p1l1676t544r1840b572],
49	Rehm3	NNP	PERSON	Rehm3	appos	20	SENT_5	[p1l1856t533r1978b576],
50	,	,	O	,	_	0	SENT_5	[p1l1856t533r1978b576],
51	Scott	NNP	PERSON	Scott	nn	53	SENT_5	[p1l1994t545r2079b572],
52	C.	NNP	PERSON	C.	nn	53	SENT_5	[p1l2094t545r2124b572],
53	Brunz	NNP	PERSON	Brunz	appos	20	SENT_5	[p1l2140t533r2246b576],
54	,	,	O	,	_	0	SENT_5	[p1l2140t533r2246b576],
55	George	NNP	PERSON	George	nn	57	SENT_5	[p1l189t603r311b637],
56	J.	NNP	PERSON	J.	nn	57	SENT_5	[p1l325t603r349b630],
57	Hannaz	NNP	PERSON	Hannaz	appos	20	SENT_5	[p1l366t591r501b634],
58	,	,	O	,	_	0	SENT_5	[p1l366t591r501b634],
59	Dale	NNP	PERSON	Dale	nn	61	SENT_5	[p1l517t602r591b630],
60	J.	NNP	PERSON	J.	nn	61	SENT_5	[p1l605t603r629b630],
61	Kempfz	NNP	PERSON	Kempfz	appos	20	SENT_5	[p1l646t591r782b637],
62	,	,	O	,	_	0	SENT_5	[p1l646t591r782b637],
63	John	NNP	PERSON	John	nn	65	SENT_5	[p1l796t602r876b629],
64	M.	NNP	PERSON	M.	nn	65	SENT_5	[p1l892t603r932b629],
65	Coffin	NNP	PERSON	Coffin	appos	20	SENT_5	[p1l946t592r1075b634],
66	‘	NN	O	‘	dep	65	SENT_5	[p1l946t592r1075b634],
67	,	,	O	,	_	0	SENT_5	[p1l946t592r1075b634],
68	John	NNP	PERSON	John	nn	72	SENT_5	[p1l1089t602r1169b630],
69	W.	NNP	PERSON	W.	nn	72	SENT_5	[p1l1184t603r1226b629],
70	MeI	NNP	PERSON	MeI	nn	72	SENT_5	[p1l1242t591r1383b630],
71	|	NNP	O	|	nn	72	SENT_5	[p1l1242t591r1383b630],
72	ors6	NN	O	ors6	appos	20	SENT_5	[p1l1242t591r1383b630],

1	1	CD	NUMBER	1	num	2	SENT_6	[p1l190t668r199b687],
2	HIV	NN	O	hiv	_	0	SENT_6	[p1l217t667r257b687],
3	Drug	NN	O	drug	nn	5	SENT_6	[p1l271t667r328b693],
4	Resistance	NN	O	resistance	nn	5	SENT_6	[p1l344t667r468b687],
5	Program	NN	O	program	dep	2	SENT_6	[p1l483t667r590b693],
6	,	,	O	,	_	0	SENT_6	[p1l483t667r590b693],
7	National	NNP	ORGANIZATION	National	nn	9	SENT_6	[p1l605t666r703b687],
8	Cancer	NNP	ORGANIZATION	Cancer	nn	9	SENT_6	[p1l717t667r800b687],
9	Institute	NNP	ORGANIZATION	Institute	appos	5	SENT_6	[p1l814t667r917b691],
10	,	,	O	,	_	0	SENT_6	[p1l814t667r917b691],
11	Frederick	NNP	PERSON	Frederick	appos	5	SENT_6	[p1l932t666r1047b691],
12	,	,	O	,	_	0	SENT_6	[p1l932t666r1047b691],
13	Maryland	NNP	LOCATION	Maryland	appos	5	SENT_6	[p1l1061t666r1178b693],
14	,	,	O	,	_	0	SENT_6	[p1l1061t666r1178b693],
15	United	NNP	ORGANIZATION	United	nn	16	SENT_6	[p1l1193t666r1270b687],
16	States	NNPS	ORGANIZATION	States	appos	5	SENT_6	[p1l1286t667r1357b687],
17	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l1370t666r1395b687],
18	America	NNP	ORGANIZATION	America	prep_of	16	SENT_6	[p1l1406t667r1510b691],
19	,	,	O	,	_	0	SENT_6	[p1l1406t667r1510b691],
20	2	CD	NUMBER	2	appos	5	SENT_6	[p1l1524t668r1537b687],
21	Global	JJ	ORGANIZATION	global	amod	23	SENT_6	[p1l1551t666r1627b687],
22	Pharmaceutical	NNP	ORGANIZATION	Pharmaceutical	nn	23	SENT_6	[p1l1643t666r1825b687],
23	Research	NNP	ORGANIZATION	Research	dep	2	SENT_6	[p1l1841t666r1945b687],
24	and	CC	ORGANIZATION	and	_	0	SENT_6	[p1l1960t666r2003b687],
25	Development	NNP	ORGANIZATION	Development	conj_and	23	SENT_6	[p1l2019t666r2188b693],
26	,	,	O	,	_	0	SENT_6	[p1l2019t666r2188b693],
27	Abbott	NNP	ORGANIZATION	Abbott	nn	28	SENT_6	[p1l2202t666r2286b687],
28	Laboratories	NNP	ORGANIZATION	Laboratories	appos	2	SENT_6	[p1l190t708r344b733],
29	,	,	O	,	_	0	SENT_6	[p1l190t708r344b733],
30	Abbott	NNP	PERSON	Abbott	nn	31	SENT_6	[p1l356t708r441b729],
31	Park	NNP	PERSON	Park	appos	2	SENT_6	[p1l455t708r510b733],
32	,	,	O	,	_	0	SENT_6	[p1l455t708r510b733],
33	Illinois	NNP	LOCATION	Illinois	appos	2	SENT_6	[p1l524t708r603b733],
34	,	,	O	,	_	0	SENT_6	[p1l524t708r603b733],
35	United	NNP	ORGANIZATION	United	nn	36	SENT_6	[p1l617t708r695b729],
36	States	NNPS	ORGANIZATION	States	appos	2	SENT_6	[p1l709t709r780b729],
37	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l793t708r818b729],
38	America	NNP	ORGANIZATION	America	prep_of	36	SENT_6	[p1l828t709r931b733],
39	,	,	O	,	_	0	SENT_6	[p1l828t709r931b733],
40	3	CD	NUMBER	3	num	42	SENT_6	[p1l944t710r958b729],
41	Lab	NN	ORGANIZATION	lab	nn	42	SENT_6	[p1l972t708r1013b729],
42	Immunoregulation	NN	ORGANIZATION	immunoregulation	appos	2	SENT_6	[p1l1026t708r1258b735],
43	,	,	O	,	_	0	SENT_6	[p1l1026t708r1258b735],
44	National	NNP	ORGANIZATION	National	nn	45	SENT_6	[p1l1272t708r1370b729],
45	Institute	NNP	ORGANIZATION	Institute	appos	2	SENT_6	[p1l1385t709r1482b729],
46	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l1495t708r1519b729],
47	Allergy	NNP	ORGANIZATION	Allergy	nn	50	SENT_6	[p1l1530t708r1613b735],
48	and	CC	O	and	_	0	SENT_6	[p1l1625t708r1669b729],
49	Infectious	JJ	O	infectious	conj_and	47	SENT_6	[p1l1683t708r1799b729],
50	Diseases	NNS	O	disease	prep_of	45	SENT_6	[p1l1813t709r1919b733],
51	,	,	O	,	_	0	SENT_6	[p1l1813t709r1919b733],
52	National	NNP	ORGANIZATION	National	nn	53	SENT_6	[p1l1933t708r2031b729],
53	Institutes	NNPS	ORGANIZATION	Institutes	appos	2	SENT_6	[p1l2045t709r2154b729],
54	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l2167t708r2192b729],
55	Health	NNP	ORGANIZATION	Health	dep	59	SENT_6	[p1l2203t708r2286b733],
56	,	,	O	,	_	0	SENT_6	[p1l2203t708r2286b733],
57	Bethesda	NNP	LOCATION	Bethesda	dep	55	SENT_6	[p1l190t749r305b774],
58	,	,	O	,	_	0	SENT_6	[p1l190t749r305b774],
59	Mawland	NNP	O	Mawland	prep_of	53	SENT_6	[p1l316t749r433b776],
60	,	,	O	,	_	0	SENT_6	[p1l316t749r433b776],
61	United	NNP	ORGANIZATION	United	nn	62	SENT_6	[p1l445t749r522b770],
62	States	NNPS	ORGANIZATION	States	appos	2	SENT_6	[p1l534t750r605b770],
63	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l616t749r641b770],
64	America	NNP	ORGANIZATION	America	prep_of	62	SENT_6	[p1l649t750r752b774],
65	,	,	O	,	_	0	SENT_6	[p1l649t750r752b774],
66	4	CD	NUMBER	4	num	67	SENT_6	[p1l763t751r778b770],
67	Department	NNP	ORGANIZATION	Department	appos	2	SENT_6	[p1l789t750r934b776],
68	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l945t749r969b770],
69	Critical	JJ	ORGANIZATION	critical	amod	70	SENT_6	[p1l978t749r1058b770],
70	Care	NN	ORGANIZATION	care	prep_of	67	SENT_6	[p1l1069t750r1128b774],
71	,	,	O	,	_	0	SENT_6	[p1l1069t750r1128b774],
72	National	NNP	ORGANIZATION	National	nn	73	SENT_6	[p1l1140t749r1238b770],
73	Institutes	NNPS	ORGANIZATION	Institutes	appos	2	SENT_6	[p1l1250t750r1359b770],
74	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l1370t749r1395b770],
75	Health	NNP	ORGANIZATION	Health	prep_of	73	SENT_6	[p1l1404t749r1480b770],
76	Clinical	JJ	ORGANIZATION	clinical	amod	75	SENT_6	[p1l1492t749r1576b770],
77	Center	NNP	ORGANIZATION	Center	nn	80	SENT_6	[p1l1587t750r1672b774],
78	,	,	O	,	_	0	SENT_6	[p1l1587t750r1672b774],
79	National	NNP	ORGANIZATION	National	appos	80	SENT_6	[p1l1684t749r1782b770],
80	Institutes	NNPS	ORGANIZATION	Institutes	dep	2	SENT_6	[p1l1794t750r1904b770],
81	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l1914t749r1939b770],
82	Health	NNP	ORGANIZATION	Health	dep	86	SENT_6	[p1l1948t749r2031b774],
83	,	,	O	,	_	0	SENT_6	[p1l1948t749r2031b774],
84	Bethesda	NNP	LOCATION	Bethesda	dep	82	SENT_6	[p1l2043t749r2158b774],
85	,	,	O	,	_	0	SENT_6	[p1l2043t749r2158b774],
86	Maryland	NNP	LOCATION	Maryland	prep_of	80	SENT_6	[p1l2169t749r2286b776],
87	,	,	O	,	_	0	SENT_6	[p1l2169t749r2286b776],
88	United	NNP	LOCATION	United	nn	89	SENT_6	[p1l190t791r268b812],
89	States	NNPS	LOCATION	States	appos	2	SENT_6	[p1l284t792r355b812],
90	of	IN	LOCATION	of	_	0	SENT_6	[p1l370t791r395b812],
91	America	NNP	LOCATION	America	prep_of	89	SENT_6	[p1l407t792r511b816],
92	,	,	O	,	_	0	SENT_6	[p1l407t792r511b816],
93	5	CD	NUMBER	5	num	94	SENT_6	[p1l526t793r540b812],
94	SAIC	NN	ORGANIZATION	saic	appos	2	SENT_6	[p1l555t791r735b816],
95	.	.	O	.	_	0	SENT_6	[p1l555t791r735b816],

1	—	NN	O	—	_	0	SENT_7	[p1l555t791r735b816],
2	.	.	O	.	_	0	SENT_7	[p1l555t791r735b816],

1	Frederick	NNP	PERSON	Frederick	nn	5	SENT_8	[p1l555t791r735b816],
2	,	,	O	,	_	0	SENT_8	[p1l555t791r735b816],
3	Frederick	NNP	PERSON	Frederick	appos	5	SENT_8	[p1l752t791r866b816],
4	,	,	O	,	_	0	SENT_8	[p1l752t791r866b816],
5	Mawland	NNP	O	Mawland	_	0	SENT_8	[p1l882t791r999b818],
6	,	,	O	,	_	0	SENT_8	[p1l882t791r999b818],
7	United	NNP	LOCATION	United	nn	8	SENT_8	[p1l1015t791r1093b812],
8	States	NNPS	LOCATION	States	dep	5	SENT_8	[p1l1109t792r1180b812],
9	of	IN	LOCATION	of	_	0	SENT_8	[p1l1195t791r1220b812],
10	America	NNP	LOCATION	America	prep_of	8	SENT_8	[p1l1232t792r1336b816],
11	,	,	O	,	_	0	SENT_8	[p1l1232t792r1336b816],
12	6	CD	NUMBER	6	num	13	SENT_8	[p1l1351t793r1366b812],
13	Division	NN	O	division	appos	10	SENT_8	[p1l1381t792r1474b812],
14	of	IN	O	of	_	0	SENT_8	[p1l1490t791r1515b812],
15	Infectious	JJ	O	infectious	amod	16	SENT_8	[p1l1529t791r1644b812],
16	Diseases	NNS	O	disease	prep_of	13	SENT_8	[p1l1661t792r1767b816],
17	,	,	O	,	_	0	SENT_8	[p1l1661t792r1767b816],
18	University	NNP	ORGANIZATION	University	appos	10	SENT_8	[p1l1783t792r1901b818],
19	of	IN	ORGANIZATION	of	_	0	SENT_8	[p1l1916t791r1940b812],
20	Pittsburgh	NNP	ORGANIZATION	Pittsburgh	nn	22	SENT_8	[p1l1954t791r2078b818],
21	Medical	NNP	ORGANIZATION	Medical	nn	22	SENT_8	[p1l2094t791r2185b812],
22	Center	NNP	ORGANIZATION	Center	prep_of	18	SENT_8	[p1l2201t792r2286b816],
23	,	,	O	,	_	0	SENT_8	[p1l2201t792r2286b816],
24	Pittsburgh	NNP	LOCATION	Pittsburgh	appos	22	SENT_8	[p1l190t832r320b859],
25	,	,	O	,	_	0	SENT_8	[p1l190t832r320b859],
26	Pennsylvania	NNP	LOCATION	Pennsylvania	appos	22	SENT_8	[p1l333t832r494b859],
27	,	,	O	,	_	0	SENT_8	[p1l333t832r494b859],
28	United	NNP	LOCATION	United	nn	29	SENT_8	[p1l507t832r585b853],
29	States	NNPS	LOCATION	States	appos	22	SENT_8	[p1l598t833r669b853],
30	of	IN	LOCATION	of	_	0	SENT_8	[p1l681t832r706b853],
31	America	NNP	LOCATION	America	prep_of	29	SENT_8	[p1l715t833r812b853],

1	Current	JJ	DATE	current	amod	3	SENT_9	[p1l189t934r321b962],
2	antiretroviral	JJ	O	antiretroviral	amod	3	SENT_9	[p1l333t933r564b962],
3	therapy	NN	O	therapy	nsubj	5	SENT_9	[p1l576t933r714b970],
4	is	VBZ	O	be	cop	5	SENT_9	[p1l726t933r750b962],
5	effective	JJ	O	effective	_	0	SENT_9	[p1l763t932r914b962],
6	in	IN	O	in	_	0	SENT_9	[p1l927t933r956b961],
7	suppressing	VBG	O	suppress	prepc_in	5	SENT_9	[p1l970t933r1180b969],
8	but	CC	O	but	_	0	SENT_9	[p1l1194t933r1252b962],
9	not	RB	O	not	_	0	SENT_9	[p1l1265t937r1322b962],
10	eliminating	VBG	O	eliminate	conj_negcc	7	SENT_9	[p1l1334t933r1532b969],
11	HIV-1	NN	MISC	hiv-1	nn	12	SENT_9	[p1l1547t934r1635b961],
12	infection	NN	O	infection	dobj	10	SENT_9	[p1l1654t932r1818b962],
13	.	.	O	.	_	0	SENT_9	[p1l1654t932r1818b962],

1	Understanding	VBG	O	understand	csubj	8	SENT_10	[p1l1831t933r2091b969],
2	the	DT	O	the	det	3	SENT_10	[p1l2103t933r2160b962],
3	source	NN	O	source	dobj	1	SENT_10	[p1l2172t941r2286b962],
4	of	IN	O	of	_	0	SENT_10	[p1l189t978r224b1008],
5	viral	JJ	O	viral	amod	6	SENT_10	[p1l238t979r314b1008],
6	persistence	NN	O	persistence	prep_of	3	SENT_10	[p1l332t979r529b1015],
7	is	VBZ	O	be	cop	8	SENT_10	[p1l547t979r571b1008],
8	essential	JJ	O	essential	_	0	SENT_10	[p1l588t979r740b1008],
9	for	IN	O	for	_	0	SENT_10	[p1l757t978r807b1008],
10	developing	VBG	O	develop	prepc_for	8	SENT_10	[p1l822t979r1019b1015],
11	strategies	NNS	O	strategy	dobj	10	SENT_10	[p1l1036t979r1208b1015],
12	to	TO	O	to	aux	13	SENT_10	[p1l1224t983r1259b1008],
13	eradicate	VB	O	eradicate	xcomp	10	SENT_10	[p1l1275t979r1437b1008],
14	HIV-1	NN	O	hiv-1	nn	15	SENT_10	[p1l1455t980r1544b1007],
15	infection	NN	O	infection	dobj	13	SENT_10	[p1l1566t978r1730b1008],
16	.	.	O	.	_	0	SENT_10	[p1l1566t978r1730b1008],

1	We	PRP	O	we	nsubj	3	SENT_11	[p1l1746t980r1800b1007],
2	therefore	RB	O	therefore	advmod	3	SENT_11	[p1l1815t978r1979b1008],
3	investigated	VBD	O	investigate	_	0	SENT_11	[p1l1996t979r2213b1015],
4	the	DT	O	the	det	5	SENT_11	[p1l2230t979r2286b1008],
5	level	NN	O	level	nsubj	14	SENT_11	[p1l190t1025r270b1053],
6	of	IN	O	of	_	0	SENT_11	[p1l288t1024r324b1054],
7	plasma	NN	O	plasma	nn	9	SENT_11	[p1l341t1025r464b1061],
8	HIV-1	NN	O	hiv-1	nn	9	SENT_11	[p1l484t1026r573b1053],
9	RNA	NN	O	rna	prep_of	5	SENT_11	[p1l598t1026r671b1053],
10	in	IN	O	in	_	0	SENT_11	[p1l689t1025r719b1053],
11	patients	NNS	O	patient	prep_in	9	SENT_11	[p1l739t1025r881b1061],
12	with	IN	O	with	_	0	SENT_11	[p1l898t1025r973b1054],
13	viremia	NN	O	viremia	prep_with	11	SENT_11	[p1l992t1025r1122b1054],
14	suppressed	VBD	O	suppress	ccomp	3	SENT_11	[p1l1141t1025r1339b1061],
15	to	TO	O	to	_	0	SENT_11	[p1l1358t1029r1393b1054],
16	less	JJR	O	less	mwe	17	SENT_11	[p1l1412t1025r1475b1054],
17	than	IN	O	than	quantmod	18	SENT_11	[p1l1492t1025r1571b1054],
18	50-75	CD	NUMBER	50-75	num	19	SENT_11	[p1l1590t1027r1694b1054],
19	copies/ml	NN	O	copies/ml	prep_to	14	SENT_11	[p1l1712t1025r1879b1061],
20	on	IN	O	on	_	0	SENT_11	[p1l1898t1033r1941b1054],
21	standard	JJ	O	standard	amod	23	SENT_11	[p1l1960t1025r2114b1054],
22	protease	NN	O	protease	nn	23	SENT_11	[p1l2134t1029r2286b1061],
23	inhibitor	NN	O	inhibitor	prep_on	14	SENT_11	[p1l189t1070r352b1099],
24	-	:	O	-	_	0	SENT_11	[p1l189t1070r352b1099],
25	or	CC	O	or	_	0	SENT_11	[p1l370t1078r406b1099],
26	non-nucleoside	JJ	O	non-nucleoside	amod	28	SENT_11	[p1l425t1070r693b1099],
27	reverse	JJ	O	reverse	amod	28	SENT_11	[p1l712t1078r839b1099],
28	transcriptase	NN	O	transcriptase	conj_or	23	SENT_11	[p1l857t1070r1085b1106],
29	inhibitor-containing	JJ	O	inhibitor-containing	amod	31	SENT_11	[p1l1104t1070r1455b1106],
30	antiretroviral	JJ	O	antiretroviral	amod	31	SENT_11	[p1l1474t1070r1705b1099],
31	therapy	NN	O	therapy	dobj	14	SENT_11	[p1l1724t1070r1861b1107],
32	using	VBG	O	use	partmod	31	SENT_11	[p1l1879t1070r1972b1106],
33	a	DT	O	a	det	38	SENT_11	[p1l1991t1078r2009b1099],
34	new	JJ	O	new	amod	38	SENT_11	[p1l2029t1078r2110b1103],
35	,	,	O	,	_	0	SENT_11	[p1l2029t1078r2110b1103],
36	real-time	JJ	O	real-time	amod	38	SENT_11	[p1l2129t1070r2286b1099],
37	PCR-based	JJ	O	pcr-based	amod	38	SENT_11	[p1l190t1116r374b1145],
38	assay	NN	O	assay	dobj	32	SENT_11	[p1l389t1124r485b1153],
39	for	IN	O	for	_	0	SENT_11	[p1l497t1115r547b1145],
40	HIV-1	NN	O	hiv-1	nn	41	SENT_11	[p1l561t1117r650b1144],
41	RNA	NN	O	rna	prep_for	38	SENT_11	[p1l671t1117r744b1144],
42	with	IN	O	with	_	0	SENT_11	[p1l757t1116r833b1145],
43	a	DT	O	a	det	44	SENT_11	[p1l848t1124r866b1145],
44	limit	NN	O	limit	prep_with	32	SENT_11	[p1l882t1116r959b1145],
45	of	IN	O	of	_	0	SENT_11	[p1l973t1115r1008b1145],
46	detection	NN	O	detection	prep_of	44	SENT_11	[p1l1021t1116r1185b1145],
47	of	IN	O	of	_	0	SENT_11	[p1l1201t1115r1236b1145],
48	one	CD	NUMBER	one	num	49	SENT_11	[p1l1248t1124r1313b1145],
49	copy	NN	O	copy	prep_of	46	SENT_11	[p1l1327t1124r1410b1153],
50	of	IN	O	of	_	0	SENT_11	[p1l1423t1115r1458b1145],
51	HIV-1	NN	O	hiv-1	nn	52	SENT_11	[p1l1472t1117r1561b1144],
52	RNA	NN	O	rna	prep_of	49	SENT_11	[p1l1582t1117r1665b1144],
53	.	.	O	.	_	0	SENT_11	[p1l1582t1117r1665b1144],

1	Single	JJ	O	single	amod	3	SENT_12	[p1l1679t1116r1786b1152],
2	copy	NN	O	copy	nn	3	SENT_12	[p1l1800t1124r1883b1153],
3	assay	NN	O	assay	nsubj	5	SENT_12	[p1l1896t1124r1992b1153],
4	results	VBZ	O	result	dep	3	SENT_12	[p1l2006t1116r2121b1145],
5	revealed	VBD	O	reveal	_	0	SENT_12	[p1l2136t1116r2285b1145],
6	that	IN	O	that	complm	19	SENT_12	[p1l188t1162r259b1191],
7	>	JJR	O	>	nsubj	19	SENT_12	[p1l273t1164r380b1191],
8	80	CD	PERCENT	80	number	9	SENT_12	[p1l273t1164r380b1191],
9	%	NN	PERCENT	%	amod	7	SENT_12	[p1l273t1164r380b1191],
10	of	IN	O	of	_	0	SENT_12	[p1l392t1161r427b1191],
11	patients	NNS	O	patient	prep_of	7	SENT_12	[p1l439t1162r580b1198],
12	on	IN	O	on	_	0	SENT_12	[p1l593t1170r635b1191],
13	initial	JJ	O	initial	amod	15	SENT_12	[p1l649t1162r746b1191],
14	antiretroviral	JJ	O	antiretroviral	amod	15	SENT_12	[p1l759t1162r990b1191],
15	therapy	NN	O	therapy	prep_on	11	SENT_12	[p1l1003t1162r1140b1199],
16	for	IN	O	for	_	0	SENT_12	[p1l1150t1161r1200b1191],
17	60	CD	DURATION	60	num	18	SENT_12	[p1l1212t1164r1253b1191],
18	wk	NN	DURATION	wk	prep_for	15	SENT_12	[p1l1264t1162r1315b1190],
19	had	VBD	O	have	ccomp	5	SENT_12	[p1l1327t1162r1390b1191],
20	persistent	JJ	O	persistent	amod	21	SENT_12	[p1l1404t1162r1578b1198],
21	Viremia	NN	O	viremia	dobj	19	SENT_12	[p1l1589t1162r1720b1191],
22	of	IN	O	of	_	0	SENT_12	[p1l1733t1161r1768b1191],
23	one	CD	NUMBER	one	num	24	SENT_12	[p1l1779t1170r1843b1191],
24	copy/ml	NN	O	copy/ml	prep_of	21	SENT_12	[p1l1855t1162r1994b1199],
25	or	CC	O	or	_	0	SENT_12	[p1l2007t1170r2043b1191],
26	more	JJR	O	more	prep_of	21	SENT_12	[p1l2055t1170r2144b1191],
27	with	IN	O	with	_	0	SENT_12	[p1l2156t1162r2231b1191],
28	an	DT	O	a	det	30	SENT_12	[p1l2244t1170r2285b1191],
29	overall	JJ	O	overall	amod	30	SENT_12	[p1l189t1207r307b1236],
30	median	NN	O	median	prep_with	19	SENT_12	[p1l325t1207r453b1236],
31	of	IN	O	of	_	0	SENT_12	[p1l470t1206r506b1236],
32	3.1	CD	NUMBER	3.1	num	33	SENT_12	[p1l520t1209r566b1236],
33	copies/ml	NN	O	copies/ml	prep_of	30	SENT_12	[p1l587t1207r765b1243],
34	.	.	O	.	_	0	SENT_12	[p1l587t1207r765b1243],

1	The	DT	O	the	det	2	SENT_13	[p1l780t1207r844b1235],
2	level	NN	O	level	nsubj	5	SENT_13	[p1l861t1207r941b1235],
3	of	IN	O	of	_	0	SENT_13	[p1l957t1206r993b1236],
4	Viremia	NNP	O	Viremia	prep_of	2	SENT_13	[p1l1006t1207r1137b1236],
5	correlated	VBD	O	correlate	_	0	SENT_13	[p1l1153t1207r1331b1236],
6	with	IN	O	with	_	0	SENT_13	[p1l1347t1207r1422b1236],
7	pretherapy	JJ	O	pretherapy	amod	10	SENT_13	[p1l1440t1207r1635b1244],
8	plasma	NN	O	plasma	nn	10	SENT_13	[p1l1650t1207r1774b1243],
9	HIV-1	NN	O	hiv-1	nn	10	SENT_13	[p1l1792t1208r1880b1235],
10	RNA	NN	O	rna	prep_with	5	SENT_13	[p1l1903t1208r1975b1235],
11	but	CC	O	but	_	0	SENT_13	[p1l1992t1207r2050b1236],
12	not	RB	O	not	_	0	SENT_13	[p1l2066t1211r2123b1236],
13	with	IN	O	with	_	0	SENT_13	[p1l2138t1207r2213b1236],
14	the	DT	O	the	det	17	SENT_13	[p1l2230t1207r2286b1236],
15	specific	JJ	O	specific	amod	17	SENT_13	[p1l189t1252r318b1289],
16	treatment	NN	O	treatment	nn	17	SENT_13	[p1l330t1257r506b1282],
17	regimen	NN	O	regimen	conj_negcc	10	SENT_13	[p1l519t1253r674b1289],
18	.	.	O	.	_	0	SENT_13	[p1l519t1253r674b1289],

1	Longitudinal	JJ	O	longitudinal	amod	2	SENT_14	[p1l687t1253r908b1289],
2	studies	NNS	O	study	nsubj	3	SENT_14	[p1l921t1253r1046b1282],
3	revealed	VBD	O	reveal	_	0	SENT_14	[p1l1059t1253r1208b1282],
4	no	DT	O	no	det	6	SENT_14	[p1l1222t1261r1265b1282],
5	significant	JJ	O	significant	amod	6	SENT_14	[p1l1277t1252r1460b1289],
6	decline	NN	O	decline	dobj	3	SENT_14	[p1l1472t1253r1597b1282],
7	in	IN	O	in	_	0	SENT_14	[p1l1610t1253r1639b1281],
8	the	DT	O	the	det	9	SENT_14	[p1l1652t1253r1709b1282],
9	level	NN	O	level	prep_in	3	SENT_14	[p1l1722t1253r1802b1281],
10	of	IN	O	of	_	0	SENT_14	[p1l1815t1252r1850b1282],
11	Viremia	NN	O	viremia	prep_of	9	SENT_14	[p1l1861t1253r1991b1282],
12	between	IN	O	between	_	0	SENT_14	[p1l2005t1253r2154b1282],
13	60	CD	NUMBER	60	num	16	SENT_14	[p1l2167t1255r2209b1282],
14	and	CC	O	and	_	0	SENT_14	[p1l2221t1253r2285b1282],
15	110	CD	DURATION	110	num	16	SENT_14	[p1l191t1301r252b1328],
16	wk	NN	DURATION	wk	prep_between	3	SENT_14	[p1l266t1299r317b1327],
17	of	IN	O	of	_	0	SENT_14	[p1l330t1298r365b1328],
18	suppressive	JJ	O	suppressive	amod	20	SENT_14	[p1l378t1299r585b1335],
19	antiretroviral	JJ	O	antiretroviral	amod	20	SENT_14	[p1l600t1299r831b1328],
20	therapy	NN	O	therapy	prep_of	16	SENT_14	[p1l846t1299r992b1336],
21	.	.	O	.	_	0	SENT_14	[p1l846t1299r992b1336],

1	These	DT	O	these	det	2	SENT_15	[p1l1006t1299r1109b1328],
2	data	NNS	O	datum	nsubj	3	SENT_15	[p1l1123t1299r1199b1328],
3	suggest	VBP	O	suggest	_	0	SENT_15	[p1l1215t1303r1352b1335],
4	that	IN	O	that	complm	13	SENT_15	[p1l1365t1299r1437b1328],
5	the	DT	O	the	det	7	SENT_15	[p1l1450t1299r1507b1328],
6	persistent	JJ	O	persistent	amod	7	SENT_15	[p1l1522t1299r1696b1335],
7	Viremia	NN	O	viremia	nsubjpass	13	SENT_15	[p1l1710t1299r1840b1328],
8	on	IN	O	on	_	0	SENT_15	[p1l1855t1307r1898b1328],
9	current	JJ	DATE	current	amod	11	SENT_15	[p1l1913t1303r2040b1328],
10	antiretroviral	JJ	O	antiretroviral	amod	11	SENT_15	[p1l2054t1299r2285b1328],
11	therapy	NN	O	therapy	prep_on	7	SENT_15	[p1l188t1344r325b1381],
12	is	VBZ	O	be	auxpass	13	SENT_15	[p1l340t1344r365b1373],
13	derived	VBN	O	derive	ccomp	3	SENT_15	[p1l381t1344r523b1377],
14	,	,	O	,	_	0	SENT_15	[p1l381t1344r523b1377],
15	at	IN	O	at	advmod	13	SENT_15	[p1l539t1348r573b1373],
16	least	JJS	O	least	pobj	15	SENT_15	[p1l589t1344r670b1373],
17	in	IN	O	in	_	0	SENT_15	[p1l686t1344r715b1372],
18	part	NN	O	part	prep_in	15	SENT_15	[p1l733t1348r813b1380],
19	,	,	O	,	_	0	SENT_15	[p1l733t1348r813b1380],
20	from	IN	O	from	_	0	SENT_15	[p1l828t1343r910b1373],
21	long-lived	JJ	O	long-lived	amod	22	SENT_15	[p1l928t1344r1102b1380],
22	cells	NNS	O	cell	prep_from	13	SENT_15	[p1l1119t1344r1193b1373],
23	that	WDT	O	that	nsubj	25	SENT_15	[p1l1208t1344r1280b1373],
24	are	VBP	O	be	cop	25	SENT_15	[p1l1295t1352r1349b1373],
25	infected	JJ	O	infected	rcmod	22	SENT_15	[p1l1365t1343r1506b1373],
26	prior	JJ	O	prior	_	0	SENT_15	[p1l1523t1344r1607b1380],
27	to	TO	O	to	_	0	SENT_15	[p1l1621t1348r1656b1373],
28	initiation	NN	O	initiation	prep_prior_to	25	SENT_15	[p1l1672t1344r1829b1373],
29	of	IN	O	of	_	0	SENT_15	[p1l1846t1343r1881b1373],
30	therapy	NN	O	therapy	prep_of	28	SENT_15	[p1l1894t1344r2041b1381],
31	.	.	O	.	_	0	SENT_15	[p1l1894t1344r2041b1381],

1	Citation	NNP	O	Citation	nsubj	24	SENT_16	[p1l188t1423r288b1443],
2	:	:	O	:	_	0	SENT_16	[p1l188t1423r288b1443],
3	Maldarelli	NN	O	maldarellus	nn	4	SENT_16	[p1l300t1422r415b1443],
4	F	NN	O	f	dep	1	SENT_16	[p1l428t1423r445b1447],
5	,	,	O	,	_	0	SENT_16	[p1l428t1423r445b1447],
6	Palmer	NNP	PERSON	Palmer	appos	4	SENT_16	[p1l457t1422r539b1443],
7	5	CD	NUMBER	5	num	6	SENT_16	[p1l550t1423r568b1447],
8	,	,	O	,	_	0	SENT_16	[p1l550t1423r568b1447],
9	King	NNP	O	King	nn	10	SENT_16	[p1l580t1423r631b1449],
10	MS	NN	O	m	appos	4	SENT_16	[p1l644t1423r684b1447],
11	,	,	O	,	_	0	SENT_16	[p1l644t1423r684b1447],
12	Wiegand	NNP	PERSON	Wiegand	nn	13	SENT_16	[p1l695t1422r801b1449],
13	A	NNP	O	A	appos	4	SENT_16	[p1l813t1423r835b1447],
14	,	,	O	,	_	0	SENT_16	[p1l813t1423r835b1447],
15	Polis	NNP	ORGANIZATION	Polis	nn	16	SENT_16	[p1l847t1422r900b1443],
16	MA	NNP	ORGANIZATION	MA	appos	4	SENT_16	[p1l912t1423r957b1447],
17	,	,	O	,	_	0	SENT_16	[p1l912t1423r957b1447],
18	et	FW	O	et	dep	4	SENT_16	[p1l968t1426r991b1443],
19	al.	FW	O	al.	nn	20	SENT_16	[p1l1001t1422r1026b1443],
20	(	FW	O	(	dep	4	SENT_16	[p1l1038t1423r1110b1447],
21	2007	CD	DATE	2007	num	23	SENT_16	[p1l1038t1423r1110b1447],
22	)	CD	NUMBER	)	num	23	SENT_16	[p1l1038t1423r1110b1447],
23	ART	NN	O	art	dep	20	SENT_16	[p1l1122t1423r1169b1443],
24	suppresses	VBZ	O	suppress	_	0	SENT_16	[p1l1180t1428r1311b1449],
25	plasma	NN	O	plasma	nn	27	SENT_16	[p1l1323t1422r1407b1449],
26	HIV-1	NN	O	hiv-1	nn	27	SENT_16	[p1l1420t1423r1478b1443],
27	RNA	NN	O	rna	dobj	24	SENT_16	[p1l1495t1423r1545b1443],
28	to	TO	O	to	_	0	SENT_16	[p1l1555t1426r1579b1443],
29	a	DT	O	a	det	32	SENT_16	[p1l1590t1429r1602b1443],
30	stable	JJ	O	stable	amod	32	SENT_16	[p1l1614t1422r1684b1443],
31	set	NN	O	set	nn	32	SENT_16	[p1l1696t1426r1730b1443],
32	point	NN	O	point	prep_to	27	SENT_16	[p1l1741t1423r1804b1449],
33	predicted	VBN	O	predict	partmod	32	SENT_16	[p1l1816t1422r1929b1449],
34	by	IN	O	by	_	0	SENT_16	[p1l1942t1422r1970b1449],
35	pretherapy	JJ	O	pretherapy	amod	36	SENT_16	[p1l1981t1422r2114b1449],
36	viremia	NN	O	viremia	agent	33	SENT_16	[p1l2124t1423r2218b1443],
37	.	.	O	.	_	0	SENT_16	[p1l2124t1423r2218b1443],

1	PLoS	NN	O	plo	nn	2	SENT_17	[p1l2230t1423r2286b1443],
2	Pathog	NN	O	pathog	_	0	SENT_17	[p1l190t1455r273b1482],
3	3	CD	NUMBER	3	num	4	SENT_17	[p1l286t1456r336b1480],
4	(	NN	O	(	dep	2	SENT_17	[p1l286t1456r336b1480],
5	4	CD	NUMBER	4	num	6	SENT_17	[p1l286t1456r336b1480],
6	)	NN	O	)	dep	2	SENT_17	[p1l286t1456r336b1480],
7	:	:	O	:	_	0	SENT_17	[p1l286t1456r336b1480],
8	e46	NN	O	e46	dep	2	SENT_17	[p1l347t1457r396b1476],
9	.	.	O	.	_	0	SENT_17	[p1l347t1457r396b1476],

1	doizl0	NN	O	doizl0	_	0	SENT_18	[p1l407t1455r814b1482],
2	.1371	CD	NUMBER	.1371	num	1	SENT_18	[p1l407t1455r814b1482],
3	/	:	O	/	punct	5	SENT_18	[p1l407t1455r814b1482],
4	journa	NN	O	journa	nn	5	SENT_18	[p1l407t1455r814b1482],
5	|	NN	O	|	dep	1	SENT_18	[p1l407t1455r814b1482],
6	.	.	O	.	_	0	SENT_18	[p1l407t1455r814b1482],

1	ppat	NN	O	ppat	_	0	SENT_19	[p1l407t1455r814b1482],
2	.0030046	CD	NUMBER	.0030046	num	1	SENT_19	[p1l407t1455r814b1482],

1	Introduction	NN	O	introduction	_	0	SENT_20	[p1l190t1574r429b1606],

1	Infection	NN	O	infection	nsubj	4	SENT_21	[p1l226t1652r376b1678],
2	with	IN	O	with	_	0	SENT_21	[p1l395t1652r465b1678],
3	HIV-1	NN	O	hiv-1	prep_with	1	SENT_21	[p1l485t1652r582b1678],
4	results	VBZ	O	result	_	0	SENT_21	[p1l606t1652r710b1678],
5	in	IN	O	in	_	0	SENT_21	[p1l732t1653r762b1677],
6	progressive	JJ	O	progressive	amod	7	SENT_21	[p1l783t1653r967b1687],
7	immunodeﬁciency	NN	O	immunodeﬁciency	prep_in	4	SENT_21	[p1l988t1652r1198b1678, p1l189t1699r291b1733],
8	and	CC	O	and	_	0	SENT_21	[p1l314t1698r373b1724],
9	death	NN	O	death	prep_in	4	SENT_21	[p1l395t1698r485b1724],
10	from	IN	O	from	_	0	SENT_21	[p1l508t1698r587b1724],
11	opportunistic	JJ	O	opportunistic	amod	12	SENT_21	[p1l610t1699r833b1733],
12	infection	NN	O	infection	prep_from	4	SENT_21	[p1l857t1698r1003b1724],
13	or	CC	O	or	_	0	SENT_21	[p1l1026t1707r1062b1724],
14	cancer	NN	O	cancer	prep_from	4	SENT_21	[p1l1083t1707r1198b1724],
15	.	.	O	.	_	0	SENT_21	[p1l1083t1707r1198b1724],

1	Current	JJ	DATE	current	amod	3	SENT_22	[p1l189t1745r320b1771],
2	antiretroviral	JJ	O	antiretroviral	amod	3	SENT_22	[p1l345t1745r565b1771],
3	therapy	NN	O	therapy	nsubj	5	SENT_22	[p1l591t1745r715b1780],
4	is	VBZ	O	be	cop	5	SENT_22	[p1l740t1746r762b1771],
5	effective	JJ	O	effective	dep	19	SENT_22	[p1l788t1745r925b1771],
6	in	IN	O	in	_	0	SENT_22	[p1l952t1746r982b1770],
7	suppressing	VBG	O	suppress	prepc_in	5	SENT_22	[p1l1007t1746r1200b1780],
8	plasma	NN	O	plasma	nn	9	SENT_22	[p1l189t1792r302b1827],
9	Viremia	NN	O	viremia	dobj	7	SENT_22	[p1l320t1793r443b1818],
10	to	TO	O	to	_	0	SENT_22	[p1l462t1798r492b1818],
11	levels	NNS	O	level	prep_to	7	SENT_22	[p1l511t1792r597b1818],
12	below	IN	O	below	_	0	SENT_22	[p1l615t1792r710b1818],
13	the	DT	O	the	det	15	SENT_22	[p1l729t1792r778b1818],
14	detection	NN	O	detection	nn	15	SENT_22	[p1l797t1792r951b1818],
15	limit	NN	O	limit	prep_below	7	SENT_22	[p1l969t1792r1045b1818],
16	of	IN	O	of	_	0	SENT_22	[p1l1064t1792r1099b1818],
17	FDAapproved	NN	O	fdaapproved	nn	18	SENT_22	[p1l1113t1792r1198b1817, p1l189t1838r343b1873],
18	assays	NNS	O	assay	prep_of	15	SENT_22	[p1l370t1847r463b1873],
19	(	VBP	O	(	_	0	SENT_22	[p1l491t1836r596b1870],
20	50-75	CD	NUMBER	50-75	num	21	SENT_22	[p1l491t1836r596b1870],
21	copies	NNS	O	copy	dobj	19	SENT_22	[p1l622t1839r723b1873],
22	HIV-1	NN	O	hiv-1	nn	24	SENT_22	[p1l750t1838r847b1864],
23	RNA/ml	NN	O	rna/ml	nn	24	SENT_22	[p1l876t1838r1024b1870],
24	)	NN	O	)	nsubj	19	SENT_22	[p1l876t1838r1024b1870],
25	,	,	O	,	_	0	SENT_22	[p1l876t1838r1024b1870],
26	restoring	VBG	O	restore	dep	24	SENT_22	[p1l1052t1839r1200b1873],
27	immune	JJ	O	immune	amod	28	SENT_22	[p1l190t1886r323b1911],
28	function	NN	O	function	dobj	26	SENT_22	[p1l347t1885r494b1916],
29	,	,	O	,	_	0	SENT_22	[p1l347t1885r494b1916],
30	and	CC	O	and	_	0	SENT_22	[p1l519t1885r578b1911],
31	reducing	VBG	O	reduce	dep	24	SENT_22	[p1l603t1885r747b1920],
32	morbidity	NN	O	morbidity	dobj	31	SENT_22	[p1l771t1885r933b1920],
33	and	CC	O	and	_	0	SENT_22	[p1l957t1885r1016b1911],
34	mortality	NN	O	mortality	conj_and	32	SENT_22	[p1l1040t1885r1198b1920],
35	.	.	O	.	_	0	SENT_22	[p1l1040t1885r1198b1920],

1	Antiretroviral	JJ	O	antiretroviral	amod	2	SENT_23	[p1l188t1931r428b1957],
2	therapy	NN	O	therapy	nsubj	5	SENT_23	[p1l458t1931r586b1966],
3	does	VBZ	O	do	aux	5	SENT_23	[p1l615t1931r689b1957],
4	not	RB	O	not	neg	5	SENT_23	[p1l719t1937r774b1957],
5	cure	VB	O	cure	_	0	SENT_23	[p1l803t1940r875b1957],
6	HIV-1	NN	O	hiv-1	nn	7	SENT_23	[p1l904t1931r1004b1957],
7	infection	NN	O	infection	dobj	5	SENT_23	[p1l1037t1931r1198b1962],
8	,	,	O	,	_	0	SENT_23	[p1l1037t1931r1198b1962],
9	however	RB	O	however	advmod	5	SENT_23	[p1l189t1978r332b2009],
10	,	,	O	,	_	0	SENT_23	[p1l189t1978r332b2009],
11	and	CC	O	and	cc	5	SENT_23	[p1l349t1978r415b2009],
12	,	,	O	,	_	0	SENT_23	[p1l349t1978r415b2009],
13	at	IN	O	at	dep	5	SENT_23	[p1l432t1983r461b2004],
14	a	DT	O	a	det	15	SENT_23	[p1l476t1987r492b2004],
15	minimum	NN	O	minimum	pobj	13	SENT_23	[p1l506t1979r673b2009],
16	,	,	O	,	_	0	SENT_23	[p1l506t1979r673b2009],
17	eradication	NN	O	eradication	nsubj	22	SENT_23	[p1l689t1978r875b2004],
18	of	IN	O	of	_	0	SENT_23	[p1l890t1978r925b2004],
19	HIV-1	NN	O	hiv-1	nn	20	SENT_23	[p1l936t1979r1033b2004],
20	infection	NN	O	infection	prep_of	17	SENT_23	[p1l1052t1978r1199b2004],
21	will	MD	O	will	aux	22	SENT_23	[p1l188t2024r244b2049],
22	require	VB	O	require	ccomp	5	SENT_23	[p1l259t2025r377b2059],
23	complete	JJ	O	complete	amod	24	SENT_23	[p1l391t2024r541b2059],
24	suppression	NN	O	suppression	dobj	22	SENT_23	[p1l555t2025r749b2059],
25	of	IN	O	of	_	0	SENT_23	[p1l763t2024r797b2050],
26	its	PRP$	O	its	poss	27	SENT_23	[p1l808t2025r843b2050],
27	replication	NN	O	replication	prep_of	24	SENT_23	[p1l858t2024r1036b2059],
28	as	RB	O	as	_	0	SENT_23	[p1l1050t2033r1079b2050],
29	well	RB	O	well	_	0	SENT_23	[p1l1093t2024r1155b2050],
30	as	IN	O	as	_	0	SENT_23	[p1l1169t2033r1198b2050],
31	elimination	NN	O	elimination	conj_and	24	SENT_23	[p1l189t2071r378b2097],
32	of	IN	O	of	_	0	SENT_23	[p1l393t2071r428b2097],
33	latent	JJ	O	latent	amod	35	SENT_23	[p1l439t2071r533b2097],
34	viral	JJ	O	viral	amod	35	SENT_23	[p1l547t2071r618b2097],
35	reservoirs	NNS	O	reservoir	prep_of	31	SENT_23	[p1l634t2072r801b2097],
36	.	.	O	.	_	0	SENT_23	[p1l634t2072r801b2097],

1	Although	IN	O	although	mark	5	SENT_24	[p1l815t2071r968b2106],
2	some	DT	O	some	det	3	SENT_24	[p1l983t2080r1066b2097],
3	reports	NNS	O	report	nsubj	5	SENT_24	[p1l1081t2076r1198b2106],
4	have	VBP	O	have	aux	5	SENT_24	[p1l189t2118r262b2144],
5	shown	VBN	O	show	csubj	45	SENT_24	[p1l274t2118r375b2144],
6	the	DT	O	the	det	7	SENT_24	[p1l388t2118r437b2144],
7	persistence	NN	O	persistence	dobj	5	SENT_24	[p1l449t2119r631b2153],
8	of	IN	O	of	_	0	SENT_24	[p1l643t2118r678b2144],
9	low-level	JJ	O	low-level	amod	10	SENT_24	[p1l686t2118r828b2144],
10	Viremia	NNP	O	Viremia	prep_of	7	SENT_24	[p1l840t2119r963b2144],
11	in	IN	O	in	_	0	SENT_24	[p1l975t2119r1005b2143],
12	patients	NNS	O	patient	prep_in	5	SENT_24	[p1l1017t2119r1146b2153],
13	on	IN	O	on	_	0	SENT_24	[p1l1158t2127r1199b2144],
14	suppressive	JJ	O	suppressive	amod	16	SENT_24	[p1l189t2165r375b2199],
15	therapy	NN	O	therapy	nn	16	SENT_24	[p1l394t2164r518b2199],
16	[	NN	O	[	prep_on	12	SENT_24	[p1l538t2164r622b2196],
17	1	CD	NUMBER	1	num	18	SENT_24	[p1l538t2164r622b2196],
18	—	NN	O	—	dep	12	SENT_24	[p1l538t2164r622b2196],
19	6	CD	NUMBER	6	num	20	SENT_24	[p1l538t2164r622b2196],
20	]	NN	O	]	dep	18	SENT_24	[p1l538t2164r622b2196],
21	,	,	O	,	_	0	SENT_24	[p1l538t2164r622b2196],
22	the	DT	O	the	det	23	SENT_24	[p1l641t2164r690b2190],
23	determinants	NNS	O	determinant	appos	12	SENT_24	[p1l709t2164r926b2190],
24	of	IN	O	of	_	0	SENT_24	[p1l944t2164r979b2190],
25	this	DT	O	this	det	26	SENT_24	[p1l994t2164r1050b2190],
26	Viremia	NN	O	viremia	prep_of	23	SENT_24	[p1l1068t2165r1198b2195],
27	,	,	O	,	_	0	SENT_24	[p1l1068t2165r1198b2195],
28	and	CC	O	and	_	0	SENT_24	[p1l189t2211r248b2237],
29	whether	IN	O	whether	dep	31	SENT_24	[p1l269t2211r403b2237],
30	it	PRP	O	it	nsubj	31	SENT_24	[p1l424t2212r446b2237],
31	results	VBZ	O	result	csubj	45	SENT_24	[p1l468t2211r572b2237],
32	from	IN	O	from	_	0	SENT_24	[p1l594t2211r673b2237],
33	ongoing	JJ	O	ongoing	amod	35	SENT_24	[p1l695t2212r828b2246],
34	replication	NN	O	replication	nn	35	SENT_24	[p1l850t2211r1028b2246],
35	cycles	NNS	O	cycle	prep_from	31	SENT_24	[p1l1050t2211r1142b2246],
36	or	CC	O	or	_	0	SENT_24	[p1l1164t2220r1200b2237],
37	release	NN	O	release	prep_from	31	SENT_24	[p1l190t2257r300b2283],
38	from	IN	O	from	_	0	SENT_24	[p1l312t2257r391b2283],
39	latent	JJ	O	latent	amod	40	SENT_24	[p1l403t2257r496b2283],
40	reservoirs	NNS	O	reservoir	prep_from	31	SENT_24	[p1l508t2258r675b2288],
41	,	,	O	,	_	0	SENT_24	[p1l508t2258r675b2288],
42	are	VBP	O	be	cop	45	SENT_24	[p1l688t2266r737b2283],
43	not	RB	O	not	neg	45	SENT_24	[p1l750t2262r804b2283],
44	well	RB	O	well	advmod	45	SENT_24	[p1l814t2257r877b2283],
45	deﬁned	JJ	O	deﬁned	_	0	SENT_24	[p1l889t2257r1010b2283],
46	[	NN	O	[	dep	45	SENT_24	[p1l1024t2255r1127b2289],
47	2,7	CD	NUMBER	2,7	num	46	SENT_24	[p1l1024t2255r1127b2289],
48	—	CD	NUMBER	—	number	49	SENT_24	[p1l1024t2255r1127b2289],
49	9	CD	NUMBER	9	num	50	SENT_24	[p1l1024t2255r1127b2289],
50	]	NN	O	]	npadvmod	51	SENT_24	[p1l1024t2255r1127b2289],
51	due	JJ	O	due	dep	45	SENT_24	[p1l1140t2257r1199b2283],
52	in	IN	O	in	_	0	SENT_24	[p1l190t2305r220b2329],
53	part	NN	O	part	prep_in	45	SENT_24	[p1l236t2309r303b2339],
54	to	TO	O	to	_	0	SENT_24	[p1l320t2310r350b2330],
55	the	DT	O	the	det	57	SENT_24	[p1l368t2304r417b2330],
56	limited	JJ	O	limited	amod	57	SENT_24	[p1l432t2304r548b2330],
57	sensitivity	NN	O	sensitivity	prep_to	45	SENT_24	[p1l564t2305r725b2339],
58	of	IN	O	of	_	0	SENT_24	[p1l741t2304r776b2330],
59	prior	JJ	O	prior	amod	62	SENT_24	[p1l789t2305r873b2339],
60	HIV-1	NN	O	hiv-1	nn	62	SENT_24	[p1l888t2305r985b2330],
61	RNA	NN	O	rna	nn	62	SENT_24	[p1l1003t2304r1081b2330],
62	assays	NNS	O	assay	prep_of	57	SENT_24	[p1l1097t2313r1198b2339],
63	.	.	O	.	_	0	SENT_24	[p1l1097t2313r1198b2339],

1	To	TO	O	to	aux	2	SENT_25	[p1l189t2351r232b2376],
2	investigate	VB	O	investigate	purpcl	7	SENT_25	[p1l253t2351r425b2385],
3	these	DT	O	these	det	4	SENT_25	[p1l446t2350r528b2376],
4	issues	NNS	O	issue	dobj	2	SENT_25	[p1l548t2351r646b2381],
5	,	,	O	,	_	0	SENT_25	[p1l548t2351r646b2381],
6	we	PRP	O	we	nsubj	7	SENT_25	[p1l665t2359r707b2376],
7	developed	VBD	O	develop	_	0	SENT_25	[p1l727t2350r893b2385],
8	a	DT	O	a	det	12	SENT_25	[p1l913t2359r929b2376],
9	real-time	JJ	O	real-time	amod	12	SENT_25	[p1l949t2350r1096b2376],
10	PCRbased	JJ	O	pcrbased	amod	12	SENT_25	[p1l1116t2350r1198b2376, p1l189t2397r279b2423],
11	method	NN	O	method	nn	12	SENT_25	[p1l298t2397r422b2423],
12	(	NN	O	(	dobj	7	SENT_25	[p1l441t2397r635b2432],
13	single-copy	JJ	O	single-copy	amod	14	SENT_25	[p1l441t2397r635b2432],
14	assay	NN	O	assay	dep	12	SENT_25	[p1l653t2406r740b2432],
15	,	,	O	,	_	0	SENT_25	[p1l653t2406r740b2432],
16	SCA	NNP	ORGANIZATION	SCA	dep	18	SENT_25	[p1l758t2397r839b2429],
17	)	CD	NUMBER	)	num	16	SENT_25	[p1l758t2397r839b2429],
18	capable	JJ	O	capable	amod	12	SENT_25	[p1l857t2397r980b2432],
19	of	IN	O	of	_	0	SENT_25	[p1l998t2397r1033b2423],
20	detecting	VBG	O	detect	prepc_of	12	SENT_25	[p1l1047t2397r1200b2432],
21	and	CC	O	and	_	0	SENT_25	[p1l189t2444r248b2470],
22	reliably	RB	O	reliably	advmod	23	SENT_25	[p1l263t2444r383b2479],
23	quantifying	VBG	O	quantify	prepc_of	12	SENT_25	[p1l397t2444r585b2479],
24	HIV-1	NN	O	hiv-1	nn	25	SENT_25	[p1l598t2444r695b2470],
25	RNA	NN	O	rna	dobj	23	SENT_25	[p1l711t2444r789b2470],
26	with	IN	O	with	_	0	SENT_25	[p1l802t2444r872b2470],
27	a	DT	O	a	det	28	SENT_25	[p1l886t2453r902b2470],
28	limit	NN	O	limit	prep_with	23	SENT_25	[p1l915t2444r992b2470],
29	of	IN	O	of	_	0	SENT_25	[p1l1005t2444r1040b2470],
30	one	CD	NUMBER	one	num	31	SENT_25	[p1l1051t2453r1109b2470],
31	copy	NN	O	copy	prep_of	28	SENT_25	[p1l1123t2453r1199b2479],
32	per	IN	O	per	_	0	SENT_25	[p1l189t2499r244b2525],
33	ml	NN	O	ml	nn	34	SENT_25	[p1l256t2490r295b2515],
34	plasma	NN	O	plasma	prep_per	31	SENT_25	[p1l308t2490r421b2525],
35	[	CD	NUMBER	[	number	36	SENT_25	[p1l436t2490r500b2522],
36	10	CD	NUMBER	10	num	37	SENT_25	[p1l436t2490r500b2522],
37	]	NN	O	]	dobj	20	SENT_25	[p1l436t2490r500b2522],
38	.	.	O	.	_	0	SENT_25	[p1l436t2490r500b2522],

1	Using	VBG	O	use	partmod	7	SENT_26	[p1l513t2491r607b2525],
2	this	DT	O	this	det	3	SENT_26	[p1l619t2490r675b2516],
3	assay	NN	O	assay	dobj	1	SENT_26	[p1l689t2499r776b2525],
4	,	,	O	,	_	0	SENT_26	[p1l689t2499r776b2525],
5	we	PRP	O	we	nsubj	7	SENT_26	[p1l789t2499r831b2516],
6	have	VBP	O	have	aux	7	SENT_26	[p1l843t2490r916b2516],
7	found	VBN	O	find	_	0	SENT_26	[p1l929t2490r1025b2516],
8	that	IN	O	that	complm	20	SENT_26	[p1l1039t2490r1102b2516],
9	more	JJR	O	more	mwe	10	SENT_26	[p1l1115t2499r1199b2516],
10	than	IN	O	than	quantmod	11	SENT_26	[p1l190t2537r262b2563],
11	80	CD	PERCENT	80	num	12	SENT_26	[p1l279t2537r347b2566],
12	%	NN	PERCENT	%	nsubj	20	SENT_26	[p1l279t2537r347b2566],
13	of	IN	O	of	_	0	SENT_26	[p1l368t2537r403b2563],
14	patients	NNS	O	patient	prep_of	12	SENT_26	[p1l416t2538r546b2572],
15	on	IN	O	on	_	0	SENT_26	[p1l563t2546r603b2563],
16	currently	RB	DATE	currently	advmod	19	SENT_26	[p1l620t2537r770b2572],
17	recommended	VBN	O	recommend	amod	19	SENT_26	[p1l787t2537r1022b2563],
18	antiretroviral	JJ	O	antiretroviral	amod	19	SENT_26	[p1l1039t2538r1198b2563, p1l188t2583r260b2609],
19	therapies	NNS	O	therapy	prep_on	14	SENT_26	[p1l275t2583r424b2618],
20	have	VBP	O	have	ccomp	7	SENT_26	[p1l439t2583r512b2609],
21	quantiﬁable	JJ	O	quantiﬁable	amod	22	SENT_26	[p1l526t2583r721b2618],
22	Viremia	NN	O	viremia	dobj	20	SENT_26	[p1l735t2584r858b2609],
23	for	IN	O	for	_	0	SENT_26	[p1l871t2583r920b2609],
24	at	IN	O	at	quantmod	26	SENT_26	[p1l933t2588r962b2609],
25	least	JJS	O	least	mwe	24	SENT_26	[p1l976t2583r1048b2609],
26	2	CD	NUMBER	2	num	27	SENT_26	[p1l1063t2583r1079b2610],
27	y	NN	O	y	prep_for	22	SENT_26	[p1l1093t2592r1109b2618],
28	after	IN	O	after	_	0	SENT_26	[p1l1123t2583r1200b2609],
29	initiation	NN	O	initiation	prep_after	20	SENT_26	[p1l190t2631r342b2656],
30	of	IN	O	of	_	0	SENT_26	[p1l359t2630r394b2656],
31	therapy	NN	O	therapy	prep_of	29	SENT_26	[p1l409t2630r539b2665],
32	.	.	O	.	_	0	SENT_26	[p1l409t2630r539b2665],

1	These	DT	O	these	det	2	SENT_27	[p1l557t2630r652b2656],
2	results	NNS	O	result	nsubj	3	SENT_27	[p1l670t2630r774b2656],
3	have	VBP	O	have	_	0	SENT_27	[p1l791t2630r864b2656],
4	important	JJ	O	important	amod	5	SENT_27	[p1l882t2631r1049b2665],
5	implications	NNS	O	implication	dobj	3	SENT_27	[p1l1066t2630r1198b2665, p1l190t2677r268b2702],
6	for	IN	O	for	_	0	SENT_27	[p1l282t2676r331b2702],
7	understanding	VBG	O	understand	prepc_for	5	SENT_27	[p1l343t2676r582b2711],
8	the	DT	O	the	det	9	SENT_27	[p1l596t2676r645b2702],
9	mechanism	NN	O	mechanism	dobj	7	SENT_27	[p1l660t2676r844b2702],
10	of	IN	O	of	_	0	SENT_27	[p1l857t2676r892b2702],
11	HIV-1	NN	O	hiv-1	nn	12	SENT_27	[p1l902t2677r999b2702],
12	persistence	NN	O	persistence	prep_of	9	SENT_27	[p1l1017t2677r1199b2711],
13	despite	IN	O	despite	_	0	SENT_27	[p1l189t2723r305b2758],
14	long-term	JJ	O	long-term	amod	16	SENT_27	[p1l320t2723r482b2758],
15	antiretroviral	JJ	O	antiretroviral	amod	16	SENT_27	[p1l497t2723r717b2749],
16	therapy	NN	O	therapy	prep_despite	7	SENT_27	[p1l734t2723r864b2758],
17	.	.	O	.	_	0	SENT_27	[p1l734t2723r864b2758],

1	Results/Discussion	NN	O	results/discussion	_	0	SENT_28	[p1l190t2822r546b2855],

1	We	PRP	O	we	nsubj	3	SENT_29	[p1l226t2901r277b2926],
2	first	RB	ORDINAL	first	advmod	3	SENT_29	[p1l293t2900r357b2926],
3	measured	VBD	O	measure	_	0	SENT_29	[p1l373t2900r529b2926],
4	plasma	NN	O	plasma	nn	6	SENT_29	[p1l546t2900r659b2935],
5	HIV-1	NN	O	hiv-1	nn	6	SENT_29	[p1l674t2900r771b2926],
6	RNA	NN	O	rna	dobj	3	SENT_29	[p1l790t2900r868b2926],
7	with	IN	O	with	_	0	SENT_29	[p1l883t2900r953b2926],
8	both	CC	O	both	preconj	11	SENT_29	[p1l969t2900r1043b2926],
9	an	DT	O	a	det	11	SENT_29	[p1l1060t2909r1097b2926],
10	FDAapproved	JJ	O	fdaapproved	amod	11	SENT_29	[p1l1113t2900r1198b2925, p1l189t2947r343b2982],
11	assay	NN	O	assay	prep_with	6	SENT_29	[p1l356t2956r435b2982],
12	(	CD	NUMBER	(	num	13	SENT_29	[p1l448t2947r567b2979],
13	bDNA	NN	O	bdna	dep	11	SENT_29	[p1l448t2947r567b2979],
14	;	:	O	;	_	0	SENT_29	[p1l448t2947r567b2979],
15	detection	NN	O	detection	nn	16	SENT_29	[p1l580t2947r733b2973],
16	limit	NN	O	limit	dep	11	SENT_29	[p1l745t2947r822b2973],
17	75	CD	NUMBER	75	num	19	SENT_29	[p1l834t2945r870b2972],
18	copies/ml	NN	O	copies/ml	nn	19	SENT_29	[p1l882t2947r1045b2982],
19	)	NN	O	)	dep	16	SENT_29	[p1l882t2947r1045b2982],
20	and	CC	O	and	_	0	SENT_29	[p1l1058t2947r1117b2973],
21	SCA	NN	ORGANIZATION	sca	conj_and	11	SENT_29	[p1l1129t2947r1199b2973],
22	in	IN	O	in	_	0	SENT_29	[p1l190t2994r220b3018],
23	three	CD	NUMBER	three	num	24	SENT_29	[p1l246t2993r329b3019],
24	patients	NNS	O	patient	prep_in	3	SENT_29	[p1l355t2994r484b3028],
25	initiating	VBG	O	initiate	partmod	24	SENT_29	[p1l510t2994r661b3028],
26	antiretroviral	JJ	O	antiretroviral	amod	27	SENT_29	[p1l685t2993r905b3019],
27	therapy	NN	O	therapy	dobj	25	SENT_29	[p1l931t2993r1062b3028],
28	.	.	O	.	_	0	SENT_29	[p1l931t2993r1062b3028],

1	As	IN	O	as	_	0	SENT_30	[p1l1087t2993r1126b3019],
2	ex	FW	O	ex	nn	3	SENT_30	[p1l1151t3002r1198b3019, p1l188t3077r261b3136],
3	O	FW	O	o	pobj	1	SENT_30	[p1l1151t3002r1198b3019, p1l188t3077r261b3136],

1	PLoS	NN	O	plo	nsubj	2	SENT_31	[p1l288t3093r352b3116],
2	Pathogens	VBD	O	pathogen	_	0	SENT_31	[p1l367t3092r511b3123],
3	|	CD	NUMBER	|	num	4	SENT_31	[p1l526t3091r528b3124],
4	www	NN	O	www	dobj	2	SENT_31	[p1l543t3092r882b3123],
5	.	.	O	.	_	0	SENT_31	[p1l543t3092r882b3123],

1	p	NN	O	p	nsubj	39	SENT_32	[p1l543t3092r882b3123],
2	|	CD	NUMBER	|	num	3	SENT_32	[p1l543t3092r882b3123],
3	ospathogens.org	NN	O	ospathogens.org	nsubj	4	SENT_32	[p1l543t3092r882b3123],
4	pected	VBD	O	pect	rcmod	1	SENT_32	[p1l1277t1559r1385b1594],
5	[	CD	NUMBER	[	num	6	SENT_32	[p1l1403t1559r1526b1591],
6	11	CD	NUMBER	11	dobj	4	SENT_32	[p1l1403t1559r1526b1591],
7	—	CD	NUMBER	—	number	8	SENT_32	[p1l1403t1559r1526b1591],
8	13	CD	NUMBER	13	num	9	SENT_32	[p1l1403t1559r1526b1591],
9	]	NN	O	]	dep	4	SENT_32	[p1l1403t1559r1526b1591],
10	,	,	O	,	_	0	SENT_32	[p1l1403t1559r1526b1591],
11	therapy	NN	O	therapy	dep	12	SENT_32	[p1l1545t1559r1668b1594],
12	produced	VBD	O	produce	dep	1	SENT_32	[p1l1685t1559r1841b1594],
13	a	DT	O	a	det	15	SENT_32	[p1l1858t1568r1874b1585],
14	rapid	JJ	O	rapid	amod	15	SENT_32	[p1l1890t1559r1976b1594],
15	decline	NN	O	decline	dobj	12	SENT_32	[p1l1993t1559r2110b1585],
16	in	IN	O	in	_	0	SENT_32	[p1l2127t1560r2157b1584],
17	plasma	NN	O	plasma	nn	19	SENT_32	[p1l2174t1559r2287b1594],
18	HIV-1	NN	O	hiv-1	nn	19	SENT_32	[p1l1277t1608r1373b1633],
19	RNA	NN	O	rna	prep_in	12	SENT_32	[p1l1396t1608r1474b1633],
20	(	CD	NUMBER	(	num	23	SENT_32	[p1l1495t1608r1609b1642],
21	Figure	NN	O	figure	nn	23	SENT_32	[p1l1495t1608r1609b1642],
22	1	CD	NUMBER	1	num	23	SENT_32	[p1l1632t1608r1665b1639],
23	)	NN	O	)	nsubj	12	SENT_32	[p1l1632t1608r1665b1639],
24	,	,	O	,	_	0	SENT_32	[p1l1632t1608r1665b1639],
25	reaching	VBG	O	reach	partmod	1	SENT_32	[p1l1686t1607r1827b1642],
26	undetectable	JJ	O	undetectable	amod	27	SENT_32	[p1l1846t1607r2057b1633],
27	levels	NNS	O	level	dobj	25	SENT_32	[p1l2077t1607r2163b1633],
28	within	IN	O	within	_	0	SENT_32	[p1l2183t1607r2286b1633],
29	50-260	CD	NUMBER	50-260	num	33	SENT_32	[p1l1278t1655r1390b1682],
30	d.	NN	O	d.	nn	33	SENT_32	[p1l1404t1655r1430b1681],
31	HIV-1	NN	O	hiv-1	nn	33	SENT_32	[p1l1443t1656r1540b1681],
32	RNA	NN	O	rna	nn	33	SENT_32	[p1l1556t1655r1634b1681],
33	values	NNS	O	value	prep_within	25	SENT_32	[p1l1645t1655r1743b1681],
34	from	IN	O	from	_	0	SENT_32	[p1l1756t1655r1835b1681],
35	the	DT	O	the	det	37	SENT_32	[p1l1849t1655r1898b1681],
36	two	CD	NUMBER	two	num	37	SENT_32	[p1l1912t1660r1968b1681],
37	assays	NNS	O	assay	prep_from	33	SENT_32	[p1l1981t1664r2074b1690],
38	were	VBD	O	be	cop	39	SENT_32	[p1l2087t1664r2163b1681],
39	similar	JJ	O	similar	_	0	SENT_32	[p1l2176t1655r2287b1681],
40	at	IN	O	at	_	0	SENT_32	[p1l1277t1707r1306b1728],
41	levels	NNS	O	level	prep_at	39	SENT_32	[p1l1326t1702r1412b1728],
42	that	WDT	O	that	nsubj	44	SENT_32	[p1l1434t1702r1496b1728],
43	were	VBD	O	be	cop	44	SENT_32	[p1l1516t1711r1592b1728],
44	detectable	JJ	O	detectable	rcmod	41	SENT_32	[p1l1612t1702r1779b1728],
45	by	IN	O	by	prep	44	SENT_32	[p1l1799t1702r1836b1737],
46	both	CC	O	both	prep	44	SENT_32	[p1l1856t1702r1930b1728],
47	assays	NNS	O	assay	dep	46	SENT_32	[p1l1951t1711r2052b1737],
48	,	,	O	,	_	0	SENT_32	[p1l1951t1711r2052b1737],
49	but	CC	O	but	_	0	SENT_32	[p1l2072t1702r2126b1728],
50	the	DT	O	the	det	51	SENT_32	[p1l2147t1702r2196b1728],
51	SCA	NNP	ORGANIZATION	SCA	nsubj	52	SENT_32	[p1l2217t1702r2287b1728],
52	continued	VBD	O	continue	conj_but	39	SENT_32	[p1l1277t1750r1442b1776],
53	to	TO	O	to	aux	54	SENT_32	[p1l1465t1755r1495b1776],
54	detect	VB	O	detect	xcomp	52	SENT_32	[p1l1518t1750r1617b1776],
55	HIV-1	NN	O	hiv-1	nn	56	SENT_32	[p1l1639t1751r1736b1776],
56	RNA	NN	O	rna	dobj	54	SENT_32	[p1l1760t1750r1838b1776],
57	throughout	IN	O	throughout	_	0	SENT_32	[p1l1861t1750r2046b1785],
58	the	DT	O	the	det	60	SENT_32	[p1l2069t1750r2118b1776],
59	sampling	NN	O	sampling	nn	60	SENT_32	[p1l2140t1750r2287b1785],
60	period	NN	O	period	prep_throughout	54	SENT_32	[p1l1277t1798r1392b1833],
61	,	,	O	,	_	0	SENT_32	[p1l1277t1798r1392b1833],
62	well	RB	O	well	advmod	54	SENT_32	[p1l1407t1798r1470b1824],
63	below	IN	O	below	_	0	SENT_32	[p1l1485t1798r1579b1824],
64	the	DT	O	the	det	65	SENT_32	[p1l1595t1798r1644b1824],
65	limit	NN	O	limit	prep_below	54	SENT_32	[p1l1659t1798r1735b1824],
66	of	IN	O	of	_	0	SENT_32	[p1l1750t1798r1785b1824],
67	detection	NN	O	detection	prep_of	65	SENT_32	[p1l1796t1798r1950b1824],
68	of	IN	O	of	_	0	SENT_32	[p1l1965t1798r2000b1824],
69	the	DT	O	the	det	71	SENT_32	[p1l2013t1798r2062b1824],
70	bDNA	NN	O	bdna	nn	71	SENT_32	[p1l2076t1798r2178b1824],
71	assay	NN	O	assay	prep_of	67	SENT_32	[p1l2193t1807r2280b1833],
72	.	.	O	.	_	0	SENT_32	[p1l2193t1807r2280b1833],

1	These	DT	O	these	det	3	SENT_33	[p1l1314t1847r1408b1873],
2	initial	JJ	O	initial	amod	3	SENT_33	[p1l1425t1847r1519b1873],
3	observations	NNS	O	observation	nsubj	4	SENT_33	[p1l1535t1847r1740b1873],
4	suggested	VBD	O	suggest	_	0	SENT_33	[p1l1756t1847r1911b1882],
5	that	IN	O	that	complm	9	SENT_33	[p1l1928t1847r1991b1873],
6	low-level	JJ	O	low-level	amod	7	SENT_33	[p1l2006t1847r2149b1873],
7	Viremia	NN	O	viremia	nsubj	9	SENT_33	[p1l2164t1848r2287b1873],
8	can	MD	O	can	aux	9	SENT_33	[p1l1277t1903r1333b1920],
9	persist	VB	O	persist	ccomp	4	SENT_33	[p1l1362t1895r1472b1929],
10	for	IN	O	for	_	0	SENT_33	[p1l1500t1894r1550b1920],
11	years	NNS	DURATION	year	prep_for	9	SENT_33	[p1l1576t1903r1661b1929],
12	in	IN	O	in	_	0	SENT_33	[p1l1690t1895r1721b1919],
13	patients	NNS	O	patient	prep_in	11	SENT_33	[p1l1750t1895r1883b1929],
14	receiving	VBG	O	receive	partmod	13	SENT_33	[p1l1913t1895r2067b1929],
15	suppressive	JJ	O	suppressive	amod	17	SENT_33	[p1l2094t1895r2286b1929],
16	antiretroviral	JJ	O	antiretroviral	amod	17	SENT_33	[p1l1277t1942r1497b1968],
17	therapy	NN	O	therapy	dobj	14	SENT_33	[p1l1515t1942r1646b1977],
18	.	.	O	.	_	0	SENT_33	[p1l1515t1942r1646b1977],

1	To	TO	O	to	aux	2	SENT_34	[p1l1663t1943r1706b1968],
2	investigate	VB	O	investigate	dep	59	SENT_34	[p1l1724t1943r1897b1977],
3	this	DT	O	this	det	4	SENT_34	[p1l1915t1942r1971b1968],
4	phenomenon	NN	O	phenomenon	dobj	2	SENT_34	[p1l1988t1942r2206b1977],
5	in	IN	O	in	_	0	SENT_34	[p1l2223t1943r2254b1967],
6	a	DT	O	a	det	9	SENT_34	[p1l2271t1951r2287b1968],
7	larger	JJR	O	larger	amod	9	SENT_34	[p1l1277t1990r1373b2025],
8	patient	NN	O	patient	nn	9	SENT_34	[p1l1397t1991r1513b2025],
9	population	NN	O	population	prep_in	4	SENT_34	[p1l1538t1990r1718b2025],
10	and	CC	O	and	_	0	SENT_34	[p1l1743t1990r1802b2016],
11	to	TO	O	to	aux	12	SENT_34	[p1l1828t1995r1858b2016],
12	compare	VB	O	compare	conj_and	2	SENT_34	[p1l1884t1999r2026b2025],
13	the	DT	O	the	det	14	SENT_34	[p1l2052t1990r2101b2016],
14	effects	NNS	O	effect	dobj	12	SENT_34	[p1l2126t1990r2230b2016],
15	of	IN	O	of	_	0	SENT_34	[p1l2255t1990r2290b2016],
16	different	JJ	O	different	amod	18	SENT_34	[p1l1277t2038r1421b2064],
17	treatment	NN	O	treatment	nn	18	SENT_34	[p1l1441t2043r1603b2064],
18	regimens	NNS	O	regimen	prep_of	14	SENT_34	[p1l1623t2039r1778b2073],
19	,	,	O	,	_	0	SENT_34	[p1l1623t2039r1778b2073],
20	we	PRP	O	we	nsubj	21	SENT_34	[p1l1798t2047r1840b2064],
21	analyzed	VBD	O	analyze	parataxis	59	SENT_34	[p1l1861t2038r2000b2073],
22	specimens	NNS	O	specimen	dobj	21	SENT_34	[p1l2020t2039r2187b2073],
23	from	IN	O	from	_	0	SENT_34	[p1l2207t2038r2287b2064],
24	study	NN	O	study	nn	26	SENT_34	[p1l1277t2085r1362b2120],
25	M98	NN	O	m98	nn	26	SENT_34	[p1l1375t2085r1530b2116],
26	—	NN	O	—	prep_from	21	SENT_34	[p1l1375t2085r1530b2116],
27	863	CD	NUMBER	863	dep	26	SENT_34	[p1l1375t2085r1530b2116],
28	,	,	O	,	_	0	SENT_34	[p1l1375t2085r1530b2116],
29	a	DT	O	a	det	30	SENT_34	[p1l1544t2094r1560b2111],
30	Phase	NN	O	phase	nsubj	59	SENT_34	[p1l1573t2085r1665b2111],
31	III	CD	NUMBER	iii	num	30	SENT_34	[p1l1679t2086r1717b2110],
32	randomized	VBN	O	randomize	partmod	30	SENT_34	[p1l1731t2085r1924b2111],
33	clinical	JJ	O	clinical	amod	34	SENT_34	[p1l1939t2085r2055b2111],
34	trial	NN	O	trial	dobj	32	SENT_34	[p1l2070t2085r2135b2111],
35	comparing	VBG	O	compare	xcomp	32	SENT_34	[p1l2149t2094r2285b2120, p1l1277t2134r1327b2168],
36	lopinavir/ritonavir	JJ	O	lopinavir/ritonavir	amod	39	SENT_34	[p1l1343t2133r1647b2168],
37	(	NN	O	(	nn	39	SENT_34	[p1l1664t2133r1778b2165],
38	LPV/r	NN	O	lpv/r	nn	39	SENT_34	[p1l1664t2133r1778b2165],
39	)	NN	O	)	dobj	35	SENT_34	[p1l1664t2133r1778b2165],
40	and	CC	O	and	_	0	SENT_34	[p1l1796t2133r1855b2159],
41	nelﬁnavir	NN	O	nelﬁnavir	nn	44	SENT_34	[p1l1872t2133r2029b2159],
42	(	CD	NUMBER	(	num	44	SENT_34	[p1l2046t2134r2148b2165],
43	NFV	NN	O	nfv	nn	44	SENT_34	[p1l2046t2134r2148b2165],
44	)	NN	O	)	dobj	35	SENT_34	[p1l2046t2134r2148b2165],
45	,	,	O	,	_	0	SENT_34	[p1l2046t2134r2148b2165],
46	each	DT	O	each	appos	44	SENT_34	[p1l2166t2133r2239b2159],
47	in	IN	O	in	_	0	SENT_34	[p1l2256t2134r2286b2158],
48	combination	NN	O	combination	prep_in	46	SENT_34	[p1l1277t2181r1485b2207],
49	with	IN	O	with	_	0	SENT_34	[p1l1506t2181r1575b2207],
50	stavudine	NN	O	stavudine	prep_with	48	SENT_34	[p1l1597t2181r1752b2207],
51	and	CC	O	and	_	0	SENT_34	[p1l1774t2181r1833b2207],
52	lamivudine	NN	O	lamivudine	prep_with	48	SENT_34	[p1l1855t2181r2044b2212],
53	,	,	O	,	_	0	SENT_34	[p1l1855t2181r2044b2212],
54	in	IN	O	in	_	0	SENT_34	[p1l2067t2182r2098b2206],
55	previously	RB	DATE	previously	advmod	56	SENT_34	[p1l2120t2181r2287b2216],
56	antiretroviral-naive	JJ	O	antiretroviral-naive	amod	58	SENT_34	[p1l1277t2229r1609b2255],
57	HIV-1-infected	JJ	O	hiv-1-infected	amod	58	SENT_34	[p1l1638t2229r1894b2255],
58	individuals	NNS	O	individual	prep_in	44	SENT_34	[p1l1923t2229r2107b2255],
59	[	VBP	O	[	_	0	SENT_34	[p1l2138t2229r2205b2261],
60	14	CD	NUMBER	14	num	61	SENT_34	[p1l2138t2229r2205b2261],
61	]	CD	NUMBER	]	dobj	59	SENT_34	[p1l2138t2229r2205b2261],
62	.	.	O	.	_	0	SENT_34	[p1l2138t2229r2205b2261],

1	We	PRP	O	we	nsubj	2	SENT_35	[p1l2234t2230r2286b2255],
2	studied	VBD	O	study	_	0	SENT_35	[p1l1277t2277r1395b2303],
3	a	DT	O	a	det	4	SENT_35	[p1l1409t2286r1425b2303],
4	subset	NN	O	subset	dobj	2	SENT_35	[p1l1438t2277r1538b2303],
5	of	IN	O	of	_	0	SENT_35	[p1l1551t2277r1586b2303],
6	145	CD	NUMBER	145	num	7	SENT_35	[p1l1599t2277r1652b2302],
7	patients	NNS	O	patient	prep_of	4	SENT_35	[p1l1666t2278r1795b2312],
8	(	IN	O	(	mark	9	SENT_35	[p1l1811t2278r1869b2309],
9	see	VBP	O	see	advcl	2	SENT_35	[p1l1811t2278r1869b2309],
10	Figure	NNP	O	Figure	nn	12	SENT_35	[p1l1882t2278r1986b2312],
11	S1	NN	O	s1	nn	12	SENT_35	[p1l2000t2277r2048b2309],
12	)	NN	O	)	dobj	9	SENT_35	[p1l2000t2277r2048b2309],
13	whose	WP$	O	whose	poss	15	SENT_35	[p1l2062t2277r2160b2303],
14	plasma	NN	O	plasma	nn	15	SENT_35	[p1l2174t2277r2287b2312],
15	HIV-1	NN	O	hiv-1	dobj	17	SENT_35	[p1l1277t2325r1373b2350],
16	RNA	NN	O	rna	nsubj	30	SENT_35	[p1l1388t2324r1466b2350],
17	declined	VBD	O	decline	rcmod	12	SENT_35	[p1l1478t2324r1616b2350],
18	to	TO	O	to	_	0	SENT_35	[p1l1629t2329r1659b2350],
19	less	JJR	O	less	mwe	20	SENT_35	[p1l1672t2324r1726b2350],
20	than	IN	O	than	quantmod	21	SENT_35	[p1l1740t2324r1811b2350],
21	50	CD	NUMBER	50	num	22	SENT_35	[p1l1825t2324r1859b2349],
22	copies/ml	NN	O	copies/ml	prep_to	17	SENT_35	[p1l1872t2324r2025b2359],
23	within	IN	O	within	_	0	SENT_35	[p1l2036t2324r2139b2350],
24	24	CD	DURATION	24	num	25	SENT_35	[p1l2153t2324r2189b2351],
25	wk	NN	DURATION	wk	prep_within	17	SENT_35	[p1l2199t2324r2243b2349],
26	of	IN	O	of	_	0	SENT_35	[p1l2255t2324r2290b2350],
27	initiating	VBG	O	initiate	prepc_of	25	SENT_35	[p1l1277t2373r1428b2407],
28	therapy	NN	O	therapy	dobj	27	SENT_35	[p1l1440t2372r1564b2407],
29	and	CC	O	and	_	0	SENT_35	[p1l1576t2372r1635b2398],
30	remained	VBD	O	remain	rcmod	12	SENT_35	[p1l1648t2372r1802b2398],
31	at	IN	O	at	_	0	SENT_35	[p1l1815t2377r1844b2398],
32	this	DT	O	this	det	33	SENT_35	[p1l1857t2372r1913b2398],
33	level	NN	O	level	prep_at	30	SENT_35	[p1l1925t2372r1998b2398],
34	at	IN	O	at	_	0	SENT_35	[p1l2011t2377r2040b2398],
35	all	DT	O	all	det	37	SENT_35	[p1l2052t2372r2088b2398],
36	time	NN	O	time	nn	37	SENT_35	[p1l2102t2373r2173b2398],
37	points	NNS	O	point	prep_at	33	SENT_35	[p1l2185t2373r2286b2407],
38	through	IN	O	through	_	0	SENT_35	[p1l1278t2420r1407b2455],
39	60	CD	DURATION	60	num	40	SENT_35	[p1l1423t2420r1458b2445],
40	wk	NN	DURATION	wk	prep_through	30	SENT_35	[p1l1473t2420r1524b2446],
41	.	.	O	.	_	0	SENT_35	[p1l1473t2420r1524b2446],

1	SCA	NNP	ORGANIZATION	SCA	nn	2	SENT_36	[p1l1540t2420r1610b2446],
2	results	NNS	O	result	nsubj	4	SENT_36	[p1l1625t2420r1729b2446],
3	were	VBD	O	be	cop	4	SENT_36	[p1l1744t2429r1820b2446],
4	available	JJ	O	available	_	0	SENT_36	[p1l1835t2420r1976b2446],
5	from	IN	O	from	_	0	SENT_36	[p1l1991t2420r2071b2446],
6	130	CD	NUMBER	130	num	7	SENT_36	[p1l2088t2420r2141b2445],
7	patients	NNS	O	patient	prep_from	4	SENT_36	[p1l2157t2421r2286b2455],
8	(	IN	O	(	_	0	SENT_36	[p1l1278t2468r1324b2500],
9	63	CD	NUMBER	63	prep_(	4	SENT_36	[p1l1278t2468r1324b2500],
10	on	IN	O	on	_	0	SENT_36	[p1l1341t2477r1381b2494],
11	LPV/r	NN	O	lpv/r	prep_on	9	SENT_36	[p1l1397t2468r1493b2494],
12	and	CC	O	and	_	0	SENT_36	[p1l1508t2468r1567b2494],
13	67	CD	NUMBER	67	conj_and	9	SENT_36	[p1l1585t2466r1620b2493],
14	on	IN	O	on	_	0	SENT_36	[p1l1637t2477r1677b2494],
15	NFV	NN	O	nfv	nn	16	SENT_36	[p1l1693t2469r1786b2500],
16	)	NN	O	)	prep_on	13	SENT_36	[p1l1693t2469r1786b2500],
17	.	.	O	.	_	0	SENT_36	[p1l1693t2469r1786b2500],

1	As	IN	O	as	mark	2	SENT_37	[p1l1803t2468r1841b2494],
2	shown	VBN	O	show	advcl	18	SENT_37	[p1l1858t2468r1960b2494],
3	in	IN	O	in	_	0	SENT_37	[p1l1977t2469r2007b2493],
4	Figure	NN	O	figure	prep_in	2	SENT_37	[p1l2023t2469r2128b2503],
5	2	CD	NUMBER	2	num	4	SENT_37	[p1l2146t2468r2169b2499],
6	,	,	O	,	_	0	SENT_37	[p1l2146t2468r2169b2499],
7	HIV-1	NN	O	hiv-1	nn	9	SENT_37	[p1l2187t2469r2283b2494],
8	RNA	NN	O	rna	nn	9	SENT_37	[p1l1276t2515r1354b2541],
9	values	NNS	O	value	nsubj	18	SENT_37	[p1l1373t2515r1471b2541],
10	at	IN	O	at	_	0	SENT_37	[p1l1491t2520r1520b2541],
11	week	NN	DURATION	week	prep_at	9	SENT_37	[p1l1540t2515r1620b2541],
12	60	CD	NUMBER	60	num	11	SENT_37	[p1l1640t2515r1675b2540],
13	in	IN	O	in	_	0	SENT_37	[p1l1696t2516r1727b2540],
14	the	DT	O	the	det	16	SENT_37	[p1l1748t2515r1797b2541],
15	two	CD	NUMBER	two	num	16	SENT_37	[p1l1818t2520r1874b2541],
16	arms	NNS	O	arm	prep_in	11	SENT_37	[p1l1895t2524r1972b2541],
17	combined	VBN	O	combine	partmod	16	SENT_37	[p1l1992t2515r2154b2541],
18	ranged	VBD	O	range	_	0	SENT_37	[p1l2175t2515r2286b2550],

1	Editor	NNP	O	Editor	_	0	SENT_38	[p1l1277t2633r1361b2654],
2	:	:	O	:	_	0	SENT_38	[p1l1277t2633r1361b2654],
3	Michael	NNP	PERSON	Michael	nn	5	SENT_38	[p1l1373t2633r1464b2654],
4	H.	NNP	PERSON	H.	nn	5	SENT_38	[p1l1477t2634r1499b2654],
5	Malim	NNP	PERSON	Malim	dep	1	SENT_38	[p1l1512t2633r1589b2658],
6	,	,	O	,	_	0	SENT_38	[p1l1512t2633r1589b2658],
7	King	NNP	ORGANIZATION	King	poss	10	SENT_38	[p1l1603t2634r1672b2660],
8	's	POS	ORGANIZATION	's	_	0	SENT_38	[p1l1603t2634r1672b2660],
9	College	NNP	ORGANIZATION	College	nn	10	SENT_38	[p1l1683t2633r1773b2660],
10	London	NNP	ORGANIZATION	London	appos	5	SENT_38	[p1l1786t2633r1883b2658],
11	,	,	O	,	_	0	SENT_38	[p1l1786t2633r1883b2658],
12	United	NNP	LOCATION	United	nn	13	SENT_38	[p1l1896t2633r1974b2654],
13	Kingdom	NNP	LOCATION	Kingdom	appos	10	SENT_38	[p1l1988t2633r2095b2660],

1	Received	VBN	O	receive	_	0	SENT_39	[p1l1277t2691r1391b2712],
2	October	NNP	DATE	October	nsubj	13	SENT_39	[p1l1402t2691r1500b2712],
3	24	CD	DATE	24	num	2	SENT_39	[p1l1511t2693r1544b2716],
4	,	,	DATE	,	_	0	SENT_39	[p1l1511t2693r1544b2716],
5	2006	CD	DATE	2006	num	2	SENT_39	[p1l1555t2693r1618b2716],
6	;	:	O	;	_	0	SENT_39	[p1l1555t2693r1618b2716],
7	Accepted	JJ	O	accepted	amod	2	SENT_39	[p1l1629t2691r1748b2718],
8	February	NNP	DATE	February	tmod	7	SENT_39	[p1l1761t2691r1866b2718],
9	13	CD	DATE	13	num	8	SENT_39	[p1l1878t2693r1910b2716],
10	,	,	DATE	,	_	0	SENT_39	[p1l1878t2693r1910b2716],
11	2007	CD	DATE	2007	num	8	SENT_39	[p1l1921t2693r1984b2716],
12	;	:	O	;	_	0	SENT_39	[p1l1921t2693r1984b2716],
13	Published	VBN	O	publish	dep	1	SENT_39	[p1l1996t2691r2122b2712],
14	April	NNP	DATE	April	tmod	13	SENT_39	[p1l2133t2691r2188b2718],
15	6	CD	DATE	6	num	14	SENT_39	[p1l2199t2693r2218b2716],
16	,	,	DATE	,	_	0	SENT_39	[p1l2199t2693r2218b2716],
17	2007	CD	DATE	2007	num	14	SENT_39	[p1l2229t2693r2286b2712],

1	This	DT	O	this	nsubj	7	SENT_40	[p1l1275t2749r1323b2770],
2	is	VBZ	O	be	cop	7	SENT_40	[p1l1332t2750r1348b2770],
3	an	DT	O	a	det	7	SENT_40	[p1l1357t2755r1384b2770],
4	open	JJ	O	open	amod	7	SENT_40	[p1l1394t2755r1542b2776],
5	—	NN	O	—	nn	7	SENT_40	[p1l1394t2755r1542b2776],
6	access	NN	O	access	nn	7	SENT_40	[p1l1394t2755r1542b2776],
7	article	NN	O	article	ccomp	36	SENT_40	[p1l1551t2749r1623b2770],
8	distributed	VBN	O	distribute	partmod	7	SENT_40	[p1l1632t2749r1763b2770],
9	under	IN	O	under	_	0	SENT_40	[p1l1774t2749r1844b2770],
10	the	DT	O	the	det	11	SENT_40	[p1l1852t2749r1891b2770],
11	terms	NNS	O	term	prep_under	8	SENT_40	[p1l1900t2753r1968b2770],
12	of	IN	O	of	_	0	SENT_40	[p1l1977t2749r2002b2770],
13	the	DT	O	the	det	18	SENT_40	[p1l2008t2749r2047b2770],
14	Creative	NNP	ORGANIZATION	Creative	nn	18	SENT_40	[p1l2056t2750r2154b2770],
15	Commons	NNP	ORGANIZATION	Commons	nn	18	SENT_40	[p1l2163t2750r2286b2770],
16	Public	NNP	ORGANIZATION	Public	nn	18	SENT_40	[p1l1277t2782r1349b2803],
17	Domain	NN	ORGANIZATION	domain	nn	18	SENT_40	[p1l1369t2783r1461b2803],
18	declaration	NN	O	declaration	prep_of	11	SENT_40	[p1l1481t2782r1622b2807],
19	,	,	O	,	_	0	SENT_40	[p1l1481t2782r1622b2807],
20	which	WDT	O	which	nsubj	21	SENT_40	[p1l1641t2782r1712b2803],
21	stipulates	VBZ	O	stipulate	rcmod	18	SENT_40	[p1l1733t2782r1847b2809],
22	that	IN	O	that	nsubj	25	SENT_40	[p1l1866t2782r1920b2807],
23	,	,	O	,	_	0	SENT_40	[p1l1866t2782r1920b2807],
24	once	RB	DATE	once	advmod	25	SENT_40	[p1l1939t2788r1997b2803],
25	placed	VBN	O	place	ccomp	21	SENT_40	[p1l2017t2782r2094b2809],
26	in	IN	O	in	_	0	SENT_40	[p1l2115t2783r2135b2803],
27	the	DT	O	the	det	29	SENT_40	[p1l2154t2782r2193b2803],
28	public	JJ	O	public	amod	29	SENT_40	[p1l2213t2782r2286b2809],
29	domain	NN	O	domain	prep_in	25	SENT_40	[p1l1276t2816r1373b2841],
30	,	,	O	,	_	0	SENT_40	[p1l1276t2816r1373b2841],
31	this	DT	O	this	det	32	SENT_40	[p1l1387t2816r1429b2837],
32	work	NN	O	work	nsubjpass	38	SENT_40	[p1l1443t2816r1503b2837],
33	may	MD	O	may	aux	36	SENT_40	[p1l1516t2822r1566b2843],
34	be	VB	O	be	auxpass	36	SENT_40	[p1l1580t2816r1608b2837],
35	freely	RB	O	freely	advmod	36	SENT_40	[p1l1622t2816r1688b2843],
36	reproduced	VBN	O	reproduce	_	0	SENT_40	[p1l1702t2816r1847b2843],
37	,	,	O	,	_	0	SENT_40	[p1l1702t2816r1847b2843],
38	distributed	VBN	O	distribute	conj_or	36	SENT_40	[p1l1861t2816r1999b2841],
39	,	,	O	,	_	0	SENT_40	[p1l1861t2816r1999b2841],
40	transmitted	VBN	O	transmit	conj_or	36	SENT_40	[p1l2012t2816r2159b2841],
41	,	,	O	,	_	0	SENT_40	[p1l2012t2816r2159b2841],
42	modiﬁed	VBN	O	modiﬁed	conj_or	36	SENT_40	[p1l2174t2816r2286b2841],
43	,	,	O	,	_	0	SENT_40	[p1l2174t2816r2286b2841],
44	built	VBN	O	build	conj_or	36	SENT_40	[p1l1277t2849r1330b2870],
45	upon	IN	O	upon	prep	44	SENT_40	[p1l1342t2855r1410b2876],
46	,	,	O	,	_	0	SENT_40	[p1l1342t2855r1410b2876],
47	or	CC	O	or	_	0	SENT_40	[p1l1422t2856r1446b2870],
48	otherwise	RB	O	otherwise	advmod	49	SENT_40	[p1l1457t2849r1575b2870],
49	used	VBN	O	use	conj_or	36	SENT_40	[p1l1588t2849r1642b2870],
50	by	IN	O	by	_	0	SENT_40	[p1l1656t2849r1684b2876],
51	anyone	NN	O	anyone	prep_by	49	SENT_40	[p1l1695t2855r1783b2876],
52	for	IN	O	for	_	0	SENT_40	[p1l1794t2849r1828b2870],
53	any	DT	O	any	det	55	SENT_40	[p1l1839t2855r1881b2876],
54	lawful	JJ	O	lawful	amod	55	SENT_40	[p1l1893t2849r1962b2870],
55	purpose	NN	O	purpose	prep_for	51	SENT_40	[p1l1976t2855r2080b2876],
56	.	.	O	.	_	0	SENT_40	[p1l1976t2855r2080b2876],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_41	[p1l1276t2907r1465b2928],
2	:	:	O	:	_	0	SENT_41	[p1l1276t2907r1465b2928],
3	LPV/r	NN	O	lpv/r	dep	1	SENT_41	[p1l1482t2908r1549b2932],
4	,	,	O	,	_	0	SENT_41	[p1l1482t2908r1549b2932],
5	Iopinavir/ritonavir	NN	O	iopinavir/ritonavir	appos	3	SENT_41	[p1l1566t2907r1788b2934],
6	;	:	O	;	_	0	SENT_41	[p1l1566t2907r1788b2934],
7	NFV	NN	O	nfv	dep	3	SENT_41	[p1l1804t2908r1857b2932],
8	,	,	O	,	_	0	SENT_41	[p1l1804t2908r1857b2932],
9	nelﬁnavir	NN	O	nelﬁnavir	appos	7	SENT_41	[p1l1873t2907r1989b2932],
10	;	:	O	;	_	0	SENT_41	[p1l1873t2907r1989b2932],
11	NNRTI	NNP	ORGANIZATION	NNRTI	dep	3	SENT_41	[p1l2006t2908r2084b2932],
12	,	,	O	,	_	0	SENT_41	[p1l2006t2908r2084b2932],
13	non	JJ	O	non	amod	20	SENT_41	[p1l2101t2907r2286b2928],
14	—	NN	O	—	nn	20	SENT_41	[p1l2101t2907r2286b2928],
15	nuc	NN	O	nuc	nn	20	SENT_41	[p1l2101t2907r2286b2928],
16	|	NN	O	|	nn	20	SENT_41	[p1l2101t2907r2286b2928],
17	eoside	NN	O	eoside	nn	20	SENT_41	[p1l2101t2907r2286b2928],
18	reverse	JJ	O	reverse	amod	20	SENT_41	[p1l1277t2946r1362b2961],
19	transcriptase	NN	O	transcriptase	nn	20	SENT_41	[p1l1373t2941r1527b2967],
20	inhibitor	NN	O	inhibitor	appos	11	SENT_41	[p1l1540t2940r1648b2965],
21	;	:	O	;	_	0	SENT_41	[p1l1540t2940r1648b2965],
22	SCA	NNP	ORGANIZATION	SCA	dep	3	SENT_41	[p1l1659t2941r1712b2965],
23	,	,	O	,	_	0	SENT_41	[p1l1659t2941r1712b2965],
24	single	JJ	O	single	amod	26	SENT_41	[p1l1724t2940r1794b2967],
25	copy	NN	O	copy	nn	26	SENT_41	[p1l1805t2946r1863b2967],
26	assay	NN	O	assay	appos	22	SENT_41	[p1l1874t2946r1938b2967],

1	*	NN	O	*	_	0	SENT_42	[p1l1276t2998r1286b3008],
2	To	TO	O	to	_	0	SENT_42	[p1l1297t2998r1326b3018],
3	whom	WP	O	whom	dobj	7	SENT_42	[p1l1338t2997r1413b3018],
4	correspondence	NN	O	correspondence	nsubjpass	7	SENT_42	[p1l1425t2997r1621b3024],
5	should	MD	O	should	aux	7	SENT_42	[p1l1633t2997r1712b3018],
6	be	VB	O	be	auxpass	7	SENT_42	[p1l1726t2997r1754b3018],
7	addressed	VBN	O	address	prepc_to	1	SENT_42	[p1l1766t2997r1895b3018],
8	.	.	O	.	_	0	SENT_42	[p1l1766t2997r1895b3018],

1	E-mail	NN	O	e-mail	_	0	SENT_43	[p1l1907t2997r1985b3018],
2	:	:	O	:	_	0	SENT_43	[p1l1907t2997r1985b3018],
3	fma	NN	O	fma	dep	1	SENT_43	[p1l1996t2997r2232b3024],
4	|	CD	NUMBER	|	num	3	SENT_43	[p1l1996t2997r2232b3024],
5	|	NN	O	|	nn	6	SENT_43	[p1l1996t2997r2232b3024],
6	i@mai	NNS	O	i@mai	nsubj	7	SENT_43	[p1l1996t2997r2232b3024],
7	|	VBP	O	|	rcmod	3	SENT_43	[p1l1996t2997r2232b3024],
8	.	.	O	.	_	0	SENT_43	[p1l1996t2997r2232b3024],

1	nih	NN	O	nih	_	0	SENT_44	[p1l1996t2997r2232b3024],
2	.	.	O	.	_	0	SENT_44	[p1l1996t2997r2232b3024],

1	gov	NN	O	gov	_	0	SENT_45	[p1l1996t2997r2232b3024],

1	April	NNP	DATE	April	_	0	SENT_46	[p1l1772t3092r1834b3123],
2	2007	CD	DATE	2007	num	1	SENT_46	[p1l1849t3094r1914b3116],
3	|	NNP	O	|	dep	1	SENT_46	[p1l1929t3091r1931b3124],
4	Volume	NN	O	volume	nn	7	SENT_46	[p1l1945t3092r2051b3116],
5	3	CD	NUMBER	3	num	7	SENT_46	[p1l2064t3094r2078b3116],
6	|	NN	O	|	nn	7	SENT_46	[p1l2093t3091r2096b3124],
7	Issue	NN	O	issue	dep	3	SENT_46	[p1l2112t3093r2178b3116],
8	4	CD	NUMBER	4	num	10	SENT_46	[p1l2190t3094r2206b3116],
9	|	NN	O	|	nn	10	SENT_46	[p1l2221t3091r2223b3124],
10	e46	NN	O	e46	dep	1	SENT_46	[p1l2238t3094r2287b3116],

1	from	IN	O	from	_	0	SENT_47	[p2l189t1066r269b1092],
2	<	JJR	O	<	prep_from	40	SENT_47	[p2l284t1064r437b1092],
3	0.6	CD	NUMBER	0.6	num	4	SENT_47	[p2l284t1064r437b1092],
4	—	NN	O	—	dep	2	SENT_47	[p2l284t1064r437b1092],
5	174	CD	NUMBER	174	num	6	SENT_47	[p2l284t1064r437b1092],
6	copies/ml	NN	O	copies/ml	dep	2	SENT_47	[p2l450t1066r603b1101],
7	with	IN	O	with	_	0	SENT_47	[p2l616t1066r686b1092],
8	a	DT	O	a	det	10	SENT_47	[p2l701t1075r717b1092],
9	geometric	JJ	O	geometric	amod	10	SENT_47	[p2l730t1066r893b1101],
10	mean	NN	O	mean	prep_with	6	SENT_47	[p2l908t1075r996b1092],
11	(	RB	O	(	advmod	13	SENT_47	[p2l1011t1066r1153b1099],
12	median	JJ	O	median	amod	13	SENT_47	[p2l1011t1066r1153b1099],
13	)	NN	O	)	rcmod	10	SENT_47	[p2l1011t1066r1153b1099],
14	of	IN	O	of	_	0	SENT_47	[p2l1168t1066r1202b1092],
15	3.2	CD	NUMBER	3.2	number	16	SENT_47	[p2l190t1112r233b1139],
16	(	CD	NUMBER	(	prep_of	13	SENT_47	[p2l263t1112r329b1145],
17	3.1	CD	NUMBER	3.1	num	19	SENT_47	[p2l263t1112r329b1145],
18	)	NN	O	)	nn	19	SENT_47	[p2l263t1112r329b1145],
19	copies/ml	NN	O	copies/ml	dep	16	SENT_47	[p2l357t1112r510b1147],
20	and	CC	O	and	_	0	SENT_47	[p2l538t1112r597b1138],
21	with	IN	O	with	_	0	SENT_47	[p2l623t1112r693b1138],
22	no	DT	O	no	det	25	SENT_47	[p2l721t1121r761b1138],
23	signiﬁcant	JJ	O	signiﬁcant	amod	25	SENT_47	[p2l789t1112r958b1147],
24	between-arm	NN	O	between-arm	nn	25	SENT_47	[p2l984t1112r1199b1138],
25	differences	NNS	O	difference	conj_and	10	SENT_47	[p2l189t1158r369b1184],
26	in	IN	O	in	_	0	SENT_47	[p2l387t1158r417b1183],
27	the	DT	O	the	det	30	SENT_47	[p2l435t1158r484b1184],
28	mean	JJ	O	mean	amod	30	SENT_47	[p2l502t1167r590b1184],
29	(	NN	O	(	nn	30	SENT_47	[p2l607t1159r634b1193],
30	[	NN	O	[	prep_in	25	SENT_47	[p2l607t1159r634b1193],
31	7	CD	NUMBER	7	number	32	SENT_47	[p2l607t1159r634b1193],
32	=	JJ	O	=	amod	30	SENT_47	[p2l647t1169r672b1178],
33	0.56	CD	NUMBER	0.56	num	34	SENT_47	[p2l686t1158r761b1191],
34	)	CD	NUMBER	)	dep	6	SENT_47	[p2l686t1158r761b1191],
35	or	CC	O	or	_	0	SENT_47	[p2l779t1167r814b1184],
36	overall	JJ	O	overall	amod	37	SENT_47	[p2l830t1158r939b1184],
37	distribution	NN	O	distribution	conj_or	2	SENT_47	[p2l956t1158r1151b1184],
38	of	IN	O	of	_	0	SENT_47	[p2l1168t1158r1203b1184],
39	values	NNS	O	value	prep_of	37	SENT_47	[p2l188t1204r286b1230],
40	(	VBP	O	(	_	0	SENT_47	[p2l304t1205r331b1239],
41	[	NN	O	[	dobj	40	SENT_47	[p2l304t1205r331b1239],
42	7	CD	NUMBER	7	num	45	SENT_47	[p2l304t1205r331b1239],
43	=	JJ	O	=	amod	45	SENT_47	[p2l344t1215r369b1224],
44	0.82	CD	NUMBER	0.82	tmod	43	SENT_47	[p2l383t1204r466b1237],
45	)	NN	O	)	nsubj	40	SENT_47	[p2l383t1204r466b1237],
46	.	.	O	.	_	0	SENT_47	[p2l383t1204r466b1237],

1	Plasma	NN	O	plasma	nn	3	SENT_48	[p2l484t1204r598b1230],
2	HIV-1	NN	O	hiv-1	nn	3	SENT_48	[p2l614t1204r711b1230],
3	RNA	NN	MISC	rna	nsubj	4	SENT_48	[p2l730t1204r808b1230],
4	was	VBD	O	be	_	0	SENT_48	[p2l824t1213r880b1230],
5	below	IN	O	below	_	0	SENT_48	[p2l896t1204r991b1230],
6	the	DT	O	the	det	7	SENT_48	[p2l1009t1204r1058b1230],
7	limit	NN	O	limit	prep_below	4	SENT_48	[p2l1075t1204r1151b1230],
8	of	IN	O	of	_	0	SENT_48	[p2l1168t1204r1202b1230],
9	quantiﬁcation	NN	O	quantiﬁcation	prep_of	7	SENT_48	[p2l189t1250r420b1285],
10	by	IN	O	by	_	0	SENT_48	[p2l434t1250r472b1285],
11	SCA	NNP	ORGANIZATION	SCA	prep_by	4	SENT_48	[p2l487t1250r557b1276],
12	in	IN	O	in	_	0	SENT_48	[p2l572t1250r603b1275],
13	about	IN	O	about	advmod	15	SENT_48	[p2l618t1250r711b1276],
14	17	CD	PERCENT	17	num	15	SENT_48	[p2l728t1247r794b1279],
15	%	NN	PERCENT	%	prep_in	4	SENT_48	[p2l728t1247r794b1279],
16	of	IN	O	of	_	0	SENT_48	[p2l814t1250r849b1276],
17	patients	NNS	O	patient	prep_of	15	SENT_48	[p2l861t1250r990b1285],
18	(	IN	O	(	_	0	SENT_48	[p2l1008t1250r1113b1283],
19	LPVlr	NN	O	lpvlr	nn	20	SENT_48	[p2l1008t1250r1113b1283],
20	arm	NN	O	arm	prep_(	17	SENT_48	[p2l1127t1259r1198b1276],
21	:	:	O	:	_	0	SENT_48	[p2l1127t1259r1198b1276],
22	17	CD	PERCENT	17	number	23	SENT_48	[p2l192t1294r270b1327],
23	%	NN	PERCENT	%	amod	15	SENT_48	[p2l192t1294r270b1327],
24	;	:	O	;	_	0	SENT_48	[p2l192t1294r270b1327],
25	NFV	NN	O	nfv	nn	26	SENT_48	[p2l285t1297r359b1322],
26	arm	NN	O	arm	dep	15	SENT_48	[p2l374t1305r445b1322],
27	:	:	O	:	_	0	SENT_48	[p2l374t1305r445b1322],
28	18	CD	PERCENT	18	num	29	SENT_48	[p2l464t1296r553b1329],
29	%	NN	PERCENT	%	dep	15	SENT_48	[p2l464t1296r553b1329],
30	)	CD	NUMBER	)	dep	29	SENT_48	[p2l464t1296r553b1329],
31	.	.	O	.	_	0	SENT_48	[p2l464t1296r553b1329],

1	We	PRP	O	we	nsubj	3	SENT_49	[p2l226t1343r277b1368],
2	also	RB	O	also	advmod	3	SENT_49	[p2l294t1342r354b1368],
3	determined	VBD	O	determine	_	0	SENT_49	[p2l371t1342r561b1368],
4	the	DT	O	the	det	5	SENT_49	[p2l578t1342r627b1368],
5	distribution	NN	O	distribution	dobj	3	SENT_49	[p2l644t1342r839b1368],
6	of	IN	O	of	_	0	SENT_49	[p2l855t1342r890b1368],
7	HIV-1	NN	O	hiv-1	nn	9	SENT_49	[p2l902t1342r1000b1368],
8	RNA	NN	O	rna	nn	9	SENT_49	[p2l1018t1342r1097b1368],
9	levels	NNS	O	level	prep_of	5	SENT_49	[p2l1112t1342r1198b1368],
10	in	IN	O	in	_	0	SENT_49	[p2l189t1387r220b1412],
11	28	CD	NUMBER	28	num	12	SENT_49	[p2l234t1387r270b1414],
12	patients	NNS	O	patient	prep_in	3	SENT_49	[p2l283t1387r413b1422],
13	enrolled	VBN	O	enrol	partmod	12	SENT_49	[p2l427t1387r562b1413],
14	in	IN	O	in	_	0	SENT_49	[p2l576t1387r607b1412],
15	National	NNP	ORGANIZATION	National	dep	22	SENT_49	[p2l619t1387r761b1413],
16	Institutes	NNPS	ORGANIZATION	Institutes	dep	15	SENT_49	[p2l773t1387r925b1413],
17	of	IN	ORGANIZATION	of	_	0	SENT_49	[p2l939t1387r974b1413],
18	Health	NNP	ORGANIZATION	Health	prep_of	15	SENT_49	[p2l984t1387r1094b1413],
19	(	CD	NUMBER	(	num	18	SENT_49	[p2l1108t1388r1198b1420],
20	NIH	NNP	ORGANIZATION	NIH	nn	22	SENT_49	[p2l1108t1388r1198b1420],
21	)	NN	O	)	nn	22	SENT_49	[p2l1108t1388r1198b1420],
22	studies	NNS	O	study	prep_in	13	SENT_49	[p2l189t1433r300b1459],
23	whose	WP$	O	whose	dep	26	SENT_49	[p2l318t1433r417b1459],
24	viremia	NN	O	viremia	nsubjpass	26	SENT_49	[p2l435t1433r559b1459],
25	was	VBD	O	be	auxpass	26	SENT_49	[p2l576t1442r632b1459],
26	suppressed	VBN	O	suppress	dep	12	SENT_49	[p2l651t1433r831b1468],
27	to	TO	O	to	_	0	SENT_49	[p2l850t1438r881b1459],
28	<	JJR	O	<	prep_to	26	SENT_49	[p2l902t1430r968b1458],
29	75	CD	NUMBER	75	num	30	SENT_49	[p2l902t1430r968b1458],
30	copies/ml	NN	O	copies/ml	dep	28	SENT_49	[p2l987t1433r1139b1468],
31	on	IN	O	on	_	0	SENT_49	[p2l1158t1442r1199b1459],
32	non-nucleoside	JJ	O	non-nucleoside	amod	36	SENT_49	[p2l189t1479r440b1505],
33	reverse	JJ	O	reverse	amod	36	SENT_49	[p2l460t1488r575b1505],
34	transriptase	NN	O	transriptase	nn	36	SENT_49	[p2l595t1479r788b1514],
35	inhibitor	NN	O	inhibitor	nn	36	SENT_49	[p2l808t1479r955b1505],
36	(	NN	O	(	prep_on	30	SENT_49	[p2l974t1480r1198b1512, p2l190t1525r305b1560],
37	NNRTI	NN	ORGANIZATION	nnrtus	dobj	26	SENT_49	[p2l974t1480r1198b1512, p2l190t1525r305b1560],
38	)	CD	NUMBER	)	num	37	SENT_49	[p2l974t1480r1198b1512, p2l190t1525r305b1560],
39	containing	VBG	O	contain	partmod	37	SENT_49	[p2l974t1480r1198b1512, p2l190t1525r305b1560],
40	regimens	NNS	O	regimen	dobj	39	SENT_49	[p2l322t1525r477b1560],
41	.	.	O	.	_	0	SENT_49	[p2l322t1525r477b1560],

1	As	IN	O	as	mark	2	SENT_50	[p2l495t1525r534b1551],
2	shown	VBN	O	show	advcl	16	SENT_50	[p2l552t1525r654b1551],
3	in	IN	O	in	_	0	SENT_50	[p2l672t1525r703b1550],
4	Figure	NN	O	figure	prep_in	2	SENT_50	[p2l720t1525r825b1560],
5	2	CD	NUMBER	2	num	4	SENT_50	[p2l844t1525r868b1556],
6	,	,	O	,	_	0	SENT_50	[p2l844t1525r868b1556],
7	the	DT	O	the	det	8	SENT_50	[p2l887t1525r937b1551],
8	distribution	NN	O	distribution	nsubj	16	SENT_50	[p2l955t1525r1150b1551],
9	of	IN	O	of	_	0	SENT_50	[p2l1168t1525r1202b1551],
10	SCA	NNP	ORGANIZATION	SCA	nn	11	SENT_50	[p2l189t1571r260b1597],
11	values	NNS	O	value	prep_of	8	SENT_50	[p2l277t1571r375b1597],
12	from	IN	O	from	_	0	SENT_50	[p2l395t1571r475b1597],
13	these	DT	O	these	det	14	SENT_50	[p2l495t1571r577b1597],
14	patients	NNS	O	patient	prep_from	11	SENT_50	[p2l597t1571r726b1606],
15	was	VBD	O	be	cop	16	SENT_50	[p2l745t1580r801b1597],
16	comparable	JJ	O	comparable	dep	59	SENT_50	[p2l821t1571r1013b1606],
17	to	TO	O	to	_	0	SENT_50	[p2l1034t1576r1064b1597],
18	that	DT	O	that	prep_to	16	SENT_50	[p2l1085t1571r1148b1597],
19	of	IN	O	of	_	0	SENT_50	[p2l1168t1571r1202b1597],
20	patients	NNS	O	patient	prep_of	18	SENT_50	[p2l189t1617r319b1652],
21	in	IN	O	in	_	0	SENT_50	[p2l333t1617r363b1642],
22	the	DT	O	the	det	27	SENT_50	[p2l377t1617r427b1643],
23	M98	NN	O	m98	nn	27	SENT_50	[p2l440t1617r586b1642],
24	—	NN	O	—	nn	27	SENT_50	[p2l440t1617r586b1642],
25	863	CD	NUMBER	863	num	27	SENT_50	[p2l440t1617r586b1642],
26	trial	NN	O	trial	nn	27	SENT_50	[p2l600t1617r666b1643],
27	(	NN	O	(	prep_in	16	SENT_50	[p2l680t1618r706b1652],
28	1	CD	NUMBER	1	num	29	SENT_50	[p2l680t1618r706b1652],
29	)	NN	O	)	dep	27	SENT_50	[p2l680t1618r706b1652],
30	=	JJ	O	=	amod	32	SENT_50	[p2l716t1628r741b1637],
31	0.22	CD	NUMBER	0.22	tmod	30	SENT_50	[p2l751t1617r835b1649],
32	)	NN	O	)	dep	29	SENT_50	[p2l751t1617r835b1649],
33	;	:	O	;	_	0	SENT_50	[p2l751t1617r835b1649],
34	speciﬁcally	RB	O	speciﬁcally	advmod	47	SENT_50	[p2l849t1617r1034b1652],
35	,	,	O	,	_	0	SENT_50	[p2l849t1617r1034b1652],
36	the	DT	O	the	det	38	SENT_50	[p2l1048t1617r1097b1643],
37	mean	NN	O	mean	nn	38	SENT_50	[p2l1111t1626r1199b1643],
38	values	NNS	O	value	nsubj	47	SENT_50	[p2l188t1663r286b1689],
39	were	VBD	O	be	cop	47	SENT_50	[p2l298t1672r374b1689],
40	not	RB	O	not	neg	47	SENT_50	[p2l387t1668r441b1689],
41	signiﬁcantly	RB	O	signiﬁcantly	advmod	47	SENT_50	[p2l453t1663r649b1698],
42	different	JJ	O	different	amod	47	SENT_50	[p2l661t1663r805b1689],
43	(	NN	O	(	nn	47	SENT_50	[p2l818t1664r844b1698],
44	p	NN	O	p	nn	47	SENT_50	[p2l818t1664r844b1698],
45	=	JJ	O	=	amod	47	SENT_50	[p2l853t1674r878b1683],
46	0.17	CD	NUMBER	0.17	num	47	SENT_50	[p2l887t1660r963b1696],
47	)	NN	O	)	parataxis	16	SENT_50	[p2l887t1660r963b1696],
48	and	CC	O	and	_	0	SENT_50	[p2l976t1663r1035b1689],
49	there	EX	O	there	expl	50	SENT_50	[p2l1048t1663r1131b1689],
50	was	VBD	O	be	parataxis	16	SENT_50	[p2l1143t1672r1199b1689],
51	no	DT	O	no	det	52	SENT_50	[p2l189t1717r229b1734],
52	difference	NN	O	difference	nsubj	50	SENT_50	[p2l246t1708r412b1734],
53	between	IN	O	between	_	0	SENT_50	[p2l429t1708r564b1734],
54	efavirenz	NN	O	efavirenz	prep_between	52	SENT_50	[p2l580t1708r740b1734],
55	-	:	O	-	_	0	SENT_50	[p2l580t1708r740b1734],
56	and	CC	O	and	_	0	SENT_50	[p2l758t1708r817b1734],
57	nevirapine-containing	JJ	O	nevirapine-containing	amod	58	SENT_50	[p2l834t1708r1200b1743],
58	regimens	NNS	O	regimen	prep_between	52	SENT_50	[p2l189t1754r337b1789],
59	(	VBP	O	(	_	0	SENT_50	[p2l353t1755r380b1789],
60	[	NN	O	[	dobj	59	SENT_50	[p2l353t1755r380b1789],
61	7	CD	NUMBER	7	num	64	SENT_50	[p2l353t1755r380b1789],
62	=	JJ	O	=	amod	64	SENT_50	[p2l391t1765r416b1774],
63	0.29	CD	NUMBER	0.29	tmod	62	SENT_50	[p2l428t1754r511b1787],
64	)	NN	O	)	nsubj	59	SENT_50	[p2l428t1754r511b1787],
65	.	.	O	.	_	0	SENT_50	[p2l428t1754r511b1787],

1	We	PRP	O	we	nsubj	2	SENT_51	[p2l226t1801r277b1826],
2	investigated	VBD	O	investigate	_	0	SENT_51	[p2l291t1800r486b1835],
3	virologic	JJ	O	virologic	amod	7	SENT_51	[p2l499t1800r649b1835],
4	,	,	O	,	_	0	SENT_51	[p2l499t1800r649b1835],
5	immunologic	JJ	O	immunologic	amod	7	SENT_51	[p2l664t1800r888b1835],
6	,	,	O	,	_	0	SENT_51	[p2l664t1800r888b1835],
7	demographic	JJ	O	demographic	dobj	2	SENT_51	[p2l902t1800r1125b1835],
8	,	,	O	,	_	0	SENT_51	[p2l902t1800r1125b1835],
9	and	CC	O	and	_	0	SENT_51	[p2l1140t1800r1199b1826],
10	clinical	JJ	O	clinical	amod	11	SENT_51	[p2l189t1846r306b1872],
11	parameters	NNS	O	parameter	dobj	2	SENT_51	[p2l328t1851r511b1881],
12	for	IN	O	for	_	0	SENT_51	[p2l534t1846r583b1872],
13	correlates	NNS	O	correlate	prep_for	7	SENT_51	[p2l604t1846r764b1872],
14	of	IN	O	of	_	0	SENT_51	[p2l787t1846r822b1872],
15	persistent	JJ	O	persistent	amod	16	SENT_51	[p2l841t1846r1001b1881],
16	viremia	NN	O	viremia	prep_of	13	SENT_51	[p2l1023t1846r1146b1872],
17	in	IN	O	in	_	0	SENT_51	[p2l1168t1846r1199b1871],
18	samples	NNS	O	sample	prep_in	2	SENT_51	[p2l189t1892r315b1927],
19	from	IN	O	from	_	0	SENT_51	[p2l328t1892r408b1918],
20	both	DT	O	both	det	21	SENT_51	[p2l420t1892r495b1918],
21	arms	NNS	O	arm	prep_from	2	SENT_51	[p2l508t1901r585b1918],
22	of	IN	O	of	_	0	SENT_51	[p2l599t1892r633b1918],
23	the	DT	O	the	det	27	SENT_51	[p2l643t1892r693b1918],
24	M98	NN	O	m98	nn	27	SENT_51	[p2l706t1892r852b1917],
25	—	NN	O	—	nn	27	SENT_51	[p2l706t1892r852b1917],
26	863	CD	NUMBER	863	num	27	SENT_51	[p2l706t1892r852b1917],
27	trial	NN	O	trial	prep_of	21	SENT_51	[p2l866t1892r940b1918],
28	.	.	O	.	_	0	SENT_51	[p2l866t1892r940b1918],

1	Comparison	NN	O	comparison	dep	20	SENT_52	[p2l954t1892r1155b1927],
2	of	IN	O	of	_	0	SENT_52	[p2l1168t1892r1202b1918],
3	the	DT	O	the	det	6	SENT_52	[p2l190t1938r239b1964],
4	HIV-1	NN	O	hiv-1	nn	6	SENT_52	[p2l255t1938r352b1964],
5	RNA	NN	O	rna	nn	6	SENT_52	[p2l370t1938r448b1964],
6	level	NN	O	level	prep_of	1	SENT_52	[p2l463t1938r535b1964],
7	by	IN	O	by	dep	1	SENT_52	[p2l550t1938r587b1973],
8	SCA	NNP	ORGANIZATION	SCA	pobj	7	SENT_52	[p2l603t1938r673b1964],
9	at	IN	O	at	dep	1	SENT_52	[p2l688t1943r717b1964],
10	week	NN	DURATION	week	pobj	9	SENT_52	[p2l731t1938r811b1964],
11	60	CD	NUMBER	60	num	10	SENT_52	[p2l827t1938r862b1963],
12	to	TO	O	to	_	0	SENT_52	[p2l879t1943r909b1964],
13	pretherapy	JJ	O	pretherapy	amod	15	SENT_52	[p2l926t1938r1107b1973],
14	RNA	NN	O	rna	nn	15	SENT_52	[p2l1121t1938r1199b1964],
15	levels	NNS	O	level	prep_to	10	SENT_52	[p2l189t1984r275b2010],
16	(	CD	NUMBER	(	num	19	SENT_52	[p2l293t1984r407b2019],
17	Figure	NNP	O	Figure	nn	19	SENT_52	[p2l293t1984r407b2019],
18	3	CD	NUMBER	3	num	19	SENT_52	[p2l423t1984r450b2016],
19	)	NN	O	)	nsubj	20	SENT_52	[p2l423t1984r450b2016],
20	showed	VBD	O	show	_	0	SENT_52	[p2l467t1984r586b2010],
21	a	DT	O	a	det	25	SENT_52	[p2l602t1993r619b2010],
22	signiﬁcant	NN	O	signiﬁcant	nn	25	SENT_52	[p2l634t1984r802b2019],
23	correlation	NN	O	correlation	nn	25	SENT_52	[p2l818t1984r1001b2010],
24	(	CD	NUMBER	(	num	25	SENT_52	[p2l1017t1985r1044b2019],
25	[	NN	O	[	iobj	20	SENT_52	[p2l1017t1985r1044b2019],
26	7	CD	NUMBER	7	number	27	SENT_52	[p2l1017t1985r1044b2019],
27	<	JJR	O	<	amod	25	SENT_52	[p2l1061t1986r1086b2008],
28	0.001	CD	NUMBER	0.001	num	29	SENT_52	[p2l1104t1984r1199b2017],
29	)	NN	O	)	dobj	20	SENT_52	[p2l1104t1984r1199b2017],
30	and	CC	O	and	_	0	SENT_52	[p2l189t2030r249b2056],
31	a	DT	O	a	det	33	SENT_52	[p2l260t2039r277b2056],
32	median	JJ	O	median	amod	33	SENT_52	[p2l288t2030r408b2056],
33	decrease	NN	O	decrease	dobj	20	SENT_52	[p2l420t2030r559b2056],
34	between	IN	O	between	_	0	SENT_52	[p2l570t2030r705b2056],
35	pretherapy	JJ	O	pretherapy	prep_between	33	SENT_52	[p2l717t2030r898b2065],
36	and	CC	O	and	_	0	SENT_52	[p2l909t2030r968b2056],
37	week	NN	DURATION	week	dep	41	SENT_52	[p2l979t2030r1059b2056],
38	60	CD	NUMBER	60	num	41	SENT_52	[p2l1071t2030r1106b2055],
39	HIV1	NN	O	hiv1	nn	41	SENT_52	[p2l1118t2031r1198b2056, p2l192t2075r203b2100],
40	RNA	NN	O	rna	nn	41	SENT_52	[p2l227t2075r305b2101],
41	values	NNS	O	value	conj_and	20	SENT_52	[p2l325t2075r423b2101],
42	of	IN	O	of	_	0	SENT_52	[p2l445t2075r480b2101],
43	14,250-fold	JJ	O	14,250-fold	amod	45	SENT_52	[p2l501t2075r680b2106],
44	(	NN	O	(	nn	45	SENT_52	[p2l703t2076r804b2110],
45	range	NN	O	range	prep_of	41	SENT_52	[p2l703t2076r804b2110],
46	448	CD	NUMBER	448	dep	45	SENT_52	[p2l825t2075r893b2100],
47	-	:	O	-	_	0	SENT_52	[p2l825t2075r893b2100],
48	to1,720,000-fold	JJ	O	to1,720,000-fold	amod	49	SENT_52	[p2l916t2073r1198b2108],
49	)	NN	O	)	dep	45	SENT_52	[p2l916t2073r1198b2108],
50	.	.	O	.	_	0	SENT_52	[p2l916t2073r1198b2108],

1	The	DT	O	the	det	8	SENT_53	[p2l189t2122r251b2148],
2	correlation	NN	O	correlation	npadvmod	3	SENT_53	[p2l273t2122r455b2148],
3	coefﬁcient	JJ	O	coefﬁcient	amod	8	SENT_53	[p2l477t2122r649b2148],
4	(	NN	O	(	nn	8	SENT_53	[p2l671t2114r708b2154],
5	72	CD	NUMBER	72	num	8	SENT_53	[p2l671t2114r708b2154],
6	=	JJ	O	=	amod	8	SENT_53	[p2l726t2133r751b2142],
7	0.17	CD	NUMBER	0.17	tmod	6	SENT_53	[p2l770t2119r845b2155],
8	)	NN	O	)	nsubj	9	SENT_53	[p2l770t2119r845b2155],
9	suggests	VBZ	O	suggest	_	0	SENT_53	[p2l867t2127r996b2157],
10	pretherapy	JJ	O	pretherapy	amod	14	SENT_53	[p2l1018t2122r1199b2157],
11	viral	JJ	O	viral	amod	14	SENT_53	[p2l188t2167r260b2193],
12	RNA	NN	O	rna	nn	14	SENT_53	[p2l275t2167r354b2193],
13	level	NN	O	level	nn	14	SENT_53	[p2l368t2167r441b2193],
14	accounts	NNS	O	account	dobj	9	SENT_53	[p2l457t2172r599b2193],
15	for	IN	O	for	_	0	SENT_53	[p2l615t2167r664b2193],
16	17	CD	PERCENT	17	num	17	SENT_53	[p2l681t2165r747b2196],
17	%	NN	PERCENT	%	prep_for	14	SENT_53	[p2l681t2165r747b2196],
18	of	IN	O	of	_	0	SENT_53	[p2l767t2167r802b2193],
19	the	DT	O	the	det	20	SENT_53	[p2l815t2167r864b2193],
20	variability	NN	O	variability	prep_of	17	SENT_53	[p2l879t2167r1044b2202],
21	in	IN	O	in	_	0	SENT_53	[p2l1060t2167r1091b2192],
22	stable	JJ	O	stable	amod	23	SENT_53	[p2l1106t2167r1199b2193],
23	viremia	NN	O	viremia	prep_in	20	SENT_53	[p2l188t2213r312b2239],
24	on	IN	O	on	dep	14	SENT_53	[p2l324t2222r365b2239],
25	therapy	NN	O	therapy	pobj	24	SENT_53	[p2l379t2213r510b2248],
26	,	,	O	,	_	0	SENT_53	[p2l379t2213r510b2248],
27	and	CC	O	and	_	0	SENT_53	[p2l524t2213r583b2239],
28	that	IN	O	that	dep	39	SENT_53	[p2l597t2213r660b2239],
29	other	JJ	O	other	amod	30	SENT_53	[p2l673t2213r761b2239],
30	factors	NNS	O	factor	nsubj	39	SENT_53	[p2l773t2213r891b2244],
31	,	,	O	,	_	0	SENT_53	[p2l773t2213r891b2244],
32	such	JJ	O	such	_	0	SENT_53	[p2l905t2213r977b2239],
33	as	IN	O	as	_	0	SENT_53	[p2l990t2222r1019b2239],
34	time	NN	O	time	prep_such_as	30	SENT_53	[p2l1034t2213r1105b2239],
35	since	IN	O	since	_	0	SENT_53	[p2l1118t2213r1199b2239],
36	infection	NN	O	infection	prep_since	34	SENT_53	[p2l189t2259r344b2290],
37	,	,	O	,	_	0	SENT_53	[p2l189t2259r344b2290],
38	may	MD	O	may	aux	39	SENT_53	[p2l360t2268r426b2294],
39	contribute	VB	O	contribute	conj_and	24	SENT_53	[p2l440t2259r612b2285],
40	to	TO	O	to	_	0	SENT_53	[p2l628t2264r659b2285],
41	the	DT	O	the	det	42	SENT_53	[p2l675t2259r724b2285],
42	level	NN	O	level	prep_to	39	SENT_53	[p2l739t2259r812b2285],
43	of	IN	O	of	_	0	SENT_53	[p2l827t2259r862b2285],
44	on-therapy	JJ	O	on-therapy	amod	45	SENT_53	[p2l873t2259r1054b2294],
45	viremia	NN	O	viremia	prep_of	42	SENT_53	[p2l1067t2259r1198b2285],
46	.	.	O	.	_	0	SENT_53	[p2l1067t2259r1198b2285],

1	No	DT	O	no	det	3	SENT_54	[p2l188t2306r235b2331],
2	signiﬁcant	NN	O	signiﬁcant	nn	3	SENT_54	[p2l263t2305r432b2340],
3	differences	NNS	O	difference	nsubjpass	8	SENT_54	[p2l459t2305r639b2331],
4	between	IN	O	between	_	0	SENT_54	[p2l666t2305r801b2331],
5	treatment	NN	O	treatment	nn	6	SENT_54	[p2l830t2310r991b2331],
6	arms	NNS	O	arm	prep_between	3	SENT_54	[p2l1018t2314r1095b2331],
7	were	VBD	O	be	auxpass	8	SENT_54	[p2l1122t2314r1199b2331],
8	detected	VBN	O	detect	_	0	SENT_54	[p2l189t2351r328b2377],
9	in	IN	O	in	_	0	SENT_54	[p2l350t2351r380b2376],
10	median	JJ	O	median	amod	13	SENT_54	[p2l402t2351r522b2377],
11	HIV-1	NN	MISC	hiv-1	nn	13	SENT_54	[p2l543t2351r640b2377],
12	RNA	NN	MISC	rna	nn	13	SENT_54	[p2l664t2351r742b2377],
13	reduction	NN	O	reduction	prep_in	8	SENT_54	[p2l763t2351r930b2382],
14	,	,	O	,	_	0	SENT_54	[p2l763t2351r930b2382],
15	and	CC	O	and	_	0	SENT_54	[p2l952t2351r1011b2377],
16	additional	JJ	O	additional	amod	17	SENT_54	[p2l1033t2351r1199b2377],
17	analyses	NNS	O	analysis	nsubj	18	SENT_54	[p2l189t2397r319b2432],
18	(	VBP	O	(	conj_and	8	SENT_54	[p2l340t2397r552b2432],
19	unpublished	JJ	O	unpublished	amod	20	SENT_54	[p2l340t2397r552b2432],
20	data	NNS	O	datum	nsubj	22	SENT_54	[p2l571t2397r651b2430],
21	)	RB	O	)	advmod	22	SENT_54	[p2l571t2397r651b2430],
22	indicated	VBD	O	indicate	ccomp	18	SENT_54	[p2l670t2397r822b2423],
23	that	IN	O	that	complm	39	SENT_54	[p2l842t2397r905b2423],
24	both	CC	O	both	preconj	26	SENT_54	[p2l923t2397r998b2423],
25	the	DT	O	the	det	26	SENT_54	[p2l1018t2397r1067b2423],
26	magnitude	NN	O	magnitude	nsubjpass	39	SENT_54	[p2l1086t2397r1198b2432, p2l190t2443r261b2469],
27	of	IN	O	of	_	0	SENT_54	[p2l283t2443r317b2469],
28	HIV-1	NN	O	hiv-1	nn	30	SENT_54	[p2l336t2443r433b2469],
29	RNA	NN	O	rna	nn	30	SENT_54	[p2l457t2443r535b2469],
30	reduction	NN	O	reduction	prep_of	26	SENT_54	[p2l557t2443r716b2469],
31	and	CC	O	and	_	0	SENT_54	[p2l738t2443r798b2469],
32	the	DT	O	the	det	33	SENT_54	[p2l820t2443r869b2469],
33	level	NN	O	level	nsubjpass	39	SENT_54	[p2l891t2443r964b2469],
34	of	IN	O	of	_	0	SENT_54	[p2l986t2443r1021b2469],
35	persistent	JJ	O	persistent	amod	36	SENT_54	[p2l1039t2443r1199b2478],
36	viremia	NN	O	viremia	prep_of	33	SENT_54	[p2l188t2488r312b2514],
37	were	VBD	O	be	auxpass	39	SENT_54	[p2l333t2497r409b2514],
38	not	RB	O	not	neg	39	SENT_54	[p2l433t2493r487b2514],
39	associated	VBN	O	associate	ccomp	22	SENT_54	[p2l509t2488r674b2514],
40	with	IN	O	with	_	0	SENT_54	[p2l696t2488r766b2514],
41	pretherapy	JJ	O	pretherapy	amod	42	SENT_54	[p2l789t2488r970b2523],
42	CD4	NN	O	cd4	prep_with	39	SENT_54	[p2l993t2488r1087b2516],
43	+	CC	O	+	_	0	SENT_54	[p2l993t2488r1087b2516],
44	T-cell	NN	O	t-cell	nn	45	SENT_54	[p2l1107t2488r1199b2514],
45	count	NN	O	count	prep_with	39	SENT_54	[p2l189t2539r290b2565],
46	,	,	O	,	_	0	SENT_54	[p2l189t2539r290b2565],
47	change	NN	O	change	prep_with	39	SENT_54	[p2l316t2534r430b2569],
48	in	IN	O	in	_	0	SENT_54	[p2l456t2534r487b2559],
49	CD4	NN	O	cd4	prep_in	47	SENT_54	[p2l513t2534r607b2562],
50	+	CC	O	+	_	0	SENT_54	[p2l513t2534r607b2562],
51	T-cell	NN	O	t-cell	nn	52	SENT_54	[p2l629t2534r722b2560],
52	count	NN	O	count	conj_+	47	SENT_54	[p2l748t2539r841b2560],
53	on	IN	O	on	_	0	SENT_54	[p2l866t2543r907b2560],
54	therapy	NN	O	therapy	prep_on	52	SENT_54	[p2l934t2534r1065b2569],
55	,	,	O	,	_	0	SENT_54	[p2l934t2534r1065b2569],
56	age	NN	O	age	prep_with	39	SENT_54	[p2l1092t2543r1144b2569],
57	at	IN	O	at	_	0	SENT_54	[p2l1170t2539r1199b2560],
58	enrollment	NN	O	enrollment	prep_at	56	SENT_54	[p2l189t2580r378b2611],
59	,	,	O	,	_	0	SENT_54	[p2l189t2580r378b2611],
60	or	CC	O	or	_	0	SENT_54	[p2l394t2589r430b2606],
61	gender	NN	O	gender	prep_with	39	SENT_54	[p2l443t2580r563b2615],
62	.	.	O	.	_	0	SENT_54	[p2l443t2580r563b2615],

1	To	TO	O	to	aux	2	SENT_55	[p2l226t2627r269b2652],
2	examine	VB	O	examine	purpcl	20	SENT_55	[p2l286t2626r422b2652],
3	the	DT	O	the	det	4	SENT_55	[p2l439t2626r488b2652],
4	stability	NN	O	stability	dobj	2	SENT_55	[p2l504t2626r632b2661],
5	of	IN	O	of	_	0	SENT_55	[p2l647t2626r682b2652],
6	the	DT	O	the	det	8	SENT_55	[p2l695t2626r744b2652],
7	low	JJ	O	low	amod	8	SENT_55	[p2l760t2626r815b2652],
8	level	NN	O	level	prep_of	4	SENT_55	[p2l830t2626r902b2652],
9	of	IN	O	of	_	0	SENT_55	[p2l918t2626r953b2652],
10	viremia	NN	O	viremia	prep_of	8	SENT_55	[p2l964t2626r1087b2652],
11	in	IN	O	in	_	0	SENT_55	[p2l1103t2626r1133b2651],
12	the	DT	O	the	det	16	SENT_55	[p2l1149t2626r1199b2652],
13	M98	NN	O	m98	nn	16	SENT_55	[p2l189t2672r335b2697],
14	—	NN	O	—	nn	16	SENT_55	[p2l189t2672r335b2697],
15	863	CD	NUMBER	863	num	16	SENT_55	[p2l189t2672r335b2697],
16	study	NN	O	study	prep_in	2	SENT_55	[p2l350t2672r442b2707],
17	,	,	O	,	_	0	SENT_55	[p2l350t2672r442b2707],
18	we	PRP	O	we	nsubj	20	SENT_55	[p2l456t2681r498b2698],
19	next	RB	O	next	advmod	20	SENT_55	[p2l513t2677r584b2698],
20	performed	VBD	O	perform	_	0	SENT_55	[p2l598t2672r773b2707],
21	a	DT	O	a	det	23	SENT_55	[p2l787t2681r803b2698],
22	longitudinal	JJ	O	longitudinal	amod	23	SENT_55	[p2l816t2672r1016b2707],
23	analysis	NN	O	analysis	dobj	20	SENT_55	[p2l1030t2672r1153b2707],
24	of	IN	O	of	_	0	SENT_55	[p2l1168t2672r1202b2698],
25	HIV-1	NN	O	hiv-1	nn	26	SENT_55	[p2l189t2718r289b2744],
26	RNA	NN	O	rna	prep_of	23	SENT_55	[p2l321t2718r401b2744],
27	after	IN	O	after	_	0	SENT_55	[p2l429t2718r510b2744],
28	week	NN	DURATION	week	prep_after	20	SENT_55	[p2l537t2718r620b2744],
29	60	CD	NUMBER	60	num	28	SENT_55	[p2l649t2718r694b2744],
30	.	.	O	.	_	0	SENT_55	[p2l649t2718r694b2744],

1	Of	IN	O	of	_	0	SENT_56	[p2l724t2718r769b2744],
2	the	DT	O	the	det	4	SENT_56	[p2l795t2718r846b2744],
3	145	CD	NUMBER	145	num	4	SENT_56	[p2l878t2718r933b2743],
4	patients	NNS	O	patient	prep_of	22	SENT_56	[p2l962t2718r1098b2753],
5	with	IN	O	with	_	0	SENT_56	[p2l1126t2718r1199b2744],
6	pretherapy	JJ	O	pretherapy	amod	7	SENT_56	[p2l189t2764r370b2799],
7	samples	NNS	O	sample	prep_with	4	SENT_56	[p2l390t2764r516b2799],
8	who	WP	O	who	nsubj	9	SENT_56	[p2l536t2764r601b2790],
9	had	VBD	O	have	rcmod	4	SENT_56	[p2l622t2764r681b2790],
10	suppression	NN	O	suppression	dobj	9	SENT_56	[p2l701t2764r895b2799],
11	of	IN	O	of	_	0	SENT_56	[p2l915t2764r950b2790],
12	plasma	NN	O	plasma	nn	14	SENT_56	[p2l966t2764r1080b2799],
13	HIV-1	NN	O	hiv-1	nn	14	SENT_56	[p2l1099t2764r1196b2790],
14	RNA	NN	O	rna	prep_of	10	SENT_56	[p2l189t2810r267b2836],
15	between	IN	O	between	_	0	SENT_56	[p2l278t2810r413b2836],
16	weeks	NNS	DURATION	week	prep_between	14	SENT_56	[p2l424t2810r518b2836],
17	24	CD	NUMBER	24	num	16	SENT_56	[p2l531t2810r568b2837],
18	and	CC	O	and	_	0	SENT_56	[p2l580t2810r639b2836],
19	60	CD	NUMBER	60	conj_and	16	SENT_56	[p2l652t2810r695b2841],
20	,	,	O	,	_	0	SENT_56	[p2l652t2810r695b2841],
21	117	CD	NUMBER	117	appos	16	SENT_56	[p2l711t2807r764b2835],
22	had	VBD	O	have	_	0	SENT_56	[p2l776t2810r835b2836],
23	samples	NNS	O	sample	dobj	22	SENT_56	[p2l847t2810r973b2845],
24	available	JJ	O	available	amod	23	SENT_56	[p2l986t2810r1127b2836],
25	and	CC	O	and	_	0	SENT_56	[p2l1140t2810r1199b2836],
26	continuous	JJ	O	continuous	conj_and	24	SENT_56	[p2l189t2856r371b2882],
27	suppression	NN	O	suppression	dep	24	SENT_56	[p2l387t2856r581b2891],
28	(	CD	NUMBER	(	num	27	SENT_56	[p2l597t2856r644b2889],
29	all	DT	O	all	dep	31	SENT_56	[p2l597t2856r644b2889],
30	values	NNS	O	value	dep	31	SENT_56	[p2l658t2856r756b2882],
31	<	JJR	O	<	rcmod	23	SENT_56	[p2l774t2856r839b2881],
32	50	CD	NUMBER	50	num	33	SENT_56	[p2l774t2856r839b2881],
33	copies/ml	NN	O	copies/ml	nsubj	22	SENT_56	[p2l855t2856r1015b2891],
34	,	,	O	,	_	0	SENT_56	[p2l855t2856r1015b2891],
35	Figure	NNP	O	Figure	nn	37	SENT_56	[p2l1031t2856r1135b2891],
36	S1	NN	O	s1	nn	37	SENT_56	[p2l1151t2856r1198b2888],
37	)	NN	O	)	appos	33	SENT_56	[p2l1151t2856r1198b2888],
38	at	IN	O	at	_	0	SENT_56	[p2l189t2907r218b2928],
39	subsequent	JJ	O	subsequent	amod	41	SENT_56	[p2l235t2902r418b2937],
40	time	NN	O	time	nn	41	SENT_56	[p2l435t2902r506b2928],
41	points	NNS	O	point	prep_at	37	SENT_56	[p2l524t2902r633b2937],
42	.	.	O	.	_	0	SENT_56	[p2l524t2902r633b2937],

1	Results	NNS	O	result	nsubjpass	26	SENT_57	[p2l650t2902r764b2928],
2	of	IN	O	of	_	0	SENT_57	[p2l782t2902r817b2928],
3	SCA	NNP	ORGANIZATION	SCA	nn	4	SENT_57	[p2l830t2902r901b2928],
4	testing	NN	O	testing	prep_of	1	SENT_57	[p2l918t2902r1027b2937],
5	of	IN	O	of	_	0	SENT_57	[p2l1043t2902r1078b2928],
6	one	CD	NUMBER	one	prep_of	4	SENT_57	[p2l1091t2911r1150b2928],
7	to	TO	O	to	aux	8	SENT_57	[p2l1168t2907r1198b2928],
8	ﬁve	VB	O	ﬁve	infmod	4	SENT_57	[p2l189t2947r244b2973],
9	samples	NNS	O	sample	dobj	8	SENT_57	[p2l264t2947r390b2982],
10	(	CD	NUMBER	(	num	11	SENT_57	[p2l411t2947r542b2980],
11	median	NN	O	median	xcomp	8	SENT_57	[p2l411t2947r542b2980],
12	of	IN	O	of	_	0	SENT_57	[p2l561t2947r595b2973],
13	three	CD	NUMBER	three	num	14	SENT_57	[p2l612t2947r707b2980],
14	)	CD	NUMBER	)	prep_of	11	SENT_57	[p2l612t2947r707b2980],
15	from	IN	O	from	_	0	SENT_57	[p2l726t2947r806b2973],
16	each	DT	O	each	prep_from	8	SENT_57	[p2l825t2947r898b2973],
17	of	IN	O	of	_	0	SENT_57	[p2l917t2947r951b2973],
18	these	DT	O	these	det	19	SENT_57	[p2l968t2947r1049b2973],
19	patients	NNS	O	patient	prep_of	16	SENT_57	[p2l1069t2947r1198b2982],
20	during	IN	O	during	_	0	SENT_57	[p2l189t2993r299b3028],
21	weeks	NNS	DURATION	week	prep_during	8	SENT_57	[p2l314t2993r408b3019],
22	60-110	CD	NUMBER	60-110	num	21	SENT_57	[p2l427t2993r540b3018],
23	of	IN	O	of	_	0	SENT_57	[p2l559t2993r593b3019],
24	therapy	NN	O	therapy	prep_of	21	SENT_57	[p2l609t2993r733b3028],
25	are	VBP	O	be	auxpass	26	SENT_57	[p2l750t3002r800b3019],
26	shown	VBN	O	show	_	0	SENT_57	[p2l818t2993r920b3019],
27	in	IN	O	in	_	0	SENT_57	[p2l938t2993r969b3018],
28	Figure	NNP	O	Figure	prep_in	26	SENT_57	[p2l986t2993r1090b3028],
29	4	CD	NUMBER	4	num	28	SENT_57	[p2l1109t2994r1133b3019],
30	.	.	O	.	_	0	SENT_57	[p2l1109t2994r1133b3019],

1	No	DT	O	no	_	0	SENT_58	[p2l1151t2994r1198b3019],

1	F	NN	O	f	nn	2	SENT_59	[p2l188t3077r261b3136],
2	PLoS	NN	O	plo	nsubj	3	SENT_59	[p2l288t3093r352b3116],
3	Pathogens	VBD	O	pathogen	_	0	SENT_59	[p2l367t3092r511b3123],
4	|	CD	NUMBER	|	num	5	SENT_59	[p2l526t3091r528b3124],
5	www	NN	O	www	dobj	3	SENT_59	[p2l543t3092r882b3123],
6	.	.	O	.	_	0	SENT_59	[p2l543t3092r882b3123],

1	p	NN	O	p	_	0	SENT_60	[p2l543t3092r882b3123],
2	|	CD	NUMBER	|	num	3	SENT_60	[p2l543t3092r882b3123],
3	ospathogens.org	NN	O	ospathogens.org	dep	1	SENT_60	[p2l543t3092r882b3123],

1	Source	NN	O	source	_	0	SENT_61	[p2l1731t107r1824b130],
2	of	IN	O	of	_	0	SENT_61	[p2l1837t106r1865b130],
3	Stable	JJ	O	stable	amod	5	SENT_61	[p2l1876t106r1960b130],
4	HIV-1	NN	O	hiv-1	nn	5	SENT_61	[p2l1975t107r2041b130],
5	Viremia	NN	O	viremia	prep_of	1	SENT_61	[p2l2058t107r2161b130],
6	on	IN	O	on	_	0	SENT_61	[p2l2175t113r2208b130],
7	ART	NN	O	art	prep_on	1	SENT_61	[p2l2222t107r2277b130],

1	signiﬁcant	NN	O	signiﬁcant	nsubj	2	SENT_62	[p2l1277t206r1445b241],
2	decreases	VBZ	O	decrease	_	0	SENT_62	[p2l1458t206r1611b232],
3	in	IN	O	in	mark	8	SENT_62	[p2l1626t206r1657b231],
4	HIV-1	NN	O	hiv-1	nn	6	SENT_62	[p2l1670t206r1767b232],
5	RNA	NN	MISC	rna	nn	6	SENT_62	[p2l1783t206r1861b232],
6	levels	NNS	O	level	nsubjpass	8	SENT_62	[p2l1874t206r1960b232],
7	were	VBD	O	be	auxpass	8	SENT_62	[p2l1973t215r2050b232],
8	detected	VBN	O	detect	advcl	2	SENT_62	[p2l2063t206r2203b232],
9	over	IN	O	over	_	0	SENT_62	[p2l2216t215r2288b232],
10	time	NN	O	time	prep_over	8	SENT_62	[p2l1277t252r1357b283],
11	,	,	O	,	_	0	SENT_62	[p2l1277t252r1357b283],
12	regardless	RB	O	regardless	_	0	SENT_62	[p2l1372t252r1534b287],
13	of	IN	O	of	_	0	SENT_62	[p2l1549t252r1583b278],
14	whether	IN	O	whether	complm	17	SENT_62	[p2l1593t252r1727b278],
15	patients	NNS	O	patient	nsubjpass	17	SENT_62	[p2l1740t252r1870b287],
16	were	VBD	O	be	auxpass	17	SENT_62	[p2l1884t261r1960b278],
17	analyzed	VBN	O	analyze	prepc_regardless_of	8	SENT_62	[p2l1975t252r2114b287],
18	overall	JJ	O	overall	advmod	17	SENT_62	[p2l2128t252r2238b278],
19	or	CC	O	or	_	0	SENT_62	[p2l2252t261r2287b278],
20	separately	RB	O	separately	conj_or	18	SENT_62	[p2l1277t298r1441b333],
21	by	IN	O	by	_	0	SENT_62	[p2l1460t298r1498b333],
22	treatment	NN	O	treatment	nn	23	SENT_62	[p2l1519t303r1680b324],
23	group	NN	O	group	agent	17	SENT_62	[p2l1700t307r1805b333],
24	;	:	O	;	_	0	SENT_62	[p2l1700t307r1805b333],
25	i.e.	FW	O	i.e.	nsubj	34	SENT_62	[p2l1827t298r1878b329],
26	,	,	O	,	_	0	SENT_62	[p2l1827t298r1878b329],
27	the	DT	O	the	det	30	SENT_62	[p2l1901t298r1950b324],
28	HIV-1	NN	O	hiv-1	dep	29	SENT_62	[p2l1970t298r2067b324],
29	RNA	NN	O	rna	amod	30	SENT_62	[p2l2091t298r2169b324],
30	slopes	NNS	O	slope	appos	25	SENT_62	[p2l2189t298r2286b333],
31	were	VBD	O	be	cop	34	SENT_62	[p2l1276t352r1352b369],
32	not	RB	O	not	neg	34	SENT_62	[p2l1372t348r1426b369],
33	signiﬁcantly	RB	O	signiﬁcantly	advmod	34	SENT_62	[p2l1445t343r1641b378],
34	different	JJ	O	different	parataxis	2	SENT_62	[p2l1660t343r1804b369],
35	from	IN	O	from	_	0	SENT_62	[p2l1823t343r1903b369],
36	o	NN	O	o	prep_in	34	SENT_62	[p2l1922t343r1938b368],
37	overall	JJ	O	overall	amod	36	SENT_62	[p2l1958t343r2067b369],
38	or	CC	O	or	_	0	SENT_62	[p2l2087t352r2122b369],
39	in	IN	O	in	_	0	SENT_62	[p2l2140t343r2171b368],
40	either	CC	O	either	dep	34	SENT_62	[p2l2191t343r2287b369],
41	treatment	NN	O	treatment	nn	42	SENT_62	[p2l1277t394r1439b415],
42	group	NN	O	group	conj	34	SENT_62	[p2l1453t398r1557b424],
43	.	.	O	.	_	0	SENT_62	[p2l1453t398r1557b424],

1	Among	IN	O	among	_	0	SENT_63	[p2l1571t389r1691b424],
2	all	DT	O	all	det	3	SENT_63	[p2l1704t389r1741b415],
3	patients	NNS	O	patient	prep_among	15	SENT_63	[p2l1755t389r1885b424],
4	combined	VBN	O	combine	partmod	3	SENT_63	[p2l1900t389r2069b420],
5	,	,	O	,	_	0	SENT_63	[p2l1900t389r2069b420],
6	a	DT	O	a	det	7	SENT_63	[p2l2085t398r2101b415],
7	half-life	NN	O	half-life	nsubjpass	15	SENT_63	[p2l2114t389r2241b415],
8	of	IN	O	of	_	0	SENT_63	[p2l2255t389r2290b415],
9	less	JJR	DURATION	less	mwe	10	SENT_63	[p2l1276t435r1331b461],
10	than	IN	DURATION	than	quantmod	11	SENT_63	[p2l1344t435r1415b461],
11	67	CD	DURATION	67	num	12	SENT_63	[p2l1428t433r1463b460],
12	wk	NN	DURATION	wk	prep_of	7	SENT_63	[p2l1474t435r1518b460],
13	could	MD	O	could	aux	15	SENT_63	[p2l1530t435r1619b461],
14	be	VB	O	be	auxpass	15	SENT_63	[p2l1630t435r1668b461],
15	excluded	VBN	O	exclude	_	0	SENT_63	[p2l1680t435r1825b461],
16	with	IN	O	with	_	0	SENT_63	[p2l1836t435r1906b461],
17	95	CD	PERCENT	95	number	18	SENT_63	[p2l1919t435r1987b464],
18	%	NN	PERCENT	%	amod	19	SENT_63	[p2l1919t435r1987b464],
19	conﬁdence	NN	O	conﬁdence	prep_with	15	SENT_63	[p2l2003t435r2189b466],
20	,	,	O	,	_	0	SENT_63	[p2l2003t435r2189b466],
21	using	VBG	O	use	xcomp	15	SENT_63	[p2l2201t435r2287b470],
22	a	DT	O	a	det	27	SENT_63	[p2l1277t489r1293b506],
23	mixed	JJ	O	mixed	amod	27	SENT_63	[p2l1308t480r1407b506],
24	model	NN	O	model	nn	27	SENT_63	[p2l1422t480r1523b506],
25	linear	JJ	O	linear	amod	27	SENT_63	[p2l1537t480r1633b506],
26	regression	NN	O	regression	nn	27	SENT_63	[p2l1647t480r1814b515],
27	analysis	NN	O	analysis	dobj	21	SENT_63	[p2l1829t480r1960b515],
28	.	.	O	.	_	0	SENT_63	[p2l1829t480r1960b515],

1	The	DT	O	the	det	2	SENT_64	[p2l1314t526r1376b552],
2	study	NN	O	study	nsubj	5	SENT_64	[p2l1396t526r1481b561],
3	presented	VBN	O	present	partmod	2	SENT_64	[p2l1501t526r1662b561],
4	here	RB	O	here	advmod	3	SENT_64	[p2l1681t526r1753b552],
5	represents	VBZ	O	represent	_	0	SENT_64	[p2l1773t531r1942b561],
6	the	DT	O	the	det	11	SENT_64	[p2l1964t526r2013b552],
7	ﬁrst	JJ	O	ﬁrst	amod	11	SENT_64	[p2l2033t526r2096b552],
8	large-scale	JJ	O	large-scale	amod	11	SENT_64	[p2l2116t526r2286b561],
9	and	CC	O	and	_	0	SENT_64	[p2l1277t572r1336b598],
10	long-term	JJ	O	long-term	amod	11	SENT_64	[p2l1354t572r1517b607],
11	analysis	NN	O	analysis	dobj	5	SENT_64	[p2l1536t572r1658b607],
12	of	IN	O	of	_	0	SENT_64	[p2l1678t572r1713b598],
13	persistent	JJ	O	persistent	amod	14	SENT_64	[p2l1728t572r1888b607],
14	viremia	NN	O	viremia	prep_of	11	SENT_64	[p2l1906t572r2029b598],
15	in	IN	O	in	_	0	SENT_64	[p2l2047t572r2078b597],
16	patients	NNS	O	patient	prep_in	5	SENT_64	[p2l2097t572r2227b607],
17	on	IN	O	on	_	0	SENT_64	[p2l2246t581r2287b598],
18	standard	JJ	O	standard	amod	20	SENT_64	[p2l1277t617r1419b643],
19	antiretroviral	JJ	O	antiretroviral	amod	20	SENT_64	[p2l1434t617r1654b643],
20	therapy	NN	O	therapy	prep_on	16	SENT_64	[p2l1670t617r1801b652],
21	.	.	O	.	_	0	SENT_64	[p2l1670t617r1801b652],

1	Residual	JJ	O	residual	amod	2	SENT_65	[p2l1817t617r1955b643],
2	viremia	NN	O	viremia	nsubj	17	SENT_65	[p2l1968t617r2092b643],
3	on	IN	O	on	_	0	SENT_65	[p2l2106t626r2147b643],
4	therapy	NN	O	therapy	nn	6	SENT_65	[p2l2163t617r2287b652],
5	(	CD	NUMBER	(	num	6	SENT_65	[p2l1278t663r1409b696],
6	median	NN	O	median	nn	8	SENT_65	[p2l1278t663r1409b696],
7	viral	JJ	O	viral	amod	8	SENT_65	[p2l1419t663r1491b689],
8	RNA	NN	O	rna	prep_on	2	SENT_65	[p2l1502t663r1581b689],
9	of	IN	O	of	_	0	SENT_65	[p2l1591t663r1626b689],
10	3.1	CD	NUMBER	3.1	num	13	SENT_65	[p2l1635t663r1676b689],
11	copies/ml	NN	O	copies/ml	nn	13	SENT_65	[p2l1691t663r1843b698],
12	plasma	NN	O	plasma	nn	13	SENT_65	[p2l1855t663r1978b698],
13	)	NN	O	)	prep_of	8	SENT_65	[p2l1855t663r1978b698],
14	was	VBD	O	be	cop	17	SENT_65	[p2l1989t672r2045b689],
15	more	JJR	O	more	dep	16	SENT_65	[p2l2057t672r2141b689],
16	than	IN	O	than	advmod	17	SENT_65	[p2l2154t663r2226b689],
17	10fold	JJ	O	10fold	_	0	SENT_65	[p2l2240t663r2286b688, p2l1276t709r1340b735],
18	below	IN	O	below	_	0	SENT_65	[p2l1360t709r1455b735],
19	the	DT	O	the	det	20	SENT_65	[p2l1477t709r1526b735],
20	limit	NN	O	limit	prep_below	17	SENT_65	[p2l1547t709r1623b735],
21	of	IN	O	of	_	0	SENT_65	[p2l1644t709r1679b735],
22	detection	NN	O	detection	prep_of	20	SENT_65	[p2l1696t709r1850b735],
23	of	IN	O	of	_	0	SENT_65	[p2l1871t709r1906b735],
24	FDA-approved	JJ	O	fda-approved	amod	27	SENT_65	[p2l1923t709r2166b744],
25	HIV-1	NN	O	hiv-1	nn	27	SENT_65	[p2l2187t709r2284b735],
26	RNA	NN	O	rna	nn	27	SENT_65	[p2l1276t755r1355b781],
27	assays	NNS	O	assay	prep_of	22	SENT_65	[p2l1366t764r1467b790],
28	.	.	O	.	_	0	SENT_65	[p2l1366t764r1467b790],

1	Viremia	NN	O	viremia	nsubjpass	3	SENT_66	[p2l1479t755r1612b781],
2	was	VBD	O	be	auxpass	3	SENT_66	[p2l1622t764r1678b781],
3	suppressed	VBN	O	suppress	_	0	SENT_66	[p2l1691t755r1870b790],
4	to	TO	O	to	aux	5	SENT_66	[p2l1883t760r1913b781],
5	less	JJR	O	less	xcomp	3	SENT_66	[p2l1926t755r1980b781],
6	than	IN	O	than	_	0	SENT_66	[p2l1993t755r2065b781],
7	0.6	CD	NUMBER	0.6	num	8	SENT_66	[p2l2077t755r2122b781],
8	copies/ml	NN	O	copies/ml	prep_than	5	SENT_66	[p2l2134t755r2286b790],
9	in	IN	O	in	_	0	SENT_66	[p2l1277t800r1308b825],
10	approximately	RB	O	approximately	advmod	11	SENT_66	[p2l1323t800r1561b835],
11	one-ﬁfth	JJ	O	one-ﬁfth	prep_in	8	SENT_66	[p2l1576t800r1717b826],
12	of	IN	O	of	_	0	SENT_66	[p2l1732t800r1767b826],
13	patients	NNS	O	patient	prep_of	11	SENT_66	[p2l1779t800r1916b835],
14	,	,	O	,	_	0	SENT_66	[p2l1779t800r1916b835],
15	nearly	RB	O	nearly	advmod	5	SENT_66	[p2l1933t800r2033b835],
16	100-fold	RB	O	100-fold	advmod	17	SENT_66	[p2l2050t800r2182b826],
17	lower	JJR	O	lower	dep	5	SENT_66	[p2l2197t800r2288b826],
18	than	IN	O	than	_	0	SENT_66	[p2l1277t846r1349b872],
19	the	DT	O	the	det	21	SENT_66	[p2l1370t846r1420b872],
20	detection	NN	O	detection	nn	21	SENT_66	[p2l1440t846r1594b872],
21	limit	NN	O	limit	prep_than	5	SENT_66	[p2l1614t846r1691b872],
22	of	IN	O	of	_	0	SENT_66	[p2l1711t846r1746b872],
23	FDA-approved	JJ	O	fda-approved	amod	24	SENT_66	[p2l1762t846r2005b881],
24	assays	NNS	O	assay	prep_of	21	SENT_66	[p2l2025t855r2126b881],
25	.	.	O	.	_	0	SENT_66	[p2l2025t855r2126b881],

1	As	IN	O	as	_	0	SENT_67	[p2l2147t846r2185b872],
2	such	JJ	O	such	prep_such_as	5	SENT_67	[p2l2206t846r2286b877],
3	,	,	O	,	_	0	SENT_67	[p2l2206t846r2286b877],
4	SCA	NNP	ORGANIZATION	SCA	nsubj	5	SENT_67	[p2l1277t892r1347b918],
5	permitted	VBD	O	permit	_	0	SENT_67	[p2l1369t892r1532b927],
6	a	DT	O	a	det	9	SENT_67	[p2l1555t901r1572b918],
7	more	RBR	O	more	advmod	8	SENT_67	[p2l1594t901r1678b918],
8	accurate	JJ	O	accurate	amod	9	SENT_67	[p2l1701t897r1838b918],
9	estimate	NN	O	estimate	dobj	5	SENT_67	[p2l1862t892r1997b918],
10	of	IN	O	of	_	0	SENT_67	[p2l2020t892r2055b918],
11	the	DT	O	the	det	13	SENT_67	[p2l2075t892r2124b918],
12	maximal	JJ	O	maximal	amod	13	SENT_67	[p2l2148t892r2286b918],
13	effect	NN	O	effect	prep_of	9	SENT_67	[p2l1277t937r1367b963],
14	of	IN	O	of	_	0	SENT_67	[p2l1379t937r1414b963],
15	antiretroviral	JJ	O	antiretroviral	amod	16	SENT_67	[p2l1422t937r1643b963],
16	therapy	NN	O	therapy	prep_of	13	SENT_67	[p2l1655t937r1786b972],
17	.	.	O	.	_	0	SENT_67	[p2l1655t937r1786b972],

1	Comparison	NN	O	comparison	nsubj	8	SENT_68	[p2l1800t937r2000b972],
2	of	IN	O	of	_	0	SENT_68	[p2l2012t937r2047b963],
3	pre	JJ	O	pre	amod	7	SENT_68	[p2l2056t946r2122b972],
4	-	:	O	-	_	0	SENT_68	[p2l2056t946r2122b972],
5	and	CC	O	and	_	0	SENT_68	[p2l2135t937r2194b963],
6	posttherapy	JJ	O	posttherapy	amod	7	SENT_68	[p2l2206t942r2286b972, p2l1277t983r1401b1018],
7	levels	NNS	O	level	prep_of	1	SENT_68	[p2l1415t983r1501b1009],
8	revealed	VBD	O	reveal	_	0	SENT_68	[p2l1516t983r1652b1009],
9	a	DT	O	a	det	11	SENT_68	[p2l1666t992r1682b1009],
10	median	JJ	O	median	amod	11	SENT_68	[p2l1696t983r1817b1009],
11	reduction	NN	O	reduction	dobj	8	SENT_68	[p2l1831t983r1990b1009],
12	in	IN	O	in	_	0	SENT_68	[p2l2005t983r2036b1008],
13	HIV-1	NN	O	hiv-1	nn	14	SENT_68	[p2l2050t983r2147b1009],
14	RNA	NN	O	rna	prep_in	8	SENT_68	[p2l2163t983r2242b1009],
15	of	IN	O	of	_	0	SENT_68	[p2l2255t983r2290b1009],
16	more	JJR	O	more	prep_of	14	SENT_68	[p2l1277t1038r1361b1055],
17	than	IN	O	than	prep	16	SENT_68	[p2l1389t1029r1461b1055],
18	14,000-fold	RB	O	14,000-fold	pcomp	17	SENT_68	[p2l1491t1029r1678b1060],
19	.	.	O	.	_	0	SENT_68	[p2l1491t1029r1678b1060],

1	After	IN	O	after	mark	7	SENT_69	[p2l1705t1029r1791b1055],
2	this	DT	O	this	det	4	SENT_69	[p2l1818t1029r1874b1055],
3	maximal	JJ	O	maximal	amod	4	SENT_69	[p2l1902t1029r2041b1055],
4	reduction	NN	O	reduction	nsubj	7	SENT_69	[p2l2069t1029r2228b1055],
5	in	IN	O	in	_	0	SENT_69	[p2l2256t1029r2287b1054],
6	viremia	NN	O	viremia	prep_in	4	SENT_69	[p2l1276t1074r1400b1100],
7	occurred	VBD	O	occur	advcl	15	SENT_69	[p2l1427t1074r1582b1105],
8	,	,	O	,	_	0	SENT_69	[p2l1427t1074r1582b1105],
9	however	RB	O	however	advmod	15	SENT_69	[p2l1610t1074r1754b1105],
10	,	,	O	,	_	0	SENT_69	[p2l1610t1074r1754b1105],
11	HIV-1	NN	O	hiv-1	nn	13	SENT_69	[p2l1783t1074r1880b1100],
12	RNA	NN	O	rna	nn	13	SENT_69	[p2l1910t1074r1989b1100],
13	levels	NNS	O	level	nsubj	15	SENT_69	[p2l2016t1074r2102b1100],
14	remained	VBD	O	remain	cop	15	SENT_69	[p2l2131t1074r2286b1100],
15	stable	JJ	O	stable	_	0	SENT_69	[p2l1277t1120r1369b1146],
16	with	IN	O	with	_	0	SENT_69	[p2l1395t1120r1465b1146],
17	no	DT	O	no	det	19	SENT_69	[p2l1493t1129r1532b1146],
18	signiﬁcant	JJ	O	signiﬁcant	amod	19	SENT_69	[p2l1560t1120r1728b1155],
19	decline	NN	O	decline	prep_with	15	SENT_69	[p2l1755t1120r1872b1146],
20	between	IN	O	between	_	0	SENT_69	[p2l1898t1120r2033b1146],
21	the	DT	O	the	det	22	SENT_69	[p2l2061t1120r2110b1146],
22	ﬁrst	NN	O	ﬁrst	prep_between	19	SENT_69	[p2l2137t1120r2201b1146],
23	and	CC	O	and	_	0	SENT_69	[p2l2227t1120r2287b1146],
24	second	JJ	ORDINAL	second	amod	25	SENT_69	[p2l1277t1166r1389b1192],
25	years	NNS	DURATION	year	prep_with	15	SENT_69	[p2l1402t1175r1484b1201],
26	of	IN	O	of	_	0	SENT_69	[p2l1500t1166r1535b1192],
27	therapy	NN	O	therapy	prep_of	25	SENT_69	[p2l1547t1166r1678b1201],
28	.	.	O	.	_	0	SENT_69	[p2l1547t1166r1678b1201],

1	In	IN	O	in	_	0	SENT_70	[p2l1313t1212r1347b1236],
2	previous	JJ	O	previous	amod	3	SENT_70	[p2l1371t1211r1509b1246],
3	studies	NNS	O	study	prep_in	10	SENT_70	[p2l1534t1211r1653b1242],
4	,	,	O	,	_	0	SENT_70	[p2l1534t1211r1653b1242],
5	investigators	NNS	O	investigator	nsubj	10	SENT_70	[p2l1678t1211r1884b1246],
6	using	VBG	O	use	partmod	5	SENT_70	[p2l1908t1211r1994b1246],
7	smaller	JJR	O	smaller	amod	8	SENT_70	[p2l2017t1211r2135b1237],
8	datasets	NNS	O	dataset	dobj	6	SENT_70	[p2l2158t1211r2286b1237],
9	have	VBP	O	have	aux	10	SENT_70	[p2l1276t1257r1349b1283],
10	reported	VBN	O	report	_	0	SENT_70	[p2l1371t1257r1515b1292],
11	slow	JJ	O	slow	amod	12	SENT_70	[p2l1537t1257r1606b1283],
12	declines	NNS	O	decline	dobj	10	SENT_70	[p2l1627t1257r1758b1283],
13	in	IN	O	in	_	0	SENT_70	[p2l1780t1257r1811b1282],
14	plasma	NN	O	plasma	nn	16	SENT_70	[p2l1832t1257r1946b1292],
15	HIV-1	NN	O	hiv-1	nn	16	SENT_70	[p2l1967t1257r2064b1283],
16	RNA	NN	O	rna	prep_in	10	SENT_70	[p2l2088t1257r2166b1283],
17	corresponding	VBG	O	correspond	partmod	16	SENT_70	[p2l2187t1266r2286b1283, p2l1277t1303r1428b1338],
18	to	TO	O	to	_	0	SENT_70	[p2l1441t1308r1471b1329],
19	half-lives	NNS	O	half-life	prep_to	17	SENT_70	[p2l1485t1303r1630b1329],
20	of	IN	O	of	_	0	SENT_70	[p2l1644t1303r1678b1329],
21	infected	JJ	O	infected	amod	22	SENT_70	[p2l1688t1303r1821b1329],
22	cells	NNS	O	cell	prep_of	19	SENT_70	[p2l1834t1303r1902b1329],
23	of	IN	O	of	_	0	SENT_70	[p2l1915t1303r1950b1329],
24	6	CD	DURATION	6	num	26	SENT_70	[p2l1961t1303r1977b1328],
25	mo	NN	DURATION	mo	nn	26	SENT_70	[p2l1991t1312r2040b1329],
26	[	NN	O	[	prep_of	22	SENT_70	[p2l2056t1303r2120b1335],
27	1,6	CD	NUMBER	1,6	number	28	SENT_70	[p2l2056t1303r2120b1335],
28	]	CD	NUMBER	]	dep	26	SENT_70	[p2l2056t1303r2120b1335],
29	or	CC	O	or	_	0	SENT_70	[p2l2135t1312r2170b1329],
30	longer	JJR	O	longer	prep_of	22	SENT_70	[p2l2182t1303r2287b1338],
31	[	CD	NUMBER	[	number	32	SENT_70	[p2l1279t1348r1371b1380],
32	8,15	CD	NUMBER	8,15	num	33	SENT_70	[p2l1279t1348r1371b1380],
33	]	NN	O	]	dep	30	SENT_70	[p2l1279t1348r1371b1380],
34	.	.	O	.	_	0	SENT_70	[p2l1279t1348r1371b1380],

1	Our	PRP$	O	we	poss	3	SENT_71	[p2l1386t1348r1452b1374],
2	longitudinal	JJ	O	longitudinal	amod	3	SENT_71	[p2l1465t1348r1664b1383],
3	analysis	NN	O	analysis	nsubj	11	SENT_71	[p2l1678t1348r1809b1383],
4	,	,	O	,	_	0	SENT_71	[p2l1678t1348r1809b1383],
5	using	VBG	O	use	partmod	3	SENT_71	[p2l1823t1348r1910b1383],
6	a	DT	O	a	det	9	SENT_71	[p2l1922t1357r1939b1374],
7	much	JJ	O	much	amod	9	SENT_71	[p2l1952t1348r2041b1374],
8	larger	JJR	O	larger	dep	7	SENT_71	[p2l2055t1348r2151b1383],
9	dataset	NN	O	dataset	dobj	5	SENT_71	[p2l2164t1348r2285b1379],
10	,	,	O	,	_	0	SENT_71	[p2l2164t1348r2285b1379],
11	revealed	VBD	O	reveal	_	0	SENT_71	[p2l1277t1394r1413b1420],
12	no	DT	O	no	det	14	SENT_71	[p2l1434t1403r1473b1420],
13	signiﬁcant	JJ	O	signiﬁcant	amod	14	SENT_71	[p2l1495t1394r1663b1429],
14	evidence	NN	O	evidence	dobj	11	SENT_71	[p2l1684t1394r1826b1420],
15	of	IN	O	of	_	0	SENT_71	[p2l1847t1394r1882b1420],
16	decline	NN	O	decline	prep_of	14	SENT_71	[p2l1899t1394r2015b1420],
17	of	IN	O	of	_	0	SENT_71	[p2l2037t1394r2071b1420],
18	HIV-1	NN	O	hiv-1	nn	20	SENT_71	[p2l2088t1394r2186b1420],
19	RNA	NN	O	rna	nn	20	SENT_71	[p2l2209t1394r2287b1420],
20	levels	NNS	O	level	prep_of	16	SENT_71	[p2l1276t1440r1363b1466],
21	between	IN	O	between	_	0	SENT_71	[p2l1387t1440r1522b1466],
22	60	CD	NUMBER	60	num	25	SENT_71	[p2l1547t1440r1582b1465],
23	and	CC	O	and	_	0	SENT_71	[p2l1608t1440r1667b1466],
24	110	CD	DURATION	110	num	25	SENT_71	[p2l1694t1440r1747b1465],
25	wk	NN	DURATION	wk	prep_between	11	SENT_71	[p2l1771t1440r1815b1465],
26	of	IN	O	of	_	0	SENT_71	[p2l1839t1440r1874b1466],
27	therapy	NN	O	therapy	prep_of	25	SENT_71	[p2l1896t1440r2027b1475],
28	.	.	O	.	_	0	SENT_71	[p2l1896t1440r2027b1475],

1	It	PRP	O	it	nsubj	3	SENT_72	[p2l2052t1441r2077b1466],
2	is	VBZ	O	be	cop	3	SENT_72	[p2l2101t1440r2123b1466],
3	possible	JJ	O	possible	_	0	SENT_72	[p2l2148t1440r2286b1475],
4	,	,	O	,	_	0	SENT_72	[p2l2148t1440r2286b1475],
5	however	RB	O	however	advmod	3	SENT_72	[p2l1276t1485r1420b1516],
6	,	,	O	,	_	0	SENT_72	[p2l1276t1485r1420b1516],
7	that	IN	O	that	complm	24	SENT_72	[p2l1438t1485r1501b1511],
8	a	DT	O	a	det	10	SENT_72	[p2l1518t1494r1534b1511],
9	slow	JJ	O	slow	amod	10	SENT_72	[p2l1550t1485r1619b1511],
10	decline	NN	O	decline	nsubjpass	24	SENT_72	[p2l1635t1485r1752b1511],
11	in	IN	O	in	_	0	SENT_72	[p2l1769t1485r1800b1510],
12	HIV-1	NN	O	hiv-1	nn	13	SENT_72	[p2l1816t1485r1913b1511],
13	RNA	NN	O	rna	prep_in	10	SENT_72	[p2l1932t1485r2010b1511],
14	with	IN	O	with	_	0	SENT_72	[p2l2026t1485r2096b1511],
15	half-life	NN	O	half-life	prep_with	13	SENT_72	[p2l2112t1485r2238b1511],
16	of	IN	O	of	_	0	SENT_72	[p2l2255t1485r2290b1511],
17	greater	JJR	O	greater	mwe	18	SENT_72	[p2l1276t1536r1394b1566],
18	than	IN	O	than	quantmod	19	SENT_72	[p2l1409t1531r1481b1557],
19	67	CD	DURATION	67	num	20	SENT_72	[p2l1497t1528r1532b1556],
20	wk	NN	DURATION	wk	prep_of	15	SENT_72	[p2l1547t1531r1591b1556],
21	could	MD	O	could	aux	24	SENT_72	[p2l1606t1531r1695b1557],
22	have	VB	O	have	aux	24	SENT_72	[p2l1709t1531r1783b1557],
23	been	VBN	O	be	auxpass	24	SENT_72	[p2l1797t1531r1876b1557],
24	missed	VBN	O	miss	ccomp	3	SENT_72	[p2l1891t1531r1999b1557],
25	with	IN	O	with	_	0	SENT_72	[p2l2013t1531r2084b1557],
26	the	DT	O	the	det	28	SENT_72	[p2l2100t1531r2149b1557],
27	current	JJ	DATE	current	amod	28	SENT_72	[p2l2165t1536r2287b1557],
28	dataset	NN	O	dataset	prep_with	24	SENT_72	[p2l1277t1577r1398b1603],
29	.	.	O	.	_	0	SENT_72	[p2l1277t1577r1398b1603],

1	We	PRP	O	we	nsubj	4	SENT_73	[p2l1418t1578r1470b1603],
2	are	VBP	O	be	aux	4	SENT_73	[p2l1490t1586r1539b1603],
3	currently	RB	DATE	currently	advmod	4	SENT_73	[p2l1560t1577r1710b1612],
4	assembling	VBG	O	assemble	_	0	SENT_73	[p2l1730t1577r1908b1612],
5	a	DT	O	a	det	7	SENT_73	[p2l1927t1586r1943b1603],
6	new	JJ	O	new	amod	7	SENT_73	[p2l1963t1586r2026b1603],
7	set	NN	O	set	dobj	4	SENT_73	[p2l2046t1582r2089b1603],
8	of	IN	O	of	_	0	SENT_73	[p2l2109t1577r2143b1603],
9	samples	NNS	O	sample	prep_of	7	SENT_73	[p2l2160t1577r2286b1612],
10	with	IN	O	with	_	0	SENT_73	[p2l1276t1623r1346b1649],
11	longer	JJR	O	longer	amod	12	SENT_73	[p2l1360t1623r1466b1658],
12	follow-up	NN	O	follow-up	prep_with	4	SENT_73	[p2l1479t1623r1634b1658],
13	to	TO	O	to	aux	14	SENT_73	[p2l1651t1628r1681b1649],
14	investigate	VB	O	investigate	xcomp	4	SENT_73	[p2l1697t1623r1870b1658],
15	this	DT	O	this	det	16	SENT_73	[p2l1886t1623r1942b1649],
16	possibility	NN	O	possibility	dobj	14	SENT_73	[p2l1958t1623r2130b1658],
17	.	.	O	.	_	0	SENT_73	[p2l1958t1623r2130b1658],

1	Three	CD	NUMBER	three	num	2	SENT_74	[p2l1314t1668r1410b1694],
2	sources	NNS	O	source	nsubjpass	8	SENT_74	[p2l1423t1677r1542b1694],
3	of	IN	O	of	_	0	SENT_74	[p2l1555t1668r1590b1694],
4	persistent	JJ	O	persistent	amod	5	SENT_74	[p2l1599t1668r1759b1703],
5	viremia	NN	O	viremia	prep_of	2	SENT_74	[p2l1770t1668r1894b1694],
6	have	VBP	O	have	aux	8	SENT_74	[p2l1905t1668r1978b1694],
7	been	VBN	O	be	auxpass	8	SENT_74	[p2l1990t1668r2068b1694],
8	proposed	VBN	O	propose	_	0	SENT_74	[p2l2081t1668r2242b1703],
9	:	:	O	:	_	0	SENT_74	[p2l2081t1668r2242b1703],
10	(	CD	NUMBER	(	num	14	SENT_74	[p2l2256t1668r2286b1701],
11	i	FW	O	i	nn	12	SENT_74	[p2l2256t1668r2286b1701],
12	)	FW	O	)	nn	14	SENT_74	[p2l2256t1668r2286b1701],
13	ongoing	JJ	O	ongoing	amod	14	SENT_74	[p2l1277t1714r1413b1749],
14	cycles	NNS	O	cycle	dobj	8	SENT_74	[p2l1441t1714r1535b1749],
15	of	IN	O	of	_	0	SENT_74	[p2l1564t1714r1600b1740],
16	viral	JJ	O	viral	amod	17	SENT_74	[p2l1624t1714r1698b1740],
17	replication	NN	O	replication	prep_of	14	SENT_74	[p2l1726t1714r1910b1749],
18	in	IN	O	in	_	0	SENT_74	[p2l1939t1714r1970b1739],
19	the	DT	O	the	det	20	SENT_74	[p2l1999t1714r2050b1740],
20	presence	NN	O	presence	prep_in	17	SENT_74	[p2l2078t1723r2226b1749],
21	of	IN	O	of	_	0	SENT_74	[p2l2255t1714r2290b1740],
22	antiretroviral	JJ	O	antiretroviral	amod	23	SENT_74	[p2l1277t1760r1497b1786],
23	drugs	NNS	O	drug	prep_of	20	SENT_74	[p2l1518t1760r1606b1795],
24	because	IN	O	because	_	0	SENT_74	[p2l1626t1760r1753b1786],
25	of	IN	O	of	_	0	SENT_74	[p2l1774t1760r1809b1786],
26	inadequate	JJ	O	inadequate	amod	29	SENT_74	[p2l1826t1760r2006b1795],
27	drug	NN	O	drug	nn	29	SENT_74	[p2l2027t1760r2103b1795],
28	inhibitory	JJ	O	inhibitory	amod	29	SENT_74	[p2l2123t1760r2287b1795],
29	potency	NN	O	potency	prep_because_of	20	SENT_74	[p2l1277t1810r1414b1840],
30	;	:	O	;	_	0	SENT_74	[p2l1277t1810r1414b1840],
31	(	CD	NUMBER	(	num	34	SENT_74	[p2l1434t1805r1475b1838],
32	ii	LS	O	ii	dep	34	SENT_74	[p2l1434t1805r1475b1838],
33	)	NN	O	)	nn	34	SENT_74	[p2l1434t1805r1475b1838],
34	production	NN	O	production	dobj	8	SENT_74	[p2l1493t1805r1678b1840],
35	of	IN	O	of	_	0	SENT_74	[p2l1696t1805r1731b1831],
36	HIV-1	NN	O	hiv-1	prep_of	34	SENT_74	[p2l1745t1805r1842b1831],
37	from	IN	O	from	_	0	SENT_74	[p2l1863t1805r1943b1831],
38	sanctuary	NN	O	sanctuary	nn	39	SENT_74	[p2l1961t1810r2117b1840],
39	sites	NNS	O	site	prep_from	36	SENT_74	[p2l2135t1805r2203b1831],
40	into	IN	O	into	_	0	SENT_74	[p2l2221t1805r2286b1831],
41	which	WDT	O	which	rel	45	SENT_74	[p2l1276t1851r1372b1877],
42	antiretrovirals	NNS	O	antiretroviral	nsubj	45	SENT_74	[p2l1394t1851r1627b1877],
43	do	VBP	O	do	aux	45	SENT_74	[p2l1650t1851r1689b1877],
44	not	RB	O	not	neg	45	SENT_74	[p2l1712t1856r1766b1877],
45	penetrate	VB	O	penetrate	rcmod	34	SENT_74	[p2l1788t1856r1945b1886],
46	sufﬁciently	RB	O	sufﬁciently	advmod	45	SENT_74	[p2l1967t1851r2154b1886],
47	;	:	O	;	_	0	SENT_74	[p2l1967t1851r2154b1886],
48	or	CC	O	or	_	0	SENT_74	[p2l2176t1860r2212b1877],
49	(	CD	NUMBER	(	number	51	SENT_74	[p2l2234t1851r2286b1884],
50	iii	LS	O	iii	dep	51	SENT_74	[p2l2234t1851r2286b1884],
51	)	CD	NUMBER	)	num	52	SENT_74	[p2l2234t1851r2286b1884],
52	reservoirs	NNS	O	reservoir	dobj	8	SENT_74	[p2l1277t1897r1436b1923],
53	of	IN	O	of	_	0	SENT_74	[p2l1448t1897r1483b1923],
54	long-lived	JJ	O	long-lived	amod	55	SENT_74	[p2l1491t1897r1653b1932],
55	cells	NNS	O	cell	prep_of	52	SENT_74	[p2l1665t1897r1733b1923],
56	infected	VBN	O	infect	partmod	55	SENT_74	[p2l1745t1897r1877b1923],
57	prior	RB	O	prior	_	0	SENT_74	[p2l1889t1897r1974b1932],
58	to	TO	O	to	_	0	SENT_74	[p2l1986t1902r2016b1923],
59	the	DT	O	the	det	60	SENT_74	[p2l2029t1897r2078b1923],
60	initiation	NN	O	initiation	prep_prior_to	56	SENT_74	[p2l2091t1897r2243b1923],
61	of	IN	O	of	_	0	SENT_74	[p2l2255t1897r2290b1923],
62	therapy	NN	O	therapy	prep_of	60	SENT_74	[p2l1277t1942r1401b1977],
63	with	IN	O	with	_	0	SENT_74	[p2l1422t1942r1492b1968],
64	production	NN	O	production	prep_with	62	SENT_74	[p2l1514t1942r1699b1977],
65	of	IN	O	of	_	0	SENT_74	[p2l1721t1942r1756b1968],
66	HIV-1	NN	O	hiv-1	prep_of	64	SENT_74	[p2l1774t1942r1871b1968],
67	from	IN	O	from	_	0	SENT_74	[p2l1896t1942r1976b1968],
68	integrated	VBN	O	integrate	amod	69	SENT_74	[p2l1998t1942r2166b1977],
69	proviruses	NNS	O	provirus	prep_from	66	SENT_74	[p2l2188t1942r2286b1977, p2l1277t1997r1366b2019],
70	,	,	O	,	_	0	SENT_74	[p2l2188t1942r2286b1977, p2l1277t1997r1366b2019],
71	but	CC	O	but	_	0	SENT_74	[p2l1384t1988r1438b2014],
72	without	IN	O	without	partmod	55	SENT_74	[p2l1455t1988r1581b2014],
73	complete	JJ	O	complete	amod	74	SENT_74	[p2l1600t1988r1750b2023],
74	cycles	NNS	O	cycle	nsubj	77	SENT_74	[p2l1769t1988r1861b2023],
75	of	IN	O	of	_	0	SENT_74	[p2l1880t1988r1915b2014],
76	replication	NN	O	replication	prep_of	74	SENT_74	[p2l1930t1988r2109b2023],
77	occurring	VBG	O	occur	pcomp	72	SENT_74	[p2l2127t1988r2287b2023],
78	because	IN	O	because	_	0	SENT_74	[p2l1276t2034r1403b2060],
79	of	IN	O	of	_	0	SENT_74	[p2l1424t2034r1458b2060],
80	blockade	NN	O	blockade	prep_because_of	84	SENT_74	[p2l1475t2034r1620b2060],
81	by	IN	O	by	_	0	SENT_74	[p2l1641t2034r1678b2069],
82	antiretroviral	JJ	O	antiretroviral	amod	83	SENT_74	[p2l1699t2034r1919b2060],
83	drugs	NNS	O	drug	prep_by	84	SENT_74	[p2l1940t2034r2028b2069],
84	[	VBP	O	[	advcl	77	SENT_74	[p2l2052t2031r2202b2066],
85	8,15	CD	NUMBER	8,15	num	86	SENT_74	[p2l2052t2031r2202b2066],
86	—	CD	NUMBER	—	dobj	84	SENT_74	[p2l2052t2031r2202b2066],
87	17	CD	NUMBER	17	num	88	SENT_74	[p2l2052t2031r2202b2066],
88	]	NN	O	]	nsubj	84	SENT_74	[p2l2052t2031r2202b2066],
89	.	.	O	.	_	0	SENT_74	[p2l2052t2031r2202b2066],

1	The	DT	O	the	det	3	SENT_75	[p2l2224t2034r2286b2060],
2	marked	JJ	O	marked	amod	3	SENT_75	[p2l1277t2079r1400b2105],
3	stability	NN	O	stability	nsubj	31	SENT_75	[p2l1412t2079r1541b2114],
4	of	IN	O	of	_	0	SENT_75	[p2l1553t2079r1588b2105],
5	viremia	NN	O	viremia	prep_of	3	SENT_75	[p2l1596t2079r1720b2105],
6	detected	VBN	O	detect	partmod	5	SENT_75	[p2l1732t2079r1871b2105],
7	in	IN	O	in	_	0	SENT_75	[p2l1884t2079r1915b2104],
8	this	DT	O	this	det	9	SENT_75	[p2l1929t2079r1985b2105],
9	study	NN	O	study	prep_in	6	SENT_75	[p2l1999t2079r2091b2114],
10	,	,	O	,	_	0	SENT_75	[p2l1999t2079r2091b2114],
11	in	IN	O	in	dep	23	SENT_75	[p2l2105t2079r2136b2104],
12	addition	NN	O	addition	pobj	11	SENT_75	[p2l2149t2079r2286b2105],
13	to	TO	O	to	_	0	SENT_75	[p2l1277t2130r1308b2151],
14	the	DT	O	the	det	16	SENT_75	[p2l1334t2125r1384b2151],
15	similar	JJ	O	similar	amod	16	SENT_75	[p2l1409t2125r1521b2151],
16	levels	NNS	O	level	prep_to	12	SENT_75	[p2l1544t2125r1630b2151],
17	of	IN	O	of	_	0	SENT_75	[p2l1656t2125r1691b2151],
18	suppression	NN	O	suppression	prep_of	16	SENT_75	[p2l1712t2125r1906b2160],
19	by	IN	O	by	_	0	SENT_75	[p2l1930t2125r1968b2160],
20	LPV/r	NN	O	lpv/r	prep_by	18	SENT_75	[p2l1992t2125r2106b2156],
21	-	:	O	-	_	0	SENT_75	[p2l1992t2125r2106b2156],
22	,	,	O	,	_	0	SENT_75	[p2l1992t2125r2106b2156],
23	NFV	NN	O	nfv	dep	9	SENT_75	[p2l2131t2126r2226b2156],
24	-	:	O	-	_	0	SENT_75	[p2l2131t2126r2226b2156],
25	,	,	O	,	_	0	SENT_75	[p2l2131t2126r2226b2156],
26	or	CC	O	or	_	0	SENT_75	[p2l2252t2134r2287b2151],
27	NNRTI-containing	JJ	O	nnrti-containing	amod	28	SENT_75	[p2l1276t2171r1586b2206],
28	regimens	NNS	O	regimen	conj_or	9	SENT_75	[p2l1605t2171r1760b2206],
29	,	,	O	,	_	0	SENT_75	[p2l1605t2171r1760b2206],
30	strongly	RB	O	strongly	advmod	31	SENT_75	[p2l1781t2171r1912b2206],
31	suggests	VBZ	O	suggest	_	0	SENT_75	[p2l1931t2176r2061b2206],
32	that	IN	O	that	complm	36	SENT_75	[p2l2082t2171r2145b2197],
33	current	JJ	DATE	current	amod	35	SENT_75	[p2l2165t2176r2287b2197],
34	antiretroviral	JJ	O	antiretroviral	amod	35	SENT_75	[p2l1277t2216r1497b2242],
35	therapies	NNS	O	therapy	nsubj	36	SENT_75	[p2l1514t2216r1663b2251],
36	inhibit	VBP	O	inhibit	ccomp	31	SENT_75	[p2l1681t2216r1790b2242],
37	HIV-1	NN	MISC	hiv-1	nn	39	SENT_75	[p2l1806t2216r1903b2242],
38	replication	NN	O	replication	nn	39	SENT_75	[p2l1922t2216r2101b2251],
39	cycles	NNS	O	cycle	dobj	36	SENT_75	[p2l2118t2216r2210b2251],
40	and	CC	O	and	_	0	SENT_75	[p2l2227t2216r2287b2242],
41	virus	NN	O	virus	nn	42	SENT_75	[p2l1276t2262r1354b2288],
42	production	NN	O	production	conj_and	39	SENT_75	[p2l1375t2262r1559b2297],
43	to	TO	O	to	_	0	SENT_75	[p2l1580t2267r1611b2288],
44	below	IN	O	below	advmod	47	SENT_75	[p2l1631t2262r1726b2288],
45	a	DT	O	a	det	46	SENT_75	[p2l1746t2271r1762b2288],
46	background	NN	O	background	pobj	44	SENT_75	[p2l1781t2262r1976b2297],
47	level	NN	O	level	prep_to	36	SENT_75	[p2l1996t2262r2069b2288],
48	set	VBN	O	set	partmod	47	SENT_75	[p2l2089t2267r2132b2288],
49	by	IN	O	by	_	0	SENT_75	[p2l2152t2262r2189b2297],
50	virus	NN	O	virus	agent	48	SENT_75	[p2l2208t2262r2286b2288],
51	released	VBN	O	release	partmod	50	SENT_75	[p2l1277t2308r1409b2334],
52	from	IN	O	from	_	0	SENT_75	[p2l1424t2308r1504b2334],
53	long-lived	JJ	O	long-lived	amod	54	SENT_75	[p2l1520t2308r1681b2343],
54	cells	NNS	O	cell	prep_from	51	SENT_75	[p2l1697t2308r1773b2334],
55	.	.	O	.	_	0	SENT_75	[p2l1697t2308r1773b2334],

1	More	RBR	O	more	advmod	2	SENT_76	[p2l1789t2309r1874b2334],
2	speciﬁcally	RB	O	speciﬁcally	ccomp	8	SENT_76	[p2l1890t2308r2075b2343],
3	,	,	O	,	_	0	SENT_76	[p2l1890t2308r2075b2343],
4	the	DT	O	the	det	6	SENT_76	[p2l2093t2308r2142b2334],
5	residual	JJ	O	residual	amod	6	SENT_76	[p2l2158t2308r2286b2334],
6	viremia	NN	O	viremia	nsubj	8	SENT_76	[p2l1276t2353r1399b2379],
7	is	VBZ	O	be	cop	8	SENT_76	[p2l1416t2353r1438b2379],
8	likely	JJ	O	likely	_	0	SENT_76	[p2l1456t2353r1542b2388],
9	derived	VBN	O	derive	dep	8	SENT_76	[p2l1559t2353r1680b2379],
10	from	IN	O	from	_	0	SENT_76	[p2l1697t2353r1777b2379],
11	a	DT	O	a	det	12	SENT_76	[p2l1794t2362r1811b2379],
12	reservoir	NN	O	reservoir	prep_from	9	SENT_76	[p2l1828t2353r1974b2379],
13	of	IN	O	of	_	0	SENT_76	[p2l1990t2353r2025b2379],
14	long-lived	JJ	O	long-lived	amod	15	SENT_76	[p2l2039t2353r2201b2388],
15	cells	NNS	O	cell	prep_of	12	SENT_76	[p2l2218t2353r2286b2379],
16	infected	VBN	O	infect	partmod	15	SENT_76	[p2l1277t2399r1409b2425],
17	before	IN	O	before	_	0	SENT_76	[p2l1420t2399r1526b2425],
18	the	DT	O	the	det	19	SENT_76	[p2l1539t2399r1588b2425],
19	initiation	NN	O	initiation	prep_before	16	SENT_76	[p2l1601t2399r1753b2425],
20	of	IN	O	of	_	0	SENT_76	[p2l1765t2399r1800b2425],
21	therapy	NN	O	therapy	prep_of	19	SENT_76	[p2l1809t2399r1940b2434],
22	.	.	O	.	_	0	SENT_76	[p2l1809t2399r1940b2434],

1	This	DT	O	this	det	2	SENT_77	[p2l1953t2399r2022b2425],
2	reservoir	NN	O	reservoir	nsubj	4	SENT_77	[p2l2035t2399r2181b2425],
3	might	MD	O	might	aux	4	SENT_77	[p2l2193t2399r2287b2434],
4	comprise	VB	O	comprise	_	0	SENT_77	[p2l1277t2445r1426b2480],
5	chronically	RB	O	chronically	advmod	7	SENT_77	[p2l1438t2445r1619b2480],
6	infected	JJ	O	infected	amod	7	SENT_77	[p2l1630t2445r1763b2471],
7	cells	NNS	O	cell	dobj	4	SENT_77	[p2l1774t2445r1842b2471],
8	that	WDT	O	that	nsubj	9	SENT_77	[p2l1854t2445r1918b2471],
9	produce	VBP	O	produce	rcmod	7	SENT_77	[p2l1929t2445r2063b2480],
10	virus	NN	O	virus	dobj	9	SENT_77	[p2l2074t2445r2152b2471],
11	at	IN	O	at	_	0	SENT_77	[p2l2165t2450r2194b2471],
12	a	DT	O	a	det	15	SENT_77	[p2l2205t2454r2221b2471],
13	low	JJ	O	low	amod	14	SENT_77	[p2l2232t2445r2287b2471],
14	stable	JJ	O	stable	amod	15	SENT_77	[p2l1277t2491r1369b2517],
15	rate	NN	O	rate	prep_at	9	SENT_77	[p2l1385t2496r1447b2517],
16	and/or	IN	O	and/or	_	0	SENT_77	[p2l1463t2491r1569b2517],
17	latently-infected	JJ	O	latently-infected	amod	18	SENT_77	[p2l1583t2491r1852b2526],
18	cells	NNS	O	cell	prep_and/or	15	SENT_77	[p2l1867t2491r1943b2522],
19	,	,	O	,	_	0	SENT_77	[p2l1867t2491r1943b2522],
20	like	IN	O	like	_	0	SENT_77	[p2l1959t2491r2016b2517],
21	resting	VBG	O	rest	prepc_like	9	SENT_77	[p2l2031t2491r2143b2526],
22	CD4	NN	O	cd4	nn	25	SENT_77	[p2l2158t2491r2252b2519],
23	+	CC	O	+	_	0	SENT_77	[p2l2158t2491r2252b2519],
24	T	NN	O	t	nn	25	SENT_77	[p2l2264t2492r2287b2516],
25	cells	NNS	O	cell	dobj	21	SENT_77	[p2l1277t2536r1353b2567],
26	,	,	O	,	_	0	SENT_77	[p2l1277t2536r1353b2567],
27	that	WDT	O	that	nsubjpass	30	SENT_77	[p2l1382t2536r1445b2562],
28	can	MD	O	can	aux	30	SENT_77	[p2l1472t2545r1528b2562],
29	be	VB	O	be	auxpass	30	SENT_77	[p2l1555t2536r1592b2562],
30	isolated	VBN	O	isolate	rcmod	25	SENT_77	[p2l1620t2536r1746b2562],
31	from	IN	O	from	_	0	SENT_77	[p2l1772t2536r1852b2562],
32	infected	JJ	O	infected	amod	33	SENT_77	[p2l1880t2536r2012b2562],
33	individuals	NNS	O	individual	prep_from	30	SENT_77	[p2l2040t2536r2218b2562],
34	on	IN	O	on	_	0	SENT_77	[p2l2246t2545r2287b2562],
35	suppressive	JJ	O	suppressive	amod	36	SENT_77	[p2l1277t2582r1463b2617],
36	therapy	NN	O	therapy	prep_on	33	SENT_77	[p2l1477t2582r1601b2617],
37	and	CC	O	and	_	0	SENT_77	[p2l1613t2582r1672b2608],
38	activated	VBN	O	activate	conj_and	30	SENT_77	[p2l1685t2582r1831b2608],
39	to	TO	O	to	aux	40	SENT_77	[p2l1844t2587r1875b2608],
40	produce	VB	O	produce	xcomp	38	SENT_77	[p2l1888t2582r2023b2617],
41	infectious	JJ	O	infectious	amod	42	SENT_77	[p2l2036t2582r2196b2608],
42	virus	NN	O	virus	iobj	40	SENT_77	[p2l2208t2582r2286b2608],
43	[	CD	NUMBER	[	number	44	SENT_77	[p2l1279t2628r1466b2660],
44	8,15,18,19	CD	NUMBER	8,15,18,19	num	45	SENT_77	[p2l1279t2628r1466b2660],
45	]	NN	O	]	dobj	40	SENT_77	[p2l1279t2628r1466b2660],
46	.	.	O	.	_	0	SENT_77	[p2l1279t2628r1466b2660],

1	Our	PRP$	O	we	poss	2	SENT_78	[p2l1483t2628r1549b2654],
2	data	NNS	O	datum	nsubj	3	SENT_78	[p2l1564t2628r1633b2654],
3	describe	VBP	O	describe	_	0	SENT_78	[p2l1649t2628r1783b2654],
4	only	RB	O	only	advmod	6	SENT_78	[p2l1800t2628r1869b2663],
5	the	DT	O	the	det	6	SENT_78	[p2l1885t2628r1934b2654],
6	level	NN	O	level	dobj	3	SENT_78	[p2l1950t2628r2023b2654],
7	of	IN	O	of	_	0	SENT_78	[p2l2039t2628r2074b2654],
8	viremia	NN	O	viremia	prep_of	6	SENT_78	[p2l2085t2628r2216b2659],
9	,	,	O	,	_	0	SENT_78	[p2l2085t2628r2216b2659],
10	not	RB	O	not	neg	8	SENT_78	[p2l2233t2633r2287b2654],
11	other	JJ	O	other	amod	13	SENT_78	[p2l1277t2673r1365b2699],
12	viral	JJ	O	viral	amod	13	SENT_78	[p2l1378t2673r1450b2699],
13	characteristics	NNS	O	characteristic	dep	8	SENT_78	[p2l1464t2673r1707b2699],
14	.	.	O	.	_	0	SENT_78	[p2l1464t2673r1707b2699],

1	Others	NNS	O	other	nsubj	3	SENT_79	[p2l1722t2673r1832b2699],
2	have	VBP	O	have	aux	3	SENT_79	[p2l1847t2673r1920b2699],
3	reported	VBN	O	report	_	0	SENT_79	[p2l1935t2673r2079b2708],
4	no	DT	O	no	det	5	SENT_79	[p2l2093t2682r2133b2699],
5	accumulation	NN	O	accumulation	dobj	3	SENT_79	[p2l2148t2682r2286b2699, p2l1276t2719r1371b2745],
6	of	IN	O	of	_	0	SENT_79	[p2l1383t2719r1418b2745],
7	new	JJ	O	new	amod	9	SENT_79	[p2l1427t2728r1491b2745],
8	resistance	NN	O	resistance	nn	9	SENT_79	[p2l1503t2719r1663b2745],
9	mutations	NNS	O	mutation	prep_of	5	SENT_79	[p2l1676t2719r1839b2745],
10	and	CC	O	and	_	0	SENT_79	[p2l1852t2719r1911b2745],
11	little	JJ	O	little	amod	13	SENT_79	[p2l1923t2719r1998b2745],
12	genetic	JJ	O	genetic	amod	13	SENT_79	[p2l2010t2719r2127b2754],
13	variation	NN	O	variation	conj_and	5	SENT_79	[p2l2139t2719r2286b2745],
14	over	IN	O	over	_	0	SENT_79	[p2l1277t2774r1349b2791],
15	time	NN	O	time	prep_over	13	SENT_79	[p2l1377t2765r1450b2791],
16	in	IN	O	in	_	0	SENT_79	[p2l1479t2765r1510b2790],
17	patients	NNS	O	patient	prep_in	3	SENT_79	[p2l1538t2765r1671b2800],
18	with	IN	O	with	_	0	SENT_79	[p2l1699t2765r1770b2791],
19	suppressed	VBN	O	suppress	amod	20	SENT_79	[p2l1799t2765r1982b2800],
20	viremia	NN	O	viremia	prep_with	17	SENT_79	[p2l2009t2765r2143b2791],
21	.	.	O	.	_	0	SENT_79	[p2l2009t2765r2143b2791],

1	Recent	JJ	O	recent	amod	2	SENT_80	[p2l2172t2766r2287b2791],
2	analyses	NNS	O	analysis	nsubj	4	SENT_80	[p2l1277t2811r1407b2846],
3	have	VBP	O	have	aux	4	SENT_80	[p2l1429t2811r1502b2837],
4	suggested	VBN	O	suggest	_	0	SENT_80	[p2l1525t2811r1680b2846],
5	that	IN	O	that	complm	12	SENT_80	[p2l1704t2811r1767b2837],
6	a	DT	O	a	det	8	SENT_80	[p2l1789t2820r1806b2837],
7	limited	JJ	O	limited	amod	8	SENT_80	[p2l1827t2811r1943b2837],
8	number	NN	O	number	nsubj	12	SENT_80	[p2l1965t2811r2094b2837],
9	of	IN	O	of	_	0	SENT_80	[p2l2116t2811r2150b2837],
10	genetic	JJ	O	genetic	amod	11	SENT_80	[p2l2169t2811r2286b2846],
11	variants	NNS	O	variant	prep_of	8	SENT_80	[p2l1276t2856r1404b2882],
12	circulate	VBP	O	circulate	ccomp	4	SENT_80	[p2l1419t2856r1560b2882],
13	during	IN	O	during	_	0	SENT_80	[p2l1575t2856r1684b2891],
14	suppression	NN	O	suppression	prep_during	12	SENT_80	[p2l1698t2856r1892b2891],
15	[	CD	NUMBER	[	num	14	SENT_80	[p2l1908t2856r2031b2888],
16	20	CD	NUMBER	20	num	17	SENT_80	[p2l1908t2856r2031b2888],
17	—	NN	O	—	dobj	12	SENT_80	[p2l1908t2856r2031b2888],
18	22	CD	NUMBER	22	num	19	SENT_80	[p2l1908t2856r2031b2888],
19	]	NN	O	]	dep	17	SENT_80	[p2l1908t2856r2031b2888],
20	,	,	O	,	_	0	SENT_80	[p2l1908t2856r2031b2888],
21	also	RB	O	also	advmod	17	SENT_80	[p2l2047t2856r2107b2882],
22	consistent	JJ	O	consistent	amod	17	SENT_80	[p2l2122t2856r2287b2882],
23	with	IN	O	with	_	0	SENT_80	[p2l1276t2902r1346b2928],
24	a	DT	O	a	det	25	SENT_80	[p2l1370t2911r1386b2928],
25	model	NN	O	model	prep_with	22	SENT_80	[p2l1409t2902r1510b2928],
26	of	IN	O	of	_	0	SENT_80	[p2l1534t2902r1568b2928],
27	HIV-1	NN	O	hiv-1	nn	28	SENT_80	[p2l1589t2902r1686b2928],
28	production	NN	O	production	prep_of	25	SENT_80	[p2l1713t2902r1897b2937],
29	from	IN	O	from	_	0	SENT_80	[p2l1921t2902r2001b2928],
30	long-lived	JJ	O	long-lived	amod	31	SENT_80	[p2l2024t2902r2186b2937],
31	cells	NNS	O	cell	prep_from	12	SENT_80	[p2l2210t2902r2285b2928],
32	.	.	O	.	_	0	SENT_80	[p2l2210t2902r2285b2928],

1	Analyses	NNS	O	analysis	_	0	SENT_81	[p2l1275t2948r1415b2983],
2	of	IN	O	of	_	0	SENT_81	[p2l1433t2948r1468b2974],
3	HIV-1	NN	O	hiv-1	nn	4	SENT_81	[p2l1482t2948r1579b2974],
4	replication	NN	O	replication	prep_of	1	SENT_81	[p2l1600t2948r1779b2983],
5	during	IN	O	during	dep	1	SENT_81	[p2l1796t2948r1906b2983],
6	suppressive	JJ	O	suppressive	amod	8	SENT_81	[p2l1922t2948r2109b2983],
7	antiretroviral	JJ	O	antiretroviral	amod	8	SENT_81	[p2l2127t2948r2286b2974, p2l1276t2993r1348b3019],
8	therapy	NN	O	therapy	pobj	5	SENT_81	[p2l1369t2993r1493b3028],
9	intended	VBN	O	intend	partmod	8	SENT_81	[p2l1513t2993r1658b3019],
10	to	TO	O	to	aux	11	SENT_81	[p2l1680t2998r1710b3019],
11	distinguish	VB	O	distinguish	xcomp	9	SENT_81	[p2l1731t2993r1909b3028],
12	between	IN	O	between	_	0	SENT_81	[p2l1928t2993r2064b3019],
13	active	JJ	O	active	amod	14	SENT_81	[p2l2084t2993r2177b3019],
14	repliApril	NN	O	repliapril	prep_between	11	SENT_81	[p2l2198t2993r2286b3028, p2l1772t3092r1834b3123],

1	2007	CD	DATE	2007	num	2	SENT_82	[p2l1849t3094r1914b3116],
2	|	CD	NUMBER	|	_	0	SENT_82	[p2l1929t3091r1931b3124],
3	Volume	NN	O	volume	nn	6	SENT_82	[p2l1945t3092r2051b3116],
4	3	CD	NUMBER	3	num	6	SENT_82	[p2l2064t3094r2078b3116],
5	|	NN	O	|	nn	6	SENT_82	[p2l2093t3091r2096b3124],
6	Issue	NN	O	issue	dep	2	SENT_82	[p2l2112t3093r2178b3116],
7	4	CD	NUMBER	4	num	9	SENT_82	[p2l2190t3094r2206b3116],
8	|	NN	O	|	nn	9	SENT_82	[p2l2221t3091r2223b3124],
9	e46	NN	O	e46	dep	2	SENT_82	[p2l2238t3094r2287b3116],

1	HIV-1	NN	O	hiv-1	nn	2	SENT_83	[p3l192t1422r229b1538],
2	RNA	NN	O	rna	_	0	SENT_83	[p3l193t1292r229b1397],
3	(	CD	NUMBER	(	num	5	SENT_83	[p3l192t1018r240b1276],
4	copies/ml	NN	O	copies/ml	nn	5	SENT_83	[p3l192t1018r240b1276],
5	)	NN	O	)	dep	2	SENT_83	[p3l192t1018r240b1276],

1	O	NN	O	o	_	0	SENT_84	[p3l404t1600r422b1618],
2	1	CD	NUMBER	1	num	3	SENT_84	[p3l574t1600r584b1618],
3	Oo	NN	O	oo	dep	1	SENT_84	[p3l592t1600r629b1618],
4	2130 300 400	CD	NUMBER	2130 300 400	dep	1	SENT_84	[p3l1132t1600r1189b1618],[p3l759t1600r814b1618],

1	Time	NNP	O	Time	_	0	SENT_85	[p3l594t2332r707b2369],
2	(	CD	NUMBER	(	num	3	SENT_85	[p3l725t2331r868b2379],
3	days	NNS	NUMBER	day	dep	1	SENT_85	[p3l725t2331r868b2379],
4	)	IN	O	)	amod	3	SENT_85	[p3l725t2331r868b2379],

1	Figure	NNP	O	Figure	_	0	SENT_86	[p3l190t2413r282b2444],
2	1	CD	NUMBER	1	dep	1	SENT_86	[p3l294t2415r317b2437],
3	.	.	O	.	_	0	SENT_86	[p3l294t2415r317b2437],

1	Decline	NN	O	decline	nn	4	SENT_87	[p3l329t2413r429b2437],
2	and	CC	O	and	_	0	SENT_87	[p3l440t2413r490b2437],
3	Stable	JJ	O	stable	conj_and	1	SENT_87	[p3l501t2413r585b2437],
4	Persistence	NN	O	persistence	nsubjpass	44	SENT_87	[p3l597t2414r750b2437],
5	of	IN	O	of	_	0	SENT_87	[p3l761t2413r789b2437],
6	Plasma	NN	O	plasma	nn	8	SENT_87	[p3l798t2413r892b2437],
7	HIV-1	NN	O	hiv-1	nn	8	SENT_87	[p3l904t2414r971b2437],
8	RNA	NN	O	rna	prep_of	4	SENT_87	[p3l988t2414r1045b2437],
9	in	IN	O	in	_	0	SENT_87	[p3l1056t2414r1078b2437],
10	Patients	NNS	O	patient	prep_in	8	SENT_87	[p3l1091t2414r1199b2437],
11	Suppressed	VBN	O	suppress	partmod	10	SENT_87	[p3l189t2455r347b2486],
12	on	IN	O	on	_	0	SENT_87	[p3l361t2462r394b2479],
13	Antiretroviral	JJ	O	antiretroviral	amod	15	SENT_87	[p3l408t2455r587b2479],
14	Therapy	NN	O	therapy	nn	15	SENT_87	[p3l600t2455r713b2486],
15	Plasma	NN	O	plasma	prep_on	11	SENT_87	[p3l190t2500r284b2524],
16	from	IN	O	from	_	0	SENT_87	[p3l300t2500r363b2524],
17	patients	NNS	O	patient	prep_from	11	SENT_87	[p3l382t2501r491b2531],
18	initiating	VBG	O	initiate	partmod	17	SENT_87	[p3l508t2501r627b2531],
19	antiretroviral	JJ	O	antiretroviral	amod	20	SENT_87	[p3l645t2500r819b2524],
20	therapy	NN	O	therapy	dobj	18	SENT_87	[p3l836t2500r942b2531],
21	with	IN	O	with	_	0	SENT_87	[p3l957t2500r1016b2524],
22	stavudine	NN	O	stavudine	nn	23	SENT_87	[p3l1033t2500r1166b2524],
23	lamivudine	NN	O	lamivudine	prep_with	18	SENT_87	[p3l1180t2515r1202b2516, p3l190t2535r340b2559],
24	+	CC	O	+	_	0	SENT_87	[p3l352t2540r374b2562],
25	efavirenz	NN	O	efavirenz	conj_+	23	SENT_87	[p3l386t2535r510b2559],
26	(	CD	NUMBER	(	num	27	SENT_87	[p3l525t2536r643b2566],
27	patients	NNS	O	patient	dep	25	SENT_87	[p3l525t2536r643b2566],
28	A	DT	O	a	dep	23	SENT_87	[p3l658t2536r676b2559],
29	and	CC	O	and	_	0	SENT_87	[p3l691t2535r741b2559],
30	B	NN	O	b	conj_and	28	SENT_87	[p3l757t2536r780b2563],
31	)	CD	NUMBER	)	dep	28	SENT_87	[p3l757t2536r780b2563],
32	or	CC	O	or	_	0	SENT_87	[p3l795t2542r823b2559],
33	stavudine	NN	O	stavudine	conj_or	23	SENT_87	[p3l837t2535r970b2559],
34	+	CC	O	+	_	0	SENT_87	[p3l982t2540r1004b2562],
35	Iamivudine	NN	O	iamivudine	nn	36	SENT_87	[p3l1017t2535r1168b2559],
36	indinavir	NN	O	indinavir	conj_or	23	SENT_87	[p3l1180t2550r1202b2551, p3l189t2571r308b2595],
37	+	CC	O	+	_	0	SENT_87	[p3l317t2576r339b2598],
38	nevirapine	NN	O	nevirapine	nn	41	SENT_87	[p3l349t2572r492b2602],
39	(	CD	NUMBER	(	num	41	SENT_87	[p3l505t2572r611b2602],
40	patient	NN	O	patient	nn	41	SENT_87	[p3l505t2572r611b2602],
41	C	NN	O	c	conj_or	23	SENT_87	[p3l623t2572r649b2599],
42	)	NN	O	)	dep	41	SENT_87	[p3l623t2572r649b2599],
43	was	VBD	O	be	auxpass	44	SENT_87	[p3l661t2578r713b2595],
44	assayed	VBN	O	assay	_	0	SENT_87	[p3l725t2571r831b2602],
45	by	IN	O	by	_	0	SENT_87	[p3l845t2571r877b2602],
46	bDNA	NN	O	bdna	agent	44	SENT_87	[p3l890t2571r970b2595],
47	(	CD	NUMBER	(	num	48	SENT_87	[p3l983t2571r1135b2599],
48	diamonds	NNS	O	diamond	tmod	46	SENT_87	[p3l983t2571r1135b2599],
49	)	RB	O	)	advmod	48	SENT_87	[p3l983t2571r1135b2599],
50	and	CC	O	and	_	0	SENT_87	[p3l1148t2571r1198b2595],
51	SCA	NNP	O	SCA	nn	53	SENT_87	[p3l189t2607r243b2630],
52	(	CD	NUMBER	(	num	53	SENT_87	[p3l255t2607r384b2637],
53	squares	NNS	O	square	conj_and	46	SENT_87	[p3l255t2607r384b2637],
54	)	CD	NUMBER	)	dep	53	SENT_87	[p3l255t2607r384b2637],
55	.	.	O	.	_	0	SENT_87	[p3l255t2607r384b2637],

1	Levels	NNS	O	level	nsubjpass	13	SENT_88	[p3l397t2606r478b2630],
2	of	IN	O	of	_	0	SENT_88	[p3l490t2606r518b2630],
3	virus	NN	O	virus	prep_of	1	SENT_88	[p3l527t2607r591b2630],
4	above	IN	O	above	_	0	SENT_88	[p3l603t2606r686b2630],
5	the	DT	O	the	det	6	SENT_88	[p3l697t2606r742b2630],
6	limit	NN	O	limit	prep_above	3	SENT_88	[p3l755t2606r813b2630],
7	of	IN	O	of	_	0	SENT_88	[p3l824t2606r852b2630],
8	detection	NN	O	detection	prep_of	6	SENT_88	[p3l862t2606r992b2630],
9	for	IN	O	for	_	0	SENT_88	[p3l1003t2606r1042b2630],
10	each	DT	O	each	det	11	SENT_88	[p3l1052t2606r1115b2630],
11	assay	NN	O	assay	prep_for	8	SENT_88	[p3l1128t2613r1200b2637],
12	are	VBP	O	be	auxpass	13	SENT_88	[p3l189t2648r230b2665],
13	shown	VBN	O	show	_	0	SENT_88	[p3l242t2641r331b2665],
14	by	IN	O	by	_	0	SENT_88	[p3l344t2641r377b2672],
15	filled	VBN	O	fill	amod	16	SENT_88	[p3l387t2641r452b2665],
16	symbols	NNS	O	symbol	agent	13	SENT_88	[p3l465t2641r584b2672],
17	;	:	O	;	_	0	SENT_88	[p3l465t2641r584b2672],
18	levels	NNS	O	level	nsubjpass	23	SENT_88	[p3l596t2641r670b2665],
19	below	IN	O	below	_	0	SENT_88	[p3l683t2641r766b2665],
20	this	DT	O	this	det	21	SENT_88	[p3l776t2641r825b2665],
21	limit	NN	O	limit	prep_below	18	SENT_88	[p3l838t2641r896b2665],
22	are	VBP	O	be	auxpass	23	SENT_88	[p3l908t2648r949b2665],
23	shown	VBN	O	show	parataxis	13	SENT_88	[p3l961t2641r1050b2665],
24	by	IN	O	by	_	0	SENT_88	[p3l1063t2641r1096b2672],
25	hollow	JJ	O	hollow	amod	26	SENT_88	[p3l1108t2641r1199b2665],
26	symbols	NNS	O	symbol	agent	23	SENT_88	[p3l189t2677r301b2708],
27	plotted	VBD	O	plot	partmod	26	SENT_88	[p3l315t2677r413b2708],
28	at	IN	O	at	_	0	SENT_88	[p3l427t2681r452b2701],
29	the	DT	O	the	det	31	SENT_88	[p3l464t2677r509b2701],
30	assay	NN	O	assay	nn	31	SENT_88	[p3l522t2684r594b2708],
31	limit	NN	O	limit	prep_at	27	SENT_88	[p3l608t2677r673b2701],
32	.	.	O	.	_	0	SENT_88	[p3l608t2677r673b2701],

1	doi	FW	O	doi	_	0	SENT_89	[p3l189t2712r722b2743],
2	:10.1371	CD	NUMBER	:10.1371	dep	1	SENT_89	[p3l189t2712r722b2743],
3	/	:	O	/	punct	5	SENT_89	[p3l189t2712r722b2743],
4	journa	NN	O	journa	nn	5	SENT_89	[p3l189t2712r722b2743],
5	|	NN	O	|	dep	2	SENT_89	[p3l189t2712r722b2743],
6	.	.	O	.	_	0	SENT_89	[p3l189t2712r722b2743],

1	ppat	NN	O	ppat	_	0	SENT_90	[p3l189t2712r722b2743],
2	.	.	O	.	_	0	SENT_90	[p3l189t2712r722b2743],

1	OO30046	NN	O	oo30046	_	0	SENT_91	[p3l189t2712r722b2743],
2	.	.	O	.	_	0	SENT_91	[p3l189t2712r722b2743],

1	g0O1	NN	O	g0o1	_	0	SENT_92	[p3l189t2712r722b2743],

1	cation	NN	O	cation	nn	2	SENT_93	[p3l189t2799r290b2824],
2	cycles	NNS	O	cycle	nsubj	8	SENT_93	[p3l311t2798r403b2833],
3	and	CC	O	and	_	0	SENT_93	[p3l424t2798r483b2824],
4	production	NN	O	production	conj_and	2	SENT_93	[p3l504t2798r688b2833],
5	from	IN	O	from	_	0	SENT_93	[p3l709t2798r789b2824],
6	reservoirs	NNS	O	reservoir	prep_from	2	SENT_93	[p3l809t2799r968b2824],
7	have	VBP	O	have	aux	8	SENT_93	[p3l989t2798r1062b2824],
8	yielded	VBN	O	yield	dep	11	SENT_93	[p3l1082t2798r1199b2833],
9	conﬂicting	JJ	O	conﬂicting	amod	10	SENT_93	[p3l189t2847r364b2882],
10	results	NNS	O	result	dobj	8	SENT_93	[p3l381t2847r485b2873],
11	[	VBP	O	[	_	0	SENT_93	[p3l505t2847r645b2879],
12	6,23,24	CD	NUMBER	6,23,24	number	13	SENT_93	[p3l505t2847r645b2879],
13	]	CD	NUMBER	]	dobj	11	SENT_93	[p3l505t2847r645b2879],
14	,	,	O	,	_	0	SENT_93	[p3l505t2847r645b2879],
15	and	CC	O	and	_	0	SENT_93	[p3l663t2847r722b2873],
16	additional	JJ	O	additional	amod	17	SENT_93	[p3l739t2847r905b2873],
17	treatment	NN	O	treatment	conj_and	13	SENT_93	[p3l923t2852r1085b2873],
18	intensiﬁcation	NN	O	intensiﬁcation	nn	19	SENT_93	[p3l1102t2848r1198b2873, p3l189t2896r337b2922],
19	trials	NNS	O	trial	dep	17	SENT_93	[p3l351t2896r430b2922],
20	to	TO	O	to	aux	21	SENT_93	[p3l445t2901r475b2922],
21	distinguish	VB	O	distinguish	xcomp	11	SENT_93	[p3l488t2896r666b2931],
22	these	DT	O	these	det	23	SENT_93	[p3l680t2896r761b2922],
23	possibilities	NNS	O	possibility	nsubj	25	SENT_93	[p3l775t2896r965b2931],
24	are	VBP	O	be	cop	25	SENT_93	[p3l978t2905r1028b2922],
25	underway	JJ	O	underway	ccomp	21	SENT_93	[p3l1040t2896r1199b2931],
26	(	CD	NUMBER	(	num	29	SENT_93	[p3l190t2946r269b2977],
27	NIH	NNP	ORGANIZATION	NIH	nn	29	SENT_93	[p3l190t2946r269b2977],
28	study	NN	O	study	nn	29	SENT_93	[p3l298t2945r383b2980],
29	02-I-0232	NN	O	02-i-0232	nsubj	11	SENT_93	[p3l411t2945r572b2976],
30	,	,	O	,	_	0	SENT_93	[p3l411t2945r572b2976],
31	http://clinicalstudies.info.nih.gov/cgi/	NN	O	http://clinicalstudies.info.nih.gov/cgi/	nn	32	SENT_93	[p3l600t2945r1200b2980],
32	protinstitute	NN	O	protinstitute	appos	29	SENT_93	[p3l189t2993r708b3028],
33	.	.	O	.	_	0	SENT_93	[p3l189t2993r708b3028],

1	cgi	NN	O	cgus	_	0	SENT_94	[p3l189t2993r708b3028],
2	?	.	O	?	_	0	SENT_94	[p3l189t2993r708b3028],

1	NIAID	NNP	ORGANIZATION	NIAID	_	0	SENT_95	[p3l189t2993r708b3028],
2	.	.	O	.	_	0	SENT_95	[p3l189t2993r708b3028],

1	O.	NNP	O	O.	_	0	SENT_96	[p3l189t2993r708b3028],
2	html	NN	O	html	nn	3	SENT_96	[p3l189t2993r708b3028],
3	)	NN	O	)	dep	1	SENT_96	[p3l189t2993r708b3028],
4	.	.	O	.	_	0	SENT_96	[p3l189t2993r708b3028],

1	Information	NN	O	information	_	0	SENT_97	[p3l723t2993r924b3019],
2	from	IN	O	from	_	0	SENT_97	[p3l938t2993r1018b3019],
3	such	JJ	O	such	amod	4	SENT_97	[p3l1032t2993r1104b3019],
4	trials	NNS	O	trial	prep_from	1	SENT_97	[p3l1119t2993r1199b3019],

1	:	:	O	:	_	0	SENT_98	[p3l188t3077r261b3136],
2	?	.	O	?	_	0	SENT_98	[p3l188t3077r261b3136],

1	PLoS	NN	O	plo	nsubj	2	SENT_99	[p3l288t3093r352b3116],
2	Pathogens	VBD	O	pathogen	_	0	SENT_99	[p3l367t3092r511b3123],
3	|	CD	NUMBER	|	num	4	SENT_99	[p3l526t3091r528b3124],
4	www	NN	O	www	dobj	2	SENT_99	[p3l543t3092r882b3123],
5	.	.	O	.	_	0	SENT_99	[p3l543t3092r882b3123],

1	p	NN	O	p	_	0	SENT_100	[p3l543t3092r882b3123],
2	|	CD	NUMBER	|	num	3	SENT_100	[p3l543t3092r882b3123],
3	ospathogens.org	NN	O	ospathogens.org	dep	1	SENT_100	[p3l543t3092r882b3123],

1	Source	NN	O	source	_	0	SENT_101	[p3l1731t107r1824b130],
2	of	IN	O	of	_	0	SENT_101	[p3l1837t106r1865b130],
3	Stable	JJ	O	stable	amod	5	SENT_101	[p3l1876t106r1960b130],
4	HIV-1	NN	O	hiv-1	nn	5	SENT_101	[p3l1975t107r2041b130],
5	Viremia	NN	O	viremia	prep_of	1	SENT_101	[p3l2059t107r2161b130],
6	on	IN	O	on	_	0	SENT_101	[p3l2175t113r2208b130],
7	ART	NN	O	art	prep_on	1	SENT_101	[p3l2222t107r2277b130],

1	O	NN	O	o	_	0	SENT_102	[p3l1813t471r1834b492],

1	-	:	O	-	_	0	SENT_103	[p3l1275t522r1300b564],
2	_	CD	PERCENT	_	num	3	SENT_103	[p3l1275t522r1300b564],
3	%	NN	PERCENT	%	_	0	SENT_103	[p3l1275t522r1300b564],
4	60	CD	PERCENT	60	num	6	SENT_103	[p3l1350t537r1381b559],
5	%	NN	PERCENT	%	nn	6	SENT_103	[p3l1281t566r1300b601],
6	A	NN	O	a	dep	3	SENT_103	[p3l1646t586r1667b607],
7	2	CD	NUMBER	2	num	8	SENT_103	[p3l1281t602r1300b628],
8	A	DT	O	a	rcmod	6	SENT_103	[p3l1584t606r1605b627],
9	S.	NNP	O	S.	prep	8	SENT_103	[p3l1275t631r1300b669],
10	’	CD	NUMBER	’	num	11	SENT_103	[p3l1275t631r1300b669],
11	40	CD	NUMBER	40	dep	9	SENT_103	[p3l1349t647r1381b669],
12	'	''	O	'	_	0	SENT_103	[p3l1695t627r1717b648],

1	‘	NN	O	‘	_	0	SENT_104	[p3l1562t684r1583b706],
2	.	.	O	.	_	0	SENT_104	[p3l1630t675r1651b701],

1	Logwviral	JJ	O	logwviral	nsubj	2	SENT_105	[p3l2022t668r2143b698],
2	RNA	NN	O	rna	_	0	SENT_105	[p3l2156t668r2216b689],
3	$	$	MONEY	$	dobj	2	SENT_105	[p3l1572t691r1636b752],
4	Mean	NN	MONEY	mean	dep	5	SENT_105	[p3l2024t706r2094b728],
5	Median	JJ	O	median	dep	11	SENT_105	[p3l2132t706r2226b728],
6	20	CD	NUMBER	20	num	7	SENT_105	[p3l1350t757r1381b779],
7	»	NN	O	»	dep	5	SENT_105	[p3l1527t748r1594b795],
8	o	NN	O	o	dep	5	SENT_105	[p3l1673t745r1689b761],
9	LopinavirlRitonavir	NNP	O	LopinavirlRitonavir	dep	5	SENT_105	[p3l1703t743r1972b771],
10	0.53	CD	NUMBER	0.53	dep	5	SENT_105	[p3l2039t743r2095b765],
11	0.51	CD	NUMBER	0.51	num	3	SENT_105	[p3l2157t743r2209b765],
12	I	PRP	O	I	nsubj	13	SENT_105	[p3l1671t788r1689b806],
13	Nelfinavir	VBP	O	nelfinavir	rcmod	3	SENT_105	[p3l1706t787r1840b810],
14	0.48	CD	NUMBER	0.48	num	15	SENT_105	[p3l2040t788r2096b810],
15	0.43	CD	NUMBER	0.43	nsubj	17	SENT_105	[p3l2164t788r2220b810],
16	A	DT	O	a	det	17	SENT_105	[p3l1669t829r1686b849],
17	NNRTI	NN	O	nnrtus	xcomp	13	SENT_105	[p3l1706t827r1793b849],
18	0.35	CD	NUMBER	0.35	num	19	SENT_105	[p3l2035t827r2092b849],
19	0.19	CD	NUMBER	0.19	dep	17	SENT_105	[p3l2156t827r2212b849],

1	o	NN	O	o	dep	5	SENT_106	[p3l1365t866r1379b888],
2	‘	CD	NUMBER	‘	num	3	SENT_106	[p3l1505t859r1527b891],
3	l	NN	O	l	dep	1	SENT_106	[p3l1557t878r1560b892],
4	I	PRP	O	I	dep	5	SENT_106	[p3l1697t880r1700b892],
5	I	PRP	O	I	dep	7	SENT_106	[p3l1838t878r1841b892],
6	I	PRP	O	I	dep	5	SENT_106	[p3l1977t880r1980b892],
7	I	PRP	O	I	dep	9	SENT_106	[p3l2118t878r2121b892],
8	-0.5	CD	NUMBER	-0.5	num	9	SENT_106	[p3l1386t913r1435b935],
9	o	NN	O	o	dep	13	SENT_106	[p3l1549t913r1564b935],
10	0.5	CD	NUMBER	0.5	number	11	SENT_106	[p3l1674t913r1713b935],
11	1	CD	NUMBER	1	num	13	SENT_106	[p3l1833t913r1841b934],
12	1.5	CD	NUMBER	1.5	number	13	SENT_106	[p3l1956t913r1994b935],
13	2	CD	NUMBER	2	_	0	SENT_106	[p3l2111t913r2125b934],
14	2.5	CD	NUMBER	2.5	dep	13	SENT_106	[p3l2236t913r2275b935],

1	Log	VB	O	log	_	0	SENT_107	[p3l1640t975r1720b1009],
2	“	RB	O	“	advmod	1	SENT_107	[p3l1640t975r1720b1009],
3	,	,	O	,	_	0	SENT_107	[p3l1640t975r1720b1009],
4	virus	NN	O	virus	prep	1	SENT_107	[p3l1730t975r1801b1000],
5	load	NN	O	load	nn	8	SENT_107	[p3l1813t975r1873b1000],
6	(	CD	NUMBER	(	num	8	SENT_107	[p3l1887t975r1969b1007],
7	c/ml	NN	O	c/ml	nn	8	SENT_107	[p3l1887t975r1969b1007],
8	)	NN	O	)	dep	4	SENT_107	[p3l1887t975r1969b1007],

1	Figure	NN	O	figure	_	0	SENT_108	[p3l1277t1043r1370b1074],
2	2	CD	NUMBER	2	dep	1	SENT_108	[p3l1390t1045r1414b1067],
3	.	.	O	.	_	0	SENT_108	[p3l1390t1045r1414b1067],

1	Distribution	NN	O	distribution	nsubjpass	54	SENT_109	[p3l1436t1043r1596b1067],
2	of	IN	O	of	_	0	SENT_109	[p3l1617t1043r1645b1067],
3	Plasma	NN	O	plasma	nn	6	SENT_109	[p3l1665t1043r1758b1067],
4	HIV-1	NN	O	hiv-1	nn	6	SENT_109	[p3l1780t1044r1847b1067],
5	RNA	NN	O	rna	nn	6	SENT_109	[p3l1874t1044r1930b1067],
6	Levels	NNS	O	level	prep_of	1	SENT_109	[p3l1952t1043r2034b1067],
7	in	IN	O	in	_	0	SENT_109	[p3l2055t1044r2076b1067],
8	Patients	NNS	O	patient	prep_in	6	SENT_109	[p3l2099t1044r2207b1067],
9	with	IN	O	with	prep	8	SENT_109	[p3l2227t1043r2285b1067],
10	Persistently	RB	O	persistently	pcomp	9	SENT_109	[p3l1277t1084r1434b1115],
11	Suppressed	VBN	O	suppress	partmod	6	SENT_109	[p3l1447t1084r1605b1115],
12	Viremia	NN	O	viremia	nn	15	SENT_109	[p3l1620t1085r1722b1108],
13	(	CD	NUMBER	(	num	15	SENT_109	[p3l1739t1085r1815b1112],
14	HIV-1	NN	O	hiv-1	nn	15	SENT_109	[p3l1739t1085r1815b1112],
15	RNA	NN	O	rna	dep	16	SENT_109	[p3l1836t1085r1892b1108],
16	<	JJR	O	<	dobj	11	SENT_109	[p3l1908t1086r1966b1108],
17	50	CD	NUMBER	50	num	18	SENT_109	[p3l1908t1086r1966b1108],
18	Copies/ml	NN	O	copies/ml	dep	6	SENT_109	[p3l1981t1084r2118b1115],
19	from	IN	O	from	_	0	SENT_109	[p3l2133t1084r2196b1108],
20	Week	NN	DURATION	week	prep_from	18	SENT_109	[p3l2212t1084r2288b1108],
21	24	CD	NUMBER	24	number	24	SENT_109	[p3l1276t1128r1308b1150],
22	to	TO	O	to	dep	24	SENT_109	[p3l1320t1130r1348b1150],
23	60	CD	NUMBER	60	number	24	SENT_109	[p3l1361t1127r1401b1154],
24	)	CD	NUMBER	)	dep	33	SENT_109	[p3l1361t1127r1401b1154],
25	on	IN	O	on	_	0	SENT_109	[p3l1416t1133r1449b1150],
26	Standard	JJ	O	standard	amod	28	SENT_109	[p3l1463t1126r1585b1150],
27	Antiretroviral	JJ	O	antiretroviral	amod	28	SENT_109	[p3l1599t1126r1778b1150],
28	Therapy	NN	O	therapy	prep_on	24	SENT_109	[p3l1791t1126r1904b1157],
29	Week	NN	DURATION	week	dep	33	SENT_109	[p3l1276t1171r1352b1195],
30	60	CD	NUMBER	60	num	29	SENT_109	[p3l1364t1173r1395b1195],
31	viral	JJ	O	viral	amod	33	SENT_109	[p3l1408t1171r1463b1195],
32	RNA	NN	O	rna	nn	33	SENT_109	[p3l1478t1172r1535b1195],
33	levels	NNS	O	level	dep	38	SENT_109	[p3l1550t1171r1623b1195],
34	for	IN	O	for	_	0	SENT_109	[p3l1636t1171r1674b1195],
35	M98	NN	O	m98	nn	36	SENT_109	[p3l1687t1172r1811b1195],
36	—	NN	O	—	prep_for	33	SENT_109	[p3l1687t1172r1811b1195],
37	863	CD	NUMBER	863	num	38	SENT_109	[p3l1687t1172r1811b1195],
38	patients	NNS	O	patient	dep	18	SENT_109	[p3l1826t1172r1935b1202],
39	on	IN	O	on	_	0	SENT_109	[p3l1948t1178r1982b1195],
40	LPV/r	NN	O	lpv/r	prep_on	38	SENT_109	[p3l1997t1172r2078b1196],
41	—	CD	NUMBER	—	number	42	SENT_109	[p3l1997t1172r2078b1196],
42	(	CD	NUMBER	(	num	44	SENT_109	[p3l2092t1171r2168b1199],
43	blue	JJ	O	blue	amod	44	SENT_109	[p3l2092t1171r2168b1199],
44	)	NN	O	)	dep	6	SENT_109	[p3l2092t1171r2168b1199],
45	or	CC	O	or	_	0	SENT_109	[p3l2182t1178r2210b1195],
46	NFV	NN	O	nfv	nn	47	SENT_109	[p3l2223t1172r2287b1195],
47	—	NN	O	—	prep_of	1	SENT_109	[p3l2223t1172r2287b1195],
48	containing	VBG	O	contain	partmod	47	SENT_109	[p3l1276t1207r1421b1237],
49	(	CD	NUMBER	(	num	52	SENT_109	[p3l1439t1206r1500b1234],
50	red	JJ	O	red	amod	52	SENT_109	[p3l1439t1206r1500b1234],
51	)	NN	O	)	nn	52	SENT_109	[p3l1439t1206r1500b1234],
52	regimens	NNS	O	regimen	dobj	48	SENT_109	[p3l1518t1207r1644b1237],
53	were	VBD	O	be	auxpass	54	SENT_109	[p3l1659t1213r1726b1230],
54	determined	VBN	O	determine	_	0	SENT_109	[p3l1742t1206r1901b1230],
55	by	IN	O	by	_	0	SENT_109	[p3l1919t1206r1951b1237],
56	SCA	NNP	ORGANIZATION	SCA	agent	54	SENT_109	[p3l1966t1207r2027b1230],
57	.	.	O	.	_	0	SENT_109	[p3l1966t1207r2027b1230],

1	The	DT	O	the	det	2	SENT_110	[p3l2042t1206r2092b1230],
2	percentile	NN	O	percentile	nsubjpass	14	SENT_110	[p3l2109t1206r2245b1237],
3	of	IN	O	of	_	0	SENT_110	[p3l2260t1206r2288b1230],
4	patients	NNS	O	patient	prep_of	2	SENT_110	[p3l1277t1242r1387b1272],
5	in	IN	O	in	_	0	SENT_110	[p3l1409t1242r1431b1265],
6	each	DT	O	each	det	7	SENT_110	[p3l1455t1241r1517b1265],
7	group	NN	O	group	prep_in	4	SENT_110	[p3l1540t1248r1623b1272],
8	with	IN	O	with	_	0	SENT_110	[p3l1645t1241r1704b1265],
9	a	DT	O	a	det	12	SENT_110	[p3l1727t1248r1740b1265],
10	given	VBN	O	give	amod	12	SENT_110	[p3l1763t1242r1837b1272],
11	RNA	NN	O	rna	nn	12	SENT_110	[p3l1861t1242r1918b1265],
12	level	NN	O	level	prep_with	7	SENT_110	[p3l1941t1241r2001b1265],
13	is	VBZ	O	be	auxpass	14	SENT_110	[p3l2025t1242r2043b1265],
14	presented	VBN	O	present	_	0	SENT_110	[p3l2066t1241r2211b1272],
15	.	.	O	.	_	0	SENT_110	[p3l2066t1241r2211b1272],

1	SCA	NNP	ORGANIZATION	SCA	nn	2	SENT_111	[p3l2233t1242r2286b1265],
2	determinations	NNS	O	determination	nsubjpass	20	SENT_111	[p3l1276t1277r1485b1301],
3	for	IN	O	for	_	0	SENT_111	[p3l1498t1277r1536b1301],
4	patients	NNS	O	patient	prep_for	2	SENT_111	[p3l1549t1278r1659b1308],
5	on	IN	O	on	_	0	SENT_111	[p3l1672t1284r1705b1301],
6	NNRT	NNP	ORGANIZATION	NNRT	nn	7	SENT_111	[p3l1721t1278r1814b1301],
7	|	NN	O	|	prep_on	4	SENT_111	[p3l1721t1278r1814b1301],
8	containing	VBG	O	contain	partmod	4	SENT_111	[p3l1827t1278r1972b1308],
9	regimens	NNS	O	regimen	dobj	8	SENT_111	[p3l1988t1278r2114b1308],
10	(	CD	NUMBER	(	num	11	SENT_111	[p3l2128t1278r2152b1305],
11	n	NN	O	n	dep	9	SENT_111	[p3l2128t1278r2152b1305],
12	:	:	O	:	_	0	SENT_111	[p3l2163t1289r2185b1297],
13	28	CD	NUMBER	28	num	14	SENT_111	[p3l2196t1278r2236b1305],
14	)	NN	O	)	dep	9	SENT_111	[p3l2196t1278r2236b1305],
15	for	IN	O	for	_	0	SENT_111	[p3l2249t1277r2287b1301],
16	>	JJR	O	>	prep_for	14	SENT_111	[p3l1278t1314r1313b1336],
17	1	CD	NUMBER	1	num	18	SENT_111	[p3l1278t1314r1313b1336],
18	y	NN	O	y	dep	16	SENT_111	[p3l1330t1320r1345b1343],
19	are	VBP	O	be	auxpass	20	SENT_111	[p3l1357t1319r1398b1336],
20	included	VBN	O	include	_	0	SENT_111	[p3l1412t1312r1528b1336],
21	(	JJ	O	(	amod	23	SENT_111	[p3l1543t1313r1646b1343],
22	green	JJ	O	green	amod	23	SENT_111	[p3l1543t1313r1646b1343],
23	)	NN	O	)	dobj	20	SENT_111	[p3l1543t1313r1646b1343],
24	.	.	O	.	_	0	SENT_111	[p3l1543t1313r1646b1343],

1	The	DT	O	the	det	2	SENT_112	[p3l1657t1312r1708b1336],
2	inset	NN	O	inset	nsubj	3	SENT_112	[p3l1721t1313r1785b1336],
3	shows	VBZ	O	show	_	0	SENT_112	[p3l1798t1312r1882b1336],
4	the	DT	O	the	det	5	SENT_112	[p3l1894t1312r1939b1336],
5	mean	NN	O	mean	dobj	3	SENT_112	[p3l1952t1319r2027b1336],
6	and	CC	O	and	_	0	SENT_112	[p3l2040t1312r2090b1336],
7	median	JJ	O	median	amod	10	SENT_112	[p3l2105t1312r2205b1336],
8	logm	NN	O	logm	nn	10	SENT_112	[p3l2220t1312r2287b1343],
9	RNA	NN	O	rna	nn	10	SENT_112	[p3l1277t1349r1334b1372],
10	levels	NNS	O	level	dobj	3	SENT_112	[p3l1348t1348r1422b1372],
11	for	IN	O	for	_	0	SENT_112	[p3l1435t1348r1473b1372],
12	each	DT	O	each	det	13	SENT_112	[p3l1485t1348r1548b1372],
13	group	NN	O	group	prep_for	10	SENT_112	[p3l1562t1355r1652b1379],
14	.	.	O	.	_	0	SENT_112	[p3l1562t1355r1652b1379],

1	doizl	NN	O	doizl	_	0	SENT_113	[p3l1276t1383r1337b1407],
2	0.1371	CD	NUMBER	0.1371	num	1	SENT_113	[p3l1345t1383r1815b1414],
3	/	:	O	/	punct	5	SENT_113	[p3l1345t1383r1815b1414],
4	journa	NN	O	journa	nn	5	SENT_113	[p3l1345t1383r1815b1414],
5	|	NN	O	|	dep	1	SENT_113	[p3l1345t1383r1815b1414],
6	.	.	O	.	_	0	SENT_113	[p3l1345t1383r1815b1414],

1	ppat	NN	O	ppat	_	0	SENT_114	[p3l1345t1383r1815b1414],
2	.	.	O	.	_	0	SENT_114	[p3l1345t1383r1815b1414],

1	O030046	CD	NUMBER	o030046	_	0	SENT_115	[p3l1345t1383r1815b1414],
2	.	.	O	.	_	0	SENT_115	[p3l1345t1383r1815b1414],

1	g002	NN	O	g002	_	0	SENT_116	[p3l1345t1383r1815b1414],

1	is	VBZ	O	be	cop	2	SENT_117	[p3l1277t1484r1299b1509],
2	essential	JJ	O	essential	_	0	SENT_117	[p3l1322t1483r1459b1509],
3	in	IN	O	in	_	0	SENT_117	[p3l1482t1484r1513b1508],
4	designing	VBG	O	design	prepc_in	2	SENT_117	[p3l1535t1483r1692b1518],
5	future	JJ	DATE	future	amod	7	SENT_117	[p3l1713t1483r1814b1509],
6	antiretroviral	JJ	O	antiretroviral	amod	7	SENT_117	[p3l1837t1483r2057b1509],
7	strategies	NNS	O	strategy	dobj	4	SENT_117	[p3l2080t1484r2232b1518],
8	to	TO	O	to	aux	10	SENT_117	[p3l2256t1489r2286b1509],
9	fully	RB	O	fully	advmod	10	SENT_117	[p3l1276t1528r1347b1563],
10	suppress	VB	O	suppress	xcomp	4	SENT_117	[p3l1362t1537r1501b1563],
11	Viremia	NNP	O	Viremia	dobj	10	SENT_117	[p3l1515t1529r1646b1554],
12	.	.	O	.	_	0	SENT_117	[p3l1515t1529r1646b1554],

1	This	DT	O	this	det	2	SENT_118	[p3l1314t1574r1383b1600],
2	study	NN	O	study	nsubj	3	SENT_118	[p3l1396t1574r1481b1609],
3	analyzed	VBD	O	analyze	_	0	SENT_118	[p3l1493t1574r1632b1609],
4	only	RB	O	only	advmod	6	SENT_118	[p3l1645t1574r1714b1609],
5	those	DT	O	those	det	6	SENT_118	[p3l1727t1574r1811b1600],
6	participants	NNS	O	participant	dobj	3	SENT_118	[p3l1824t1575r2021b1609],
7	in	IN	O	in	_	0	SENT_118	[p3l2034t1575r2064b1599],
8	the	DT	O	the	det	12	SENT_118	[p3l2078t1574r2127b1600],
9	M98	NN	O	m98	nn	12	SENT_118	[p3l2140t1574r2286b1599],
10	—	NN	O	—	nn	12	SENT_118	[p3l2140t1574r2286b1599],
11	863	CD	NUMBER	863	num	12	SENT_118	[p3l2140t1574r2286b1599],
12	study	NN	O	study	prep_in	6	SENT_118	[p3l1277t1620r1362b1655],
13	whose	WP$	O	whose	dep	16	SENT_118	[p3l1378t1620r1476b1646],
14	Viremia	NNP	O	Viremia	nsubjpass	16	SENT_118	[p3l1493t1621r1616b1646],
15	remained	VBD	O	remain	auxpass	16	SENT_118	[p3l1633t1620r1787b1646],
16	suppressed	VBN	O	suppress	dep	6	SENT_118	[p3l1804t1620r1983b1655],
17	to	TO	O	to	_	0	SENT_118	[p3l2002t1625r2032b1646],
18	<	JJR	O	<	prep_to	16	SENT_118	[p3l2051t1620r2116b1645],
19	50	CD	NUMBER	50	num	20	SENT_118	[p3l2051t1620r2116b1645],
20	copies/ml	NN	O	copies/ml	dep	18	SENT_118	[p3l2134t1620r2286b1655],
21	for	IN	O	for	_	0	SENT_118	[p3l1276t1666r1325b1692],
22	60-110	CD	NUMBER	60-110	num	23	SENT_118	[p3l1350t1666r1463b1691],
23	wk	NN	DURATION	wk	prep_for	20	SENT_118	[p3l1489t1666r1540b1692],
24	.	.	O	.	_	0	SENT_118	[p3l1489t1666r1540b1692],

1	As	IN	O	as	mark	2	SENT_119	[p3l1566t1666r1604b1692],
2	demonstrated	VBN	O	demonstrate	advcl	13	SENT_119	[p3l1631t1666r1857b1692],
3	in	IN	O	in	_	0	SENT_119	[p3l1884t1667r1914b1691],
4	prior	JJ	O	prior	amod	6	SENT_119	[p3l1940t1667r2025b1701],
5	intent-to-treat	NN	O	intent-to-treat	nn	6	SENT_119	[p3l2050t1667r2287b1692],
6	analyses	NNS	O	analysis	prep_in	2	SENT_119	[p3l1277t1711r1407b1746],
7	of	IN	O	of	_	0	SENT_119	[p3l1424t1711r1459b1737],
8	M98	NN	O	m98	nn	9	SENT_119	[p3l1472t1711r1626b1742],
9	—	NN	O	—	prep_of	6	SENT_119	[p3l1472t1711r1626b1742],
10	863	CD	NUMBER	863	num	9	SENT_119	[p3l1472t1711r1626b1742],
11	,	,	O	,	_	0	SENT_119	[p3l1472t1711r1626b1742],
12	LPV/r	NN	O	lpv/r	nsubj	13	SENT_119	[p3l1644t1711r1739b1737],
13	had	VBD	O	have	_	0	SENT_119	[p3l1754t1711r1813b1737],
14	superior	JJ	O	superior	amod	15	SENT_119	[p3l1830t1712r1968b1746],
15	efﬁcacy	NN	O	efﬁcacy	dobj	13	SENT_119	[p3l1984t1711r2106b1746],
16	compared	VBN	O	compare	_	0	SENT_119	[p3l2123t1711r2286b1746],
17	to	TO	O	to	prepc_compared_to	15	SENT_119	[p3l1278t1762r1308b1783],
18	NFV	NN	O	nfv	pobj	15	SENT_119	[p3l1323t1758r1398b1783],
19	as	IN	O	as	mark	20	SENT_119	[p3l1413t1766r1442b1783],
20	judged	VBN	O	judge	advcl	13	SENT_119	[p3l1452t1757r1567b1792],
21	by	IN	O	by	_	0	SENT_119	[p3l1582t1757r1618b1792],
22	Kaplan-Meier	NN	PERSON	kaplan-meier	nn	23	SENT_119	[p3l1633t1757r1859b1792],
23	analysis	NN	O	analysis	prep_by	20	SENT_119	[p3l1873t1757r1996b1792],
24	of	IN	O	of	_	0	SENT_119	[p3l2012t1757r2047b1783],
25	plasma	NN	O	plasma	nn	28	SENT_119	[p3l2059t1757r2172b1792],
26	HIV-1	NN	O	hiv-1	nn	28	SENT_119	[p3l2187t1758r2283b1783],
27	RNA	NN	O	rna	nn	28	SENT_119	[p3l1276t1803r1354b1829],
28	rebound	NN	O	rebound	prep_of	23	SENT_119	[p3l1372t1803r1510b1829],
29	to	TO	O	to	_	0	SENT_119	[p3l1528t1808r1558b1829],
30	greater	JJR	O	greater	mwe	31	SENT_119	[p3l1576t1808r1693b1838],
31	than	IN	O	than	quantmod	32	SENT_119	[p3l1710t1803r1782b1829],
32	400	CD	NUMBER	400	num	33	SENT_119	[p3l1799t1803r1855b1828],
33	copies/ml	NN	O	copies/ml	prep_to	20	SENT_119	[p3l1872t1803r2025b1838],
34	through	IN	O	through	_	0	SENT_119	[p3l2043t1803r2173b1838],
35	96	CD	DURATION	96	num	37	SENT_119	[p3l2191t1803r2227b1828],
36	wk	NN	DURATION	wk	nn	37	SENT_119	[p3l2243t1803r2287b1828],
37	[	NN	O	[	prep_through	20	SENT_119	[p3l1279t1846r1449b1881],
38	14,25	CD	NUMBER	14,25	number	39	SENT_119	[p3l1279t1846r1449b1881],
39	—	CD	NUMBER	—	dep	37	SENT_119	[p3l1279t1846r1449b1881],
40	27	CD	NUMBER	27	num	41	SENT_119	[p3l1279t1846r1449b1881],
41	]	NN	O	]	dep	39	SENT_119	[p3l1279t1846r1449b1881],
42	.	.	O	.	_	0	SENT_119	[p3l1279t1846r1449b1881],

1	The	DT	O	the	det	3	SENT_120	[p3l1468t1849r1530b1875],
2	present	JJ	DATE	present	amod	3	SENT_120	[p3l1549t1854r1670b1884],
3	results	NNS	O	result	nsubj	4	SENT_120	[p3l1689t1849r1793b1875],
4	imply	VBP	O	imply	_	0	SENT_120	[p3l1812t1849r1903b1884],
5	that	IN	O	that	complm	12	SENT_120	[p3l1922t1849r1984b1875],
6	the	DT	O	the	det	7	SENT_120	[p3l2003t1849r2052b1875],
7	difference	NN	O	difference	nsubjpass	12	SENT_120	[p3l2071t1849r2237b1875],
8	in	IN	O	in	_	0	SENT_120	[p3l2256t1850r2286b1874],
9	efﬁcacy	NN	O	efﬁcacy	prep_in	7	SENT_120	[p3l1277t1895r1398b1930],
10	is	VBZ	O	be	auxpass	12	SENT_120	[p3l1413t1896r1435b1921],
11	not	RB	O	not	neg	12	SENT_120	[p3l1450t1900r1504b1921],
12	associated	VBN	O	associate	ccomp	4	SENT_120	[p3l1519t1895r1683b1921],
13	with	IN	O	with	_	0	SENT_120	[p3l1697t1895r1767b1921],
14	differences	NNS	O	difference	prep_with	12	SENT_120	[p3l1781t1895r1961b1921],
15	in	IN	O	in	_	0	SENT_120	[p3l1977t1896r2007b1920],
16	residual	JJ	O	residual	amod	17	SENT_120	[p3l2022t1895r2150b1921],
17	Viremia	NN	O	viremia	prep_in	14	SENT_120	[p3l2164t1896r2287b1921],
18	in	IN	O	in	_	0	SENT_120	[p3l1277t1941r1308b1965],
19	the	DT	O	the	det	21	SENT_120	[p3l1335t1940r1384b1966],
20	two	CD	NUMBER	two	num	21	SENT_120	[p3l1412t1945r1467b1966],
21	groups	NNS	O	group	prep_in	17	SENT_120	[p3l1494t1949r1613b1975],
22	.	.	O	.	_	0	SENT_120	[p3l1494t1949r1613b1975],

1	Early	RB	O	early	advmod	3	SENT_121	[p3l1639t1940r1722b1975],
2	therapeutic	JJ	O	therapeutic	amod	3	SENT_121	[p3l1750t1940r1936b1975],
3	failures	NNS	O	failure	nsubjpass	6	SENT_121	[p3l1963t1940r2083b1966],
4	have	VBP	O	have	aux	6	SENT_121	[p3l2109t1940r2182b1966],
5	been	VBN	O	be	auxpass	6	SENT_121	[p3l2209t1940r2286b1966],
6	hypothesized	VBN	O	hypothesize	_	0	SENT_121	[p3l1276t1986r1489b2021],
7	to	TO	O	to	aux	8	SENT_121	[p3l1504t1991r1534b2012],
8	result	VB	O	result	xcomp	6	SENT_121	[p3l1549t1986r1640b2012],
9	from	IN	O	from	_	0	SENT_121	[p3l1653t1986r1732b2012],
10	the	DT	O	the	det	11	SENT_121	[p3l1747t1986r1796b2012],
11	emergence	NN	O	emergence	prep_from	8	SENT_121	[p3l1810t1995r1986b2021],
12	of	IN	O	of	_	0	SENT_121	[p3l2000t1986r2035b2012],
13	mutations	NNS	O	mutation	prep_of	11	SENT_121	[p3l2046t1987r2209b2012],
14	that	WDT	O	that	nsubj	15	SENT_121	[p3l2224t1986r2287b2012],
15	exist	VBP	O	exist	rcmod	13	SENT_121	[p3l1277t2033r1351b2058],
16	prior	RB	O	prior	_	0	SENT_121	[p3l1369t2033r1453b2067],
17	to	TO	O	to	_	0	SENT_121	[p3l1471t2037r1501b2058],
18	initiation	NN	O	initiation	prep_prior_to	15	SENT_121	[p3l1521t2033r1672b2058],
19	of	IN	O	of	_	0	SENT_121	[p3l1691t2032r1725b2058],
20	antiretroviral	JJ	O	antiretroviral	amod	21	SENT_121	[p3l1740t2032r1960b2058],
21	therapy	NN	O	therapy	prep_of	18	SENT_121	[p3l1979t2032r2103b2067],
22	[	CD	NUMBER	[	number	23	SENT_121	[p3l2123t2032r2234b2064],
23	16,28	CD	NUMBER	16,28	num	24	SENT_121	[p3l2123t2032r2234b2064],
24	]	NN	O	]	dobj	15	SENT_121	[p3l2123t2032r2234b2064],
25	.	.	O	.	_	0	SENT_121	[p3l2123t2032r2234b2064],

1	In	IN	O	in	_	0	SENT_122	[p3l2253t2033r2286b2057],
2	this	DT	O	this	det	3	SENT_122	[p3l1278t2078r1334b2104],
3	regard	NN	O	regard	prep_in	11	SENT_122	[p3l1347t2078r1460b2113],
4	,	,	O	,	_	0	SENT_122	[p3l1347t2078r1460b2113],
5	the	DT	O	the	det	6	SENT_122	[p3l1475t2078r1524b2104],
6	superiority	NN	O	superiority	nsubj	30	SENT_122	[p3l1537t2079r1716b2113],
7	of	IN	O	of	_	0	SENT_122	[p3l1729t2078r1763b2104],
8	LPV/r	NN	O	lpv/r	prep_of	6	SENT_122	[p3l1772t2078r1867b2104],
9	may	MD	O	may	aux	11	SENT_122	[p3l1879t2087r1944b2113],
10	be	VB	O	be	aux	11	SENT_122	[p3l1956t2078r1993b2104],
11	related	VBN	O	relate	_	0	SENT_122	[p3l2006t2078r2119b2104],
12	in	IN	O	in	_	0	SENT_122	[p3l2132t2079r2162b2103],
13	part	NN	O	part	prep_in	11	SENT_122	[p3l2175t2083r2243b2113],
14	to	TO	O	to	_	0	SENT_122	[p3l2256t2084r2286b2104],
15	its	PRP$	O	its	poss	16	SENT_122	[p3l1277t2124r1312b2149],
16	contribution	NN	O	contribution	prep_to	11	SENT_122	[p3l1328t2123r1537b2149],
17	to	TO	O	to	_	0	SENT_122	[p3l1554t2128r1584b2149],
18	a	DT	O	a	det	21	SENT_122	[p3l1601t2132r1617b2149],
19	higher	JJR	O	higher	amod	21	SENT_122	[p3l1632t2123r1738b2158],
20	genetic	JJ	O	genetic	amod	21	SENT_122	[p3l1752t2124r1868b2158],
21	barrier	NN	O	barrier	prep_to	11	SENT_122	[p3l1885t2123r2000b2149],
22	to	TO	O	to	_	0	SENT_122	[p3l2016t2128r2046b2149],
23	resistance	NN	O	resistance	prep_to	21	SENT_122	[p3l2063t2124r2223b2149],
24	for	IN	O	for	_	0	SENT_122	[p3l2239t2123r2287b2149],
25	the	DT	O	the	det	27	SENT_122	[p3l1278t2169r1327b2195],
26	combination	NN	O	combination	nn	27	SENT_122	[p3l1343t2169r1551b2195],
27	regimen	NN	O	regimen	prep_for	23	SENT_122	[p3l1568t2170r1709b2204],
28	,	,	O	,	_	0	SENT_122	[p3l1568t2170r1709b2204],
29	as	IN	O	as	_	0	SENT_122	[p3l1726t2178r1755b2195],
30	compared	VBN	O	compare	conj_as	11	SENT_122	[p3l1771t2169r1935b2204],
31	to	TO	O	to	_	0	SENT_122	[p3l1952t2174r1982b2195],
32	NFV	NN	O	nfv	prep_to	30	SENT_122	[p3l1998t2170r2080b2200],
33	,	,	O	,	_	0	SENT_122	[p3l1998t2170r2080b2200],
34	for	IN	O	for	_	0	SENT_122	[p3l2097t2169r2145b2195],
35	which	WDT	O	which	rel	39	SENT_122	[p3l2159t2169r2255b2195],
36	a	DT	O	a	det	38	SENT_122	[p3l2271t2178r2287b2195],
37	single	JJ	O	single	amod	38	SENT_122	[p3l1277t2215r1369b2250],
38	mutation	NN	O	mutation	nsubj	39	SENT_122	[p3l1387t2216r1537b2241],
39	confers	VBZ	O	confer	rcmod	32	SENT_122	[p3l1555t2215r1674b2241],
40	signiﬁcant	JJ	O	signiﬁcant	amod	41	SENT_122	[p3l1692t2215r1861b2250],
41	resistance	NN	O	resistance	dobj	39	SENT_122	[p3l1879t2216r2038b2241],
42	[	CD	NUMBER	[	num	44	SENT_122	[p3l2059t2215r2171b2247],
43	29,30	CD	NUMBER	29,30	num	44	SENT_122	[p3l2059t2215r2171b2247],
44	]	NN	O	]	dobj	11	SENT_122	[p3l2059t2215r2171b2247],
45	.	.	O	.	_	0	SENT_122	[p3l2059t2215r2171b2247],

1	Other	JJ	O	other	amod	2	SENT_123	[p3l2190t2215r2288b2241],
2	factors	NNS	O	factor	nsubj	17	SENT_123	[p3l1276t2261r1386b2287],
3	that	WDT	O	that	nsubj	6	SENT_123	[p3l1402t2261r1465b2287],
4	may	MD	O	may	aux	6	SENT_123	[p3l1480t2270r1545b2296],
5	have	VB	O	have	aux	6	SENT_123	[p3l1559t2261r1632b2287],
6	contributed	VBN	O	contribute	rcmod	2	SENT_123	[p3l1647t2261r1841b2287],
7	to	TO	O	to	_	0	SENT_123	[p3l1856t2266r1886b2287],
8	the	DT	O	the	det	10	SENT_123	[p3l1903t2261r1952b2287],
9	differential	JJ	O	differential	amod	10	SENT_123	[p3l1966t2261r2150b2287],
10	efﬁcacy	NN	O	efﬁcacy	prep_to	6	SENT_123	[p3l2165t2261r2286b2296],
11	observed	VBN	O	observe	partmod	10	SENT_123	[p3l1277t2307r1421b2333],
12	between	IN	O	between	_	0	SENT_123	[p3l1437t2307r1572b2333],
13	LPV/r	NN	O	lpv/r	prep_between	11	SENT_123	[p3l1588t2307r1683b2333],
14	and	CC	O	and	_	0	SENT_123	[p3l1698t2307r1757b2333],
15	NFV	NN	O	nfv	prep_between	11	SENT_123	[p3l1772t2308r1847b2333],
16	are	VBP	O	be	cop	17	SENT_123	[p3l1863t2316r1912b2333],
17	related	JJ	O	related	_	0	SENT_123	[p3l1929t2307r2042b2333],
18	to	TO	O	to	_	0	SENT_123	[p3l2059t2312r2089b2333],
19	differences	NNS	O	difference	prep_to	17	SENT_123	[p3l2106t2307r2286b2333],
20	in	IN	O	in	_	0	SENT_123	[p3l1277t2353r1308b2377],
21	pharmacokinetic	JJ	O	pharmacokinetic	amod	22	SENT_123	[p3l1325t2352r1601b2387],
22	proﬁles	NNS	O	proﬁles	prep_in	19	SENT_123	[p3l1620t2352r1749b2387],
23	,	,	O	,	_	0	SENT_123	[p3l1620t2352r1749b2387],
24	as	IN	O	as	mark	28	SENT_123	[p3l1768t2361r1797b2378],
25	lopinavir	NN	O	lopinavir	nn	27	SENT_123	[p3l1815t2352r1963b2387],
26	plasma	NN	O	plasma	nn	27	SENT_123	[p3l1980t2352r2093b2387],
27	concentrations	NNS	O	concentration	nsubj	28	SENT_123	[p3l2110t2357r2285b2378, p3l1278t2399r1355b2424],
28	exceed	VBP	O	exceed	advcl	17	SENT_123	[p3l1376t2398r1486b2424],
29	the	DT	O	the	det	30	SENT_123	[p3l1508t2398r1557b2424],
30	IC5o	NN	O	ic5o	dobj	28	SENT_123	[p3l1577t2398r1642b2429],
31	for	IN	O	for	_	0	SENT_123	[p3l1663t2398r1711b2424],
32	wild-type	JJ	O	wild-type	amod	33	SENT_123	[p3l1730t2398r1880b2433],
33	HIV	NN	O	hiv	prep_for	30	SENT_123	[p3l1900t2399r1969b2424],
34	by	IN	O	by	_	0	SENT_123	[p3l1988t2398r2024b2433],
35	a	DT	O	a	det	38	SENT_123	[p3l2044t2407r2060b2424],
36	considerably	RB	O	considerably	advmod	37	SENT_123	[p3l2080t2398r2287b2433],
37	greater	JJR	O	greater	amod	38	SENT_123	[p3l1276t2449r1395b2479],
38	margin	NN	O	margin	prep_by	28	SENT_123	[p3l1422t2445r1539b2479],
39	than	IN	O	than	advmod	40	SENT_123	[p3l1568t2444r1641b2470],
40	observed	VBN	O	observe	partmod	38	SENT_123	[p3l1669t2444r1815b2470],
41	with	IN	O	with	_	0	SENT_123	[p3l1843t2444r1913b2470],
42	NFV	NN	O	nfv	prep_with	40	SENT_123	[p3l1941t2445r2023b2470],
43	.	.	O	.	_	0	SENT_123	[p3l1941t2445r2023b2470],

1	Consequently	RB	O	consequently	advmod	12	SENT_124	[p3l2052t2444r2285b2479],
2	,	,	O	,	_	0	SENT_124	[p3l2052t2444r2285b2479],
3	individual	JJ	O	individual	amod	5	SENT_124	[p3l1277t2490r1440b2516],
4	pharmacokinetic	JJ	O	pharmacokinetic	amod	5	SENT_124	[p3l1457t2490r1733b2525],
5	variability	NN	O	variability	nsubj	12	SENT_124	[p3l1750t2490r1914b2525],
6	and	CC	O	and	_	0	SENT_124	[p3l1931t2490r1990b2516],
7	adherence	NN	O	adherence	nn	8	SENT_124	[p3l2007t2490r2175b2516],
8	lapses	NNS	O	lapse	conj_and	5	SENT_124	[p3l2191t2490r2286b2525],
9	may	MD	O	may	aux	12	SENT_124	[p3l1277t2544r1342b2570],
10	be	VB	O	be	cop	12	SENT_124	[p3l1355t2535r1392b2561],
11	more	RBR	O	more	advmod	12	SENT_124	[p3l1405t2544r1490b2561],
12	likely	JJ	O	likely	_	0	SENT_124	[p3l1503t2535r1588b2570],
13	to	TO	O	to	aux	14	SENT_124	[p3l1603t2540r1633b2561],
14	result	VB	O	result	xcomp	12	SENT_124	[p3l1647t2535r1738b2561],
15	in	IN	O	in	_	0	SENT_124	[p3l1751t2536r1782b2560],
16	loss	NN	O	loss	prep_in	14	SENT_124	[p3l1795t2535r1852b2561],
17	of	IN	O	of	_	0	SENT_124	[p3l1866t2535r1901b2561],
18	suppression	NN	O	suppression	prep_of	16	SENT_124	[p3l1910t2536r2104b2570],
19	with	IN	O	with	_	0	SENT_124	[p3l2117t2535r2187b2561],
20	NFVbased	JJ	MISC	nfvbased	amod	21	SENT_124	[p3l2199t2536r2286b2561, p3l1276t2581r1367b2607],
21	regimens	NNS	O	regimen	prep_with	14	SENT_124	[p3l1389t2582r1536b2616],
22	compared	VBN	O	compare	_	0	SENT_124	[p3l1557t2581r1721b2616],
23	to	TO	O	to	prepc_compared_to	21	SENT_124	[p3l1743t2586r1773b2607],
24	LPV/r-based	JJ	O	lpv/r-based	amod	25	SENT_124	[p3l1795t2581r1994b2607],
25	therapy	NN	O	therapy	pobj	21	SENT_124	[p3l2017t2581r2147b2616],
26	.	.	O	.	_	0	SENT_124	[p3l2017t2581r2147b2616],

1	Similar	JJ	O	similar	amod	2	SENT_125	[p3l2170t2581r2287b2607],
2	levels	NNS	O	level	nsubj	14	SENT_125	[p3l1276t2627r1363b2653],
3	of	IN	O	of	_	0	SENT_125	[p3l1382t2627r1417b2653],
4	persistent	JJ	O	persistent	amod	5	SENT_125	[p3l1432t2628r1592b2662],
5	Viremia	NN	O	viremia	prep_of	2	SENT_125	[p3l1610t2628r1733b2653],
6	in	IN	O	in	_	0	SENT_125	[p3l1751t2628r1782b2652],
7	patients	NNS	O	patient	prep_in	5	SENT_125	[p3l1801t2628r1930b2662],
8	undergoing	VBG	O	undergo	partmod	7	SENT_125	[p3l1949t2627r2138b2662],
9	NNRTIcontaining	JJ	O	nnrticontaining	amod	10	SENT_125	[p3l2156t2628r2286b2653, p3l1277t2674r1453b2708],
10	therapy	NN	O	therapy	dobj	8	SENT_125	[p3l1467t2673r1591b2708],
11	for	IN	O	for	_	0	SENT_125	[p3l1605t2673r1654b2699],
12	prolonged	JJ	O	prolonged	amod	13	SENT_125	[p3l1668t2673r1836b2708],
13	periods	NNS	O	period	prep_for	8	SENT_125	[p3l1851t2673r1971b2708],
14	(	VBP	O	(	_	0	SENT_125	[p3l1988t2674r2086b2705],
15	mean	NN	O	mean	nsubjpass	21	SENT_125	[p3l1988t2674r2086b2705],
16	=	JJ	O	=	dep	21	SENT_125	[p3l2098t2684r2122b2693],
17	111.2	CD	DURATION	111.2	num	19	SENT_125	[p3l2137t2673r2217b2700],
18	wk	NN	DURATION	wk	nn	19	SENT_125	[p3l2232t2673r2286b2705],
19	)	NN	O	)	nsubjpass	21	SENT_125	[p3l2232t2673r2286b2705],
20	were	VBD	O	be	auxpass	21	SENT_125	[p3l1276t2728r1352b2745],
21	noted	VBN	O	note	xcomp	14	SENT_125	[p3l1364t2719r1457b2745],
22	even	RB	O	even	advmod	30	SENT_125	[p3l1469t2728r1542b2745],
23	though	IN	O	though	dep	30	SENT_125	[p3l1555t2719r1668b2754],
24	the	DT	O	the	det	26	SENT_125	[p3l1681t2719r1730b2745],
25	genetic	JJ	O	genetic	amod	26	SENT_125	[p3l1741t2720r1857b2754],
26	barrier	NN	O	barrier	nsubj	30	SENT_125	[p3l1869t2719r1985b2745],
27	to	TO	O	to	_	0	SENT_125	[p3l1996t2724r2026b2745],
28	NNRTI	NNP	ORGANIZATION	NNRTI	prep_to	26	SENT_125	[p3l2038t2720r2156b2745],
29	is	VBZ	O	be	cop	30	SENT_125	[p3l2168t2720r2190b2745],
30	likely	JJ	O	likely	ccomp	21	SENT_125	[p3l2201t2719r2287b2754],
31	to	TO	O	to	aux	33	SENT_125	[p3l1278t2769r1308b2790],
32	be	VB	O	be	cop	33	SENT_125	[p3l1333t2764r1370b2790],
33	low	JJ	O	low	xcomp	30	SENT_125	[p3l1395t2764r1458b2795],
34	;	:	O	;	_	0	SENT_125	[p3l1395t2764r1458b2795],
35	again	RB	O	again	advmod	46	SENT_125	[p3l1484t2765r1577b2799],
36	,	,	O	,	_	0	SENT_125	[p3l1484t2765r1577b2799],
37	early	JJ	O	early	amod	39	SENT_125	[p3l1603t2764r1681b2799],
38	drug	NN	O	drug	nn	39	SENT_125	[p3l1706t2764r1782b2799],
39	failures	NNS	O	failure	nsubjpass	46	SENT_125	[p3l1806t2764r1925b2790],
40	due	JJ	O	due	_	0	SENT_125	[p3l1951t2764r2009b2790],
41	to	TO	O	to	_	0	SENT_125	[p3l2036t2769r2066b2790],
42	pre-existing	JJ	O	pre-existing	amod	43	SENT_125	[p3l2092t2765r2287b2799],
43	mutations	NNS	O	mutation	prep_due_to	39	SENT_125	[p3l1277t2811r1440b2836],
44	were	VBD	O	be	auxpass	46	SENT_125	[p3l1454t2819r1530b2836],
45	likely	JJ	O	likely	advmod	46	SENT_125	[p3l1545t2810r1630b2845],
46	excluded	VBN	O	exclude	parataxis	14	SENT_125	[p3l1645t2810r1790b2836],
47	from	IN	O	from	_	0	SENT_125	[p3l1805t2810r1884b2836],
48	selection	NN	O	selection	prep_from	46	SENT_125	[p3l1899t2810r2050b2836],
49	.	.	O	.	_	0	SENT_125	[p3l1899t2810r2050b2836],

1	The	DT	O	the	det	2	SENT_126	[p3l2065t2810r2127b2836],
2	presence	NN	O	presence	nsubj	6	SENT_126	[p3l2143t2819r2286b2845],
3	of	IN	O	of	_	0	SENT_126	[p3l1277t2856r1311b2882],
4	persistent	JJ	O	persistent	amod	5	SENT_126	[p3l1321t2857r1481b2891],
5	Viremia	NNP	O	Viremia	prep_of	2	SENT_126	[p3l1493t2857r1616b2882],
6	has	VBZ	O	have	_	0	SENT_126	[p3l1627t2856r1679b2882],
7	a	DT	O	a	det	8	SENT_126	[p3l1692t2865r1708b2882],
8	number	NN	O	number	dobj	6	SENT_126	[p3l1721t2856r1849b2882],
9	of	IN	O	of	_	0	SENT_126	[p3l1861t2856r1896b2882],
10	important	JJ	O	important	amod	11	SENT_126	[p3l1905t2857r2072b2891],
11	implications	NNS	O	implication	prep_of	8	SENT_126	[p3l2085t2856r2286b2891],
12	for	IN	O	for	_	0	SENT_126	[p3l1276t2902r1325b2928],
13	development	NN	O	development	prep_for	11	SENT_126	[p3l1340t2902r1552b2937],
14	and	CC	O	and	_	0	SENT_126	[p3l1568t2902r1627b2928],
15	application	NN	O	application	conj_and	13	SENT_126	[p3l1643t2902r1828b2937],
16	of	IN	O	of	_	0	SENT_126	[p3l1844t2902r1879b2928],
17	antiretroviral	JJ	O	antiretroviral	amod	18	SENT_126	[p3l1892t2902r2111b2928],
18	therapies	NNS	O	therapy	prep_of	8	SENT_126	[p3l2128t2902r2285b2937],
19	.	.	O	.	_	0	SENT_126	[p3l2128t2902r2285b2937],

1	Few	JJ	O	few	amod	2	SENT_127	[p3l1276t2949r1339b2974],
2	patients	NNS	O	patient	nsubj	7	SENT_127	[p3l1358t2949r1487b2983],
3	on	IN	O	on	_	0	SENT_127	[p3l1506t2957r1547b2974],
4	antiretroviral	JJ	O	antiretroviral	amod	5	SENT_127	[p3l1565t2948r1785b2974],
5	therapy	NN	O	therapy	prep_on	2	SENT_127	[p3l1805t2948r1928b2983],
6	have	VBP	O	have	aux	7	SENT_127	[p3l1946t2948r2019b2974],
7	“	VBN	O	“	_	0	SENT_127	[p3l2039t2947r2285b2974],
8	undetectable	JJ	O	undetectable	amod	10	SENT_127	[p3l2039t2947r2285b2974],
9	”	NN	O	”	nn	10	SENT_127	[p3l2039t2947r2285b2974],
10	viremia	NN	O	viremia	dobj	7	SENT_127	[p3l1276t2994r1399b3019],
11	if	IN	O	if	mark	16	SENT_127	[p3l1425t2993r1449b3018],
12	sufﬁciently	RB	O	sufﬁciently	advmod	13	SENT_127	[p3l1472t2993r1650b3028],
13	sensitive	JJ	O	sensitive	amod	14	SENT_127	[p3l1676t2994r1813b3019],
14	assays	NNS	O	assay	nsubjpass	16	SENT_127	[p3l1839t3002r1932b3028],
15	are	VBP	O	be	auxpass	16	SENT_127	[p3l1959t3002r2008b3019],
16	employed	VBN	O	employ	advcl	7	SENT_127	[p3l2034t2993r2200b3028],
17	,	,	O	,	_	0	SENT_127	[p3l2034t2993r2200b3028],
18	and	CC	O	and	advmod	16	SENT_127	[p3l2227t2993r2286b3019],

1	April	NNP	DATE	April	_	0	SENT_128	[p3l1772t3092r1834b3123],
2	2007	CD	DATE	2007	num	1	SENT_128	[p3l1849t3094r1914b3116],
3	|	NNP	O	|	dep	1	SENT_128	[p3l1929t3091r1931b3124],
4	Volume	NN	O	volume	nn	7	SENT_128	[p3l1945t3092r2051b3116],
5	3	CD	NUMBER	3	num	7	SENT_128	[p3l2064t3094r2078b3116],
6	|	NN	O	|	nn	7	SENT_128	[p3l2093t3091r2096b3124],
7	Issue	NN	O	issue	dep	3	SENT_128	[p3l2112t3093r2178b3116],
8	4	CD	NUMBER	4	num	10	SENT_128	[p3l2190t3094r2206b3116],
9	|	NN	O	|	nn	10	SENT_128	[p3l2221t3091r2223b3124],
10	e46	NN	O	e46	dep	1	SENT_128	[p3l2238t3094r2287b3116],

1	.	.	O	.	_	0	SENT_129	[p4l231t229r260b257],
2	'	''	O	'	_	0	SENT_129	[p4l231t229r260b257],

1	°	NN	O	°	_	0	SENT_130	[p4l231t229r260b257],
2	:3	CD	NUMBER	:3	number	3	SENT_130	[p4l263t229r281b257],
3	.5	CD	NUMBER	.5	num	1	SENT_130	[p4l234t349r246b377],
4	.	.	O	.	_	0	SENT_130	[p4l234t349r246b377],

1	UI	NNP	O	UI	_	0	SENT_131	[p4l263t349r282b377],
2	_	CD	NUMBER	_	num	1	SENT_131	[p4l234t467r246b496],
3	L	NN	O	l	nn	5	SENT_131	[p4l234t467r246b496],
4	O	NN	O	o	nn	5	SENT_131	[p4l263t469r281b496],
5	P	NN	O	p	dep	1	SENT_131	[p4l233t586r260b614],
6	01	CD	NUMBER	01	num	9	SENT_131	[p4l263t587r282b614],
7	F	NN	O	f	nn	9	SENT_131	[p4l233t706r260b734],
8	’	NN	O	’	nn	9	SENT_131	[p4l233t706r260b734],
9	o	NN	O	o	dep	1	SENT_131	[p4l263t706r281b734],

1	HIV-1	NN	O	hiv-1	nn	2	SENT_132	[p4l188t791r207b853],
2	RNA	NN	O	rna	nsubj	5	SENT_132	[p4l188t724r207b779],
3	by	IN	O	by	_	0	SENT_132	[p4l188t686r213b715],
4	Single	JJ	O	single	prep_by	2	SENT_132	[p4l188t601r213b677],
5	Copy	VBP	O	copy	_	0	SENT_132	[p4l188t527r213b590],
6	Assay	NN	O	assay	nn	7	SENT_132	[p4l188t442r213b518],
7	tlogm	NN	O	tlogm	dobj	5	SENT_132	[p4l189t371r213b433],
8	i	FW	O	i	dep	7	SENT_132	[p4l189t235r212b364],
9	:	:	O	:	_	0	SENT_132	[p4l189t235r212b364],
10	apies	NNS	O	apy	dep	7	SENT_132	[p4l189t235r212b364],
11	.	.	O	.	_	0	SENT_132	[p4l189t235r212b364],
12	'	''	O	'	_	0	SENT_132	[p4l189t235r212b364],

1	mL	NN	O	ml	_	0	SENT_133	[p4l189t235r212b364],
2	)	CD	NUMBER	)	num	1	SENT_133	[p4l189t235r212b364],
3	:	:	O	:	_	0	SENT_133	[p4l219t826r260b854],
4	'	''	O	'	_	0	SENT_133	[p4l219t826r260b854],
5	=	JJ	O	=	amod	7	SENT_133	[p4l219t826r260b854],
6	o	NN	O	o	nn	7	SENT_133	[p4l264t826r282b854],
7	|	NN	O	|	dep	1	SENT_133	[p4l264t826r282b854],
8	2	CD	NUMBER	2	number	9	SENT_133	[p4l300t877r318b905],
9	3	CD	NUMBER	3	num	11	SENT_133	[p4l474t877r492b905],
10	4	CD	NUMBER	4	number	11	SENT_133	[p4l651t877r670b904],
11	5	CD	NUMBER	5	dep	7	SENT_133	[p4l826t877r844b905],
12	6	CD	NUMBER	6	number	13	SENT_133	[p4l1002t877r1020b905],
13	7	CD	NUMBER	7	amod	11	SENT_133	[p4l1177t877r1195b904],

1	Baseline	NN	O	baseline	_	0	SENT_134	[p4l481t934r606b959],
2	HIV	NN	O	hiv	nn	5	SENT_134	[p4l616t934r664b958],
3	RNA	NN	O	rna	nn	5	SENT_134	[p4l676t934r741b958],
4	(	NN	O	(	nn	5	SENT_134	[p4l750t934r823b965],
5	log	NN	O	log	dep	1	SENT_134	[p4l750t934r823b965],
6	.	.	O	.	_	0	SENT_134	[p4l750t934r823b965],

1	.	.	O	.	_	0	SENT_135	[p4l750t934r823b965],

1	,	,	O	,	_	0	SENT_136	[p4l750t934r823b965],
2	copieslmL	NN	O	copieslml	nn	3	SENT_136	[p4l832t934r994b965],
3	)	NN	O	)	_	0	SENT_136	[p4l832t934r994b965],

1	Figure	NNP	O	Figure	_	0	SENT_137	[p4l190t1000r282b1031],
2	3	CD	NUMBER	3	dep	1	SENT_137	[p4l300t1002r324b1024],
3	.	.	O	.	_	0	SENT_137	[p4l300t1002r324b1024],

1	Correlation	NN	O	correlation	_	0	SENT_138	[p4l342t1000r493b1024],
2	between	IN	O	between	_	0	SENT_138	[p4l513t1000r631b1024],
3	Pretherapy	NNP	O	Pretherapy	prep_between	1	SENT_138	[p4l651t1000r801b1031],
4	and	CC	O	and	_	0	SENT_138	[p4l817t1000r867b1024],
5	On	NNP	O	On	prep_between	1	SENT_138	[p4l886t1000r1048b1031],
6	.	.	O	.	_	0	SENT_138	[p4l886t1000r1048b1031],

1	—	NN	O	—	_	0	SENT_139	[p4l886t1000r1048b1031],
2	.	.	O	.	_	0	SENT_139	[p4l886t1000r1048b1031],

1	Therapy	NN	O	therapy	_	0	SENT_140	[p4l886t1000r1048b1031],
2	Viral	JJ	O	viral	amod	4	SENT_140	[p4l1064t1000r1122b1024],
3	RNA	NN	O	rna	nn	4	SENT_140	[p4l1142t1001r1199b1024],
4	Levels	NNS	O	level	dep	1	SENT_140	[p4l190t1041r272b1065],

1	Pretherapy	NNP	O	Pretherapy	nn	6	SENT_141	[p4l190t1086r339b1117],
2	and	CC	O	and	_	0	SENT_141	[p4l353t1086r403b1110],
3	week	NN	DURATION	week	nn	6	SENT_141	[p4l418t1086r490b1110],
4	60	CD	NUMBER	60	num	6	SENT_141	[p4l504t1088r536b1110],
5	SCA	NN	ORGANIZATION	sca	nn	6	SENT_141	[p4l551t1087r604b1110],
6	values	NNS	O	value	nsubjpass	8	SENT_141	[p4l618t1086r704b1110],
7	were	VBD	O	be	auxpass	8	SENT_141	[p4l718t1093r785b1110],
8	determined	VBN	O	determine	_	0	SENT_141	[p4l799t1086r958b1110],
9	for	IN	O	for	_	0	SENT_141	[p4l973t1086r1011b1110],
10	130	CD	NUMBER	130	num	11	SENT_141	[p4l1028t1088r1074b1110],
11	patients	NNS	O	patient	prep_for	8	SENT_141	[p4l1090t1087r1199b1117],
12	from	IN	O	from	_	0	SENT_141	[p4l188t1121r252b1145],
13	both	CC	O	both	preconj	15	SENT_141	[p4l267t1121r329b1145],
14	the	DT	O	the	det	15	SENT_141	[p4l343t1121r388b1145],
15	NFV	NN	ORGANIZATION	nfv	prep_from	8	SENT_141	[p4l402t1122r456b1145],
16	and	CC	O	and	_	0	SENT_141	[p4l468t1121r518b1145],
17	LPV/r	NN	O	lpv/r	nn	18	SENT_141	[p4l533t1122r605b1146],
18	arms	NNS	O	arm	prep_from	8	SENT_141	[p4l617t1128r682b1145],
19	in	IN	O	in	_	0	SENT_141	[p4l696t1122r718b1145],
20	M98	NN	O	m98	nn	21	SENT_141	[p4l733t1122r865b1145],
21	—	NN	O	—	prep_in	8	SENT_141	[p4l733t1122r865b1145],
22	863	CD	NUMBER	863	num	21	SENT_141	[p4l733t1122r865b1145],
23	.	.	O	.	_	0	SENT_141	[p4l733t1122r865b1145],

1	Correlation	NN	O	correlation	nn	2	SENT_142	[p4l878t1121r1029b1145],
2	coefficients	NNS	O	coefficient	nsubj	11	SENT_142	[p4l1043t1121r1198b1145],
3	for	IN	O	for	_	0	SENT_142	[p4l188t1157r226b1181],
4	patients	NNS	O	patient	prep_for	2	SENT_142	[p4l239t1158r349b1188],
5	taking	VBG	O	take	partmod	4	SENT_142	[p4l361t1157r445b1188],
6	LPV/r	NN	O	lpv/r	nn	9	SENT_142	[p4l461t1158r533b1182],
7	and	CC	O	and	_	0	SENT_142	[p4l545t1157r594b1181],
8	NFV	NN	O	nfv	nn	9	SENT_142	[p4l610t1158r664b1181],
9	regimens	NNS	O	regimen	dobj	5	SENT_142	[p4l677t1158r803b1188],
10	were	VBD	O	be	cop	11	SENT_142	[p4l816t1164r883b1181],
11	similar	JJ	O	similar	_	0	SENT_142	[p4l896t1157r991b1181],
12	.	.	O	.	_	0	SENT_142	[p4l896t1157r991b1181],

1	doi	FW	O	doi	_	0	SENT_143	[p4l189t1192r726b1223],
2	:10.1371	CD	NUMBER	:10.1371	dep	1	SENT_143	[p4l189t1192r726b1223],
3	/	:	O	/	punct	5	SENT_143	[p4l189t1192r726b1223],
4	journa	NN	O	journa	nn	5	SENT_143	[p4l189t1192r726b1223],
5	|	NN	O	|	dep	2	SENT_143	[p4l189t1192r726b1223],
6	.	.	O	.	_	0	SENT_143	[p4l189t1192r726b1223],

1	ppat	NN	O	ppat	_	0	SENT_144	[p4l189t1192r726b1223],
2	.	.	O	.	_	0	SENT_144	[p4l189t1192r726b1223],

1	OO30046	NN	O	oo30046	_	0	SENT_145	[p4l189t1192r726b1223],
2	.	.	O	.	_	0	SENT_145	[p4l189t1192r726b1223],

1	g0O3	NN	O	g0o3	_	0	SENT_146	[p4l189t1192r726b1223],

1	greater	JJR	O	greater	amod	2	SENT_147	[p4l189t1313r306b1343],
2	suppression	NN	O	suppression	nsubjpass	9	SENT_147	[p4l320t1309r513b1343],
3	of	IN	O	of	_	0	SENT_147	[p4l528t1308r562b1334],
4	Viremia	NNP	O	Viremia	prep_of	2	SENT_147	[p4l572t1309r696b1334],
5	can	MD	O	can	aux	9	SENT_147	[p4l709t1317r765b1334],
6	probably	RB	O	probably	advmod	9	SENT_147	[p4l779t1308r924b1343],
7	not	RB	O	not	neg	9	SENT_147	[p4l939t1313r992b1334],
8	be	VB	O	be	auxpass	9	SENT_147	[p4l1006t1308r1043b1334],
9	achieved	VBN	O	achieve	_	0	SENT_147	[p4l1058t1308r1199b1334],
10	using	VBG	O	use	xcomp	9	SENT_147	[p4l189t1355r278b1389],
11	current	JJ	DATE	current	amod	12	SENT_147	[p4l306t1359r433b1380],
12	inhibitors	NNS	O	inhibitor	dobj	10	SENT_147	[p4l463t1354r629b1380],
13	of	IN	O	of	_	0	SENT_147	[p4l658t1354r694b1380],
14	HIV-1	NN	O	hiv-1	nn	15	SENT_147	[p4l719t1355r819b1380],
15	replication	NN	O	replication	prep_of	12	SENT_147	[p4l852t1354r1039b1389],
16	because	IN	O	because	mark	20	SENT_147	[p4l1068t1354r1199b1380],
17	persistent	JJ	O	persistent	amod	18	SENT_147	[p4l189t1402r349b1436],
18	Viremia	NN	O	viremia	nsubj	20	SENT_147	[p4l364t1402r487b1427],
19	likely	JJ	O	likely	advmod	20	SENT_147	[p4l502t1401r587b1436],
20	arises	VBZ	O	arise	advcl	9	SENT_147	[p4l603t1402r700b1432],
21	,	,	O	,	_	0	SENT_147	[p4l603t1402r700b1432],
22	at	IN	O	at	advmod	20	SENT_147	[p4l716t1407r745b1427],
23	least	JJS	O	least	pobj	22	SENT_147	[p4l760t1401r832b1427],
24	in	IN	O	in	_	0	SENT_147	[p4l848t1402r878b1426],
25	part	NN	O	part	prep_in	20	SENT_147	[p4l894t1406r969b1436],
26	,	,	O	,	_	0	SENT_147	[p4l894t1406r969b1436],
27	from	IN	O	from	_	0	SENT_147	[p4l984t1401r1064b1427],
28	chronically	RB	O	chronically	advmod	30	SENT_147	[p4l1079t1401r1198b1427, p4l189t1447r261b1482],
29	infected	JJ	O	infected	amod	30	SENT_147	[p4l275t1447r407b1473],
30	cells	NNS	O	cell	prep_from	20	SENT_147	[p4l420t1447r496b1473],
31	.	.	O	.	_	0	SENT_147	[p4l420t1447r496b1473],

1	New	NNP	O	New	nn	3	SENT_148	[p4l510t1448r581b1473],
2	therapeutic	JJ	O	therapeutic	amod	3	SENT_148	[p4l595t1447r782b1482],
3	strategies	NNS	O	strategy	nsubjpass	6	SENT_148	[p4l796t1448r948b1482],
4	will	MD	O	will	aux	6	SENT_148	[p4l962t1447r1018b1472],
5	be	VB	O	be	auxpass	6	SENT_148	[p4l1031t1447r1068b1473],
6	needed	VBN	O	need	_	0	SENT_148	[p4l1082t1447r1199b1473],
7	to	TO	O	to	aux	8	SENT_148	[p4l190t1499r220b1520],
8	eliminate	VB	O	eliminate	xcomp	6	SENT_148	[p4l236t1494r388b1520],
9	persistent	JJ	O	persistent	amod	10	SENT_148	[p4l404t1495r564b1529],
10	Viremia	NN	O	viremia	dobj	8	SENT_148	[p4l578t1495r701b1520],
11	and	CC	O	and	_	0	SENT_148	[p4l716t1494r775b1520],
12	its	PRP$	O	its	poss	13	SENT_148	[p4l790t1495r825b1520],
13	source	NN	O	source	dobj	8	SENT_148	[p4l841t1503r954b1520],
14	.	.	O	.	_	0	SENT_148	[p4l841t1503r954b1520],

1	Materials	NNPS	O	Materials	_	0	SENT_149	[p4l190t1593r367b1625],
2	and	CC	O	and	_	0	SENT_149	[p4l384t1593r455b1625],
3	Methods	NNS	O	method	conj_and	1	SENT_149	[p4l474t1593r641b1625],

1	Research	NN	O	research	nn	2	SENT_150	[p4l225t1663r358b1686],
2	participants	NNS	O	participant	_	0	SENT_150	[p4l370t1663r551b1694],
3	.	.	O	.	_	0	SENT_150	[p4l370t1663r551b1694],

1	Plasma	NN	O	plasma	nn	2	SENT_151	[p4l566t1663r666b1686],
2	samples	NNS	O	sample	nsubjpass	4	SENT_151	[p4l679t1663r791b1694],
3	were	VBD	O	be	auxpass	4	SENT_151	[p4l804t1671r871b1686],
4	obtained	VBN	O	obtain	_	0	SENT_151	[p4l885t1663r1013b1686],
5	from	IN	O	from	_	0	SENT_151	[p4l1025t1663r1096b1685],
6	stored	VBN	O	store	prepc_from	4	SENT_151	[p4l1109t1663r1199b1686],
7	specimens	NNS	O	specimen	dobj	6	SENT_151	[p4l189t1699r337b1730],
8	from	IN	O	from	_	0	SENT_151	[p4l352t1699r422b1721],
9	patients	NNS	O	patient	prep_from	6	SENT_151	[p4l438t1699r553b1730],
10	with	IN	O	with	_	0	SENT_151	[p4l567t1699r629b1722],
11	plasma	NN	O	plasma	nn	13	SENT_151	[p4l644t1699r745b1730],
12	HIV-1	NN	O	hiv-1	nn	13	SENT_151	[p4l759t1699r845b1722],
13	RNA	NN	O	rna	dep	14	SENT_151	[p4l863t1699r932b1722],
14	<	JJR	O	<	prep_with	9	SENT_151	[p4l948t1699r1006b1721],
15	50	CD	NUMBER	50	num	16	SENT_151	[p4l948t1699r1006b1721],
16	Copies/ml	NN	O	copies/ml	dep	14	SENT_151	[p4l1021t1699r1156b1730],
17	in	IN	O	in	_	0	SENT_151	[p4l1172t1699r1199b1721],
18	the	DT	O	the	det	22	SENT_151	[p4l190t1735r233b1758],
19	M98	NN	O	m98	nn	22	SENT_151	[p4l244t1735r374b1757],
20	—	NN	O	—	nn	22	SENT_151	[p4l244t1735r374b1757],
21	863	CD	NUMBER	863	num	22	SENT_151	[p4l244t1735r374b1757],
22	trial	NN	O	trial	prep_in	16	SENT_151	[p4l385t1735r443b1758],
23	and	CC	O	and	_	0	SENT_151	[p4l454t1735r507b1758],
24	from	IN	O	from	_	0	SENT_151	[p4l517t1735r588b1757],
25	patients	NNS	O	patient	prep_from	6	SENT_151	[p4l598t1735r713b1766],
26	on	IN	O	on	_	0	SENT_151	[p4l724t1743r760b1757],
27	treatment	NN	O	treatment	prep_on	25	SENT_151	[p4l771t1740r915b1758],
28	at	IN	O	at	_	0	SENT_151	[p4l925t1740r951b1758],
29	the	DT	O	the	det	30	SENT_151	[p4l962t1735r1006b1758],
30	NIH	NNP	O	NIH	prep_at	27	SENT_151	[p4l1016t1736r1077b1758],
31	Clinical	JJ	O	clinical	amod	32	SENT_151	[p4l1089t1735r1199b1758],
32	Center	NNP	O	Center	dep	6	SENT_151	[p4l189t1771r289b1794],
33	as	IN	O	as	mark	34	SENT_151	[p4l301t1779r327b1794],
34	follows	VBZ	O	follow	advcl	6	SENT_151	[p4l340t1771r447b1794],
35	.	.	O	.	_	0	SENT_151	[p4l340t1771r447b1794],

1	M98	CD	NUMBER	m98	num	2	SENT_152	[p4l226t1808r351b1831],
2	—	NN	O	—	_	0	SENT_152	[p4l226t1808r351b1831],
3	863	CD	NUMBER	863	num	4	SENT_152	[p4l226t1808r351b1831],
4	patients	NNS	O	patient	dep	2	SENT_152	[p4l363t1808r487b1839],
5	.	.	O	.	_	0	SENT_152	[p4l363t1808r487b1839],

1	M98	CD	NUMBER	m98	num	2	SENT_153	[p4l500t1808r629b1830],
2	—	NN	O	—	_	0	SENT_153	[p4l500t1808r629b1830],
3	863	CD	NUMBER	863	nsubjpass	6	SENT_153	[p4l500t1808r629b1830],
4	was	VBD	O	be	auxpass	6	SENT_153	[p4l640t1816r690b1831],
5	a	DT	O	a	dep	6	SENT_153	[p4l702t1816r716b1831],
6	randomized	VBN	O	randomize	rcmod	2	SENT_153	[p4l728t1808r900b1831],
7	double-blind	JJ	O	double-blind	amod	11	SENT_153	[p4l912t1808r1105b1835],
8	,	,	O	,	_	0	SENT_153	[p4l912t1808r1105b1835],
9	Phase	NN	O	phase	dep	11	SENT_153	[p4l1118t1808r1199b1831],
10	III	CD	NUMBER	iii	num	11	SENT_153	[p4l189t1845r222b1866],
11	study	NN	O	study	nsubj	12	SENT_153	[p4l232t1844r308b1875],
12	comparing	VBG	O	compare	dep	6	SENT_153	[p4l317t1844r475b1875],
13	LPV/r	NN	O	lpv/r	dobj	12	SENT_153	[p4l484t1844r568b1867],
14	(	CD	NUMBER	(	number	15	SENT_153	[p4l578t1844r696b1873],
15	400/100	CD	NUMBER	400/100	num	16	SENT_153	[p4l578t1844r696b1873],
16	mg	NN	O	mg	npadvmod	17	SENT_153	[p4l707t1852r750b1875],
17	twice	RB	O	twice	advmod	12	SENT_153	[p4l760t1844r833b1867],
18	daily	JJ	SET	daily	amod	20	SENT_153	[p4l843t1844r921b1875],
19	)	NN	O	)	nn	20	SENT_153	[p4l843t1844r921b1875],
20	(	NN	O	(	dep	2	SENT_153	[p4l932t1845r957b1873],
21	7	CD	NUMBER	7	dep	20	SENT_153	[p4l932t1845r957b1873],
22	;	:	O	;	_	0	SENT_153	[p4l932t1845r957b1873],
23	:	:	O	:	_	0	SENT_153	[p4l964t1854r986b1862],
24	326	CD	NUMBER	326	num	25	SENT_153	[p4l994t1844r1052b1873],
25	)	NN	O	)	dep	2	SENT_153	[p4l994t1844r1052b1873],
26	with	IN	O	with	_	0	SENT_153	[p4l1062t1844r1124b1867],
27	NFV	NN	O	nfv	nn	28	SENT_153	[p4l1134t1845r1199b1867],
28	(	NN	O	(	prep_with	25	SENT_153	[p4l190t1878r248b1909],
29	750	CD	NUMBER	750	num	30	SENT_153	[p4l190t1878r248b1909],
30	mg	NN	O	mg	dep	25	SENT_153	[p4l263t1888r306b1911],
31	three	CD	NUMBER	three	num	32	SENT_153	[p4l319t1880r393b1903],
32	times	NNS	O	time	npadvmod	33	SENT_153	[p4l407t1880r483b1903],
33	daily	JJ	SET	daily	amod	30	SENT_153	[p4l496t1880r564b1911],
34	or	CC	O	or	_	0	SENT_153	[p4l578t1888r609b1902],
35	1,250	CD	NUMBER	1,250	num	36	SENT_153	[p4l625t1880r696b1907],
36	mg	NN	O	mg	conj_or	25	SENT_153	[p4l710t1888r753b1911],
37	twice	RB	O	twice	advmod	42	SENT_153	[p4l766t1880r839b1903],
38	daily	RB	SET	daily	advmod	42	SENT_153	[p4l853t1880r930b1911],
39	)	CD	NUMBER	)	num	40	SENT_153	[p4l853t1880r930b1911],
40	(	CD	NUMBER	(	pobj	38	SENT_153	[p4l945t1881r970b1908],
41	11	CD	NUMBER	11	number	42	SENT_153	[p4l945t1881r970b1908],
42	2	CD	NUMBER	2	dep	36	SENT_153	[p4l980t1890r1002b1898],
43	327	CD	NUMBER	327	num	44	SENT_153	[p4l1014t1878r1079b1909],
44	)	NN	O	)	dep	42	SENT_153	[p4l1014t1878r1079b1909],
45	,	,	O	,	_	0	SENT_153	[p4l1014t1878r1079b1909],
46	each	DT	O	each	appos	42	SENT_153	[p4l1093t1880r1158b1903],
47	in	IN	O	in	_	0	SENT_153	[p4l1172t1880r1199b1902],
48	combination	NN	O	combination	prep_in	46	SENT_153	[p4l189t1916r373b1939],
49	with	IN	O	with	_	0	SENT_153	[p4l392t1916r454b1939],
50	stavudine	NN	O	stavudine	prep_with	48	SENT_153	[p4l473t1916r610b1939],
51	and	CC	O	and	_	0	SENT_153	[p4l629t1916r682b1939],
52	lamivudine	NN	O	lamivudine	conj_and	50	SENT_153	[p4l701t1916r869b1943],
53	,	,	O	,	_	0	SENT_153	[p4l701t1916r869b1943],
54	in	IN	O	in	_	0	SENT_153	[p4l889t1916r916b1938],
55	previously	RB	DATE	previously	advmod	56	SENT_153	[p4l935t1916r1083b1947],
56	antiretroviral-naive	JJ	O	antiretroviral-naive	amod	58	SENT_153	[p4l1102t1916r1198b1939, p4l190t1952r385b1975],
57	HIV-1-infected	JJ	O	hiv-1-infected	amod	58	SENT_153	[p4l401t1952r620b1975],
58	patients	NNS	O	patient	prep_in	48	SENT_153	[p4l636t1952r751b1983],
59	[	IN	O	[	_	0	SENT_153	[p4l768t1952r825b1980],
60	14	CD	NUMBER	14	num	61	SENT_153	[p4l768t1952r825b1980],
61	]	NN	O	]	prep_[	58	SENT_153	[p4l768t1952r825b1980],
62	.	.	O	.	_	0	SENT_153	[p4l768t1952r825b1980],

1	All	DT	O	all	det	2	SENT_154	[p4l840t1952r880b1974],
2	patients	NNS	O	patient	_	0	SENT_154	[p4l896t1952r1011b1983],
3	in	IN	O	in	_	0	SENT_154	[p4l1027t1952r1054b1974],
4	M98	NN	O	m98	nn	5	SENT_154	[p4l1069t1952r1199b1974],
5	—	NN	O	—	prep_in	2	SENT_154	[p4l1069t1952r1199b1974],
6	863	CD	NUMBER	863	num	5	SENT_154	[p4l1069t1952r1199b1974],
7	who	WP	O	who	nsubj	8	SENT_154	[p4l188t1988r246b2010],
8	achieved	VBD	O	achieve	rcmod	2	SENT_154	[p4l259t1988r384b2011],
9	plasma	NN	O	plasma	nn	12	SENT_154	[p4l396t1988r496b2019],
10	HIV-1	NN	O	hiv-1	nn	12	SENT_154	[p4l507t1988r592b2011],
11	RNA	NN	O	rna	nn	12	SENT_154	[p4l607t1988r676b2011],
12	values	NNS	O	value	nsubj	15	SENT_154	[p4l686t1988r773b2011],
13	<	JJR	O	<	dep	15	SENT_154	[p4l786t1988r844b2010],
14	50	CD	NUMBER	50	num	15	SENT_154	[p4l786t1988r844b2010],
15	copies/ml	NN	O	copies/ml	xcomp	8	SENT_154	[p4l856t1988r991b2019],
16	by	IN	O	by	_	0	SENT_154	[p4l1002t1988r1035b2019],
17	week	NN	DURATION	week	prep_by	15	SENT_154	[p4l1045t1988r1116b2011],
18	24	CD	NUMBER	24	num	17	SENT_154	[p4l1128t1988r1160b2011],
19	of	IN	O	of	_	0	SENT_154	[p4l1171t1988r1202b2010],
20	therapy	NN	O	therapy	prep_of	17	SENT_154	[p4l190t2024r300b2055],
21	and	CC	O	and	_	0	SENT_154	[p4l310t2024r362b2047],
22	who	WP	O	who	nsubj	23	SENT_154	[p4l372t2024r430b2046],
23	remained	VBD	O	remain	xcomp	8	SENT_154	[p4l442t2024r579b2047],
24	undetectable	JJ	O	undetectable	amod	31	SENT_154	[p4l589t2024r776b2047],
25	at	IN	O	at	_	0	SENT_154	[p4l787t2029r812b2047],
26	that	DT	O	that	det	27	SENT_154	[p4l823t2024r879b2047],
27	level	NN	O	level	prep_at	24	SENT_154	[p4l890t2024r954b2047],
28	at	IN	O	at	_	0	SENT_154	[p4l964t2029r990b2047],
29	all	DT	O	all	det	30	SENT_154	[p4l1000t2024r1033b2046],
30	study	NN	O	study	prep_at	27	SENT_154	[p4l1044t2024r1119b2055],
31	visits	NNS	O	visit	nsubjpass	38	SENT_154	[p4l1128t2024r1199b2047],
32	through	IN	O	through	_	0	SENT_154	[p4l190t2060r305b2091],
33	week	NN	DURATION	week	prep_through	31	SENT_154	[p4l318t2060r389b2083],
34	60	CD	NUMBER	60	num	33	SENT_154	[p4l405t2060r436b2082],
35	of	IN	O	of	_	0	SENT_154	[p4l451t2060r482b2082],
36	follow-up	NN	O	follow-up	prep_of	33	SENT_154	[p4l492t2060r630b2091],
37	were	VBD	O	be	auxpass	38	SENT_154	[p4l644t2068r712b2083],
38	identiﬁed	VBN	O	identiﬁed	ccomp	23	SENT_154	[p4l728t2060r866b2083],
39	for	IN	O	for	_	0	SENT_154	[p4l880t2060r924b2082],
40	analysis	NN	O	analysis	nn	41	SENT_154	[p4l937t2060r1046b2091],
41	(	NN	O	(	prep_for	38	SENT_154	[p4l1062t2061r1087b2089],
42	7	CD	NUMBER	7	num	41	SENT_154	[p4l1062t2061r1087b2089],
43	;	:	O	;	_	0	SENT_154	[p4l1062t2061r1087b2089],
44	:	:	O	:	_	0	SENT_154	[p4l1098t2070r1120b2078],
45	237	CD	NUMBER	237	dep	2	SENT_154	[p4l1133t2058r1198b2089],
46	)	NN	O	)	dep	45	SENT_154	[p4l1133t2058r1198b2089],
47	.	.	O	.	_	0	SENT_154	[p4l1133t2058r1198b2089],

1	From	IN	O	from	_	0	SENT_155	[p4l189t2097r266b2118],
2	this	DT	O	this	det	3	SENT_155	[p4l284t2096r334b2119],
3	group	NN	O	group	prep_from	18	SENT_155	[p4l351t2104r444b2127],
4	,	,	O	,	_	0	SENT_155	[p4l351t2104r444b2127],
5	a	DT	O	a	det	6	SENT_155	[p4l461t2104r476b2118],
6	subset	NN	O	subset	nsubjpass	18	SENT_155	[p4l492t2096r580b2119],
7	of	IN	O	of	_	0	SENT_155	[p4l597t2096r628b2118],
8	163	CD	NUMBER	163	num	9	SENT_155	[p4l644t2096r691b2118],
9	participants	NNS	O	participant	prep_of	6	SENT_155	[p4l708t2096r882b2127],
10	treated	VBN	O	treat	partmod	9	SENT_155	[p4l900t2096r1002b2119],
11	at	IN	O	at	_	0	SENT_155	[p4l1019t2101r1045b2119],
12	investigational	JJ	O	investigational	amod	13	SENT_155	[p4l1062t2096r1199b2127, p4l190t2132r272b2155],
13	sites	NNS	O	site	prep_at	10	SENT_155	[p4l283t2132r343b2155],
14	in	IN	O	in	_	0	SENT_155	[p4l355t2132r382b2154],
15	North	NNP	LOCATION	North	nn	16	SENT_155	[p4l392t2132r479b2155],
16	America	NNP	LOCATION	America	prep_in	13	SENT_155	[p4l489t2132r612b2155],
17	was	VBD	O	be	auxpass	18	SENT_155	[p4l621t2140r671b2155],
18	identiﬁed	VBN	O	identiﬁed	_	0	SENT_155	[p4l682t2132r821b2155],
19	for	IN	O	for	_	0	SENT_155	[p4l831t2132r875b2154],
20	SCA	NNP	ORGANIZATION	SCA	nn	21	SENT_155	[p4l885t2132r947b2155],
21	testing	NN	O	testing	prep_for	18	SENT_155	[p4l958t2132r1060b2163],
22	.	.	O	.	_	0	SENT_155	[p4l958t2132r1060b2163],

1	Of	IN	O	of	_	0	SENT_156	[p4l1072t2132r1111b2155],
2	these	DT	O	these	prep_of	6	SENT_156	[p4l1119t2132r1199b2159],
3	,	,	O	,	_	0	SENT_156	[p4l1119t2132r1199b2159],
4	six	CD	NUMBER	six	nsubjpass	6	SENT_156	[p4l189t2168r227b2191],
5	were	VBD	O	be	auxpass	6	SENT_156	[p4l238t2176r306b2191],
6	excluded	VBN	O	exclude	_	0	SENT_156	[p4l319t2168r448b2191],
7	for	IN	O	for	_	0	SENT_156	[p4l460t2168r504b2190],
8	lack	NN	O	lack	prep_for	6	SENT_156	[p4l516t2168r572b2191],
9	of	IN	O	of	_	0	SENT_156	[p4l584t2168r615b2190],
10	archived	JJ	O	archived	amod	11	SENT_156	[p4l625t2168r748b2191],
11	samples	NNS	O	sample	prep_of	8	SENT_156	[p4l761t2168r873b2199],
12	and	CC	O	and	_	0	SENT_156	[p4l886t2168r939b2191],
13	12	CD	NUMBER	12	prep_for	6	SENT_156	[p4l955t2168r983b2191],
14	for	IN	O	for	_	0	SENT_156	[p4l996t2168r1040b2190],
15	inefﬁcient	JJ	O	inefﬁcient	amod	16	SENT_156	[p4l1052t2168r1199b2191],
16	ampliﬁcation	NN	O	ampliﬁcation	prep_for	13	SENT_156	[p4l189t2204r390b2235],
17	of	IN	O	of	_	0	SENT_156	[p4l416t2204r448b2226],
18	baseline	NN	O	baseline	nn	19	SENT_156	[p4l470t2204r592b2227],
19	sample	NN	O	sample	prep_of	16	SENT_156	[p4l619t2204r730b2235],
20	.	.	O	.	_	0	SENT_156	[p4l619t2204r730b2235],

1	Pretherapy	JJ	O	pretherapy	amod	2	SENT_157	[p4l757t2204r924b2235],
2	samples	NNS	O	sample	nsubj	13	SENT_157	[p4l950t2204r1067b2235],
3	of	IN	O	of	_	0	SENT_157	[p4l1093t2204r1125b2226],
4	145	CD	NUMBER	145	num	5	SENT_157	[p4l1151t2204r1199b2226],
5	participants	NNS	O	participant	prep_of	2	SENT_157	[p4l189t2240r363b2271],
6	were	VBD	O	be	cop	13	SENT_157	[p4l382t2248r450b2263],
7	ampliﬁable	JJ	O	ampliﬁable	amod	13	SENT_157	[p4l470t2240r630b2271],
8	by	IN	O	by	_	0	SENT_157	[p4l649t2240r682b2271],
9	SCA	NNP	ORGANIZATION	SCA	prep_by	7	SENT_157	[p4l701t2240r764b2263],
10	(	CD	NUMBER	(	num	9	SENT_157	[p4l783t2240r884b2271],
11	Figure	NNP	O	Figure	nn	13	SENT_157	[p4l783t2240r884b2271],
12	S1	NN	O	s1	nn	13	SENT_157	[p4l904t2240r954b2268],
13	)	NN	O	)	_	0	SENT_157	[p4l904t2240r954b2268],
14	,	,	O	,	_	0	SENT_157	[p4l904t2240r954b2268],
15	and	CC	O	and	_	0	SENT_157	[p4l974t2240r1026b2263],
16	only	RB	O	only	advmod	18	SENT_157	[p4l1046t2240r1107b2271],
17	these	DT	O	these	det	18	SENT_157	[p4l1126t2240r1199b2263],
18	participants	NNS	O	participant	nsubj	20	SENT_157	[p4l189t2276r363b2307],
19	were	VBD	O	be	cop	20	SENT_157	[p4l377t2284r444b2299],
20	candidates	NNS	O	candidate	conj_and	13	SENT_157	[p4l458t2276r612b2299],
21	for	IN	O	for	_	0	SENT_157	[p4l626t2276r669b2298],
22	further	JJ	O	further	amod	23	SENT_157	[p4l681t2276r786b2299],
23	analyses	NNS	O	analysis	prep_for	20	SENT_157	[p4l800t2276r922b2307],
24	.	.	O	.	_	0	SENT_157	[p4l800t2276r922b2307],

1	Of	IN	O	of	_	0	SENT_158	[p4l937t2276r976b2299],
2	these	DT	O	these	prep_of	6	SENT_158	[p4l987t2276r1067b2303],
3	,	,	O	,	_	0	SENT_158	[p4l987t2276r1067b2303],
4	130	CD	NUMBER	130	nsubj	15	SENT_158	[p4l1084t2276r1130b2298],
5	also	RB	O	also	advmod	6	SENT_158	[p4l1145t2276r1199b2299],
6	had	VBD	O	have	_	0	SENT_158	[p4l189t2312r241b2335],
7	valid	JJ	O	valid	amod	8	SENT_158	[p4l253t2312r321b2335],
8	assay	NN	O	assay	dobj	6	SENT_158	[p4l334t2320r405b2343],
9	results	VBZ	O	result	rcmod	8	SENT_158	[p4l418t2312r510b2335],
10	for	IN	O	for	_	0	SENT_158	[p4l522t2312r566b2334],
11	week	NN	DURATION	week	nn	13	SENT_158	[p4l577t2312r648b2335],
12	60	CD	NUMBER	60	num	13	SENT_158	[p4l661t2312r692b2334],
13	samples	NNS	O	sample	prep_for	9	SENT_158	[p4l705t2312r817b2343],
14	and	CC	O	and	_	0	SENT_158	[p4l830t2312r883b2335],
15	constituted	VBD	O	constitute	conj_and	6	SENT_158	[p4l895t2312r1059b2335],
16	the	DT	DATE	the	det	20	SENT_158	[p4l1072t2312r1116b2335],
17	week	NN	DATE	week	nn	20	SENT_158	[p4l1128t2312r1199b2335],
18	60	CD	NUMBER	60	num	20	SENT_158	[p4l190t2348r221b2370],
19	group	NN	O	group	nn	20	SENT_158	[p4l237t2356r323b2379],
20	analysis	NN	O	analysis	tmod	15	SENT_158	[p4l339t2348r455b2379],
21	.	.	O	.	_	0	SENT_158	[p4l339t2348r455b2379],

1	All	DT	O	all	det	3	SENT_159	[p4l471t2348r512b2370],
2	145	CD	NUMBER	145	num	3	SENT_159	[p4l531t2348r578b2370],
3	participants	NNS	O	participant	nsubj	14	SENT_159	[p4l594t2348r768b2379],
4	with	IN	O	with	_	0	SENT_159	[p4l783t2348r845b2371],
5	ampliﬁable	JJ	O	ampliﬁable	amod	7	SENT_159	[p4l862t2348r1022b2379],
6	pretherapy	JJ	O	pretherapy	amod	7	SENT_159	[p4l1039t2348r1199b2379],
7	samples	NNS	O	sample	prep_with	3	SENT_159	[p4l189t2384r301b2415],
8	who	WP	O	who	nsubj	13	SENT_159	[p4l315t2384r373b2406],
9	remained	VBD	O	remain	rcmod	7	SENT_159	[p4l389t2384r526b2407],
10	on	IN	O	on	_	0	SENT_159	[p4l540t2392r576b2406],
11	study	NN	O	study	prep_on	9	SENT_159	[p4l590t2384r666b2415],
12	and	CC	O	and	_	0	SENT_159	[p4l680t2384r733b2407],
13	maintained	VBD	O	maintain	rcmod	7	SENT_159	[p4l748t2384r912b2407],
14	suppressed	VBN	O	suppress	_	0	SENT_159	[p4l926t2384r1085b2415],
15	plasma	NN	O	plasma	nn	18	SENT_159	[p4l1099t2384r1200b2415],
16	HIV-1	NN	O	hiv-1	nn	18	SENT_159	[p4l189t2420r275b2442],
17	RNA	NN	O	rna	nn	18	SENT_159	[p4l292t2420r361b2442],
18	levels	NNS	O	level	nsubjpass	28	SENT_159	[p4l375t2420r451b2443],
19	<	JJR	O	<	dep	28	SENT_159	[p4l468t2420r526b2442],
20	50	CD	NUMBER	50	num	21	SENT_159	[p4l468t2420r526b2442],
21	copies/ml	NN	O	copies/ml	nsubjpass	28	SENT_159	[p4l541t2420r676b2451],
22	through	IN	O	through	_	0	SENT_159	[p4l691t2420r807b2451],
23	110	CD	DURATION	110	num	24	SENT_159	[p4l824t2420r870b2442],
24	wk	NN	DURATION	wk	prep_through	21	SENT_159	[p4l884t2420r923b2442],
25	of	IN	O	of	_	0	SENT_159	[p4l937t2420r968b2442],
26	follow-up	NN	O	follow-up	prep_of	24	SENT_159	[p4l979t2420r1117b2451],
27	were	VBD	O	be	auxpass	28	SENT_159	[p4l1131t2428r1199b2443],
28	considered	VBN	O	consider	xcomp	14	SENT_159	[p4l189t2456r347b2479],
29	for	IN	O	for	_	0	SENT_159	[p4l368t2456r412b2478],
30	longitudinal	JJ	O	longitudinal	amod	31	SENT_159	[p4l433t2456r609b2487],
31	analysis	NN	O	analysis	prep_for	28	SENT_159	[p4l631t2456r747b2487],
32	.	.	O	.	_	0	SENT_159	[p4l631t2456r747b2487],

1	As	IN	O	as	mark	2	SENT_160	[p4l769t2456r803b2479],
2	shown	VBN	O	show	advcl	11	SENT_160	[p4l825t2456r915b2479],
3	in	IN	O	in	_	0	SENT_160	[p4l937t2456r964b2478],
4	Figure	NNP	O	Figure	nn	5	SENT_160	[p4l986t2456r1078b2487],
5	S1	NN	O	s1	prep_in	2	SENT_160	[p4l1100t2456r1139b2483],
6	,	,	O	,	_	0	SENT_160	[p4l1100t2456r1139b2483],
7	six	CD	NUMBER	six	num	8	SENT_160	[p4l1162t2456r1199b2479],
8	participants	NNS	O	participant	nsubj	11	SENT_160	[p4l189t2492r363b2523],
9	did	VBD	O	do	aux	11	SENT_160	[p4l376t2492r422b2515],
10	not	RB	O	not	neg	11	SENT_160	[p4l435t2497r482b2515],
11	have	VB	O	have	_	0	SENT_160	[p4l494t2492r559b2515],
12	samples	NNS	O	sample	nsubj	13	SENT_160	[p4l572t2492r683b2523],
13	available	JJ	O	available	xcomp	11	SENT_160	[p4l696t2492r821b2515],
14	after	IN	O	after	_	0	SENT_160	[p4l834t2492r902b2515],
15	week	NN	DURATION	week	prep_after	11	SENT_160	[p4l913t2492r984b2515],
16	60	CD	NUMBER	60	num	15	SENT_160	[p4l997t2492r1036b2519],
17	;	:	O	;	_	0	SENT_160	[p4l997t2492r1036b2519],
18	21	CD	NUMBER	21	nsubj	21	SENT_160	[p4l1049t2492r1078b2515],
19	did	VBD	O	do	aux	21	SENT_160	[p4l1093t2492r1139b2515],
20	not	RB	O	not	neg	21	SENT_160	[p4l1152t2497r1199b2515],
21	maintain	VB	O	maintain	conj_and	11	SENT_160	[p4l190t2528r319b2551],
22	complete	JJ	O	complete	amod	23	SENT_160	[p4l334t2528r467b2559],
23	suppression	NN	O	suppression	dobj	21	SENT_160	[p4l483t2528r654b2559],
24	after	IN	O	after	_	0	SENT_160	[p4l670t2528r738b2551],
25	week	NN	DURATION	week	prep_after	21	SENT_160	[p4l752t2528r823b2551],
26	60	CD	NUMBER	60	num	25	SENT_160	[p4l838t2528r869b2550],
27	by	IN	O	by	_	0	SENT_160	[p4l885t2528r917b2559],
28	conventional	JJ	O	conventional	amod	31	SENT_160	[p4l932t2528r1120b2551],
29	viral	JJ	O	viral	amod	31	SENT_160	[p4l1135t2528r1199b2551],
30	RNA	NN	O	rna	nn	31	SENT_160	[p4l189t2564r258b2586],
31	testing	NN	O	testing	prep_by	21	SENT_160	[p4l278t2564r381b2595],
32	;	:	O	;	_	0	SENT_160	[p4l278t2564r381b2595],
33	and	CC	O	and	_	0	SENT_160	[p4l401t2564r454b2587],
34	one	CD	NUMBER	one	nsubj	35	SENT_160	[p4l474t2572r526b2587],
35	had	VBD	O	have	conj_and	11	SENT_160	[p4l546t2564r598b2587],
36	no	DT	O	no	det	39	SENT_160	[p4l619t2572r654b2586],
37	valid	JJ	O	valid	amod	39	SENT_160	[p4l674t2564r742b2587],
38	assay	NN	O	assay	nn	39	SENT_160	[p4l762t2572r833b2595],
39	results	NNS	O	result	dobj	35	SENT_160	[p4l853t2564r945b2587],
40	during	IN	O	during	_	0	SENT_160	[p4l966t2564r1063b2595],
41	analysis	NN	O	analysis	prep_during	39	SENT_160	[p4l1082t2564r1198b2595],
42	.	.	O	.	_	0	SENT_160	[p4l1082t2564r1198b2595],

1	Therefore	RB	O	therefore	advmod	6	SENT_161	[p4l188t2600r345b2627],
2	,	,	O	,	_	0	SENT_161	[p4l188t2600r345b2627],
3	117	CD	NUMBER	117	num	4	SENT_161	[p4l373t2598r420b2622],
4	participants	NNS	O	participant	nsubjpass	6	SENT_161	[p4l446t2600r624b2631],
5	were	VBD	O	be	auxpass	6	SENT_161	[p4l648t2608r717b2623],
6	included	VBN	O	include	_	0	SENT_161	[p4l743t2600r870b2623],
7	in	IN	O	in	_	0	SENT_161	[p4l896t2600r923b2622],
8	the	DT	O	the	det	10	SENT_161	[p4l949t2600r993b2623],
9	longitudinal	JJ	O	longitudinal	amod	10	SENT_161	[p4l1019t2600r1199b2631],
10	analysis	NN	O	analysis	prep_in	6	SENT_161	[p4l189t2636r305b2667],
11	.	.	O	.	_	0	SENT_161	[p4l189t2636r305b2667],

1	Prior	RB	O	prior	advmod	2	SENT_162	[p4l227t2672r302b2694],
2	to	TO	O	to	advcl	13	SENT_162	[p4l314t2677r341b2695],
3	participation	NN	O	participation	pobj	2	SENT_162	[p4l355t2672r545b2703],
4	in	IN	O	in	_	0	SENT_162	[p4l559t2672r586b2694],
5	the	DT	O	the	det	6	SENT_162	[p4l600t2672r643b2695],
6	study	NN	O	study	prep_in	3	SENT_162	[p4l657t2672r739b2703],
7	,	,	O	,	_	0	SENT_162	[p4l657t2672r739b2703],
8	all	DT	O	all	det	10	SENT_162	[p4l753t2672r785b2695],
9	M98	NN	O	m98	nn	10	SENT_162	[p4l798t2672r928b2694],
10	—	NN	O	—	nsubj	13	SENT_162	[p4l798t2672r928b2694],
11	863	CD	NUMBER	863	num	12	SENT_162	[p4l798t2672r928b2694],
12	patients	NNS	O	patient	dep	10	SENT_162	[p4l941t2672r1056b2703],
13	provided	VBD	O	provide	_	0	SENT_162	[p4l1069t2672r1199b2703],
14	informed	VBN	O	inform	amod	15	SENT_162	[p4l190t2708r324b2731],
15	consent	NN	O	consent	dobj	13	SENT_162	[p4l344t2713r456b2731],
16	for	IN	O	for	_	0	SENT_162	[p4l474t2708r518b2730],
17	viral	JJ	O	viral	amod	19	SENT_162	[p4l536t2708r599b2731],
18	RNA	NN	O	rna	nn	19	SENT_162	[p4l619t2708r688b2731],
19	quantitation	NN	O	quantitation	prep_for	15	SENT_162	[p4l707t2708r895b2739],
20	.	.	O	.	_	0	SENT_162	[p4l707t2708r895b2739],

1	The	DT	O	the	det	2	SENT_163	[p4l915t2708r970b2731],
2	protocols	NNS	O	protocol	nsubjpass	19	SENT_163	[p4l991t2708r1127b2739],
3	and	CC	O	and	_	0	SENT_163	[p4l1147t2708r1199b2731],
4	procedures	NNS	O	procedure	nsubjpass	19	SENT_163	[p4l189t2744r351b2775],
5	for	IN	O	for	_	0	SENT_163	[p4l363t2744r407b2766],
6	subsequent	JJ	O	subsequent	amod	8	SENT_163	[p4l418t2744r580b2775],
7	SCA	NN	ORGANIZATION	sca	nn	8	SENT_163	[p4l592t2744r654b2767],
8	analysis	NN	O	analysis	prep_for	2	SENT_163	[p4l666t2744r775b2775],
9	of	IN	O	of	_	0	SENT_163	[p4l788t2744r819b2766],
10	these	DT	O	these	det	11	SENT_163	[p4l829t2744r901b2767],
11	samples	NNS	O	sample	prep_of	8	SENT_163	[p4l914t2744r1026b2775],
12	by	IN	O	by	_	0	SENT_163	[p4l1038t2744r1070b2775],
13	the	DT	O	the	det	17	SENT_163	[p4l1083t2744r1127b2767],
14	HIV	NN	O	hiv	nn	17	SENT_163	[p4l1139t2745r1199b2767],
15	Drug	NN	O	drug	nn	17	SENT_163	[p4l189t2781r262b2811],
16	Resistance	NN	O	resistance	nn	17	SENT_163	[p4l273t2780r423b2803],
17	Program	NN	O	program	prep_by	11	SENT_163	[p4l435t2781r560b2811],
18	were	VBD	O	be	auxpass	19	SENT_163	[p4l572t2788r639b2803],
19	reviewed	VBN	O	review	_	0	SENT_163	[p4l652t2780r779b2803],
20	and	CC	O	and	_	0	SENT_163	[p4l791t2780r844b2803],
21	approved	VBN	O	approve	conj_and	19	SENT_163	[p4l856t2780r992b2811],
22	by	IN	O	by	_	0	SENT_163	[p4l1004t2780r1036b2811],
23	the	DT	O	the	det	25	SENT_163	[p4l1049t2780r1092b2803],
24	NIAID	NNP	ORGANIZATION	NIAID	nn	25	SENT_163	[p4l1105t2780r1198b2803],
25	IRB	NNP	O	IRB	agent	19	SENT_163	[p4l189t2816r249b2838],
26	.	.	O	.	_	0	SENT_163	[p4l189t2816r249b2838],

1	Patients	NNS	O	patient	_	0	SENT_164	[p4l225t2852r346b2875],
2	taking	VBG	O	take	partmod	1	SENT_164	[p4l371t2852r463b2883],
3	NNRTI-containing	JJ	O	nnrti-containing	amod	4	SENT_164	[p4l487t2852r768b2883],
4	regimens	NNS	O	regimen	dobj	2	SENT_164	[p4l792t2852r937b2883],
5	.	.	O	.	_	0	SENT_164	[p4l792t2852r937b2883],

1	Patients	NNS	O	patient	nsubjpass	16	SENT_165	[p4l963t2852r1082b2875],
2	taking	VBG	O	take	partmod	1	SENT_165	[p4l1108t2852r1200b2883],
3	NNRTI-containing	JJ	O	nnrti-containing	amod	4	SENT_165	[p4l189t2888r463b2919],
4	regimens	NNS	O	regimen	dobj	2	SENT_165	[p4l484t2888r614b2919],
5	with	IN	O	with	_	0	SENT_165	[p4l635t2888r697b2911],
6	suppressed	VBN	O	suppress	prepc_with	2	SENT_165	[p4l719t2888r878b2919],
7	plasma	NN	O	plasma	nn	10	SENT_165	[p4l899t2888r1000b2919],
8	HIV-1	NN	O	hiv-1	nn	10	SENT_165	[p4l1021t2888r1106b2911],
9	RNA	NN	O	rna	nn	10	SENT_165	[p4l1131t2888r1200b2910],
10	levels	NNS	O	level	dobj	6	SENT_165	[p4l189t2924r265b2947],
11	by	IN	O	by	_	0	SENT_165	[p4l281t2924r313b2955],
12	FDA-approved	JJ	O	fda-approved	amod	13	SENT_165	[p4l328t2924r543b2955],
13	testing	NN	O	testing	prep_by	6	SENT_165	[p4l559t2924r655b2955],
14	were	VBD	O	be	auxpass	16	SENT_165	[p4l668t2932r736b2947],
15	also	RB	O	also	advmod	16	SENT_165	[p4l752t2924r805b2947],
16	recruited	VBN	O	recruit	_	0	SENT_165	[p4l822t2924r955b2947],
17	from	IN	O	from	_	0	SENT_165	[p4l970t2924r1040b2946],
18	treatment	NN	O	treatment	prep_from	16	SENT_165	[p4l1056t2929r1199b2947],
19	studies	NNS	O	study	dep	18	SENT_165	[p4l189t2960r287b2983],
20	performed	VBN	O	perform	partmod	19	SENT_165	[p4l303t2960r458b2991],
21	at	IN	O	at	_	0	SENT_165	[p4l474t2965r499b2983],
22	the	DT	O	the	det	23	SENT_165	[p4l515t2960r559b2983],
23	NIH	NNP	ORGANIZATION	NIH	prep_at	20	SENT_165	[p4l574t2961r635b2983],
24	Clinical	JJ	ORGANIZATION	clinical	amod	26	SENT_165	[p4l652t2960r762b2983],
25	Center	NNP	ORGANIZATION	Center	nn	26	SENT_165	[p4l778t2960r877b2983],
26	(	NN	O	(	tmod	20	SENT_165	[p4l892t2961r917b2989],
27	7	CD	NUMBER	7	dep	26	SENT_165	[p4l892t2961r917b2989],
28	;	:	O	;	_	0	SENT_165	[p4l892t2961r917b2989],
29	:	:	O	:	_	0	SENT_165	[p4l929t2970r951b2978],
30	28	CD	NUMBER	28	num	31	SENT_165	[p4l964t2960r1013b2988],
31	)	NN	O	)	dep	16	SENT_165	[p4l964t2960r1013b2988],
32	.	.	O	.	_	0	SENT_165	[p4l964t2960r1013b2988],

1	All	DT	O	all	det	2	SENT_166	[p4l1028t2960r1068b2982],
2	patients	NNS	O	patient	nsubj	4	SENT_166	[p4l1084t2960r1199b2991],
3	were	VBD	O	be	aux	4	SENT_166	[p4l188t3004r256b3019],
4	taking	VBG	O	take	_	0	SENT_166	[p4l277t2996r367b3027],
5	Department	NNP	ORGANIZATION	Department	dep	4	SENT_166	[p4l386t2997r562b3027],
6	of	IN	ORGANIZATION	of	_	0	SENT_166	[p4l582t2996r613b3018],
7	Health	NNP	ORGANIZATION	Health	nn	10	SENT_166	[p4l631t2996r728b3019],
8	and	CC	ORGANIZATION	and	_	0	SENT_166	[p4l748t2996r800b3019],
9	Human	NNP	ORGANIZATION	Human	nn	10	SENT_166	[p4l821t2997r929b3018],
10	Services	NNPS	ORGANIZATION	Services	prep_of	5	SENT_166	[p4l949t2996r1064b3019],
11	(	CD	NUMBER	(	num	12	SENT_166	[p4l1086t2996r1199b3025],
12	DHHS	NNS	ORGANIZATION	dhh	npadvmod	13	SENT_166	[p4l1086t2996r1199b3025],
13	)	IN	O	)	dep	5	SENT_166	[p4l1086t2996r1199b3025],

1	߉	CD	NUMBER	߉	num	2	SENT_167	[p4l188t3077r261b3136],
2	PLoS	NN	O	plo	nsubj	3	SENT_167	[p4l288t3093r352b3116],
3	Pathogens	VBD	O	pathogen	_	0	SENT_167	[p4l367t3092r511b3123],
4	|	CD	NUMBER	|	num	5	SENT_167	[p4l526t3091r528b3124],
5	www	NN	O	www	dobj	3	SENT_167	[p4l543t3092r882b3123],
6	.	.	O	.	_	0	SENT_167	[p4l543t3092r882b3123],

1	p	NN	O	p	_	0	SENT_168	[p4l543t3092r882b3123],
2	|	CD	NUMBER	|	num	3	SENT_168	[p4l543t3092r882b3123],
3	ospathogens.org	NN	O	ospathogens.org	dep	1	SENT_168	[p4l543t3092r882b3123],

1	Source	NN	O	source	_	0	SENT_169	[p4l1731t107r1824b130],
2	of	IN	O	of	_	0	SENT_169	[p4l1837t106r1865b130],
3	Stable	JJ	O	stable	amod	5	SENT_169	[p4l1876t106r1960b130],
4	HIV-1	NN	O	hiv-1	nn	5	SENT_169	[p4l1975t107r2041b130],
5	Viremia	NN	O	viremia	prep_of	1	SENT_169	[p4l2059t107r2161b130],
6	on	IN	O	on	_	0	SENT_169	[p4l2175t113r2208b130],
7	ART	NN	O	art	prep_on	1	SENT_169	[p4l2222t107r2277b130],

1	___	NN	O	___	nn	4	SENT_170	[p4l1275t253r1296b259],
2	2.5	CD	NUMBER	2.5	num	4	SENT_170	[p4l1332t233r1368b253],
3	_	NN	O	_	nn	4	SENT_170	[p4l1275t260r1292b272],
4	l	NN	O	l	_	0	SENT_170	[p4l1275t260r1292b272],
5	E	NN	O	e	dep	4	SENT_170	[p4l1275t275r1292b301],
6	E	NN	O	e	dobj	5	SENT_170	[p4l1275t301r1292b331],
7	3	CD	NUMBER	3	num	6	SENT_170	[p4l1280t334r1296b359],
8	'	''	O	'	_	0	SENT_170	[p4l1280t334r1296b359],
9	2	CD	NUMBER	2	dep	4	SENT_170	[p4l1355t334r1368b353],
10	A	DT	O	a	det	11	SENT_170	[p4l1772t343r1785b355],
11	LI	NN	O	li	dep	9	SENT_170	[p4l1280t361r1292b371],

1	3	CD	NUMBER	3	dep	5	SENT_171	[p4l1275t389r1298b428],
2	I	PRP	O	I	dep	1	SENT_171	[p4l1275t431r1296b455],
3	1.5	CD	NUMBER	1.5	num	5	SENT_171	[p4l1332t433r1368b452],
4	N	NN	O	n	nn	5	SENT_171	[p4l1280t458r1292b469],
5	R	NN	O	r	_	0	SENT_171	[p4l1280t470r1292b493],
6	-	:	O	-	_	0	SENT_171	[p4l1275t494r1292b511],
7	a	DT	O	a	dep	14	SENT_171	[p4l1275t494r1292b511],
8	:	:	O	:	_	0	SENT_171	[p4l1275t494r1292b511],
9	3	CD	NUMBER	3	number	10	SENT_171	[p4l1280t518r1296b542],
10	1	CD	NUMBER	1	num	14	SENT_171	[p4l1355t533r1365b553],
11	D	NN	O	d	nn	14	SENT_171	[p4l1280t545r1292b557],
12	o	NN	O	o	nn	14	SENT_171	[p4l1275t559r1292b574],
13	2	CD	NUMBER	2	num	14	SENT_171	[p4l1275t581r1292b599],
14	E	NN	O	e	parataxis	5	SENT_171	[p4l1280t602r1296b626],
15	‘	CD	NUMBER	‘	number	16	SENT_171	[p4l1280t602r1296b626],
16	5	CD	NUMBER	5	num	14	SENT_171	[p4l1275t629r1292b648],
17	0.5	CD	NUMBER	0.5	number	18	SENT_171	[p4l1332t633r1368b654],
18	3	CD	NUMBER	3	amod	14	SENT_171	[p4l1275t657r1296b681],
19	:	:	O	:	_	0	SENT_171	[p4l1275t657r1296b681],
20	‘	CD	NUMBER	‘	num	22	SENT_171	[p4l1275t657r1296b681],
21	<	JJR	O	<	amod	22	SENT_171	[p4l1275t689r1292b705],
22	A.	NN	O	a.	dep	14	SENT_171	[p4l1831t690r1861b708],
23	E	NNP	O	E	nn	25	SENT_171	[p4l1275t707r1292b756],
24	o	NN	O	o	nn	25	SENT_171	[p4l1355t732r1368b753],
25	fan	NN	O	fan	dep	22	SENT_171	[p4l1805t702r1858b744],
26	;	:	O	;	_	0	SENT_171	[p4l1275t758r1292b801],
27	.	.	O	.	_	0	SENT_171	[p4l1807t765r1860b791],

1	:	:	O	:	_	0	SENT_172	[p4l1807t765r1860b791],
2	.	.	O	.	_	0	SENT_172	[p4l1807t765r1860b791],

1	.	.	O	.	_	0	SENT_173	[p4l1807t765r1860b791],

1	Week	NN	DURATION	week	_	0	SENT_174	[p4l1787t909r1858b930],

1	Figure	NNP	O	Figure	_	0	SENT_175	[p4l1277t964r1370b995],
2	4	CD	NUMBER	4	dep	1	SENT_175	[p4l1386t966r1412b988],
3	.	.	O	.	_	0	SENT_175	[p4l1386t966r1412b988],

1	HIV-1	NN	O	hiv-1	_	0	SENT_176	[p4l1430t965r1497b988],
2	RNA	NN	O	rna	nn	3	SENT_176	[p4l1521t965r1578b988],
3	Levels	NNS	O	level	dep	1	SENT_176	[p4l1596t964r1678b988],
4	Over	IN	O	over	rcmod	3	SENT_176	[p4l1696t965r1761b988],
5	50	CD	DURATION	50	num	6	SENT_176	[p4l1777t966r1809b988],
6	wk	NN	DURATION	wk	pobj	4	SENT_176	[p4l1826t964r1865b988],
7	of	IN	O	of	_	0	SENT_176	[p4l1882t964r1910b988],
8	Suppressive	JJ	O	suppressive	amod	10	SENT_176	[p4l1925t965r2089b995],
9	Antiretroviral	JJ	O	antiretroviral	amod	10	SENT_176	[p4l2106t964r2285b988],
10	Therapy	NN	O	therapy	prep_of	6	SENT_176	[p4l1275t1006r1388b1037],

1	Plasma	NN	O	plasma	nn	2	SENT_177	[p4l1277t1051r1371b1075],
2	samples	NNS	O	sample	nsubj	16	SENT_177	[p4l1388t1051r1498b1082],
3	from	IN	O	from	_	0	SENT_177	[p4l1513t1051r1576b1075],
4	patients	NNS	O	patient	prep_from	2	SENT_177	[p4l1594t1052r1704b1082],
5	in	IN	O	in	_	0	SENT_177	[p4l1720t1052r1742b1075],
6	both	DT	O	both	det	7	SENT_177	[p4l1759t1051r1822b1075],
7	arms	NNS	O	arm	prep_in	4	SENT_177	[p4l1838t1058r1903b1075],
8	of	IN	O	of	_	0	SENT_177	[p4l1919t1051r1947b1075],
9	the	DT	O	the	det	13	SENT_177	[p4l1960t1051r2004b1075],
10	M98	NN	O	m98	nn	13	SENT_177	[p4l2021t1052r2144b1075],
11	—	NN	O	—	nn	13	SENT_177	[p4l2021t1052r2144b1075],
12	863	CD	NUMBER	863	num	13	SENT_177	[p4l2021t1052r2144b1075],
13	trial	NN	O	trial	prep_of	7	SENT_177	[p4l2160t1051r2210b1075],
14	with	IN	O	with	_	0	SENT_177	[p4l2227t1051r2285b1075],
15	viremia	NN	O	viremia	prep_with	13	SENT_177	[p4l1276t1087r1375b1110],
16	suppressed	VBD	O	suppress	_	0	SENT_177	[p4l1400t1086r1555b1117],
17	to	TO	O	to	_	0	SENT_177	[p4l1580t1090r1608b1110],
18	<	JJR	O	<	prep_to	16	SENT_177	[p4l1633t1088r1691b1110],
19	50	CD	NUMBER	50	num	20	SENT_177	[p4l1633t1088r1691b1110],
20	copies/ml	NN	O	copies/ml	dep	18	SENT_177	[p4l1716t1086r1848b1117],
21	during	IN	O	during	_	0	SENT_177	[p4l1874t1086r1963b1117],
22	weeks	NNS	DURATION	week	prep_during	16	SENT_177	[p4l1988t1086r2072b1110],
23	60-110	CD	NUMBER	60-110	nsubjpass	25	SENT_177	[p4l2097t1088r2196b1110],
24	were	VBD	O	be	auxpass	25	SENT_177	[p4l2220t1093r2286b1110],
25	subjected	VBN	O	subject	rcmod	22	SENT_177	[p4l1276t1121r1409b1152],
26	to	TO	O	to	_	0	SENT_177	[p4l1433t1125r1461b1145],
27	SCA	NN	ORGANIZATION	sca	nn	28	SENT_177	[p4l1485t1122r1539b1145],
28	analysis	NN	O	analysis	prep_to	25	SENT_177	[p4l1563t1121r1675b1152],
29	.	.	O	.	_	0	SENT_177	[p4l1563t1121r1675b1152],

1	HIV-1	NN	O	hiv-1	nn	3	SENT_178	[p4l1700t1122r1766b1145],
2	RNA	NN	O	rna	nn	3	SENT_178	[p4l1797t1122r1853b1145],
3	levels	NNS	O	level	nsubjpass	8	SENT_178	[p4l1879t1121r1952b1145],
4	for	IN	O	for	_	0	SENT_178	[p4l1976t1121r2014b1145],
5	each	DT	O	each	det	6	SENT_178	[p4l2037t1121r2099b1145],
6	patient	NN	O	patient	prep_for	3	SENT_178	[p4l2125t1122r2222b1152],
7	are	VBP	O	be	auxpass	8	SENT_178	[p4l2245t1128r2286b1145],
8	presented	VBN	O	present	_	0	SENT_178	[p4l1277t1157r1414b1188],
9	here	RB	O	here	advmod	8	SENT_178	[p4l1429t1157r1488b1181],
10	as	IN	O	as	_	0	SENT_178	[p4l1501t1164r1527b1181],
11	a	DT	O	a	det	12	SENT_178	[p4l1541t1164r1554b1181],
12	function	NN	O	function	prep_as	8	SENT_178	[p4l1567t1157r1681b1181],
13	of	IN	O	of	_	0	SENT_178	[p4l1695t1157r1723b1181],
14	weeks	NNS	DURATION	week	prep_of	12	SENT_178	[p4l1733t1157r1818b1181],
15	on	IN	O	on	_	0	SENT_178	[p4l1831t1164r1865b1181],
16	therapy	NN	O	therapy	prep_on	14	SENT_178	[p4l1878t1157r1990b1188],
17	.	.	O	.	_	0	SENT_178	[p4l1878t1157r1990b1188],

1	doizl	NN	O	doizl	_	0	SENT_179	[p4l1276t1192r1337b1216],
2	0.1371	CD	NUMBER	0.1371	num	1	SENT_179	[p4l1345t1192r1816b1223],
3	/	:	O	/	punct	5	SENT_179	[p4l1345t1192r1816b1223],
4	journa	NN	O	journa	nn	5	SENT_179	[p4l1345t1192r1816b1223],
5	|	NN	O	|	dep	1	SENT_179	[p4l1345t1192r1816b1223],
6	.	.	O	.	_	0	SENT_179	[p4l1345t1192r1816b1223],

1	ppat	NN	O	ppat	_	0	SENT_180	[p4l1345t1192r1816b1223],
2	.	.	O	.	_	0	SENT_180	[p4l1345t1192r1816b1223],

1	O030046	CD	NUMBER	o030046	_	0	SENT_181	[p4l1345t1192r1816b1223],
2	.	.	O	.	_	0	SENT_181	[p4l1345t1192r1816b1223],

1	g004	NN	O	g004	_	0	SENT_182	[p4l1345t1192r1816b1223],

1	guideline-approved	JJ	O	guideline-approved	amod	3	SENT_183	[p4l1276t1291r1561b1322],
2	antiretroviral	JJ	O	antiretroviral	amod	3	SENT_183	[p4l1573t1291r1767b1314],
3	regimens	NNS	O	regimen	nsubjpass	21	SENT_183	[p4l1780t1291r1911b1322],
4	containing	VBG	O	contain	partmod	3	SENT_183	[p4l1923t1291r2079b1322],
5	efavirenz	NN	O	efavirenz	nn	7	SENT_183	[p4l2090t1291r2221b1314],
6	(	NN	O	(	nn	7	SENT_183	[p4l2234t1292r2259b1320],
7	n	NN	O	n	dobj	4	SENT_183	[p4l2234t1292r2259b1320],
8	2	CD	NUMBER	2	number	9	SENT_183	[p4l2267t1301r2289b1309],
9	22	CD	NUMBER	22	num	10	SENT_183	[p4l1277t1327r1319b1355],
10	)	NN	O	)	dep	7	SENT_183	[p4l1277t1327r1319b1355],
11	or	CC	O	or	_	0	SENT_183	[p4l1329t1335r1360b1349],
12	nevirapine	NN	O	nevirapine	nn	14	SENT_183	[p4l1370t1327r1524b1358],
13	(	NN	O	(	nn	14	SENT_183	[p4l1535t1328r1560b1355],
14	n	NN	O	n	conj_or	7	SENT_183	[p4l1535t1328r1560b1355],
15	:	:	O	:	_	0	SENT_183	[p4l1567t1337r1589b1345],
16	6	CD	NUMBER	6	num	17	SENT_183	[p4l1597t1327r1621b1356],
17	)	NN	O	)	dep	14	SENT_183	[p4l1597t1327r1621b1356],
18	and	CC	O	and	cc	4	SENT_183	[p4l1632t1327r1684b1350],
19	were	VBD	O	be	auxpass	21	SENT_183	[p4l1693t1335r1761b1350],
20	either	DT	O	either	dep	21	SENT_183	[p4l1771t1327r1858b1350],
21	sampled	VBN	O	sample	_	0	SENT_183	[p4l1867t1327r1986b1358],
22	frequently	RB	O	frequently	advmod	21	SENT_183	[p4l1995t1327r2145b1358],
23	by	IN	O	by	_	0	SENT_183	[p4l2155t1327r2187b1358],
24	bDNA	NN	O	bdna	nn	28	SENT_183	[p4l2197t1327r2287b1350],
25	or	CC	O	or	_	0	SENT_183	[p4l1276t1371r1308b1385],
26	SCA	NN	ORGANIZATION	sca	nn	28	SENT_183	[p4l1319t1363r1381b1386],
27	following	VBG	O	follow	amod	28	SENT_183	[p4l1391t1363r1527b1394],
28	initiation	NN	O	initiation	agent	21	SENT_183	[p4l1538t1363r1673b1386],
29	of	IN	O	of	_	0	SENT_183	[p4l1685t1363r1716b1385],
30	therapy	NN	O	therapy	prep_of	28	SENT_183	[p4l1725t1363r1834b1394],
31	or	CC	O	or	_	0	SENT_183	[p4l1846t1371r1877b1385],
32	had	VBD	O	have	aux	33	SENT_183	[p4l1888t1363r1940b1386],
33	been	VBN	O	be	conj_or	21	SENT_183	[p4l1951t1363r2020b1386],
34	on	IN	O	on	_	0	SENT_183	[p4l2031t1371r2067b1385],
35	therapy	NN	O	therapy	prep_on	33	SENT_183	[p4l2080t1363r2190b1394],
36	for	IN	O	for	_	0	SENT_183	[p4l2200t1363r2244b1385],
37	20	CD	NUMBER	20	prep_for	35	SENT_183	[p4l2255t1363r2286b1386],
38	to	TO	O	to	_	0	SENT_183	[p4l1277t1403r1304b1421],
39	>	JJR	O	>	prep_to	33	SENT_183	[p4l1317t1398r1392b1421],
40	250	CD	DURATION	250	num	41	SENT_183	[p4l1317t1398r1392b1421],
41	wk	NN	DURATION	wk	nsubj	43	SENT_183	[p4l1403t1398r1442b1420],
42	(	FW	O	(	dep	41	SENT_183	[p4l1453t1399r1541b1426],
43	mean	VB	O	mean	rcmod	39	SENT_183	[p4l1453t1399r1541b1426],
44	111.2	CD	DURATION	111.2	num	46	SENT_183	[p4l1555t1398r1626b1421],
45	wk	NN	DURATION	wk	nn	46	SENT_183	[p4l1636t1398r1685b1426],
46	)	NN	O	)	npadvmod	43	SENT_183	[p4l1636t1398r1685b1426],
47	prior	RB	O	prior	_	0	SENT_183	[p4l1696t1398r1772b1429],
48	to	TO	O	to	_	0	SENT_183	[p4l1782t1403r1809b1421],
49	SCA	NNP	ORGANIZATION	SCA	nn	50	SENT_183	[p4l1821t1398r1883b1421],
50	sampling	NN	O	sampling	prep_prior_to	43	SENT_183	[p4l1894t1398r2031b1429],
51	.	.	O	.	_	0	SENT_183	[p4l1894t1398r2031b1429],

1	All	DT	O	all	det	2	SENT_184	[p4l2041t1398r2082b1420],
2	patients	NNS	O	patient	nsubj	18	SENT_184	[p4l2093t1398r2208b1429],
3	were	VBD	O	be	_	0	SENT_184	[p4l2219t1406r2286b1421],
4	well	RB	O	well	advmod	3	SENT_184	[p4l1276t1433r1332b1456],
5	and	CC	O	and	_	0	SENT_184	[p4l1345t1433r1397b1456],
6	without	IN	O	without	_	0	SENT_184	[p4l1410t1433r1522b1456],
7	history	NN	O	history	prep_without	18	SENT_184	[p4l1534t1433r1634b1464],
8	of	IN	O	of	_	0	SENT_184	[p4l1647t1433r1678b1455],
9	recent	JJ	O	recent	amod	11	SENT_184	[p4l1688t1438r1779b1456],
10	intercurrent	JJ	O	intercurrent	amod	11	SENT_184	[p4l1793t1433r1972b1456],
11	illness	NN	O	illness	prep_of	7	SENT_184	[p4l1986t1433r2072b1456],
12	at	IN	O	at	_	0	SENT_184	[p4l2085t1438r2111b1456],
13	the	DT	O	the	det	14	SENT_184	[p4l2125t1433r2168b1456],
14	time	NN	O	time	prep_at	11	SENT_184	[p4l2182t1433r2245b1456],
15	of	IN	O	of	_	0	SENT_184	[p4l2259t1433r2290b1455],
16	phlebotomy	NN	O	phlebotomy	prep_of	14	SENT_184	[p4l1277t1469r1457b1500],
17	,	,	O	,	_	0	SENT_184	[p4l1277t1469r1457b1500],
18	had	VBD	O	have	conj_and	3	SENT_184	[p4l1469t1469r1521b1492],
19	hemoglobin	NN	O	hemoglobin	nn	20	SENT_184	[p4l1533t1469r1705b1500],
20	levels	NNS	O	level	dobj	18	SENT_184	[p4l1718t1469r1794b1492],
21	212	CD	NUMBER	212	num	22	SENT_184	[p4l1807t1469r1863b1496],
22	g/dl	NN	O	g/dl	dep	20	SENT_184	[p4l1876t1469r1933b1500],
23	,	,	O	,	_	0	SENT_184	[p4l1876t1469r1933b1500],
24	and	CC	O	and	_	0	SENT_184	[p4l1946t1469r1998b1492],
25	provided	VBD	O	provide	conj_and	18	SENT_184	[p4l2010t1469r2140b1500],
26	informed	VBN	O	inform	amod	27	SENT_184	[p4l2152t1469r2286b1492],
27	consent	NN	O	consent	dobj	25	SENT_184	[p4l1276t1509r1389b1527],
28	for	IN	O	for	_	0	SENT_184	[p4l1401t1504r1444b1526],
29	phlebotomy	NN	O	phlebotomy	prep_for	25	SENT_184	[p4l1457t1504r1630b1535],
30	and	CC	O	and	_	0	SENT_184	[p4l1643t1504r1696b1527],
31	for	IN	O	for	_	0	SENT_184	[p4l1708t1504r1752b1526],
32	research	NN	O	research	nn	34	SENT_184	[p4l1765t1504r1886b1527],
33	sample	NN	O	sample	nn	34	SENT_184	[p4l1899t1504r1999b1535],
34	storage	NN	O	storage	prep_for	25	SENT_184	[p4l2012t1509r2123b1535],
35	.	.	O	.	_	0	SENT_184	[p4l2012t1509r2123b1535],

1	HIV-1	NN	O	hiv-1	_	0	SENT_185	[p4l1313t1540r1399b1563],
2	RNA	NN	O	rna	nn	3	SENT_185	[p4l1411t1540r1483b1563],
3	determination	NN	O	determination	dep	1	SENT_185	[p4l1493t1540r1707b1563],
4	.	.	O	.	_	0	SENT_185	[p4l1493t1540r1707b1563],

1	The	DT	O	the	det	2	SENT_186	[p4l1718t1540r1774b1563],
2	SCA	NNP	ORGANIZATION	SCA	nsubjpass	8	SENT_186	[p4l1785t1540r1848b1563],
3	for	IN	O	for	_	0	SENT_186	[p4l1858t1540r1901b1562],
4	HIV-1	NN	O	hiv-1	nn	6	SENT_186	[p4l1911t1540r1997b1562],
5	RNA	NN	O	rna	nn	6	SENT_186	[p4l2010t1540r2080b1563],
6	detection	NN	O	detection	prep_for	2	SENT_186	[p4l2090t1540r2226b1563],
7	was	VBD	O	be	auxpass	8	SENT_186	[p4l2237t1548r2286b1563],
8	performed	VBN	O	perform	_	0	SENT_186	[p4l1277t1576r1432b1607],
9	as	IN	O	as	mark	10	SENT_186	[p4l1449t1584r1475b1599],
10	described	VBN	O	describe	advcl	8	SENT_186	[p4l1492t1576r1631b1599],
11	previously	RB	DATE	previously	advmod	10	SENT_186	[p4l1648t1576r1796b1607],
12	[	CD	NUMBER	[	number	13	SENT_186	[p4l1815t1576r1872b1604],
13	10	CD	NUMBER	10	num	14	SENT_186	[p4l1815t1576r1872b1604],
14	]	NN	O	]	pobj	11	SENT_186	[p4l1815t1576r1872b1604],
15	,	,	O	,	_	0	SENT_186	[p4l1815t1576r1872b1604],
16	starting	VBG	O	start	prep	10	SENT_186	[p4l1890t1576r2001b1607],
17	with	IN	O	with	pcomp	16	SENT_186	[p4l2016t1576r2078b1599],
18	7	CD	NUMBER	7	num	20	SENT_186	[p4l2096t1574r2110b1598],
19	ml	NN	O	ml	nn	20	SENT_186	[p4l2128t1576r2162b1598],
20	plasma	NN	O	plasma	pobj	17	SENT_186	[p4l2179t1576r2286b1607],
21	,	,	O	,	_	0	SENT_186	[p4l2179t1576r2286b1607],
22	except	IN	O	except	_	0	SENT_186	[p4l1276t1616r1371b1642],
23	for	IN	O	for	_	0	SENT_186	[p4l1385t1611r1429b1633],
24	the	DT	O	the	det	26	SENT_186	[p4l1443t1611r1487b1634],
25	M98	NN	O	m98	nn	26	SENT_186	[p4l1503t1611r1632b1633],
26	—	NN	O	—	prep_except_for	8	SENT_186	[p4l1503t1611r1632b1633],
27	863	CD	NUMBER	863	num	28	SENT_186	[p4l1503t1611r1632b1633],
28	samples	NNS	O	sample	tmod	26	SENT_186	[p4l1647t1611r1767b1642],
29	,	,	O	,	_	0	SENT_186	[p4l1647t1611r1767b1642],
30	from	IN	O	from	_	0	SENT_186	[p4l1781t1611r1852b1633],
31	which	WDT	O	which	rel	37	SENT_186	[p4l1866t1611r1951b1634],
32	only	RB	O	only	quantmod	33	SENT_186	[p4l1966t1611r2027b1642],
33	3	CD	NUMBER	3	num	35	SENT_186	[p4l2043t1611r2057b1633],
34	ml	NN	O	ml	nn	35	SENT_186	[p4l2073t1611r2107b1633],
35	plasma	NN	O	plasma	nsubj	37	SENT_186	[p4l2123t1611r2223b1642],
36	was	VBD	O	be	cop	37	SENT_186	[p4l2237t1619r2286b1634],
37	available	JJ	O	available	rcmod	28	SENT_186	[p4l1277t1647r1408b1670],
38	.	.	O	.	_	0	SENT_186	[p4l1277t1647r1408b1670],

1	As	IN	O	as	_	0	SENT_187	[p4l1419t1647r1453b1670],
2	a	DT	O	a	det	3	SENT_187	[p4l1464t1655r1478b1670],
3	result	NN	O	result	prep_as	17	SENT_187	[p4l1489t1647r1576b1674],
4	,	,	O	,	_	0	SENT_187	[p4l1489t1647r1576b1674],
5	the	DT	O	the	det	7	SENT_187	[p4l1588t1647r1631b1670],
6	lower	JJR	O	lower	amod	7	SENT_187	[p4l1642t1647r1722b1670],
7	limit	NN	O	limit	nsubj	17	SENT_187	[p4l1731t1647r1799b1670],
8	of	IN	O	of	_	0	SENT_187	[p4l1809t1647r1840b1669],
9	quantitation	NN	O	quantitation	prep_of	7	SENT_187	[p4l1847t1647r2028b1678],
10	for	IN	O	for	_	0	SENT_187	[p4l2038t1647r2081b1669],
11	these	DT	O	these	det	12	SENT_187	[p4l2091t1647r2164b1670],
12	samples	NNS	O	sample	prep_for	9	SENT_187	[p4l2174t1647r2286b1678],
13	was	VBD	O	be	cop	17	SENT_187	[p4l1276t1690r1325b1705],
14	0.6	CD	NUMBER	0.6	num	17	SENT_187	[p4l1339t1682r1379b1704],
15	copies	NNS	O	copy	nn	17	SENT_187	[p4l1392t1682r1482b1713],
16	HIV-1	NN	O	hiv-1	nn	17	SENT_187	[p4l1496t1682r1582b1705],
17	RNA/ml	NN	O	rna/ml	_	0	SENT_187	[p4l1597t1682r1718b1709],
18	,	,	O	,	_	0	SENT_187	[p4l1597t1682r1718b1709],
19	compared	VBN	O	compare	_	0	SENT_187	[p4l1732t1682r1877b1713],
20	to	TO	O	to	prepc_compared_to	17	SENT_187	[p4l1892t1687r1918b1705],
21	0.3	CD	NUMBER	0.3	num	22	SENT_187	[p4l1932t1682r1972b1704],
22	copies/ml	NN	O	copies/ml	pobj	17	SENT_187	[p4l1985t1682r2121b1713],
23	when	WRB	O	when	advmod	28	SENT_187	[p4l2133t1682r2209b1705],
24	7	CD	NUMBER	7	num	26	SENT_187	[p4l2224t1680r2238b1704],
25	ml	NN	O	ml	nn	26	SENT_187	[p4l2252t1682r2286b1704],
26	plasma	NN	O	plasma	nsubjpass	28	SENT_187	[p4l1277t1718r1377b1749],
27	was	VBD	O	be	auxpass	28	SENT_187	[p4l1389t1726r1439b1741],
28	used	VBN	O	use	dep	22	SENT_187	[p4l1453t1718r1524b1741],
29	.	.	O	.	_	0	SENT_187	[p4l1453t1718r1524b1741],

1	In	IN	O	in	_	0	SENT_188	[p4l1539t1719r1568b1740],
2	all	DT	O	all	det	3	SENT_188	[p4l1582t1718r1614b1741],
3	analyses	NNS	O	analysis	prep_in	21	SENT_188	[p4l1628t1718r1751b1749],
4	,	,	O	,	_	0	SENT_188	[p4l1628t1718r1751b1749],
5	values	NNS	O	value	nsubjpass	21	SENT_188	[p4l1765t1718r1851b1741],
6	below	IN	O	below	_	0	SENT_188	[p4l1865t1718r1949b1741],
7	the	DT	O	the	det	10	SENT_188	[p4l1963t1718r2007b1741],
8	assay	NN	O	assay	nn	10	SENT_188	[p4l2021t1726r2092b1749],
9	quantitation	NN	O	quantitation	nn	10	SENT_188	[p4l2106t1718r2286b1749],
10	limit	NN	O	limit	prep_below	5	SENT_188	[p4l1277t1753r1344b1776],
11	for	IN	O	for	_	0	SENT_188	[p4l1356t1753r1399b1775],
12	study	NN	O	study	nn	14	SENT_188	[p4l1411t1753r1486b1784],
13	M98	NN	O	m98	nn	14	SENT_188	[p4l1499t1753r1628b1775],
14	—	NN	O	—	prep_for	10	SENT_188	[p4l1499t1753r1628b1775],
15	863	CD	NUMBER	863	num	16	SENT_188	[p4l1499t1753r1628b1775],
16	(	NN	O	(	dep	14	SENT_188	[p4l1642t1753r1691b1782],
17	0.6	CD	NUMBER	0.6	num	19	SENT_188	[p4l1642t1753r1691b1782],
18	copies/mL	NN	O	copies/ml	nn	19	SENT_188	[p4l1704t1753r1860b1784],
19	)	NN	O	)	dep	16	SENT_188	[p4l1704t1753r1860b1784],
20	were	VBD	O	be	auxpass	21	SENT_188	[p4l1872t1761r1940b1776],
21	Considered	VBN	O	consider	_	0	SENT_188	[p4l1952t1753r2111b1776],
22	to	TO	O	to	aux	24	SENT_188	[p4l2124t1758r2151b1776],
23	be	VB	O	be	cop	24	SENT_188	[p4l2164t1753r2196b1776],
24	equal	JJ	O	equal	xcomp	21	SENT_188	[p4l2209t1753r2286b1784],
25	to	TO	O	to	_	0	SENT_188	[p4l1277t1794r1304b1812],
26	the	DT	O	the	det	28	SENT_188	[p4l1322t1789r1366b1812],
27	assay	NN	O	assay	nn	28	SENT_188	[p4l1383t1797r1453b1820],
28	limit	NN	O	limit	prep_to	24	SENT_188	[p4l1470t1789r1544b1812],
29	.	.	O	.	_	0	SENT_188	[p4l1470t1789r1544b1812],

1	Plasma	NN	O	plasma	nsubjpass	15	SENT_189	[p4l1562t1789r1662b1812],
2	was	VBD	O	be	auxpass	3	SENT_189	[p4l1677t1797r1727b1812],
3	obtained	VBN	O	obtain	_	0	SENT_189	[p4l1744t1789r1872b1812],
4	from	IN	O	from	_	0	SENT_189	[p4l1888t1789r1958b1811],
5	whole	JJ	O	whole	amod	7	SENT_189	[p4l1974t1789r2059b1812],
6	blood	NN	O	blood	nn	7	SENT_189	[p4l2075t1789r2158b1812],
7	samples	NNS	O	sample	prep_from	3	SENT_189	[p4l2174t1789r2286b1820],
8	within	IN	O	within	_	0	SENT_189	[p4l1276t1824r1367b1847],
9	2-4	CD	NUMBER	2-4	num	10	SENT_189	[p4l1378t1824r1427b1847],
10	h	NN	O	h	prep_within	3	SENT_189	[p4l1437t1824r1454b1846],
11	of	IN	O	of	_	0	SENT_189	[p4l1464t1824r1495b1846],
12	phlebotomy	NN	O	phlebotomy	prep_of	10	SENT_189	[p4l1502t1824r1675b1855],
13	and	CC	O	and	_	0	SENT_189	[p4l1685t1824r1738b1847],
14	immediately	RB	O	immediately	advmod	15	SENT_189	[p4l1749t1824r1927b1855],
15	frozen	VBN	O	freeze	conj_and	3	SENT_189	[p4l1936t1824r2028b1847],
16	at	IN	O	at	_	0	SENT_189	[p4l2038t1829r2064b1847],
17	-70	CD	NUMBER	-70	num	18	SENT_189	[p4l2072t1822r2125b1846],
18	°	CD	NUMBER	°	prep_at	15	SENT_189	[p4l2135t1822r2174b1847],
19	C.	NNP	O	C.	dobj	3	SENT_189	[p4l2135t1822r2174b1847],
20	[	CD	NUMBER	[	num	19	SENT_189	[p4l2187t1824r2286b1852],
21	10,31	CD	NUMBER	10,31	num	22	SENT_189	[p4l2187t1824r2286b1852],
22	]	NN	O	]	dep	19	SENT_189	[p4l2187t1824r2286b1852],
23	.	.	O	.	_	0	SENT_189	[p4l2187t1824r2286b1852],

1	For	IN	O	for	_	0	SENT_190	[p4l1276t1861r1327b1882],
2	each	DT	O	each	det	3	SENT_190	[p4l1339t1860r1404b1883],
3	sample	NN	O	sample	prep_for	13	SENT_190	[p4l1418t1860r1525b1891],
4	,	,	O	,	_	0	SENT_190	[p4l1418t1860r1525b1891],
5	three	CD	NUMBER	three	num	7	SENT_190	[p4l1540t1860r1614b1883],
6	separate	JJ	O	separate	amod	7	SENT_190	[p4l1628t1865r1748b1891],
7	aliquots	NNS	O	aliquot	nsubjpass	13	SENT_190	[p4l1763t1860r1876b1891],
8	of	IN	O	of	_	0	SENT_190	[p4l1890t1860r1921b1882],
9	the	DT	O	the	det	11	SENT_190	[p4l1932t1860r1976b1883],
10	CDNA	NNP	ORGANIZATION	CDNA	nn	11	SENT_190	[p4l1990t1860r2077b1883],
11	product	NN	O	product	prep_of	7	SENT_190	[p4l2090t1860r2206b1891],
12	were	VBD	O	be	auxpass	13	SENT_190	[p4l2219t1868r2286b1883],
13	assayed	VBN	O	assay	_	0	SENT_190	[p4l1277t1895r1382b1926],
14	for	IN	O	for	_	0	SENT_190	[p4l1396t1895r1439b1917],
15	HIV-1	NN	O	hiv-1	nn	16	SENT_190	[p4l1452t1895r1538b1917],
16	RNA	NN	O	rna	prep_for	13	SENT_190	[p4l1554t1895r1624b1918],
17	and	CC	O	and	_	0	SENT_190	[p4l1637t1895r1690b1918],
18	two	CD	NUMBER	two	num	19	SENT_190	[p4l1704t1900r1754b1918],
19	aliquots	NNS	O	aliquot	conj_and	16	SENT_190	[p4l1769t1895r1882b1926],
20	for	IN	O	for	_	0	SENT_190	[p4l1896t1895r1939b1917],
21	the	DT	O	the	det	24	SENT_190	[p4l1953t1895r1997b1918],
22	recombinant	JJ	O	recombinant	amod	24	SENT_190	[p4l2012t1895r2197b1918],
23	avian	JJ	O	avian	amod	24	SENT_190	[p4l2211t1895r2286b1918],
24	retrovirus	NN	O	retrovirus	prep_for	19	SENT_190	[p4l1277t1931r1420b1954],
25	internal	JJ	O	internal	amod	27	SENT_190	[p4l1435t1931r1549b1954],
26	standard	JJ	O	standard	amod	27	SENT_190	[p4l1564t1931r1690b1954],
27	RNA	NN	O	rna	dobj	13	SENT_190	[p4l1704t1931r1773b1954],
28	using	VBG	O	use	partmod	27	SENT_190	[p4l1787t1931r1864b1962],
29	real-time	JJ	O	real-time	amod	30	SENT_190	[p4l1878t1931r2008b1954],
30	PCR	NN	O	pcr	dobj	28	SENT_190	[p4l2023t1931r2086b1954],
31	of	IN	O	of	_	0	SENT_190	[p4l2099t1931r2130b1953],
32	conserved	VBN	O	conserve	prepc_of	30	SENT_190	[p4l2141t1931r2287b1954],
33	sequences	NNS	O	sequence	dobj	32	SENT_190	[p4l1277t1974r1420b1997],
34	within	IN	O	within	_	0	SENT_190	[p4l1442t1966r1533b1989],
35	gag	NN	O	gag	prep_within	32	SENT_190	[p4l1552t1974r1599b1997],
36	as	IN	O	as	mark	37	SENT_190	[p4l1619t1974r1645b1989],
37	described	VBN	O	describe	advcl	32	SENT_190	[p4l1667t1966r1806b1989],
38	[	NN	O	[	nn	40	SENT_190	[p4l1830t1966r1887b1994],
39	10	CD	NUMBER	10	num	40	SENT_190	[p4l1830t1966r1887b1994],
40	]	NN	O	]	dobj	37	SENT_190	[p4l1830t1966r1887b1994],
41	.	.	O	.	_	0	SENT_190	[p4l1830t1966r1887b1994],

1	About	IN	O	about	_	0	SENT_191	[p4l1909t1966r1999b1989],
2	10	CD	PERCENT	10	num	3	SENT_191	[p4l2024t1965r2082b1991],
3	%	NN	PERCENT	%	prep_about	10	SENT_191	[p4l2024t1965r2082b1991],
4	of	IN	O	of	_	0	SENT_191	[p4l2107t1966r2138b1988],
5	M98	NN	O	m98	nn	6	SENT_191	[p4l2157t1966r2286b1988],
6	—	NN	O	—	prep_of	3	SENT_191	[p4l2157t1966r2286b1988],
7	863	CD	NUMBER	863	num	8	SENT_191	[p4l2157t1966r2286b1988],
8	patients	NNS	O	patient	nsubjpass	10	SENT_191	[p4l1277t2002r1394b2033],
9	were	VBD	O	be	auxpass	10	SENT_191	[p4l1419t2010r1487b2025],
10	excluded	VBN	O	exclude	dep	44	SENT_191	[p4l1513t2002r1645b2025],
11	because	IN	O	because	mark	43	SENT_191	[p4l1670t2002r1784b2025],
12	SCA	NNP	ORGANIZATION	SCA	nn	15	SENT_191	[p4l1810t2002r1872b2025],
13	and	CC	O	and	_	0	SENT_191	[p4l1897t2002r1950b2025],
14	Amplicor	NNP	O	Amplicor	nn	15	SENT_191	[p4l1975t2002r2116b2033],
15	assays	NNS	O	assay	nsubj	43	SENT_191	[p4l2140t2010r2225b2033],
16	on	IN	O	on	_	0	SENT_191	[p4l2250t2010r2286b2024],
17	pretherapy	JJ	O	pretherapy	amod	18	SENT_191	[p4l1277t2037r1437b2068],
18	samples	NNS	O	sample	prep_on	15	SENT_191	[p4l1453t2037r1565b2068],
19	were	VBD	O	be	cop	43	SENT_191	[p4l1581t2045r1649b2060],
20	signiﬁcantly	RB	O	signiﬁcantly	advmod	43	SENT_191	[p4l1665t2037r1840b2068],
21	discordant	JJ	O	discordant	amod	43	SENT_191	[p4l1855t2037r2010b2060],
22	due	JJ	O	due	_	0	SENT_191	[p4l2026t2037r2078b2060],
23	to	TO	O	to	_	0	SENT_191	[p4l2095t2042r2122b2060],
24	inefﬁcient	JJ	O	inefﬁcient	amod	25	SENT_191	[p4l2140t2037r2287b2060],
25	ampliﬁcation	NN	O	ampliﬁcation	prep_due_to	43	SENT_191	[p4l1277t2073r1469b2104],
26	by	IN	O	by	_	0	SENT_191	[p4l1481t2073r1513b2104],
27	SCA	NNP	ORGANIZATION	SCA	prep_by	25	SENT_191	[p4l1525t2073r1588b2096],
28	(	CD	NUMBER	(	num	27	SENT_191	[p4l1600t2073r1701b2104],
29	Figure	NNP	O	Figure	nn	43	SENT_191	[p4l1600t2073r1701b2104],
30	S2	NN	O	s2	nn	43	SENT_191	[p4l1714t2073r1763b2102],
31	)	NN	O	)	nn	43	SENT_191	[p4l1714t2073r1763b2102],
32	,	,	O	,	_	0	SENT_191	[p4l1714t2073r1763b2102],
33	probably	RB	O	probably	dep	35	SENT_191	[p4l1776t2073r1905b2104],
34	a	DT	O	a	det	35	SENT_191	[p4l1917t2081r1931b2096],
35	result	NN	O	result	dep	43	SENT_191	[p4l1944t2073r2024b2096],
36	of	IN	O	of	_	0	SENT_191	[p4l2035t2073r2066b2095],
37	polymorphism	NN	O	polymorphism	prep_of	35	SENT_191	[p4l2076t2073r2286b2104],
38	in	IN	O	in	_	0	SENT_191	[p4l1277t2108r1304b2130],
39	the	DT	O	the	det	40	SENT_191	[p4l1327t2108r1371b2131],
40	probe	NN	O	probe	prep_in	35	SENT_191	[p4l1394t2108r1479b2139],
41	or	CC	O	or	_	0	SENT_191	[p4l1502t2116r1533b2130],
42	primer	NN	O	primer	conj_or	40	SENT_191	[p4l1555t2108r1657b2139],
43	sequences	NNS	O	sequence	advcl	10	SENT_191	[p4l1679t2116r1822b2139],
44	(	VBP	O	(	_	0	SENT_191	[p4l1846t2108r1883b2137],
45	A.	NN	PERSON	a.	dobj	44	SENT_191	[p4l1846t2108r1883b2137],
46	Wiegand	NNP	PERSON	Wiegand	nn	49	SENT_191	[p4l1906t2108r2033b2139],
47	and	CC	O	and	_	0	SENT_191	[p4l2056t2108r2109b2131],
48	S.	NNP	PERSON	S.	conj_and	46	SENT_191	[p4l2132t2108r2154b2131],
49	Palmer	NNP	PERSON	Palmer	nsubj	44	SENT_191	[p4l2178t2108r2286b2135],
50	,	,	O	,	_	0	SENT_191	[p4l2178t2108r2286b2135],
51	unpublished	JJ	O	unpublished	amod	52	SENT_191	[p4l1276t2144r1456b2175],
52	data	NNS	O	datum	appos	49	SENT_191	[p4l1468t2144r1546b2173],
53	)	NN	O	)	dep	52	SENT_191	[p4l1468t2144r1546b2173],
54	.	.	O	.	_	0	SENT_191	[p4l1468t2144r1546b2173],

1	In	IN	O	in	_	0	SENT_192	[p4l1559t2145r1588b2166],
2	all	DT	O	all	det	4	SENT_192	[p4l1601t2144r1633b2167],
3	other	JJ	O	other	amod	4	SENT_192	[p4l1645t2144r1724b2167],
4	samples	NNS	O	sample	prep_in	7	SENT_192	[p4l1735t2144r1855b2175],
5	,	,	O	,	_	0	SENT_192	[p4l1735t2144r1855b2175],
6	there	EX	O	there	expl	7	SENT_192	[p4l1868t2144r1942b2167],
7	was	VBD	O	be	_	0	SENT_192	[p4l1954t2152r2003b2167],
8	a	DT	O	a	det	10	SENT_192	[p4l2016t2152r2031b2166],
9	close	JJ	O	close	amod	10	SENT_192	[p4l2042t2144r2112b2167],
10	correlation	NN	O	correlation	nsubj	7	SENT_192	[p4l2125t2144r2286b2167],
11	between	IN	O	between	_	0	SENT_192	[p4l1276t2179r1395b2202],
12	commercial	JJ	O	commercial	amod	14	SENT_192	[p4l1409t2179r1578b2214],
13	Amplicor	NNP	O	Amplicor	nn	14	SENT_192	[p4l1591t2179r1729b2210],
14	RT	NN	O	rt	prep_between	10	SENT_192	[p4l1741t2179r1860b2202],
15	.	.	O	.	_	0	SENT_192	[p4l1741t2179r1860b2202],

1	—	NN	O	—	_	0	SENT_193	[p4l1741t2179r1860b2202],
2	.	.	O	.	_	0	SENT_193	[p4l1741t2179r1860b2202],

1	PCR	NN	O	pcr	nn	4	SENT_194	[p4l1741t2179r1860b2202],
2	and	CC	O	and	_	0	SENT_194	[p4l1872t2179r1924b2202],
3	SCA	NN	ORGANIZATION	sca	nn	4	SENT_194	[p4l1938t2179r2000b2202],
4	values	NNS	O	value	nsubj	8	SENT_194	[p4l2011t2179r2098b2202],
5	for	IN	O	for	_	0	SENT_194	[p4l2111t2179r2154b2201],
6	pretherapy	JJ	O	pretherapy	amod	7	SENT_194	[p4l2166t2179r2286b2210, p4l1277t2223r1326b2246],
7	samples	NNS	O	sample	prep_for	4	SENT_194	[p4l1346t2215r1458b2246],
8	(	VBP	O	(	_	0	SENT_194	[p4l1480t2207r1512b2244],
9	72	CD	NUMBER	72	num	11	SENT_194	[p4l1480t2207r1512b2244],
10	:	:	O	:	_	0	SENT_194	[p4l1529t2225r1551b2233],
11	0.61	CD	NUMBER	0.61	dobj	8	SENT_194	[p4l1569t2215r1633b2242],
12	,	,	O	,	_	0	SENT_194	[p4l1569t2215r1633b2242],
13	Figure	NNP	O	Figure	nn	15	SENT_194	[p4l1654t2215r1747b2246],
14	S2	NN	O	s2	nn	15	SENT_194	[p4l1767t2215r1817b2244],
15	)	NN	O	)	appos	11	SENT_194	[p4l1767t2215r1817b2244],
16	.	.	O	.	_	0	SENT_194	[p4l1767t2215r1817b2244],

1	Further	JJ	O	further	amod	2	SENT_195	[p4l1838t2215r1950b2238],
2	details	NNS	O	detail	nsubjpass	27	SENT_195	[p4l1969t2215r2061b2238],
3	of	IN	O	of	_	0	SENT_195	[p4l2082t2215r2113b2237],
4	extraction	NN	O	extraction	prep_of	2	SENT_195	[p4l2130t2215r2286b2242],
5	,	,	O	,	_	0	SENT_195	[p4l2130t2215r2286b2242],
6	optimum	JJ	O	optimum	amod	8	SENT_195	[p4l1276t2250r1410b2281],
7	ampliﬁcation	NN	O	ampliﬁcation	nn	8	SENT_195	[p4l1423t2250r1616b2281],
8	conditions	NNS	O	condition	conj_and	4	SENT_195	[p4l1629t2250r1789b2277],
9	,	,	O	,	_	0	SENT_195	[p4l1629t2250r1789b2277],
10	and	CC	O	and	_	0	SENT_195	[p4l1803t2250r1856b2273],
11	performance	NN	O	performance	nn	12	SENT_195	[p4l1869t2250r2057b2281],
12	characteristics	NNS	O	characteristic	conj_and	4	SENT_195	[p4l2070t2250r2286b2277],
13	,	,	O	,	_	0	SENT_195	[p4l2070t2250r2286b2277],
14	as	RB	O	as	_	0	SENT_195	[p4l1277t2294r1303b2309],
15	well	RB	O	well	_	0	SENT_195	[p4l1329t2286r1388b2309],
16	as	IN	O	as	_	0	SENT_195	[p4l1414t2294r1441b2309],
17	quality	NN	O	quality	nn	19	SENT_195	[p4l1467t2286r1571b2317],
18	control	NN	O	control	nn	19	SENT_195	[p4l1597t2286r1707b2309],
19	procedures	NNS	O	procedure	conj_and	4	SENT_195	[p4l1734t2286r1904b2317],
20	to	TO	O	to	aux	21	SENT_195	[p4l1932t2291r1959b2309],
21	prevent	VB	O	prevent	infmod	19	SENT_195	[p4l1986t2291r2103b2317],
22	artifactual	JJ	O	artifactual	amod	23	SENT_195	[p4l2129t2286r2286b2309],
23	ampliﬁcation	NN	O	ampliﬁcation	dobj	21	SENT_195	[p4l1277t2321r1476b2352],
24	,	,	O	,	_	0	SENT_195	[p4l1277t2321r1476b2352],
25	have	VBP	O	have	aux	27	SENT_195	[p4l1490t2321r1554b2344],
26	been	VBN	O	be	auxpass	27	SENT_195	[p4l1568t2321r1636b2344],
27	described	VBN	O	describe	_	0	SENT_195	[p4l1650t2321r1789b2344],
28	[	CD	NUMBER	[	number	29	SENT_195	[p4l1804t2321r1861b2349],
29	10	CD	NUMBER	10	num	30	SENT_195	[p4l1804t2321r1861b2349],
30	]	NN	O	]	dobj	27	SENT_195	[p4l1804t2321r1861b2349],
31	.	.	O	.	_	0	SENT_195	[p4l1804t2321r1861b2349],

1	Study	NNP	O	Study	nn	2	SENT_196	[p4l1314t2357r1395b2388],
2	M98	NNP	O	M98	_	0	SENT_196	[p4l1411t2357r1540b2379],
3	—	NN	O	—	nsubj	5	SENT_196	[p4l1411t2357r1540b2379],
4	863	CD	NUMBER	863	num	3	SENT_196	[p4l1411t2357r1540b2379],
5	used	VBD	O	use	rcmod	2	SENT_196	[p4l1556t2357r1621b2380],
6	the	DT	O	the	det	8	SENT_196	[p4l1637t2357r1681b2380],
7	PCR	NN	O	pcr	nn	8	SENT_196	[p4l1697t2357r1853b2380],
8	—	NN	O	—	dobj	5	SENT_196	[p4l1697t2357r1853b2380],
9	based	VBN	O	base	prep	5	SENT_196	[p4l1697t2357r1853b2380],
10	Amplicor	NNP	O	Amplicor	nn	13	SENT_196	[p4l1868t2357r2006b2388],
11	HIV-1	NN	O	hiv-1	nn	13	SENT_196	[p4l2021t2357r2107b2379],
12	MONITOR	NN	O	monitor	nn	13	SENT_196	[p4l2126t2357r2288b2380],
13	assay	NN	O	assay	dep	9	SENT_196	[p4l1277t2400r1347b2423],
14	version	NN	O	version	dep	13	SENT_196	[p4l1365t2392r1470b2415],
15	1.0	CD	NUMBER	1.0	num	14	SENT_196	[p4l1493t2392r1529b2414],
16	for	IN	O	for	_	0	SENT_196	[p4l1548t2392r1591b2414],
17	plasma	NN	O	plasma	nn	20	SENT_196	[p4l1610t2392r1710b2423],
18	HIV-1	NN	O	hiv-1	nn	20	SENT_196	[p4l1729t2392r1814b2415],
19	RNA	NN	O	rna	nn	20	SENT_196	[p4l1836t2392r1905b2414],
20	quantitation	NN	O	quantitation	prep_for	14	SENT_196	[p4l1924t2392r2111b2423],
21	,	,	O	,	_	0	SENT_196	[p4l1924t2392r2111b2423],
22	performed	VBN	O	perform	partmod	14	SENT_196	[p4l2131t2392r2287b2423],
23	according	VBG	O	accord	_	0	SENT_196	[p4l1277t2428r1420b2459],
24	to	TO	O	to	prepc_according_to	22	SENT_196	[p4l1432t2433r1458b2451],
25	manufacturer	NN	O	manufacturer	poss	27	SENT_196	[p4l1471t2428r1689b2451],
26	’s	POS	O	’s	_	0	SENT_196	[p4l1471t2428r1689b2451],
27	speciﬁcations	NNS	O	speciﬁcations	pobj	22	SENT_196	[p4l1702t2428r1897b2459],
28	(	CD	NUMBER	(	num	30	SENT_196	[p4l1910t2428r2008b2457],
29	Roche	NNP	ORGANIZATION	Roche	nn	30	SENT_196	[p4l1910t2428r2008b2457],
30	Diagnostics	NNPS	ORGANIZATION	Diagnostics	tmod	27	SENT_196	[p4l2019t2428r2192b2459],
31	,	,	O	,	_	0	SENT_196	[p4l2019t2428r2192b2459],
32	http	NN	O	http	appos	30	SENT_196	[p4l2204t2428r2288b2459],
33	:	:	O	:	_	0	SENT_196	[p4l2204t2428r2288b2459],
34	/	:	O	/	punct	2	SENT_196	[p4l2204t2428r2288b2459],
35	/	:	O	/	punct	36	SENT_196	[p4l2204t2428r2288b2459],
36	www.roche.com	NNP	O	www.roche.com	dep	2	SENT_196	[p4l1276t2464r1520b2493],
37	)	CD	NUMBER	)	num	36	SENT_196	[p4l1276t2464r1520b2493],
38	.	.	O	.	_	0	SENT_196	[p4l1276t2464r1520b2493],

1	For	IN	O	for	_	0	SENT_197	[p4l1541t2465r1591b2486],
2	patients	NNS	O	patient	nsubj	3	SENT_197	[p4l1610t2464r1725b2495],
3	taking	VBG	O	take	prepc_for	11	SENT_197	[p4l1746t2464r1836b2495],
4	NNRTI-containing	JJ	O	nnrti-containing	amod	5	SENT_197	[p4l1855t2464r2129b2495],
5	regimens	NNS	O	regimen	dobj	3	SENT_197	[p4l2149t2464r2286b2495],
6	,	,	O	,	_	0	SENT_197	[p4l2149t2464r2286b2495],
7	plasma	NN	O	plasma	nn	9	SENT_197	[p4l1277t2499r1377b2530],
8	HIV-1	NN	O	hiv-1	nn	9	SENT_197	[p4l1389t2499r1475b2521],
9	RNA	NN	MISC	rna	nsubjpass	11	SENT_197	[p4l1490t2499r1559b2521],
10	was	VBD	O	be	auxpass	11	SENT_197	[p4l1571t2507r1620b2522],
11	quantiﬁed	VBN	O	quantiﬁed	_	0	SENT_197	[p4l1633t2499r1781b2530],
12	using	VBG	O	use	xcomp	11	SENT_197	[p4l1793t2499r1870b2530],
13	the	DT	O	the	det	19	SENT_197	[p4l1882t2499r1926b2522],
14	bDNA-based	JJ	O	bdna-based	amod	19	SENT_197	[p4l1939t2499r2122b2522],
15	VERSANT	NNP	O	VERSANT	nn	19	SENT_197	[p4l2134t2499r2287b2522],
16	HIV-1	NN	O	hiv-1	nn	19	SENT_197	[p4l1277t2534r1362b2557],
17	RNA	NN	O	rna	nn	19	SENT_197	[p4l1379t2534r1448b2556],
18	assay	NN	O	assay	nn	19	SENT_197	[p4l1462t2542r1533b2565],
19	version	NN	O	version	dobj	12	SENT_197	[p4l1546t2534r1651b2557],
20	3.0	CD	NUMBER	3.0	dep	28	SENT_197	[p4l1666t2534r1704b2556],
21	according	VBG	O	accord	_	0	SENT_197	[p4l1719t2534r1863b2565],
22	to	TO	O	to	prepc_according_to	20	SENT_197	[p4l1877t2539r1904b2557],
23	manufacturer	NN	O	manufacturer	poss	25	SENT_197	[p4l1919t2534r2138b2557],
24	’s	POS	O	’s	_	0	SENT_197	[p4l1919t2534r2138b2557],
25	speciﬁcations	NNS	O	speciﬁcations	pobj	20	SENT_197	[p4l2153t2534r2286b2565, p4l1277t2570r1346b2593],
26	(	CD	NUMBER	(	num	28	SENT_197	[p4l1363t2570r1455b2601],
27	Bayer	NNP	ORGANIZATION	Bayer	nn	28	SENT_197	[p4l1363t2570r1455b2601],
28	Diagnostics	NNPS	ORGANIZATION	Diagnostics	rcmod	19	SENT_197	[p4l1469t2570r1642b2601],
29	,	,	O	,	_	0	SENT_197	[p4l1469t2570r1642b2601],
30	http://diagnostics.siemens.com	NNP	O	http://diagnostics.siemens.com	appos	19	SENT_197	[p4l1658t2570r2105b2601],
31	)	CD	NUMBER	)	num	30	SENT_197	[p4l1658t2570r2105b2601],
32	in	IN	O	in	_	0	SENT_197	[p4l2122t2570r2149b2592],
33	a	DT	O	a	det	35	SENT_197	[p4l2165t2578r2179b2593],
34	manufacturer-certiﬁed	JJ	O	manufacturer-certiﬁed	amod	35	SENT_197	[p4l2195t2578r2286b2593, p4l1276t2606r1526b2629],
35	site	NN	O	site	prep_in	30	SENT_197	[p4l1546t2606r1594b2629],
36	using	VBG	O	use	partmod	35	SENT_197	[p4l1614t2606r1691b2637],
37	the	DT	O	the	det	42	SENT_197	[p4l1710t2606r1754b2629],
38	semiautomated	JJ	O	semiautomated	amod	42	SENT_197	[p4l1775t2606r1996b2629],
39	Bayer	NNP	O	Bayer	nn	42	SENT_197	[p4l2016t2606r2098b2637],
40	System	NNP	O	System	nn	42	SENT_197	[p4l2117t2606r2217b2637],
41	340	CD	NUMBER	340	num	42	SENT_197	[p4l2238t2606r2286b2628],
42	unit	NN	O	unit	dobj	36	SENT_197	[p4l1276t2641r1341b2664],
43	.	.	O	.	_	0	SENT_197	[p4l1276t2641r1341b2664],

1	Versant	NNP	O	Versant	nn	4	SENT_198	[p4l1359t2642r1472b2664],
2	HIV-1	NN	O	hiv-1	nn	4	SENT_198	[p4l1489t2641r1574b2664],
3	RNA	NN	O	rna	nn	4	SENT_198	[p4l1594t2641r1664b2664],
4	version	NN	O	version	nsubjpass	7	SENT_198	[p4l1680t2641r1785b2664],
5	3.0	CD	NUMBER	3.0	dep	4	SENT_198	[p4l1803t2641r1842b2663],
6	is	VBZ	O	be	auxpass	7	SENT_198	[p4l1860t2641r1879b2664],
7	approved	VBN	O	approve	_	0	SENT_198	[p4l1897t2641r2034b2672],
8	by	IN	O	by	_	0	SENT_198	[p4l2051t2641r2084b2672],
9	the	DT	O	the	det	10	SENT_198	[p4l2102t2641r2145b2664],
10	FDA	NNP	ORGANIZATION	FDA	agent	7	SENT_198	[p4l2163t2641r2228b2663],
11	for	IN	O	for	_	0	SENT_198	[p4l2244t2641r2288b2663],
12	clinical	JJ	O	clinical	amod	13	SENT_198	[p4l1276t2677r1380b2700],
13	use	NN	O	use	prep_for	10	SENT_198	[p4l1392t2685r1437b2700],
14	with	IN	O	with	_	0	SENT_198	[p4l1449t2677r1511b2700],
15	a	DT	O	a	det	16	SENT_198	[p4l1523t2685r1538b2699],
16	limit	NN	O	limit	prep_with	7	SENT_198	[p4l1550t2677r1617b2700],
17	of	IN	O	of	_	0	SENT_198	[p4l1629t2677r1660b2699],
18	quantiﬁcation	NN	O	quantiﬁcation	prep_of	16	SENT_198	[p4l1669t2677r1873b2708],
19	of	IN	O	of	_	0	SENT_198	[p4l1885t2677r1916b2699],
20	75	CD	NUMBER	75	num	24	SENT_198	[p4l1926t2675r1958b2699],
21	copies	NNS	O	copy	nn	24	SENT_198	[p4l1970t2677r2060b2708],
22	HIV-1	NN	O	hiv-1	nn	24	SENT_198	[p4l2072t2677r2158b2700],
23	RNA/ml	NN	O	rna/ml	nn	24	SENT_198	[p4l2173t2677r2286b2700],
24	plasma	NN	O	plasma	prep_of	18	SENT_198	[p4l1277t2712r1384b2743],
25	,	,	O	,	_	0	SENT_198	[p4l1277t2712r1384b2743],
26	although	IN	O	although	mark	33	SENT_198	[p4l1397t2712r1524b2743],
27	our	PRP$	O	we	poss	29	SENT_198	[p4l1536t2720r1587b2734],
28	reported	VBN	O	report	amod	29	SENT_198	[p4l1599t2712r1726b2743],
29	experience	NN	O	experience	nsubj	33	SENT_198	[p4l1739t2712r1897b2743],
30	with	IN	O	with	_	0	SENT_198	[p4l1910t2712r1972b2735],
31	this	DT	O	this	det	32	SENT_198	[p4l1985t2712r2035b2735],
32	assay	NN	O	assay	prep_with	29	SENT_198	[p4l2048t2720r2119b2743],
33	indicates	VBZ	O	indicate	advcl	7	SENT_198	[p4l2132t2712r2260b2735],
34	a	DT	O	a	det	36	SENT_198	[p4l2273t2720r2287b2735],
35	quantiﬁcation	NN	O	quantiﬁcation	nn	36	SENT_198	[p4l1276t2747r1481b2778],
36	limit	NN	O	limit	dobj	33	SENT_198	[p4l1494t2747r1562b2770],
37	of	IN	O	of	_	0	SENT_198	[p4l1574t2747r1605b2769],
38	50	CD	NUMBER	50	num	39	SENT_198	[p4l1616t2747r1647b2769],
39	copies/ml	NN	O	copies/ml	prep_of	36	SENT_198	[p4l1661t2747r1796b2778],
40	[	CD	NUMBER	[	number	41	SENT_198	[p4l1812t2747r1911b2775],
41	32,33	CD	NUMBER	32,33	num	42	SENT_198	[p4l1812t2747r1911b2775],
42	]	NN	O	]	dep	39	SENT_198	[p4l1812t2747r1911b2775],
43	.	.	O	.	_	0	SENT_198	[p4l1812t2747r1911b2775],

1	Statistical	JJ	O	statistical	amod	2	SENT_199	[p4l1314t2783r1460b2806],
2	analysis	NN	O	analysis	_	0	SENT_199	[p4l1484t2783r1609b2814],
3	.	.	O	.	_	0	SENT_199	[p4l1484t2783r1609b2814],

1	For	IN	O	for	_	0	SENT_200	[p4l1636t2784r1687b2805],
2	log-transformed	JJ	O	log-transformed	amod	6	SENT_200	[p4l1712t2783r1955b2814],
3	baseline	NN	O	baseline	nn	6	SENT_200	[p4l1980t2783r2100b2806],
4	viral	JJ	O	viral	amod	6	SENT_200	[p4l2125t2783r2191b2806],
5	RNA	NN	O	rna	nn	6	SENT_200	[p4l2217t2783r2287b2806],
6	determinations	NNS	O	determination	prep_for	17	SENT_200	[p4l1276t2819r1505b2846],
7	,	,	O	,	_	0	SENT_200	[p4l1276t2819r1505b2846],
8	comparisons	NNS	O	comparison	nsubjpass	17	SENT_200	[p4l1523t2819r1705b2850],
9	between	IN	O	between	_	0	SENT_200	[p4l1723t2819r1842b2842],
10	Amplicor	JJ	O	amplicor	amod	13	SENT_200	[p4l1858t2819r1997b2850],
11	HIV-1	NN	O	hiv-1	nn	13	SENT_200	[p4l2013t2819r2099b2842],
12	RNA	NN	O	rna	nn	13	SENT_200	[p4l2118t2819r2187b2841],
13	assays	NNS	O	assay	prep_between	8	SENT_200	[p4l2204t2827r2286b2850],
14	and	CC	O	and	_	0	SENT_200	[p4l1277t2854r1329b2877],
15	SCA	NNP	ORGANIZATION	SCA	prep_between	8	SENT_200	[p4l1352t2854r1414b2877],
16	were	VBD	O	be	auxpass	17	SENT_200	[p4l1436t2862r1504b2877],
17	conducted	VBN	O	conduct	_	0	SENT_200	[p4l1526t2854r1679b2877],
18	using	VBG	O	use	xcomp	17	SENT_200	[p4l1701t2854r1778b2885],
19	linear	JJ	O	linear	amod	20	SENT_200	[p4l1800t2854r1884b2877],
20	regression	NN	O	regression	dobj	18	SENT_200	[p4l1906t2854r2053b2885],
21	and	CC	O	and	_	0	SENT_200	[p4l2077t2854r2129b2877],
22	Pearson	NNP	PERSON	Pearson	poss	24	SENT_200	[p4l2152t2854r2286b2877],
23	’s	POS	O	’s	_	0	SENT_200	[p4l2152t2854r2286b2877],
24	correlation	NN	O	correlation	conj_and	20	SENT_200	[p4l1276t2890r1445b2917],
25	,	,	O	,	_	0	SENT_200	[p4l1276t2890r1445b2917],
26	as	IN	O	as	mark	28	SENT_200	[p4l1457t2898r1483b2913],
27	were	VBD	O	be	cop	28	SENT_200	[p4l1494t2898r1561b2913],
28	comparisons	NNS	O	comparison	advcl	17	SENT_200	[p4l1573t2890r1756b2921],
29	between	IN	O	between	_	0	SENT_200	[p4l1767t2890r1886b2913],
30	log-transformed	JJ	O	log-transformed	amod	33	SENT_200	[p4l1898t2890r2133b2921],
31	viral	JJ	O	viral	amod	33	SENT_200	[p4l2143t2890r2207b2913],
32	RNA	NN	O	rna	nn	33	SENT_200	[p4l2218t2890r2287b2912],
33	determinations	NNS	O	determination	prep_between	28	SENT_200	[p4l1276t2925r1498b2948],
34	at	IN	O	at	_	0	SENT_200	[p4l1519t2930r1545b2948],
35	baseline	NN	O	baseline	prep_at	33	SENT_200	[p4l1566t2925r1682b2948],
36	and	CC	O	and	_	0	SENT_200	[p4l1704t2925r1756b2948],
37	week	NN	DURATION	week	conj_and	35	SENT_200	[p4l1776t2925r1847b2948],
38	60	CD	NUMBER	60	num	37	SENT_200	[p4l1869t2925r1907b2947],
39	.	.	O	.	_	0	SENT_200	[p4l1869t2925r1907b2947],

1	Mean	NN	O	mean	nn	3	SENT_201	[p4l1930t2926r2008b2948],
2	SCA	NN	O	sca	nn	3	SENT_201	[p4l2029t2925r2092b2948],
3	values	NNS	O	value	nsubj	4	SENT_201	[p4l2111t2925r2198b2948],
4	were	VBD	O	be	_	0	SENT_201	[p4l2219t2933r2286b2948],
5	Compared	VBN	O	compare	prep	4	SENT_201	[p4l1276t2961r1422b2992],
6	between	IN	O	between	pcomp	5	SENT_201	[p4l1443t2961r1563b2984],
7	groups	NNS	O	group	pobj	6	SENT_201	[p4l1584t2969r1682b2992],
8	using	VBG	O	use	partmod	7	SENT_201	[p4l1704t2961r1781b2992],
9	a	DT	O	a	det	11	SENT_201	[p4l1802t2969r1816b2984],
10	one-way	JJ	O	one-way	amod	11	SENT_201	[p4l1837t2969r1956b2992],
11	analysis	NN	O	analysis	dobj	8	SENT_201	[p4l1977t2961r2086b2992],
12	of	IN	O	of	_	0	SENT_201	[p4l2108t2961r2139b2983],
13	variance	NN	O	variance	prep_of	11	SENT_201	[p4l2157t2961r2287b2988],
14	;	:	O	;	_	0	SENT_201	[p4l2157t2961r2287b2988],
15	comparisons	NNS	O	comparison	nsubjpass	22	SENT_201	[p4l1276t2996r1459b3027],
16	of	IN	O	of	_	0	SENT_201	[p4l1471t2996r1502b3018],
17	distributions	NNS	O	distribution	prep_of	15	SENT_201	[p4l1509t2996r1694b3019],
18	of	IN	O	of	_	0	SENT_201	[p4l1705t2996r1736b3018],
19	SCA	NNP	ORGANIZATION	SCA	nn	20	SENT_201	[p4l1744t2996r1807b3019],
20	values	NNS	O	value	prep_of	17	SENT_201	[p4l1816t2996r1903b3019],
21	were	VBD	O	be	auxpass	22	SENT_201	[p4l1914t3004r1981b3019],
22	conducted	VBN	O	conduct	parataxis	4	SENT_201	[p4l1993t2996r2144b3019],
23	using	VBG	O	use	xcomp	22	SENT_201	[p4l2155t2996r2232b3027],
24	the	DT	O	the	dobj	23	SENT_201	[p4l2243t2996r2286b3019],

1	April	NNP	DATE	April	_	0	SENT_202	[p4l1772t3092r1834b3123],
2	2007	CD	DATE	2007	num	1	SENT_202	[p4l1849t3094r1914b3116],
3	|	NNP	O	|	dep	1	SENT_202	[p4l1929t3091r1931b3124],
4	Volume	NN	O	volume	nn	7	SENT_202	[p4l1945t3092r2051b3116],
5	3	CD	NUMBER	3	num	7	SENT_202	[p4l2064t3094r2078b3116],
6	|	NN	O	|	nn	7	SENT_202	[p4l2093t3091r2096b3124],
7	Issue	NN	O	issue	dep	3	SENT_202	[p4l2112t3093r2178b3116],
8	4	CD	NUMBER	4	num	10	SENT_202	[p4l2190t3094r2206b3116],
9	|	NN	O	|	nn	10	SENT_202	[p4l2221t3091r2223b3124],
10	e46	NN	O	e46	dep	1	SENT_202	[p4l2238t3094r2287b3116],

1	Kolmogorov-Smirnov	NNP	O	Kolmogorov-Smirnov	nsubj	2	SENT_203	[p5l189t206r504b237],
2	test	NN	O	test	_	0	SENT_203	[p5l521t211r577b229],
3	.	.	O	.	_	0	SENT_203	[p5l521t211r577b229],

1	A	DT	O	a	det	6	SENT_204	[p5l593t206r616b228],
2	linear	JJ	O	linear	amod	6	SENT_204	[p5l632t206r716b229],
3	mixed	JJ	O	mixed	amod	6	SENT_204	[p5l732t206r820b229],
4	effects	NNS	O	effect	nn	6	SENT_204	[p5l836t206r929b229],
5	regression	NN	O	regression	nn	6	SENT_204	[p5l946t206r1093b237],
6	model	NN	O	model	nsubjpass	23	SENT_204	[p5l1111t206r1199b229],
7	with	IN	O	with	_	0	SENT_204	[p5l188t242r250b265],
8	a	DT	O	a	det	12	SENT_204	[p5l264t250r278b265],
9	spatial	JJ	O	spatial	amod	12	SENT_204	[p5l291t242r384b273],
10	linear	JJ	O	linear	amod	12	SENT_204	[p5l397t242r482b265],
11	correlation	NN	O	correlation	nn	12	SENT_204	[p5l494t242r655b265],
12	structure	NN	O	structure	prep_with	6	SENT_204	[p5l669t247r800b265],
13	to	TO	O	to	aux	14	SENT_204	[p5l814t247r841b265],
14	account	VB	O	account	infmod	6	SENT_204	[p5l855t247r969b265],
15	for	IN	O	for	_	0	SENT_204	[p5l982t242r1025b264],
16	correlation	NN	O	correlation	prep_for	14	SENT_204	[p5l1037t242r1199b265],
17	between	IN	O	between	_	0	SENT_204	[p5l189t279r308b302],
18	repeated	JJ	O	repeated	amod	19	SENT_204	[p5l330t279r457b310],
19	measurements	NNS	O	measurement	prep_between	16	SENT_204	[p5l478t284r686b302],
20	within	IN	O	within	_	0	SENT_204	[p5l706t279r798b302],
21	participants	NNS	O	participant	prep_within	14	SENT_204	[p5l819t279r994b310],
22	was	VBD	O	be	auxpass	23	SENT_204	[p5l1014t287r1064b302],
23	used	VBN	O	use	_	0	SENT_204	[p5l1085t279r1150b302],
24	to	TO	O	to	aux	25	SENT_204	[p5l1172t284r1198b302],
25	assess	VB	O	assess	xcomp	23	SENT_204	[p5l189t322r269b337],
26	the	DT	O	the	det	27	SENT_204	[p5l295t314r338b337],
27	relationship	NN	O	relationship	dobj	25	SENT_204	[p5l364t314r539b345],
28	between	IN	O	between	_	0	SENT_204	[p5l563t314r683b337],
29	time	NN	O	time	nn	33	SENT_204	[p5l709t314r772b337],
30	and	CC	O	and	_	0	SENT_204	[p5l797t314r850b337],
31	log-transformed	JJ	O	log-transformed	nn	33	SENT_204	[p5l874t314r1111b345],
32	viral	JJ	O	viral	amod	33	SENT_204	[p5l1135t314r1198b337],
33	determinations	NNS	O	determination	prep_between	27	SENT_204	[p5l189t351r410b374],
34	using	VBG	O	use	xcomp	25	SENT_204	[p5l430t351r506b382],
35	SCA	NNP	ORGANIZATION	SCA	dobj	34	SENT_204	[p5l525t351r593b374],
36	.	.	O	.	_	0	SENT_204	[p5l525t351r593b374],

1	In	IN	O	in	_	0	SENT_205	[p5l613t352r642b373],
2	all	DT	O	all	det	3	SENT_205	[p5l662t351r694b374],
3	analyses	NNS	O	analysis	prep_in	21	SENT_205	[p5l714t351r836b382],
4	,	,	O	,	_	0	SENT_205	[p5l714t351r836b382],
5	values	NNS	O	value	nsubjpass	21	SENT_205	[p5l855t351r942b374],
6	below	IN	O	below	_	0	SENT_205	[p5l962t351r1046b374],
7	the	DT	O	the	det	10	SENT_205	[p5l1065t351r1109b374],
8	assay	NN	O	assay	nn	10	SENT_205	[p5l1129t359r1199b382],
9	quantitation	NN	O	quantitation	nn	10	SENT_205	[p5l189t386r370b417],
10	limit	NN	O	limit	prep_below	5	SENT_205	[p5l380t386r448b409],
11	for	IN	O	for	_	0	SENT_205	[p5l457t386r501b408],
12	study	NN	O	study	nn	14	SENT_205	[p5l510t386r586b417],
13	M98	NN	O	m98	nn	14	SENT_205	[p5l596t386r725b408],
14	—	NN	O	—	prep_for	10	SENT_205	[p5l596t386r725b408],
15	863	CD	NUMBER	863	num	16	SENT_205	[p5l596t386r725b408],
16	(	NN	O	(	dep	14	SENT_205	[p5l737t386r786b415],
17	0.6	CD	NUMBER	0.6	num	19	SENT_205	[p5l737t386r786b415],
18	copies/mL	NN	O	copies/ml	nn	19	SENT_205	[p5l796t386r953b417],
19	)	NN	O	)	dep	16	SENT_205	[p5l796t386r953b417],
20	were	VBD	O	be	auxpass	21	SENT_205	[p5l962t394r1030b409],
21	considered	VBN	O	consider	_	0	SENT_205	[p5l1041t386r1199b409],
22	to	TO	O	to	aux	24	SENT_205	[p5l190t427r216b445],
23	be	VB	O	be	cop	24	SENT_205	[p5l240t422r273b445],
24	equal	JJ	O	equal	xcomp	21	SENT_205	[p5l297t422r374b453],
25	to	TO	O	to	_	0	SENT_205	[p5l399t427r425b445],
26	the	DT	O	the	det	28	SENT_205	[p5l450t422r494b445],
27	assay	NN	O	assay	nn	28	SENT_205	[p5l518t430r589b453],
28	limit	NN	O	limit	prep_to	24	SENT_205	[p5l613t422r686b445],
29	.	.	O	.	_	0	SENT_205	[p5l613t422r686b445],

1	Sensitivity	NN	O	sensitivity	nn	2	SENT_206	[p5l711t422r859b453],
2	analyses	NNS	O	analysis	nsubj	9	SENT_206	[p5l883t422r999b453],
3	using	VBG	O	use	partmod	2	SENT_206	[p5l1022t422r1099b453],
4	other	JJ	O	other	amod	6	SENT_206	[p5l1122t422r1200b445],
5	imputation	NN	O	imputation	nn	6	SENT_206	[p5l190t459r351b490],
6	methods	NNS	O	method	dobj	3	SENT_206	[p5l366t459r488b482],
7	did	VBD	O	do	aux	9	SENT_206	[p5l501t459r547b482],
8	not	RB	O	not	neg	9	SENT_206	[p5l561t464r608b482],
9	alter	VB	O	alter	_	0	SENT_206	[p5l621t459r688b482],
10	results	NNS	O	result	dobj	9	SENT_206	[p5l701t459r792b482],
11	meaningfully	RB	O	meaningfully	advmod	9	SENT_206	[p5l807t459r1002b490],
12	.	.	O	.	_	0	SENT_206	[p5l807t459r1002b490],

1	Supporting	VBG	O	support	_	0	SENT_207	[p5l189t554r406b594],
2	Information	NNP	O	Information	nn	4	SENT_207	[p5l425t553r653b586],
3	Figure	NNP	O	Figure	nn	4	SENT_207	[p5l188t625r282b656],
4	S1	NN	O	s1	dobj	1	SENT_207	[p5l292t625r332b648],
5	.	.	O	.	_	0	SENT_207	[p5l292t625r332b648],

1	Schematic	JJ	O	schematic	nsubj	15	SENT_208	[p5l344t625r491b648],
2	Describing	VBG	O	describe	partmod	1	SENT_208	[p5l503t625r659b656],
3	Patient	NN	O	patient	nn	4	SENT_208	[p5l669t625r773b648],
4	Inclusion	NNP	O	Inclusion	dobj	2	SENT_208	[p5l783t625r917b648],
5	for	IN	O	for	_	0	SENT_208	[p5l927t625r970b647],
6	Study	NNP	O	Study	prep_for	4	SENT_208	[p5l980t625r1061b656],
7	of	IN	O	of	_	0	SENT_208	[p5l1072t625r1103b647],
8	HIV-1	NN	O	hiv-1	nn	9	SENT_208	[p5l1111t625r1196b648],
9	Viremia	NN	O	viremia	prep_of	6	SENT_208	[p5l188t661r306b684],
10	in	IN	O	in	_	0	SENT_208	[p5l319t661r345b683],
11	M98	NN	O	m98	nn	12	SENT_208	[p5l359t661r489b683],
12	—	NN	O	—	prep_in	2	SENT_208	[p5l359t661r489b683],
13	863	CD	NUMBER	863	num	14	SENT_208	[p5l359t661r489b683],
14	Patients	NNS	O	patient	dep	12	SENT_208	[p5l502t661r617b684],
15	Found	VBP	O	find	_	0	SENT_208	[p5l189t710r282b733],
16	at	IN	O	at	_	0	SENT_208	[p5l295t715r321b733],
17	doi	FW	O	doi	nn	18	SENT_208	[p5l334t708r900b741],
18	:10.1371	FW	O	:10.1371	prep_at	15	SENT_208	[p5l334t708r900b741],
19	Qournal	NN	O	qournal	dep	18	SENT_208	[p5l334t708r900b741],
20	.	.	O	.	_	0	SENT_208	[p5l334t708r900b741],

1	ppat	NN	O	ppat	_	0	SENT_209	[p5l334t708r900b741],
2	.0030046	CD	NUMBER	.0030046	dep	1	SENT_209	[p5l334t708r900b741],
3	.	.	O	.	_	0	SENT_209	[p5l334t708r900b741],

1	sg001	NN	O	sg001	_	0	SENT_210	[p5l334t708r900b741],
2	(	CD	NUMBER	(	number	3	SENT_210	[p5l917t710r956b738],
3	21	CD	NUMBER	21	num	5	SENT_210	[p5l917t710r956b738],
4	KB	NN	ORGANIZATION	kb	nn	5	SENT_210	[p5l972t710r1014b732],
5	DOC	NN	ORGANIZATION	doc	dep	1	SENT_210	[p5l1028t710r1117b738],
6	)	CD	NUMBER	)	dep	5	SENT_210	[p5l1028t710r1117b738],
7	.	.	O	.	_	0	SENT_210	[p5l1028t710r1117b738],

1	Figure	NNP	O	Figure	_	0	SENT_211	[p5l188t771r282b802],
2	S2	NN	O	s2	dep	1	SENT_211	[p5l292t771r332b795],
3	.	.	O	.	_	0	SENT_211	[p5l292t771r332b795],

1	Correlation	NN	O	correlation	nsubjpass	23	SENT_212	[p5l343t771r512b794],
2	between	IN	O	between	_	0	SENT_212	[p5l522t771r642b794],
3	Pretherapy	NNP	O	Pretherapy	nn	7	SENT_212	[p5l653t771r813b802],
4	Plasma	NN	O	plasma	nn	7	SENT_212	[p5l823t771r924b794],
5	HIV-1	NN	O	hiv-1	nn	7	SENT_212	[p5l934t771r1019b794],
6	RNA	NN	O	rna	nn	7	SENT_212	[p5l1032t771r1101b794],
7	Levels	NNS	O	level	prep_between	1	SENT_212	[p5l1111t771r1199b794],
8	as	IN	O	as	mark	9	SENT_212	[p5l189t815r215b830],
9	Determined	VBN	O	determine	dep	1	SENT_212	[p5l228t807r402b830],
10	by	IN	O	by	_	0	SENT_212	[p5l415t807r448b838],
11	Amplicor	JJ	O	amplicor	amod	14	SENT_212	[p5l460t807r599b838],
12	HIV-1	NN	O	hiv-1	nn	14	SENT_212	[p5l611t807r697b830],
13	Monitor	NNP	O	Monitor	nn	14	SENT_212	[p5l713t807r833b830],
14	Assay	NN	O	assay	prep_by	9	SENT_212	[p5l844t807r923b838],
15	and	CC	O	and	_	0	SENT_212	[p5l936t807r989b830],
16	SCA	NNP	ORGANIZATION	SCA	nn	18	SENT_212	[p5l1002t807r1064b830],
17	Pretherapy	NNP	O	Pretherapy	nn	18	SENT_212	[p5l189t856r350b887],
18	samples	NNS	O	sample	prep_by	9	SENT_212	[p5l369t856r481b887],
19	from	IN	O	from	_	0	SENT_212	[p5l500t856r570b878],
20	157	CD	NUMBER	157	num	21	SENT_212	[p5l593t854r639b878],
21	participants	NNS	O	participant	prep_from	9	SENT_212	[p5l659t856r833b887],
22	were	VBD	O	be	auxpass	23	SENT_212	[p5l852t864r920b879],
23	analyzed	VBN	O	analyze	_	0	SENT_212	[p5l939t856r1063b887],
24	by	IN	O	by	prep	23	SENT_212	[p5l1082t856r1114b887],
25	both	CC	O	both	prep	23	SENT_212	[p5l1133t856r1199b879],
26	assays	NNS	O	assay	dep	25	SENT_212	[p5l189t900r279b923],
27	.	.	O	.	_	0	SENT_212	[p5l189t900r279b923],

1	12	CD	NUMBER	12	num	2	SENT_213	[p5l295t892r324b915],
2	samples	NNS	O	sample	nsubjpass	15	SENT_213	[p5l337t892r449b923],
3	(	CD	NUMBER	(	num	4	SENT_213	[p5l463t892r606b923],
4	triangles	NNS	O	triangle	dep	2	SENT_213	[p5l463t892r606b923],
5	)	CD	NUMBER	)	dep	2	SENT_213	[p5l463t892r606b923],
6	had	VBD	O	have	_	0	SENT_213	[p5l619t892r671b915],
7	SCA	NNP	O	SCA	nn	8	SENT_213	[p5l683t892r746b915],
8	values	NNS	O	value	dobj	6	SENT_213	[p5l757t892r844b915],
9	signiﬁcantly	RB	O	signiﬁcantly	advmod	10	SENT_213	[p5l857t892r1031b923],
10	lower	JJR	O	lower	amod	8	SENT_213	[p5l1043t892r1123b915],
11	than	IN	O	than	_	0	SENT_213	[p5l1135t892r1199b915],
12	Amplicor	NN	O	amplicor	prep_than	6	SENT_213	[p5l188t928r328b959],
13	and	CC	O	and	_	0	SENT_213	[p5l351t928r404b951],
14	were	VBD	O	be	auxpass	15	SENT_213	[p5l428t936r496b951],
15	excluded	VBN	O	exclude	conj_and	6	SENT_213	[p5l521t928r651b951],
16	from	IN	O	from	_	0	SENT_213	[p5l675t928r745b950],
17	further	JJ	O	further	amod	18	SENT_213	[p5l770t928r875b951],
18	analysis	NN	O	analysis	prep_from	15	SENT_213	[p5l899t928r1016b959],
19	.	.	O	.	_	0	SENT_213	[p5l899t928r1016b959],

1	Remaining	VBG	O	remain	_	0	SENT_214	[p5l1042t928r1200b959],
2	samples	NNS	O	sample	dobj	1	SENT_214	[p5l189t964r301b995],
3	(	CD	NUMBER	(	num	4	SENT_214	[p5l314t965r339b993],
4	n	NN	O	n	dep	2	SENT_214	[p5l314t965r339b993],
5	:	:	O	:	_	0	SENT_214	[p5l347t974r369b982],
6	145	CD	NUMBER	145	dep	2	SENT_214	[p5l381t964r434b991],
7	,	,	O	,	_	0	SENT_214	[p5l381t964r434b991],
8	diamonds	NNS	O	diamond	appos	6	SENT_214	[p5l447t964r597b993],
9	)	CD	NUMBER	)	num	8	SENT_214	[p5l447t964r597b993],
10	were	VBD	O	be	auxpass	12	SENT_214	[p5l608t972r676b987],
11	highly	RB	O	highly	advmod	12	SENT_214	[p5l688t964r775b995],
12	correlated	VBN	O	correlate	aux	1	SENT_214	[p5l787t964r936b987],
13	(	CD	NUMBER	(	num	14	SENT_214	[p5l948t956r981b992],
14	T2	NN	O	t2	nsubj	1	SENT_214	[p5l948t956r981b992],
15	:	:	O	:	_	0	SENT_214	[p5l989t974r1011b982],
16	0.61	CD	NUMBER	0.61	dep	14	SENT_214	[p5l1021t964r1085b991],
17	,	,	O	,	_	0	SENT_214	[p5l1021t964r1085b991],
18	broken	VBN	O	break	partmod	16	SENT_214	[p5l1097t964r1199b987],

1	References	NNS	O	reference	_	0	SENT_215	[p5l188t1074r328b1094],
2	1	CD	NUMBER	1	num	1	SENT_215	[p5l191t1113r208b1132],
3	.	.	O	.	_	0	SENT_215	[p5l191t1113r208b1132],

1	Di	NNP	ORGANIZATION	Di	nn	3	SENT_216	[p5l239t1113r266b1132],
2	Mascio	NNP	ORGANIZATION	Mascio	nn	3	SENT_216	[p5l281t1113r367b1132],
3	M	NN	ORGANIZATION	m	nsubj	41	SENT_216	[p5l382t1113r411b1136],
4	,	,	O	,	_	0	SENT_216	[p5l382t1113r411b1136],
5	Dornadula	NNP	O	Dornadula	nn	6	SENT_216	[p5l426t1113r561b1132],
6	G	NNP	O	G	dep	38	SENT_216	[p5l575t1113r601b1136],
7	,	,	O	,	_	0	SENT_216	[p5l575t1113r601b1136],
8	Zhang	NNP	PERSON	Zhang	nn	9	SENT_216	[p5l616t1113r694b1140],
9	H	NNP	PERSON	H	appos	6	SENT_216	[p5l708t1113r735b1136],
10	,	,	O	,	_	0	SENT_216	[p5l708t1113r735b1136],
11	Sullivan	NNP	PERSON	Sullivan	nn	12	SENT_216	[p5l750t1113r850b1133],
12	J	NNP	PERSON	J	appos	6	SENT_216	[p5l859t1113r878b1140],
13	,	,	O	,	_	0	SENT_216	[p5l859t1113r878b1140],
14	Xu	NNP	O	Xu	nn	15	SENT_216	[p5l893t1113r928b1132],
15	Y	NN	O	y	appos	6	SENT_216	[p5l942t1113r965b1136],
16	,	,	O	,	_	0	SENT_216	[p5l942t1113r965b1136],
17	et	FW	O	et	appos	6	SENT_216	[p5l980t1117r1002b1132],
18	al.	FW	O	al.	nn	19	SENT_216	[p5l1017t1113r1042b1132],
19	(	FW	O	(	rcmod	17	SENT_216	[p5l1058t1113r1133b1138],
20	2003	CD	DATE	2003	num	21	SENT_216	[p5l1058t1113r1133b1138],
21	)	CD	NUMBER	)	dep	19	SENT_216	[p5l1058t1113r1133b1138],
22	In	IN	O	in	dep	19	SENT_216	[p5l1147t1113r1172b1132],
23	a	DT	O	a	det	24	SENT_216	[p5l1187t1120r1199b1132],
24	subset	NN	O	subset	pobj	22	SENT_216	[p5l239t1146r320b1165],
25	of	IN	O	of	_	0	SENT_216	[p5l343t1146r370b1165],
26	subjects	NNS	O	subject	prep_of	24	SENT_216	[p5l390t1146r494b1173],
27	on	IN	O	on	_	0	SENT_216	[p5l517t1153r549b1165],
28	highly	RB	O	highly	advmod	29	SENT_216	[p5l572t1146r652b1173],
29	active	JJ	O	active	amod	31	SENT_216	[p5l675t1146r751b1165],
30	antiretroviral	JJ	O	antiretroviral	amod	31	SENT_216	[p5l774t1146r954b1165],
31	therapy	NN	O	therapy	prep_on	26	SENT_216	[p5l978t1146r1085b1173],
32	,	,	O	,	_	0	SENT_216	[p5l978t1146r1085b1173],
33	human	JJ	O	human	amod	35	SENT_216	[p5l1108t1146r1199b1165],
34	immunodeﬁciency	NN	O	immunodeﬁciency	nn	35	SENT_216	[p5l239t1179r475b1206],
35	virus	NN	O	virus	appos	6	SENT_216	[p5l492t1179r552b1198],
36	type	NN	O	type	dep	38	SENT_216	[p5l571t1183r623b1206],
37	1	CD	NUMBER	1	num	36	SENT_216	[p5l643t1179r652b1198],
38	RNA	NN	O	rna	dep	3	SENT_216	[p5l672t1179r732b1199],
39	in	IN	O	in	_	0	SENT_216	[p5l750t1179r773b1198],
40	plasma	NN	O	plasma	prep_in	38	SENT_216	[p5l791t1179r878b1206],
41	decays	VBZ	O	decay	_	0	SENT_216	[p5l896t1179r977b1206],
42	from	IN	O	from	_	0	SENT_216	[p5l995t1179r1056b1198],
43	50	CD	NUMBER	50	prep_from	41	SENT_216	[p5l1075t1179r1102b1198],
44	to	TO	O	to	_	0	SENT_216	[p5l1120t1183r1144b1198],
45	<	JJR	O	<	prep_to	41	SENT_216	[p5l1163t1179r1199b1198],
46	5	CD	NUMBER	5	num	47	SENT_216	[p5l1163t1179r1199b1198],
47	copies	NNS	O	copy	dep	45	SENT_216	[p5l239t1212r317b1239],
48	per	IN	O	per	_	0	SENT_216	[p5l330t1218r372b1239],
49	milliliter	NN	O	milliliter	prep_per	47	SENT_216	[p5l384t1212r500b1235],
50	,	,	O	,	_	0	SENT_216	[p5l384t1212r500b1235],
51	with	IN	O	with	_	0	SENT_216	[p5l512t1212r566b1231],
52	a	DT	O	a	det	53	SENT_216	[p5l578t1219r590b1231],
53	half-life	NN	O	half-life	prep_with	41	SENT_216	[p5l602t1212r699b1231],
54	of	IN	O	of	_	0	SENT_216	[p5l712t1212r739b1231],
55	6	CD	DURATION	6	num	56	SENT_216	[p5l748t1212r761b1231],
56	months	NNS	NUMBER	month	prep_of	53	SENT_216	[p5l773t1212r893b1239],
57	.	.	O	.	_	0	SENT_216	[p5l773t1212r893b1239],

1	J	NNP	O	J	nn	2	SENT_217	[p5l773t1212r893b1239],
2	Virol	NNP	O	Virol	_	0	SENT_217	[p5l904t1212r969b1231],
3	77	CD	NUMBER	77	num	2	SENT_217	[p5l982t1210r1015b1231],
4	:	:	O	:	_	0	SENT_217	[p5l982t1210r1015b1231],
5	2271-2275	CD	DATE	2271-2275	dep	2	SENT_217	[p5l1028t1210r1168b1232],
6	.	.	O	.	_	0	SENT_217	[p5l1028t1210r1168b1232],

1	Dornadula	NNP	O	Dornadula	nn	2	SENT_218	[p5l239t1245r374b1264],
2	G	NNP	O	G	_	0	SENT_218	[p5l387t1245r413b1268],
3	,	,	O	,	_	0	SENT_218	[p5l387t1245r413b1268],
4	Zhang	NNP	PERSON	Zhang	nn	5	SENT_218	[p5l426t1245r505b1272],
5	H	NNP	PERSON	H	appos	2	SENT_218	[p5l517t1245r544b1268],
6	,	,	O	,	_	0	SENT_218	[p5l517t1245r544b1268],
7	VanUitert	NNP	O	VanUitert	nn	8	SENT_218	[p5l557t1245r686b1265],
8	B	NNP	O	B	appos	2	SENT_218	[p5l698t1245r721b1268],
9	,	,	O	,	_	0	SENT_218	[p5l698t1245r721b1268],
10	Stern	NNP	PERSON	Stern	nn	11	SENT_218	[p5l735t1245r802b1265],
11	J	NNP	PERSON	J	appos	2	SENT_218	[p5l811t1245r829b1272],
12	,	,	O	,	_	0	SENT_218	[p5l811t1245r829b1272],
13	Livornese	NNP	PERSON	Livornese	nn	14	SENT_218	[p5l843t1245r966b1264],
14	LJr	NNP	O	LJr	nsubj	29	SENT_218	[p5l979t1245r1034b1272],
15	,	,	O	,	_	0	SENT_218	[p5l979t1245r1034b1272],
16	et	FW	O	et	dep	23	SENT_218	[p5l1048t1249r1070b1264],
17	al.	FW	O	al.	nn	18	SENT_218	[p5l1083t1245r1109b1264],
18	(	FW	O	(	dep	16	SENT_218	[p5l1124t1245r1199b1270],
19	1999	CD	DATE	1999	dep	23	SENT_218	[p5l1124t1245r1199b1270],
20	)	CD	NUMBER	)	num	23	SENT_218	[p5l1124t1245r1199b1270],
21	Residual	JJ	O	residual	amod	23	SENT_218	[p5l239t1279r345b1298],
22	HIV-1	NN	O	hiv-1	nn	23	SENT_218	[p5l357t1279r431b1299],
23	RNA	NN	O	rna	dep	14	SENT_218	[p5l445t1279r505b1299],
24	in	IN	O	in	_	0	SENT_218	[p5l516t1279r539b1298],
25	blood	NN	O	blood	nn	26	SENT_218	[p5l550t1279r622b1298],
26	plasma	NN	O	plasma	prep_in	23	SENT_218	[p5l633t1279r720b1306],
27	of	IN	O	of	_	0	SENT_218	[p5l731t1279r758b1298],
28	patients	NNS	O	patient	prep_of	26	SENT_218	[p5l766t1279r867b1306],
29	taking	VBG	O	take	dep	2	SENT_218	[p5l878t1279r957b1306],
30	suppressive	JJ	O	suppressive	acomp	29	SENT_218	[p5l967t1279r1111b1306],
31	highly	RB	O	highly	advmod	32	SENT_218	[p5l1123t1279r1199b1306],
32	active	JJ	O	active	amod	34	SENT_218	[p5l239t1312r311b1331],
33	antiretroviral	JJ	O	antiretroviral	amod	34	SENT_218	[p5l324t1312r494b1331],
34	therapy	NN	O	therapy	dep	30	SENT_218	[p5l507t1312r696b1339],
35	.	.	O	.	_	0	SENT_218	[p5l507t1312r696b1339],

1	JAMA	NN	O	jama	_	0	SENT_219	[p5l507t1312r696b1339],
2	282	CD	NUMBER	282	num	1	SENT_219	[p5l708t1312r757b1332],
3	:	:	O	:	_	0	SENT_219	[p5l708t1312r757b1332],
4	1627-1632	CD	DATE	1627-1632	dep	1	SENT_219	[p5l772t1310r909b1332],
5	.	.	O	.	_	0	SENT_219	[p5l772t1310r909b1332],

1	Frenkel	NNP	ORGANIZATION	Frenkel	nn	2	SENT_220	[p5l239t1345r334b1364],
2	LM	NNP	ORGANIZATION	LM	nsubj	25	SENT_220	[p5l351t1345r399b1368],
3	,	,	O	,	_	0	SENT_220	[p5l351t1345r399b1368],
4	Wang	NNP	PERSON	Wang	nn	5	SENT_220	[p5l416t1345r488b1372],
5	Y	NN	PERSON	y	appos	2	SENT_220	[p5l504t1345r527b1368],
6	,	,	O	,	_	0	SENT_220	[p5l504t1345r527b1368],
7	Learn	VB	O	learn	parataxis	25	SENT_220	[p5l545t1345r619b1364],
8	GH	NN	O	gh	dep	7	SENT_220	[p5l636t1345r685b1368],
9	,	,	O	,	_	0	SENT_220	[p5l636t1345r685b1368],
10	McKernan	NNP	PERSON	McKernan	nn	11	SENT_220	[p5l703t1345r836b1364],
11	JL	NNP	O	JL	appos	8	SENT_220	[p5l848t1345r885b1372],
12	,	,	O	,	_	0	SENT_220	[p5l848t1345r885b1372],
13	Ellis	NNP	ORGANIZATION	Ellis	nn	14	SENT_220	[p5l902t1345r954b1364],
14	GM	NNP	ORGANIZATION	GM	appos	11	SENT_220	[p5l971t1345r1022b1368],
15	,	,	O	,	_	0	SENT_220	[p5l971t1345r1022b1368],
16	et	FW	O	et	nn	18	SENT_220	[p5l1039t1349r1062b1364],
17	al.	FW	O	al.	nn	18	SENT_220	[p5l1079t1345r1105b1364],
18	(	FW	O	(	dobj	7	SENT_220	[p5l1124t1345r1199b1370],
19	2003	CD	DATE	2003	nsubj	7	SENT_220	[p5l1124t1345r1199b1370],
20	)	CD	NUMBER	)	num	24	SENT_220	[p5l1124t1345r1199b1370],
21	Multiple	JJ	O	multiple	amod	24	SENT_220	[p5l239t1378r345b1405],
22	viral	JJ	O	viral	amod	24	SENT_220	[p5l358t1378r413b1397],
23	genetic	JJ	O	genetic	amod	24	SENT_220	[p5l427t1378r517b1405],
24	analyses	NNS	O	analysis	nsubj	25	SENT_220	[p5l532t1378r633b1405],
25	detect	VBP	O	detect	_	0	SENT_220	[p5l647t1378r724b1397],
26	low-level	JJ	O	low-level	amod	30	SENT_220	[p5l738t1378r848b1397],
27	human	JJ	O	human	amod	30	SENT_220	[p5l862t1378r949b1397],
28	immunodeﬁciency	NN	O	immunodeﬁciency	nn	30	SENT_220	[p5l963t1378r1199b1405],
29	virus	NN	O	virus	nn	30	SENT_220	[p5l238t1411r299b1430],
30	type	NN	O	type	dobj	25	SENT_220	[p5l322t1415r375b1438],
31	1	CD	NUMBER	1	num	32	SENT_220	[p5l399t1411r408b1430],
32	replication	NN	O	replication	npadvmod	25	SENT_220	[p5l432t1411r572b1438],
33	during	IN	O	during	_	0	SENT_220	[p5l594t1411r680b1438],
34	effective	JJ	O	effective	amod	38	SENT_220	[p5l701t1411r809b1430],
35	highly	RB	O	highly	advmod	34	SENT_220	[p5l831t1411r909b1438],
36	active	JJ	O	active	amod	38	SENT_220	[p5l931t1411r1003b1430],
37	antiretroviral	JJ	O	antiretroviral	amod	38	SENT_220	[p5l1026t1411r1198b1430],
38	therapy	NN	O	therapy	prep_during	25	SENT_220	[p5l239t1445r362b1472],
39	.	.	O	.	_	0	SENT_220	[p5l239t1445r362b1472],

1	J	NNP	O	J	nn	2	SENT_221	[p5l239t1445r362b1472],
2	Virol	NNP	O	Virol	_	0	SENT_221	[p5l373t1445r437b1465],
3	77	CD	NUMBER	77	num	2	SENT_221	[p5l450t1443r484b1464],
4	:	:	O	:	_	0	SENT_221	[p5l450t1443r484b1464],
5	5721-5730	CD	DURATION	5721-5730	dep	2	SENT_221	[p5l497t1443r636b1465],
6	.	.	O	.	_	0	SENT_221	[p5l497t1443r636b1465],

1	Pomerantz	NNP	PERSON	Pomerantz	nn	2	SENT_222	[p5l239t1478r380b1497],
2	RJ	NN	PERSON	rj	nsubj	6	SENT_222	[p5l402t1478r437b1505],
3	,	,	O	,	_	0	SENT_222	[p5l402t1478r437b1505],
4	Zhang	NNP	PERSON	Zhang	nn	5	SENT_222	[p5l460t1478r540b1505],
5	H	NNP	PERSON	H	nsubj	6	SENT_222	[p5l562t1478r583b1497],
6	(	VBD	O	(	_	0	SENT_222	[p5l607t1478r685b1503],
7	2001	CD	DATE	2001	num	8	SENT_222	[p5l607t1478r685b1503],
8	)	CD	NUMBER	)	dobj	6	SENT_222	[p5l607t1478r685b1503],
9	Residual	JJ	O	residual	amod	11	SENT_222	[p5l708t1478r817b1497],
10	HIV-1	NN	O	hiv-1	nn	11	SENT_222	[p5l841t1478r918b1498],
11	persistence	NN	O	persistence	npadvmod	6	SENT_222	[p5l943t1478r1090b1505],
12	during	IN	O	during	_	0	SENT_222	[p5l1112t1478r1200b1505],
13	suppressive	JJ	O	suppressive	amod	14	SENT_222	[p5l239t1511r383b1538],
14	HAART	NN	O	haart	prep_during	6	SENT_222	[p5l396t1511r503b1530],
15	.	.	O	.	_	0	SENT_222	[p5l396t1511r503b1530],

1	Curr	NNP	O	Curr	nn	5	SENT_223	[p5l516t1511r576b1531],
2	Clin	NNP	O	Clin	nn	5	SENT_223	[p5l587t1511r639b1531],
3	Top	NNP	O	Top	nn	5	SENT_223	[p5l650t1511r701b1538],
4	Infect	NNP	O	Infect	nn	5	SENT_223	[p5l713t1511r787b1530],
5	Dis	NNP	O	Dis	_	0	SENT_223	[p5l799t1511r838b1530],
6	21	CD	NUMBER	21	num	5	SENT_223	[p5l850t1511r884b1530],
7	:	:	O	:	_	0	SENT_223	[p5l850t1511r884b1530],
8	1-30	CD	NUMBER	1-30	dep	5	SENT_223	[p5l899t1511r961b1530],
9	.	.	O	.	_	0	SENT_223	[p5l899t1511r961b1530],

1	Wong	NNP	ORGANIZATION	Wong	nn	2	SENT_224	[p5l238t1544r313b1571],
2	JK	NNP	ORGANIZATION	JK	nsubj	18	SENT_224	[p5l320t1544r360b1571],
3	,	,	O	,	_	0	SENT_224	[p5l320t1544r360b1571],
4	Hezareh	NNP	O	Hezareh	nn	5	SENT_224	[p5l374t1544r479b1563],
5	M	NNP	O	M	appos	2	SENT_224	[p5l493t1544r522b1567],
6	,	,	O	,	_	0	SENT_224	[p5l493t1544r522b1567],
7	Gunthard	NNP	O	Gunthard	nn	8	SENT_224	[p5l536t1544r659b1564],
8	HF	NN	O	hf	appos	5	SENT_224	[p5l673t1544r717b1567],
9	,	,	O	,	_	0	SENT_224	[p5l673t1544r717b1567],
10	Havlir	NNP	PERSON	Havlir	nn	11	SENT_224	[p5l731t1544r810b1563],
11	DV	NNP	O	DV	appos	8	SENT_224	[p5l822t1544r869b1567],
12	,	,	O	,	_	0	SENT_224	[p5l822t1544r869b1567],
13	Ignacio	NNP	ORGANIZATION	Ignacio	nn	14	SENT_224	[p5l882t1544r975b1571],
14	CC	NN	ORGANIZATION	cc	appos	5	SENT_224	[p5l989t1544r1033b1567],
15	,	,	O	,	_	0	SENT_224	[p5l989t1544r1033b1567],
16	et	FW	O	et	nn	18	SENT_224	[p5l1047t1548r1069b1563],
17	al.	FW	O	al.	nn	18	SENT_224	[p5l1083t1544r1109b1563],
18	(	FW	O	(	_	0	SENT_224	[p5l1124t1542r1199b1569],
19	1997	CD	DATE	1997	num	21	SENT_224	[p5l1124t1542r1199b1569],
20	)	CD	NUMBER	)	num	21	SENT_224	[p5l1124t1542r1199b1569],
21	Recovery	NN	O	recovery	dobj	18	SENT_224	[p5l239t1577r354b1604],
22	of	IN	O	of	_	0	SENT_224	[p5l366t1577r393b1596],
23	replication-competent	JJ	O	replication-competent	amod	24	SENT_224	[p5l402t1577r690b1604],
24	HIV	NN	O	hiv	prep_of	21	SENT_224	[p5l702t1577r755b1596],
25	despite	IN	O	despite	_	0	SENT_224	[p5l767t1577r856b1604],
26	prolonged	JJ	O	prolonged	amod	27	SENT_224	[p5l869t1577r1000b1604],
27	suppression	NN	O	suppression	prep_despite	18	SENT_224	[p5l1012t1577r1162b1604],
28	of	IN	O	of	_	0	SENT_224	[p5l1175t1577r1202b1596],
29	plasma	NN	O	plasma	nn	30	SENT_224	[p5l239t1611r326b1638],
30	viremia	NN	O	viremia	prep_of	27	SENT_224	[p5l337t1611r439b1630],
31	.	.	O	.	_	0	SENT_224	[p5l337t1611r439b1630],

1	Science	NNP	O	Science	_	0	SENT_225	[p5l451t1611r547b1631],
2	278	CD	NUMBER	278	num	1	SENT_225	[p5l559t1609r608b1630],
3	:	:	O	:	_	0	SENT_225	[p5l559t1609r608b1630],
4	1291-1295	CD	DATE	1291-1295	dep	1	SENT_225	[p5l623t1611r761b1631],
5	.	.	O	.	_	0	SENT_225	[p5l623t1611r761b1631],

1	Zhang	NNP	PERSON	Zhang	nn	2	SENT_226	[p5l239t1644r317b1671],
2	L	NNP	PERSON	L	_	0	SENT_226	[p5l331t1644r353b1667],
3	,	,	O	,	_	0	SENT_226	[p5l331t1644r353b1667],
4	Ramratnam	NNP	O	Ramratnam	nn	5	SENT_226	[p5l369t1644r518b1663],
5	B	NNP	O	B	appos	2	SENT_226	[p5l533t1644r556b1667],
6	,	,	O	,	_	0	SENT_226	[p5l533t1644r556b1667],
7	Tenner-Racz	NNP	O	Tenner-Racz	nn	8	SENT_226	[p5l571t1644r734b1663],
8	K	NNP	O	K	appos	2	SENT_226	[p5l749t1644r773b1667],
9	,	,	O	,	_	0	SENT_226	[p5l749t1644r773b1667],
10	He	PRP	O	he	dep	11	SENT_226	[p5l789t1644r824b1663],
11	Y	NN	O	y	appos	2	SENT_226	[p5l839t1644r862b1667],
12	,	,	O	,	_	0	SENT_226	[p5l839t1644r862b1667],
13	Vesanen	NN	O	vesanen	nn	14	SENT_226	[p5l877t1644r984b1664],
14	M	NN	O	m	appos	2	SENT_226	[p5l999t1644r1028b1667],
15	,	,	O	,	_	0	SENT_226	[p5l999t1644r1028b1667],
16	et	FW	O	et	appos	2	SENT_226	[p5l1044t1648r1066b1663],
17	al.	FW	O	al.	nn	20	SENT_226	[p5l1081t1644r1107b1663],
18	(	FW	O	(	dep	20	SENT_226	[p5l1124t1644r1199b1669],
19	1999	CD	DATE	1999	num	20	SENT_226	[p5l1124t1644r1199b1669],
20	)	CD	NUMBER	)	advmod	21	SENT_226	[p5l1124t1644r1199b1669],
21	Quantifying	VBG	O	quantify	partmod	16	SENT_226	[p5l239t1677r392b1704],
22	residual	JJ	O	residual	amod	24	SENT_226	[p5l405t1677r504b1696],
23	HIV-1	NN	MISC	hiv-1	nn	24	SENT_226	[p5l517t1677r592b1697],
24	replication	NN	O	replication	dobj	21	SENT_226	[p5l607t1677r746b1704],
25	in	IN	O	in	_	0	SENT_226	[p5l759t1677r782b1696],
26	patients	NNS	O	patient	prep_in	24	SENT_226	[p5l795t1677r896b1704],
27	receiving	VBG	O	receive	partmod	26	SENT_226	[p5l909t1677r1025b1704],
28	combination	NN	O	combination	nn	30	SENT_226	[p5l1037t1677r1199b1696],
29	antiretroviral	JJ	O	antiretroviral	amod	30	SENT_226	[p5l239t1710r409b1729],
30	therapy	NN	O	therapy	dobj	27	SENT_226	[p5l423t1710r524b1737],
31	.	.	O	.	_	0	SENT_226	[p5l423t1710r524b1737],

1	N	NN	O	n	nn	2	SENT_227	[p5l537t1710r557b1729],
2	EnglJ	NN	O	englj	nsubj	3	SENT_227	[p5l569t1710r644b1737],
3	Med	VBD	O	med	_	0	SENT_227	[p5l656t1710r709b1729],
4	340	CD	NUMBER	340	dobj	3	SENT_227	[p5l722t1710r771b1729],
5	:	:	O	:	_	0	SENT_227	[p5l722t1710r771b1729],
6	1605-1613	CD	DATE	1605-1613	dep	4	SENT_227	[p5l785t1710r923b1729],
7	.	.	O	.	_	0	SENT_227	[p5l785t1710r923b1729],

1	Blankson	NNP	PERSON	Blankson	nn	2	SENT_228	[p5l239t1743r354b1762],
2	JN	NN	O	jn	_	0	SENT_228	[p5l371t1743r412b1770],
3	,	,	O	,	_	0	SENT_228	[p5l371t1743r412b1770],
4	Persaud	NN	PERSON	persaud	nn	5	SENT_228	[p5l435t1743r535b1762],
5	D	NN	O	d	appos	2	SENT_228	[p5l556t1743r582b1766],
6	,	,	O	,	_	0	SENT_228	[p5l556t1743r582b1766],
7	Siliciano	NNP	PERSON	Siliciano	nn	8	SENT_228	[p5l604t1743r713b1763],
8	RF	NN	PERSON	rf	appos	2	SENT_228	[p5l735t1743r769b1762],
9	(	CD	NUMBER	(	num	8	SENT_228	[p5l791t1743r866b1768],
10	2002	CD	DATE	2002	num	11	SENT_228	[p5l791t1743r866b1768],
11	)	CD	NUMBER	)	dep	8	SENT_228	[p5l791t1743r866b1768],
12	The	DT	O	the	det	13	SENT_228	[p5l887t1743r936b1762],
13	challenge	NN	O	challenge	dep	2	SENT_228	[p5l957t1743r1076b1770],
14	of	IN	O	of	_	0	SENT_228	[p5l1098t1743r1125b1762],
15	viral	JJ	O	viral	amod	16	SENT_228	[p5l1143t1743r1198b1762],
16	reservoirs	NNS	O	reservoir	prep_of	13	SENT_228	[p5l239t1777r363b1796],
17	in	IN	O	in	_	0	SENT_228	[p5l375t1777r398b1796],
18	HIV-1	NN	O	hiv-1	nn	19	SENT_228	[p5l411t1777r485b1797],
19	infection	NN	O	infection	prep_in	16	SENT_228	[p5l500t1777r620b1796],
20	.	.	O	.	_	0	SENT_228	[p5l500t1777r620b1796],

1	Annu	NNP	PERSON	Annu	nn	2	SENT_229	[p5l632t1777r702b1796],
2	Rev	NN	PERSON	rev	nsubj	3	SENT_229	[p5l714t1777r760b1796],
3	Med	VBD	O	med	_	0	SENT_229	[p5l772t1777r825b1796],
4	53	CD	NUMBER	53	dobj	3	SENT_229	[p5l838t1777r871b1796],
5	:	:	O	:	_	0	SENT_229	[p5l838t1777r871b1796],
6	557-593	CD	NUMBER	557-593	dep	4	SENT_229	[p5l885t1775r993b1796],
7	.	.	O	.	_	0	SENT_229	[p5l885t1775r993b1796],

1	Finzi	NNP	PERSON	Finzi	nn	2	SENT_230	[p5l239t1810r299b1829],
2	D	NNP	O	D	_	0	SENT_230	[p5l313t1810r339b1833],
3	,	,	O	,	_	0	SENT_230	[p5l313t1810r339b1833],
4	Blankson	NNP	PERSON	Blankson	nn	5	SENT_230	[p5l353t1810r469b1829],
5	J	NNP	PERSON	J	appos	2	SENT_230	[p5l478t1810r497b1837],
6	,	,	O	,	_	0	SENT_230	[p5l478t1810r497b1837],
7	Siliciano	NNP	PERSON	Siliciano	nn	8	SENT_230	[p5l511t1810r620b1830],
8	JD	NNP	O	JD	appos	2	SENT_230	[p5l629t1810r670b1837],
9	,	,	O	,	_	0	SENT_230	[p5l629t1810r670b1837],
10	Margolick	NNP	PERSON	Margolick	nn	11	SENT_230	[p5l684t1810r810b1837],
11	JB	NNP	O	JB	appos	2	SENT_230	[p5l819t1810r857b1837],
12	,	,	O	,	_	0	SENT_230	[p5l819t1810r857b1837],
13	Chadwick	NNP	PERSON	Chadwick	nn	14	SENT_230	[p5l871t1810r994b1830],
14	K	NNP	O	K	nsubj	28	SENT_230	[p5l1008t1810r1032b1833],
15	,	,	O	,	_	0	SENT_230	[p5l1008t1810r1032b1833],
16	et	FW	O	et	dep	22	SENT_230	[p5l1047t1814r1069b1829],
17	al.	FW	O	al.	nn	18	SENT_230	[p5l1083t1810r1109b1829],
18	(	FW	O	(	dep	16	SENT_230	[p5l1124t1810r1199b1835],
19	1999	CD	DATE	1999	dep	22	SENT_230	[p5l1124t1810r1199b1835],
20	)	CD	NUMBER	)	num	22	SENT_230	[p5l1124t1810r1199b1835],
21	Latent	JJ	O	latent	amod	22	SENT_230	[p5l239t1843r321b1862],
22	infection	NN	O	infection	dep	28	SENT_230	[p5l342t1843r455b1862],
23	of	IN	O	of	_	0	SENT_230	[p5l476t1843r503b1862],
24	CD4	NN	O	cd4	prep_of	22	SENT_230	[p5l520t1843r594b1864],
25	+	CC	O	+	_	0	SENT_230	[p5l520t1843r594b1864],
26	T	NN	O	t	prep_of	22	SENT_230	[p5l611t1843r629b1862],
27	cells	NNS	O	cell	nsubj	28	SENT_230	[p5l649t1843r702b1862],
28	provides	VBZ	O	provide	dep	2	SENT_230	[p5l723t1843r830b1870],
29	a	DT	O	a	det	30	SENT_230	[p5l851t1850r863b1862],
30	mechanism	NN	O	mechanism	dobj	28	SENT_230	[p5l883t1843r1026b1862],
31	for	IN	O	for	_	0	SENT_230	[p5l1047t1843r1084b1862],
32	lifelong	JJ	O	lifelong	amod	33	SENT_230	[p5l1104t1843r1200b1870],
33	persistence	NN	O	persistence	prep_for	28	SENT_230	[p5l239t1876r380b1903],
34	of	IN	O	of	_	0	SENT_230	[p5l394t1876r421b1895],
35	HIV-1	NN	O	hiv-1	prep_of	33	SENT_230	[p5l433t1876r516b1899],
36	,	,	O	,	_	0	SENT_230	[p5l433t1876r516b1899],
37	even	RB	O	even	advmod	28	SENT_230	[p5l530t1882r587b1895],
38	in	IN	O	in	_	0	SENT_230	[p5l602t1876r625b1895],
39	patients	NNS	O	patient	prep_in	28	SENT_230	[p5l639t1876r740b1903],
40	on	IN	O	on	_	0	SENT_230	[p5l754t1882r785b1895],
41	effective	JJ	O	effective	amod	43	SENT_230	[p5l799t1876r906b1895],
42	combination	NN	O	combination	nn	43	SENT_230	[p5l920t1876r1081b1895],
43	therapy	NN	O	therapy	prep_on	39	SENT_230	[p5l1096t1876r1198b1903],
44	.	.	O	.	_	0	SENT_230	[p5l1096t1876r1198b1903],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_231	[p5l239t1910r283b1930],
2	Med	NNP	O	Med	_	0	SENT_231	[p5l295t1910r349b1929],
3	5	CD	NUMBER	5	num	2	SENT_231	[p5l362t1910r380b1929],
4	:	:	O	:	_	0	SENT_231	[p5l362t1910r380b1929],
5	512-517	CD	NUMBER	512-517	dep	2	SENT_231	[p5l393t1908r502b1930],
6	.	.	O	.	_	0	SENT_231	[p5l393t1908r502b1930],

1	Siliciano	NNP	PERSON	Siliciano	nn	5	SENT_232	[p5l239t1943r348b1963],
2	JD	NNP	O	JD	nn	5	SENT_232	[p5l358t1943r398b1970],
3	,	,	O	,	_	0	SENT_232	[p5l358t1943r398b1970],
4	Siliciano	NNP	PERSON	Siliciano	appos	5	SENT_232	[p5l413t1943r522b1963],
5	RF	NN	PERSON	rf	_	0	SENT_232	[p5l537t1943r571b1962],
6	(	CD	NUMBER	(	num	5	SENT_232	[p5l586t1943r661b1968],
7	2004	CD	DATE	2004	num	8	SENT_232	[p5l586t1943r661b1968],
8	)	NN	O	)	dep	5	SENT_232	[p5l586t1943r661b1968],
9	A	DT	O	a	det	12	SENT_232	[p5l675t1943r694b1962],
10	long-term	JJ	O	long-term	amod	11	SENT_232	[p5l709t1943r834b1970],
11	latent	JJ	O	latent	amod	12	SENT_232	[p5l849t1943r922b1962],
12	reservoir	NN	O	reservoir	dep	5	SENT_232	[p5l936t1943r1050b1962],
13	for	IN	O	for	_	0	SENT_232	[p5l1064t1943r1101b1962],
14	HIV-1	NN	O	hiv-1	prep_for	12	SENT_232	[p5l1115t1943r1198b1963],
15	:	:	O	:	_	0	SENT_232	[p5l1115t1943r1198b1963],
16	Discovery	NNP	O	Discovery	dep	5	SENT_232	[p5l239t1976r362b2003],
17	and	CC	O	and	_	0	SENT_232	[p5l374t1976r420b1995],
18	clinical	JJ	O	clinical	amod	19	SENT_232	[p5l431t1976r521b1995],
19	implications	NNS	O	implication	dep	5	SENT_232	[p5l534t1976r697b2003],
20	.	.	O	.	_	0	SENT_232	[p5l534t1976r697b2003],

1	J	NNP	O	J	nn	3	SENT_233	[p5l705t1976r718b2003],
2	Antimicrob	NNP	O	Antimicrob	nn	3	SENT_233	[p5l729t1976r876b1995],
3	Chemother	NNP	O	Chemother	_	0	SENT_233	[p5l888t1976r1033b1996],
4	54	CD	NUMBER	54	num	3	SENT_233	[p5l1045t1976r1078b1995],
5	:	:	O	:	_	0	SENT_233	[p5l1045t1976r1078b1995],
6	6-9	CD	NUMBER	6-9	dep	3	SENT_233	[p5l1091t1976r1140b1995],
7	.	.	O	.	_	0	SENT_233	[p5l1091t1976r1140b1995],

1	Palmer	NNP	LOCATION	Palmer	nn	2	SENT_234	[p5l239t2009r328b2028],
2	S	NNP	LOCATION	S	_	0	SENT_234	[p5l339t2009r359b2032],
3	,	,	O	,	_	0	SENT_234	[p5l339t2009r359b2032],
4	Wiegand	NNP	ORGANIZATION	Wiegand	nn	5	SENT_234	[p5l370t2009r481b2036],
5	AP	NNP	ORGANIZATION	AP	appos	2	SENT_234	[p5l492t2009r535b2032],
6	,	,	O	,	_	0	SENT_234	[p5l492t2009r535b2032],
7	Maldarelli	NNP	PERSON	Maldarelli	nn	8	SENT_234	[p5l547t2009r675b2028],
8	F	NN	PERSON	f	appos	2	SENT_234	[p5l686t2009r707b2032],
9	,	,	O	,	_	0	SENT_234	[p5l686t2009r707b2032],
10	Bazmi	NN	LOCATION	bazmus	nn	11	SENT_234	[p5l718t2009r795b2028],
11	H	NN	O	h	appos	2	SENT_234	[p5l807t2009r834b2032],
12	,	,	O	,	_	0	SENT_234	[p5l807t2009r834b2032],
13	Mican	NNP	O	Mican	nn	14	SENT_234	[p5l846t2009r922b2028],
14	JM	NN	O	jm	appos	11	SENT_234	[p5l929t2009r973b2036],
15	,	,	O	,	_	0	SENT_234	[p5l929t2009r973b2036],
16	et	FW	O	et	dep	11	SENT_234	[p5l985t2013r1008b2028],
17	al.	FW	O	al.	nn	18	SENT_234	[p5l1019t2009r1045b2028],
18	(	FW	O	(	dep	11	SENT_234	[p5l1058t2009r1133b2034],
19	2003	CD	DATE	2003	num	20	SENT_234	[p5l1058t2009r1133b2034],
20	)	CD	NUMBER	)	dep	2	SENT_234	[p5l1058t2009r1133b2034],
21	New	NNP	O	New	dep	20	SENT_234	[p5l1144t2009r1199b2028],
22	real-time	JJ	O	real-time	amod	26	SENT_234	[p5l239t2042r357b2061],
23	reverse	JJ	O	reverse	amod	26	SENT_234	[p5l380t2048r472b2061],
24	transcriptase-initiated	JJ	O	transcriptase-initiated	amod	26	SENT_234	[p5l495t2042r789b2069],
25	PCR	NN	O	pcr	nn	26	SENT_234	[p5l811t2042r867b2062],
26	assay	NN	O	assay	dep	2	SENT_234	[p5l889t2048r953b2069],
27	with	IN	O	with	_	0	SENT_234	[p5l975t2042r1030b2061],
28	single-copy	JJ	O	single-copy	amod	29	SENT_234	[p5l1052t2042r1199b2069],
29	sensitivity	NN	O	sensitivity	prep_with	26	SENT_234	[p5l239t2076r364b2103],
30	for	IN	O	for	_	0	SENT_234	[p5l380t2076r418b2095],
31	human	JJ	O	human	amod	34	SENT_234	[p5l433t2076r520b2095],
32	immunodeﬁciency	NN	O	immunodeﬁciency	nn	34	SENT_234	[p5l538t2076r773b2103],
33	virus	NN	O	virus	nn	34	SENT_234	[p5l789t2076r849b2095],
34	type	NN	O	type	prep_for	29	SENT_234	[p5l866t2080r919b2103],
35	1	CD	NUMBER	1	num	36	SENT_234	[p5l938t2076r946b2095],
36	RNA	NN	O	rna	dep	2	SENT_234	[p5l965t2076r1024b2096],
37	in	IN	O	in	_	0	SENT_234	[p5l1041t2076r1064b2095],
38	plasma	NN	O	plasma	prep_in	36	SENT_234	[p5l1081t2076r1174b2103],
39	.	.	O	.	_	0	SENT_234	[p5l1081t2076r1174b2103],

1	J	NNP	O	J	nn	3	SENT_235	[p5l1186t2076r1199b2103],
2	Clin	NNP	PERSON	Clin	nn	3	SENT_235	[p5l239t2109r290b2129],
3	Microbi	NNP	PERSON	Microbi	_	0	SENT_235	[p5l303t2109r426b2128],
4	(	CD	NUMBER	(	num	6	SENT_235	[p5l303t2109r426b2128],
5	)	CD	NUMBER	)	num	6	SENT_235	[p5l303t2109r426b2128],
6	l	NN	O	l	dep	3	SENT_235	[p5l303t2109r426b2128],
7	41	CD	NUMBER	41	num	9	SENT_235	[p5l438t2109r472b2128],
8	:	:	O	:	_	0	SENT_235	[p5l438t2109r472b2128],
9	4531-4536	CD	DURATION	4531-4536	dep	6	SENT_235	[p5l485t2109r625b2128],
10	.	.	O	.	_	0	SENT_235	[p5l485t2109r625b2128],

1	Perelson	NNP	PERSON	Perelson	nn	2	SENT_236	[p5l239t2142r347b2161],
2	AS	NNP	O	AS	nsubj	18	SENT_236	[p5l359t2142r400b2165],
3	,	,	O	,	_	0	SENT_236	[p5l359t2142r400b2165],
4	Essunger	NNP	O	Essunger	nn	5	SENT_236	[p5l412t2142r525b2169],
5	P	NN	O	p	appos	2	SENT_236	[p5l537t2142r558b2165],
6	,	,	O	,	_	0	SENT_236	[p5l537t2142r558b2165],
7	Cao	NNP	O	Cao	nn	8	SENT_236	[p5l570t2142r618b2162],
8	Y	NN	O	y	appos	5	SENT_236	[p5l630t2142r654b2165],
9	,	,	O	,	_	0	SENT_236	[p5l630t2142r654b2165],
10	Vesanen	NN	O	vesanen	nn	11	SENT_236	[p5l665t2142r772b2161],
11	M	NN	O	m	appos	8	SENT_236	[p5l785t2142r814b2165],
12	,	,	O	,	_	0	SENT_236	[p5l785t2142r814b2165],
13	Hurley	NNP	PERSON	Hurley	nn	14	SENT_236	[p5l827t2142r913b2169],
14	A	NNP	O	A	appos	5	SENT_236	[p5l925t2142r950b2165],
15	,	,	O	,	_	0	SENT_236	[p5l925t2142r950b2165],
16	et	FW	O	et	nn	18	SENT_236	[p5l962t2146r985b2161],
17	al.	FW	O	al.	nn	18	SENT_236	[p5l997t2142r1023b2161],
18	(	FW	O	(	_	0	SENT_236	[p5l1037t2140r1112b2167],
19	1997	CD	DATE	1997	number	20	SENT_236	[p5l1037t2140r1112b2167],
20	)	CD	NUMBER	)	num	22	SENT_236	[p5l1037t2140r1112b2167],
21	Decay	NN	O	decay	nn	22	SENT_236	[p5l1124t2142r1199b2169],
22	characteristics	NNS	O	characteristic	dobj	18	SENT_236	[p5l239t2175r426b2194],
23	of	IN	O	of	_	0	SENT_236	[p5l449t2175r476b2194],
24	HIV-1-infected	JJ	O	hiv-1-infected	amod	25	SENT_236	[p5l496t2175r693b2194],
25	compartments	NNS	O	compartment	prep_of	22	SENT_236	[p5l715t2179r903b2202],
26	during	IN	O	during	_	0	SENT_236	[p5l925t2175r1012b2202],
27	combination	NN	O	combination	nn	28	SENT_236	[p5l1034t2175r1199b2194],
28	therapy	NN	O	therapy	prep_during	18	SENT_236	[p5l239t2208r341b2235],
29	.	.	O	.	_	0	SENT_236	[p5l239t2208r341b2235],

1	Nature	NNP	O	Nature	_	0	SENT_237	[p5l354t2208r441b2228],
2	387	CD	NUMBER	387	num	1	SENT_237	[p5l454t2206r503b2227],
3	:	:	O	:	_	0	SENT_237	[p5l454t2206r503b2227],
4	188-191	CD	NUMBER	188-191	dep	1	SENT_237	[p5l518t2208r625b2227],
5	.	.	O	.	_	0	SENT_237	[p5l518t2208r625b2227],

1	Perelson	NNP	PERSON	Perelson	nn	2	SENT_238	[p5l239t2242r347b2261],
2	AS	NNP	O	AS	_	0	SENT_238	[p5l357t2242r398b2265],
3	,	,	O	,	_	0	SENT_238	[p5l357t2242r398b2265],
4	Neumann	NNP	ORGANIZATION	Neumann	nn	5	SENT_238	[p5l409t2242r533b2262],
5	AU	NN	ORGANIZATION	au	appos	2	SENT_238	[p5l543t2242r590b2265],
6	,	,	O	,	_	0	SENT_238	[p5l543t2242r590b2265],
7	Markowitz	NNP	PERSON	Markowitz	nn	8	SENT_238	[p5l602t2242r733b2261],
8	M	NNP	O	M	appos	2	SENT_238	[p5l744t2242r773b2265],
9	,	,	O	,	_	0	SENT_238	[p5l744t2242r773b2265],
10	LeonardJM	NNP	O	LeonardJM	appos	2	SENT_238	[p5l784t2242r940b2269],
11	,	,	O	,	_	0	SENT_238	[p5l784t2242r940b2269],
12	Ho	NNP	PERSON	Ho	nn	13	SENT_238	[p5l951t2242r988b2261],
13	DD	NNP	PERSON	DD	appos	2	SENT_238	[p5l999t2242r1039b2261],
14	(	CD	NUMBER	(	num	15	SENT_238	[p5l1051t2242r1126b2267],
15	1996	CD	DATE	1996	rcmod	13	SENT_238	[p5l1051t2242r1126b2267],
16	)	CD	NUMBER	)	num	18	SENT_238	[p5l1051t2242r1126b2267],
17	HIV1	NN	O	hiv1	nn	18	SENT_238	[p5l1137t2242r1198b2262, p5l241t2275r249b2294],
18	dynamics	NNS	O	dynamics	dep	15	SENT_238	[p5l263t2275r381b2302],
19	in	FW	O	in	dep	15	SENT_238	[p5l394t2275r417b2294],
20	vivo	FW	O	vivo	pobj	19	SENT_238	[p5l428t2275r485b2294],
21	:	:	O	:	_	0	SENT_238	[p5l428t2275r485b2294],
22	Virion	NN	O	virion	nn	24	SENT_238	[p5l496t2275r579b2295],
23	clearance	NN	O	clearance	nn	24	SENT_238	[p5l591t2275r711b2294],
24	rate	NN	O	rate	dep	2	SENT_238	[p5l723t2279r778b2298],
25	,	,	O	,	_	0	SENT_238	[p5l723t2279r778b2298],
26	infected	JJ	O	infected	amod	28	SENT_238	[p5l791t2275r893b2294],
27	cell	NN	O	cell	nn	28	SENT_238	[p5l905t2275r947b2294],
28	life-span	NN	O	life-span	dep	2	SENT_238	[p5l959t2275r1074b2302],
29	,	,	O	,	_	0	SENT_238	[p5l959t2275r1074b2302],
30	and	CC	O	and	_	0	SENT_238	[p5l1086t2275r1132b2294],
31	viral	JJ	O	viral	amod	33	SENT_238	[p5l1143t2275r1198b2294],
32	generation	NN	O	generation	nn	33	SENT_238	[p5l239t2308r376b2335],
33	time	NN	O	time	dep	2	SENT_238	[p5l389t2308r450b2327],
34	.	.	O	.	_	0	SENT_238	[p5l389t2308r450b2327],

1	Science	NNP	O	Science	_	0	SENT_239	[p5l463t2308r558b2328],
2	271	CD	NUMBER	271	num	1	SENT_239	[p5l570t2306r619b2327],
3	:	:	O	:	_	0	SENT_239	[p5l570t2306r619b2327],
4	1582-1586	CD	DATE	1582-1586	dep	1	SENT_239	[p5l634t2308r772b2328],
5	.	.	O	.	_	0	SENT_239	[p5l634t2308r772b2328],

1	Polis	NNP	PERSON	Polis	nn	2	SENT_240	[p5l239t2341r298b2360],
2	MA	NNP	PERSON	MA	nsubj	17	SENT_240	[p5l316t2341r366b2364],
3	,	,	O	,	_	0	SENT_240	[p5l316t2341r366b2364],
4	Sidorov	NNP	PERSON	Sidorov	nn	5	SENT_240	[p5l385t2341r483b2361],
5	IA	NNP	O	IA	appos	2	SENT_240	[p5l501t2341r536b2364],
6	,	,	O	,	_	0	SENT_240	[p5l501t2341r536b2364],
7	Yoder	NNP	PERSON	Yoder	nn	8	SENT_240	[p5l554t2341r631b2360],
8	C	NNP	O	C	appos	5	SENT_240	[p5l649t2341r673b2364],
9	,	,	O	,	_	0	SENT_240	[p5l649t2341r673b2364],
10	Jankelevich	NNP	PERSON	Jankelevich	nn	11	SENT_240	[p5l687t2341r835b2368],
11	S	NNP	O	S	appos	8	SENT_240	[p5l854t2341r874b2364],
12	,	,	O	,	_	0	SENT_240	[p5l854t2341r874b2364],
13	MetcalfJ	NNP	O	MetcalfJ	appos	5	SENT_240	[p5l893t2341r1018b2368],
14	,	,	O	,	_	0	SENT_240	[p5l893t2341r1018b2368],
15	et	FW	O	et	nn	17	SENT_240	[p5l1037t2345r1060b2360],
16	al.	FW	O	al.	nn	17	SENT_240	[p5l1078t2341r1104b2360],
17	(	FW	O	(	_	0	SENT_240	[p5l1124t2341r1199b2366],
18	2001	CD	DATE	2001	num	20	SENT_240	[p5l1124t2341r1199b2366],
19	)	CD	NUMBER	)	num	20	SENT_240	[p5l1124t2341r1199b2366],
20	Correlation	NN	O	correlation	dobj	17	SENT_240	[p5l239t2374r387b2394],
21	between	IN	O	between	_	0	SENT_240	[p5l405t2374r509b2393],
22	reduction	NN	O	reduction	prep_between	20	SENT_240	[p5l527t2374r651b2393],
23	in	IN	O	in	_	0	SENT_240	[p5l669t2374r692b2393],
24	plasma	NN	O	plasma	nn	27	SENT_240	[p5l711t2374r798b2401],
25	HIV-1	NN	O	hiv-1	nn	27	SENT_240	[p5l816t2374r891b2394],
26	RNA	NN	O	rna	nn	27	SENT_240	[p5l911t2374r971b2394],
27	concentration	NN	O	concentration	prep_in	22	SENT_240	[p5l988t2374r1168b2393],
28	1	CD	DURATION	1	num	29	SENT_240	[p5l1188t2374r1197b2393],
29	week	NN	NUMBER	week	tmod	22	SENT_240	[p5l238t2408r300b2427],
30	after	IN	O	after	_	0	SENT_240	[p5l321t2408r380b2427],
31	start	NN	O	start	prep_after	17	SENT_240	[p5l400t2412r456b2427],
32	of	IN	O	of	_	0	SENT_240	[p5l476t2408r503b2427],
33	antiretroviral	JJ	O	antiretroviral	amod	34	SENT_240	[p5l521t2408r692b2427],
34	treatment	NN	O	treatment	prep_of	31	SENT_240	[p5l713t2412r838b2427],
35	and	CC	O	and	_	0	SENT_240	[p5l859t2408r904b2427],
36	longer-term	JJ	O	longer-term	amod	37	SENT_240	[p5l925t2408r1077b2435],
37	efﬁcacy	NN	O	efﬁcacy	prep_of	31	SENT_240	[p5l1098t2408r1198b2435],
38	.	.	O	.	_	0	SENT_240	[p5l1098t2408r1198b2435],

1	Lancet	NNP	O	Lancet	_	0	SENT_241	[p5l239t2441r324b2460],
2	358	CD	NUMBER	358	num	1	SENT_241	[p5l336t2441r385b2460],
3	:	:	O	:	_	0	SENT_241	[p5l336t2441r385b2460],
4	1760-1765	CD	DATE	1760-1765	dep	1	SENT_241	[p5l400t2439r538b2460],
5	.	.	O	.	_	0	SENT_241	[p5l400t2439r538b2460],

1	Walmsley	NNP	PERSON	Walmsley	nn	2	SENT_242	[p5l238t2474r358b2501],
2	S	NNP	O	S	nsubj	17	SENT_242	[p5l368t2474r388b2497],
3	,	,	O	,	_	0	SENT_242	[p5l368t2474r388b2497],
4	Bernstein	NNP	PERSON	Bernstein	nn	5	SENT_242	[p5l398t2474r520b2493],
5	B	NNP	O	B	appos	2	SENT_242	[p5l530t2474r553b2497],
6	,	,	O	,	_	0	SENT_242	[p5l530t2474r553b2497],
7	King	NNP	O	King	nn	8	SENT_242	[p5l564t2474r624b2501],
8	M	NN	O	m	appos	5	SENT_242	[p5l633t2474r662b2497],
9	,	,	O	,	_	0	SENT_242	[p5l633t2474r662b2497],
10	ArribasJ	NN	O	arribasj	appos	8	SENT_242	[p5l672t2474r791b2501],
11	,	,	O	,	_	0	SENT_242	[p5l672t2474r791b2501],
12	Beall	NNP	PERSON	Beall	nn	13	SENT_242	[p5l801t2474r862b2493],
13	G	NNP	O	G	appos	5	SENT_242	[p5l873t2474r898b2497],
14	,	,	O	,	_	0	SENT_242	[p5l873t2474r898b2497],
15	et	FW	O	et	nn	17	SENT_242	[p5l909t2478r931b2493],
16	al.	FW	O	al.	nn	17	SENT_242	[p5l942t2474r968b2493],
17	(	FW	O	(	_	0	SENT_242	[p5l979t2474r1054b2499],
18	2002	CD	DATE	2002	number	19	SENT_242	[p5l979t2474r1054b2499],
19	)	CD	NUMBER	)	num	20	SENT_242	[p5l979t2474r1054b2499],
20	Lopinavirritonavir	NNP	O	Lopinavirritonavir	dobj	17	SENT_242	[p5l1064t2474r1198b2501, p5l239t2507r351b2526],
21	versus	CC	O	versus	prep	20	SENT_242	[p5l359t2513r436b2526],
22	nelﬁnavir	NN	O	nelﬁnavir	dep	21	SENT_242	[p5l446t2507r568b2526],
23	for	IN	O	for	_	0	SENT_242	[p5l576t2507r614b2526],
24	the	DT	O	the	det	26	SENT_242	[p5l623t2507r661b2526],
25	initial	JJ	O	initial	amod	26	SENT_242	[p5l671t2507r744b2526],
26	treatment	NN	O	treatment	prep_for	17	SENT_242	[p5l754t2511r880b2526],
27	of	IN	O	of	_	0	SENT_242	[p5l889t2507r916b2526],
28	HIV	NN	MISC	hiv	nn	29	SENT_242	[p5l923t2507r975b2527],
29	infection	NN	O	infection	prep_of	26	SENT_242	[p5l985t2507r1105b2526],
30	.	.	O	.	_	0	SENT_242	[p5l985t2507r1105b2526],

1	N	NN	O	n	nn	3	SENT_243	[p5l1115t2507r1134b2527],
2	Engl	NNP	O	Engl	nn	3	SENT_243	[p5l1144t2507r1199b2534],
3	J	NNP	O	J	nsubj	4	SENT_243	[p5l234t2540r247b2567],
4	Med	VBD	O	med	_	0	SENT_243	[p5l259t2540r312b2559],
5	346	CD	NUMBER	346	dobj	4	SENT_243	[p5l324t2540r373b2559],
6	:	:	O	:	_	0	SENT_243	[p5l324t2540r373b2559],
7	2039-2046	CD	DATE	2039-2046	dep	5	SENT_243	[p5l386t2540r526b2560],
8	.	.	O	.	_	0	SENT_243	[p5l386t2540r526b2560],

1	.	.	O	.	_	0	SENT_244	[p5l220t2590r223b2593],

1	Siliciano	NNP	PERSON	Siliciano	nn	2	SENT_245	[p5l239t2574r348b2594],
2	JD	NNP	O	JD	nsubj	23	SENT_245	[p5l355t2574r396b2601],
3	,	,	O	,	_	0	SENT_245	[p5l355t2574r396b2601],
4	Ka_jdasJ	NNP	O	Ka_jdasJ	appos	2	SENT_245	[p5l409t2574r517b2601],
5	,	,	O	,	_	0	SENT_245	[p5l409t2574r517b2601],
6	Finzi	NNP	ORGANIZATION	Finzi	nn	7	SENT_245	[p5l530t2574r591b2593],
7	D	NNP	ORGANIZATION	D	appos	2	SENT_245	[p5l603t2574r629b2597],
8	,	,	O	,	_	0	SENT_245	[p5l603t2574r629b2597],
9	Quinn	NNP	ORGANIZATION	Quinn	nn	10	SENT_245	[p5l641t2574r722b2600],
10	TC	NNP	ORGANIZATION	TC	appos	2	SENT_245	[p5l734t2574r778b2597],
11	,	,	O	,	_	0	SENT_245	[p5l734t2574r778b2597],
12	Chadwick	NNP	PERSON	Chadwick	nn	13	SENT_245	[p5l791t2574r914b2594],
13	K	NNP	O	K	appos	2	SENT_245	[p5l927t2574r951b2597],
14	,	,	O	,	_	0	SENT_245	[p5l927t2574r951b2597],
15	et	FW	O	et	appos	2	SENT_245	[p5l963t2578r986b2593],
16	al.	FW	O	al.	nn	17	SENT_245	[p5l998t2574r1024b2593],
17	(	FW	O	(	dep	15	SENT_245	[p5l1038t2574r1113b2599],
18	2003	CD	DATE	2003	num	22	SENT_245	[p5l1038t2574r1113b2599],
19	)	CD	NUMBER	)	num	22	SENT_245	[p5l1038t2574r1113b2599],
20	Longterm	NNP	O	Longterm	nn	22	SENT_245	[p5l1125t2574r1198b2601, p5l239t2611r298b2626],
21	follow-up	NN	O	follow-up	nn	22	SENT_245	[p5l308t2607r428b2634],
22	studies	NNS	O	study	dep	2	SENT_245	[p5l439t2607r525b2626],
23	conﬁrm	VBP	O	conﬁrm	_	0	SENT_245	[p5l535t2607r634b2626],
24	the	DT	O	the	det	25	SENT_245	[p5l645t2607r683b2626],
25	stability	NN	O	stability	dobj	23	SENT_245	[p5l693t2607r792b2634],
26	of	IN	O	of	_	0	SENT_245	[p5l802t2607r829b2626],
27	the	DT	O	the	det	29	SENT_245	[p5l837t2607r875b2626],
28	latent	JJ	O	latent	amod	29	SENT_245	[p5l885t2607r957b2626],
29	reservoir	NN	O	reservoir	prep_of	25	SENT_245	[p5l967t2607r1081b2626],
30	for	IN	O	for	_	0	SENT_245	[p5l1090t2607r1127b2626],
31	HIV1	NN	O	hiv1	prep_for	29	SENT_245	[p5l1137t2607r1198b2627, p5l241t2640r249b2659],
32	in	IN	O	in	_	0	SENT_245	[p5l264t2640r287b2659],
33	resting	VBG	O	rest	prepc_in	23	SENT_245	[p5l299t2640r386b2667],
34	CD4	NN	O	cd4	dobj	33	SENT_245	[p5l397t2640r471b2661],
35	+	CC	O	+	_	0	SENT_245	[p5l397t2640r471b2661],
36	T	NN	O	t	nn	37	SENT_245	[p5l480t2640r498b2659],
37	cells	NNS	O	cell	dobj	33	SENT_245	[p5l509t2640r568b2659],
38	.	.	O	.	_	0	SENT_245	[p5l509t2640r568b2659],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_246	[p5l581t2640r626b2660],
2	Med	NNP	O	Med	_	0	SENT_246	[p5l638t2640r691b2659],
3	9	CD	NUMBER	9	num	2	SENT_246	[p5l703t2640r722b2659],
4	:	:	O	:	_	0	SENT_246	[p5l703t2640r722b2659],
5	727-728	CD	NUMBER	727-728	dep	2	SENT_246	[p5l736t2638r844b2660],
6	.	.	O	.	_	0	SENT_246	[p5l736t2638r844b2660],

1	Bonhoeffer	NNP	PERSON	Bonhoeffer	nn	2	SENT_247	[p5l239t2673r383b2692],
2	S	NNP	O	S	_	0	SENT_247	[p5l400t2673r420b2696],
3	,	,	O	,	_	0	SENT_247	[p5l400t2673r420b2696],
4	Nowak	NNP	PERSON	Nowak	nn	6	SENT_247	[p5l437t2673r523b2692],
5	MA	NNP	PERSON	MA	nn	6	SENT_247	[p5l540t2673r584b2692],
6	(	NNP	O	(	appos	2	SENT_247	[p5l602t2671r677b2698],
7	1997	CD	DATE	1997	num	9	SENT_247	[p5l602t2671r677b2698],
8	)	CD	NUMBER	)	num	9	SENT_247	[p5l602t2671r677b2698],
9	Pre-existence	NN	O	pre-existence	dep	6	SENT_247	[p5l694t2673r864b2692],
10	and	CC	O	and	_	0	SENT_247	[p5l882t2673r928b2692],
11	emergence	NN	O	emergence	appos	2	SENT_247	[p5l945t2679r1082b2700],
12	of	IN	O	of	_	0	SENT_247	[p5l1100t2673r1127b2692],
13	drug	NN	O	drug	nn	14	SENT_247	[p5l1141t2673r1200b2700],
14	resistance	NN	O	resistance	prep_of	11	SENT_247	[p5l239t2707r363b2726],
15	in	IN	O	in	_	0	SENT_247	[p5l376t2707r399b2726],
16	HIV-1	NN	O	hiv-1	nn	17	SENT_247	[p5l411t2707r486b2726],
17	infection	NN	O	infection	prep_in	14	SENT_247	[p5l501t2707r621b2726],
18	.	.	O	.	_	0	SENT_247	[p5l501t2707r621b2726],

1	Proc	NNP	O	Proc	nn	3	SENT_248	[p5l634t2707r690b2726],
2	Biol	NNP	O	Biol	nn	3	SENT_248	[p5l703t2707r752b2726],
3	Sci	NNP	O	Sci	_	0	SENT_248	[p5l765t2707r800b2727],
4	264	CD	NUMBER	264	num	3	SENT_248	[p5l813t2707r862b2727],
5	:	:	O	:	_	0	SENT_248	[p5l813t2707r862b2727],
6	631-637	CD	NUMBER	631-637	dep	3	SENT_248	[p5l875t2705r984b2726],
7	.	.	O	.	_	0	SENT_248	[p5l875t2705r984b2726],

1	Grossman	NNP	PERSON	Grossman	nn	2	SENT_249	[p5l239t2740r365b2760],
2	Z	NNP	O	Z	_	0	SENT_249	[p5l384t2740r405b2763],
3	,	,	O	,	_	0	SENT_249	[p5l384t2740r405b2763],
4	Polis	NNP	PERSON	Polis	nn	5	SENT_249	[p5l424t2740r483b2759],
5	M	NNP	O	M	appos	2	SENT_249	[p5l502t2740r531b2763],
6	,	,	O	,	_	0	SENT_249	[p5l502t2740r531b2763],
7	Feinberg	NNP	PERSON	Feinberg	nn	8	SENT_249	[p5l550t2740r663b2767],
8	MB	NNP	O	MB	appos	2	SENT_249	[p5l681t2740r728b2763],
9	,	,	O	,	_	0	SENT_249	[p5l681t2740r728b2763],
10	Grossman	NNP	PERSON	Grossman	nn	11	SENT_249	[p5l747t2740r873b2760],
11	Z	NNP	O	Z	appos	2	SENT_249	[p5l893t2740r913b2763],
12	,	,	O	,	_	0	SENT_249	[p5l893t2740r913b2763],
13	Levi	NNP	PERSON	Levi	appos	11	SENT_249	[p5l932t2740r984b2759],
14	I	PRP	PERSON	I	nn	13	SENT_249	[p5l1003t2740r1018b2763],
15	,	,	O	,	_	0	SENT_249	[p5l1003t2740r1018b2763],
16	et	FW	O	et	dep	13	SENT_249	[p5l1037t2744r1059b2759],
17	al.	FW	O	al.	nn	18	SENT_249	[p5l1078t2740r1104b2759],
18	(	FW	O	(	dep	2	SENT_249	[p5l1124t2740r1199b2765],
19	1999	CD	DATE	1999	num	20	SENT_249	[p5l1124t2740r1199b2765],
20	)	CD	NUMBER	)	dep	18	SENT_249	[p5l1124t2740r1199b2765],
21	Ongoing	JJ	O	ongoing	amod	23	SENT_249	[p5l239t2773r350b2800],
22	HIV	NN	O	hiv	nn	23	SENT_249	[p5l361t2773r414b2793],
23	dissemination	NN	O	dissemination	dep	2	SENT_249	[p5l425t2773r602b2792],
24	during	IN	O	during	_	0	SENT_249	[p5l614t2773r699b2800],
25	HAART	NNP	PERSON	HAART	prep_during	23	SENT_249	[p5l710t2773r817b2792],
26	.	.	O	.	_	0	SENT_249	[p5l710t2773r817b2792],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_250	[p5l830t2773r875b2793],
2	Med	NNP	O	Med	_	0	SENT_250	[p5l887t2773r940b2792],
3	5	CD	NUMBER	5	num	2	SENT_250	[p5l953t2773r971b2792],
4	:	:	O	:	_	0	SENT_250	[p5l953t2773r971b2792],
5	1099-1104	CD	DATE	1099-1104	dep	2	SENT_250	[p5l986t2773r1124b2792],
6	.	.	O	.	_	0	SENT_250	[p5l986t2773r1124b2792],

1	Chun	NNP	ORGANIZATION	Chun	nn	2	SENT_251	[p5l239t2806r307b2826],
2	TW	NNP	ORGANIZATION	TW	nsubj	18	SENT_251	[p5l326t2806r377b2829],
3	,	,	O	,	_	0	SENT_251	[p5l326t2806r377b2829],
4	Carruth	NNP	PERSON	Carruth	nn	5	SENT_251	[p5l397t2806r498b2826],
5	L	NNP	PERSON	L	appos	2	SENT_251	[p5l517t2806r539b2829],
6	,	,	O	,	_	0	SENT_251	[p5l517t2806r539b2829],
7	Finzi	NNP	ORGANIZATION	Finzi	nn	8	SENT_251	[p5l559t2806r620b2825],
8	D	NNP	ORGANIZATION	D	appos	5	SENT_251	[p5l640t2806r665b2829],
9	,	,	O	,	_	0	SENT_251	[p5l640t2806r665b2829],
10	Shen	NNP	O	Shen	nn	11	SENT_251	[p5l685t2806r747b2826],
11	X	NNP	O	X	appos	8	SENT_251	[p5l766t2806r791b2829],
12	,	,	O	,	_	0	SENT_251	[p5l766t2806r791b2829],
13	DiGiuseppe	NNP	PERSON	DiGiuseppe	nn	14	SENT_251	[p5l811t2806r960b2833],
14	JA	NNP	O	JA	appos	5	SENT_251	[p5l975t2806r1015b2833],
15	,	,	O	,	_	0	SENT_251	[p5l975t2806r1015b2833],
16	et	FW	O	et	nn	18	SENT_251	[p5l1035t2810r1057b2825],
17	al.	FW	O	al.	nn	18	SENT_251	[p5l1077t2806r1103b2825],
18	(	FW	O	(	_	0	SENT_251	[p5l1124t2804r1199b2831],
19	1997	CD	DATE	1997	num	21	SENT_251	[p5l1124t2804r1199b2831],
20	)	CD	NUMBER	)	num	21	SENT_251	[p5l1124t2804r1199b2831],
21	Quantiﬁcation	NN	O	quantiﬁcation	dobj	18	SENT_251	[p5l239t2839r425b2865],
22	of	IN	O	of	_	0	SENT_251	[p5l435t2839r462b2858],
23	latent	JJ	O	latent	amod	25	SENT_251	[p5l470t2839r542b2858],
24	tissue	NN	O	tissue	nn	25	SENT_251	[p5l552t2839r621b2858],
25	reservoirs	NNS	O	reservoir	prep_of	21	SENT_251	[p5l632t2839r755b2858],
26	and	CC	O	and	_	0	SENT_251	[p5l766t2839r811b2858],
27	total	JJ	O	total	amod	30	SENT_251	[p5l822t2839r878b2858],
28	body	NN	O	body	nn	30	SENT_251	[p5l888t2839r950b2866],
29	viral	JJ	O	viral	amod	30	SENT_251	[p5l959t2839r1014b2858],
30	load	NN	O	load	prep_of	21	SENT_251	[p5l1025t2839r1078b2858],
31	in	IN	O	in	_	0	SENT_251	[p5l1088t2839r1111b2858],
32	HIV-1	NN	O	hiv-1	nn	33	SENT_251	[p5l1122t2839r1197b2859],
33	infection	NN	O	infection	prep_in	18	SENT_251	[p5l239t2873r359b2892],
34	.	.	O	.	_	0	SENT_251	[p5l239t2873r359b2892],

1	Nature	NNP	O	Nature	_	0	SENT_252	[p5l371t2873r459b2892],
2	387	CD	NUMBER	387	num	1	SENT_252	[p5l472t2871r520b2892],
3	:	:	O	:	_	0	SENT_252	[p5l472t2871r520b2892],
4	183-188	CD	NUMBER	183-188	dep	1	SENT_252	[p5l536t2873r643b2892],
5	.	.	O	.	_	0	SENT_252	[p5l536t2873r643b2892],

1	Chun	NNP	ORGANIZATION	Chun	nn	2	SENT_253	[p5l239t2906r307b2926],
2	TW	NNP	ORGANIZATION	TW	_	0	SENT_253	[p5l316t2906r367b2929],
3	,	,	O	,	_	0	SENT_253	[p5l316t2906r367b2929],
4	Nickle	NNP	ORGANIZATION	Nickle	nn	5	SENT_253	[p5l376t2906r456b2925],
5	DC	NNP	ORGANIZATION	DC	appos	2	SENT_253	[p5l466t2906r687b2933],
6	,	,	O	,	_	0	SENT_253	[p5l466t2906r687b2933],
7	JustementJS	NN	O	justementj	appos	2	SENT_253	[p5l466t2906r687b2933],
8	,	,	O	,	_	0	SENT_253	[p5l466t2906r687b2933],
9	Large	JJ	O	large	amod	10	SENT_253	[p5l696t2906r767b2933],
10	D	NN	O	d	appos	2	SENT_253	[p5l777t2906r802b2929],
11	,	,	O	,	_	0	SENT_253	[p5l777t2906r802b2929],
12	Semerjian	NNP	MISC	Semerjian	nn	13	SENT_253	[p5l812t2906r939b2933],
13	A	NNP	MISC	A	appos	2	SENT_253	[p5l948t2906r974b2929],
14	,	,	O	,	_	0	SENT_253	[p5l948t2906r974b2929],
15	et	FW	O	et	appos	2	SENT_253	[p5l984t2910r1006b2925],
16	al.	FW	O	al.	nn	17	SENT_253	[p5l1016t2906r1041b2925],
17	(	FW	O	(	dep	2	SENT_253	[p5l1052t2906r1127b2931],
18	2005	CD	DATE	2005	num	20	SENT_253	[p5l1052t2906r1127b2931],
19	)	CD	NUMBER	)	num	20	SENT_253	[p5l1052t2906r1127b2931],
20	HIVxi	NN	O	hivxus	dep	17	SENT_253	[p5l1137t2906r1198b2926, p5l190t1741r202b1762],

1	PLoS	NN	O	plo	nsubj	2	SENT_254	[p5l288t3093r352b3116],
2	Pathogens	VBD	O	pathogen	_	0	SENT_254	[p5l367t3092r511b3123],
3	|	CD	NUMBER	|	num	4	SENT_254	[p5l526t3091r528b3124],
4	www	NN	O	www	dobj	2	SENT_254	[p5l543t3092r882b3123],
5	.	.	O	.	_	0	SENT_254	[p5l543t3092r882b3123],

1	p	NN	O	p	_	0	SENT_255	[p5l543t3092r882b3123],
2	|	CD	NUMBER	|	num	3	SENT_255	[p5l543t3092r882b3123],
3	ospathogens.org	NN	O	ospathogens.org	dep	1	SENT_255	[p5l543t3092r882b3123],

1	Source	NN	O	source	_	0	SENT_256	[p5l1731t107r1824b130],
2	of	IN	O	of	_	0	SENT_256	[p5l1837t106r1865b130],
3	Stable	JJ	O	stable	amod	5	SENT_256	[p5l1876t106r1960b130],
4	HIV-1	NN	O	hiv-1	nn	5	SENT_256	[p5l1975t107r2041b130],
5	Viremia	NN	O	viremia	prep_of	1	SENT_256	[p5l2059t107r2161b130],
6	on	IN	O	on	_	0	SENT_256	[p5l2175t113r2208b130],
7	ART	NN	O	art	prep_on	1	SENT_256	[p5l2222t107r2277b130],

1	lines	NNS	O	line	nsubj	2	SENT_257	[p5l1277t206r1342b229],
2	represent	VBP	O	represent	_	0	SENT_257	[p5l1353t211r1491b237],
3	i	FW	O	i	nsubj	6	SENT_257	[p5l1504t207r1523b227],
4	0.5	CD	NUMBER	0.5	num	6	SENT_257	[p5l1537t206r1577b228],
5	log	NN	O	log	nn	6	SENT_257	[p5l1588t206r1655b237],
6	“	NN	O	“	xcomp	2	SENT_257	[p5l1588t206r1655b237],
7	,	,	O	,	_	0	SENT_257	[p5l1588t206r1655b237],
8	copies/mL	NN	O	copies/ml	appos	6	SENT_257	[p5l1666t206r1814b237],
9	from	IN	O	from	_	0	SENT_257	[p5l1823t206r1894b228],
10	Y	NN	O	y	prep_from	8	SENT_257	[p5l1904t207r1953b228],
11	:	:	O	:	_	0	SENT_257	[p5l1904t207r1953b228],
12	X	NN	O	x	nn	14	SENT_257	[p5l1961t207r1983b228],
13	line	NN	O	line	nn	14	SENT_257	[p5l1994t206r2064b235],
14	)	NN	O	)	dep	8	SENT_257	[p5l1994t206r2064b235],
15	;	:	O	;	_	0	SENT_257	[p5l1994t206r2064b235],
16	corresponding	VBG	O	correspond	amod	17	SENT_257	[p5l2075t206r2288b237],
17	participants	NNS	O	participant	nsubjpass	19	SENT_257	[p5l1277t242r1451b273],
18	were	VBD	O	be	auxpass	19	SENT_257	[p5l1464t250r1531b265],
19	included	VBN	O	include	parataxis	2	SENT_257	[p5l1546t242r1670b265],
20	in	IN	O	in	_	0	SENT_257	[p5l1684t242r1711b264],
21	subsequent	JJ	O	subsequent	amod	22	SENT_257	[p5l1724t242r1886b273],
22	analyses	NNS	O	analysis	prep_in	19	SENT_257	[p5l1899t242r2022b273],
23	.	.	O	.	_	0	SENT_257	[p5l1899t242r2022b273],

1	Found	VBN	O	find	_	0	SENT_258	[p5l1276t289r1369b312],
2	at	IN	O	at	_	0	SENT_258	[p5l1383t294r1408b312],
3	doi	FW	O	doi	nn	4	SENT_258	[p5l1421t287r1990b320],
4	:10.1371	FW	O	:10.1371	prep_at	1	SENT_258	[p5l1421t287r1990b320],
5	ﬁournal	NN	O	ﬁournal	dep	4	SENT_258	[p5l1421t287r1990b320],
6	.	.	O	.	_	0	SENT_258	[p5l1421t287r1990b320],

1	ppat	NN	O	ppat	_	0	SENT_259	[p5l1421t287r1990b320],
2	.0030046	CD	NUMBER	.0030046	dep	1	SENT_259	[p5l1421t287r1990b320],
3	.	.	O	.	_	0	SENT_259	[p5l1421t287r1990b320],

1	sg002	NN	O	sg002	_	0	SENT_260	[p5l1421t287r1990b320],
2	(	CD	NUMBER	(	number	3	SENT_260	[p5l2005t289r2045b318],
3	32	CD	NUMBER	32	dep	1	SENT_260	[p5l2005t289r2045b318],
4	KB	NN	O	kb	nn	6	SENT_260	[p5l2060t289r2102b311],
5	PDF	NN	O	pdf	nn	6	SENT_260	[p5l2115t290r2193b317],
6	)	NN	O	)	dep	3	SENT_260	[p5l2115t290r2193b317],
7	.	.	O	.	_	0	SENT_260	[p5l2115t290r2193b317],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_261	[p5l1276t384r1636b424],

1	We	PRP	O	we	nsubj	2	SENT_262	[p5l1276t459r1321b481],
2	thank	VBP	O	thank	_	0	SENT_262	[p5l1336t458r1417b481],
3	H.	NNP	PERSON	H.	nn	5	SENT_262	[p5l1432t459r1463b480],
4	C.	NNP	PERSON	C.	nn	5	SENT_262	[p5l1478t458r1505b481],
5	Lane	NNP	PERSON	Lane	dobj	2	SENT_262	[p5l1520t459r1591b481],
6	and	CC	O	and	_	0	SENT_262	[p5l1605t458r1657b481],
7	H.	NNP	PERSON	H.	nn	8	SENT_262	[p5l1672t459r1703b480],
8	Masur	NNP	PERSON	Masur	dobj	2	SENT_262	[p5l1718t459r1808b481],
9	for	IN	O	for	_	0	SENT_262	[p5l1820t458r1864b480],
10	advice	NN	O	advice	prep_for	5	SENT_262	[p5l1877t458r1967b481],
11	and	CC	O	and	_	0	SENT_262	[p5l1982t458r2034b481],
12	support	NN	O	support	conj_and	10	SENT_262	[p5l2048t463r2162b489],
13	and	CC	O	and	_	0	SENT_262	[p5l2176t458r2228b481],
14	are	VBP	O	be	cop	15	SENT_262	[p5l2243t466r2286b481],
15	grateful	JJ	O	grateful	conj_and	2	SENT_262	[p5l1276t493r1389b524],
16	to	TO	O	to	_	0	SENT_262	[p5l1400t498r1427b516],
17	the	DT	O	the	det	18	SENT_262	[p5l1439t493r1483b516],
18	patients	NNS	O	patient	prep_to	15	SENT_262	[p5l1494t493r1609b524],
19	for	IN	O	for	_	0	SENT_262	[p5l1620t493r1663b515],
20	their	PRP$	O	they	poss	22	SENT_262	[p5l1674t493r1743b516],
21	generous	JJ	O	generous	amod	22	SENT_262	[p5l1753t501r1883b524],
22	contributions	NNS	O	contribution	prep_for	18	SENT_262	[p5l1894t493r2091b516],
23	to	TO	O	to	_	0	SENT_262	[p5l2103t498r2130b516],
24	this	DT	O	this	det	25	SENT_262	[p5l2143t493r2192b516],
25	study	NN	O	study	prep_to	15	SENT_262	[p5l2204t493r2286b524],
26	.	.	O	.	_	0	SENT_262	[p5l2204t493r2286b524],

1	Author	NN	O	author	nn	2	SENT_263	[p5l1313t532r1417b554],
2	contributions	NNS	O	contribution	_	0	SENT_263	[p5l1430t532r1632b555],
3	.	.	O	.	_	0	SENT_263	[p5l1430t532r1632b555],

1	JMC	NN	O	jmc	nsubj	10	SENT_264	[p5l1643t532r1708b563],
2	and	CC	O	and	_	0	SENT_264	[p5l1724t532r1776b555],
3	JWM	NN	O	jwm	conj_and	1	SENT_264	[p5l1785t533r1859b563],
4	conceived	VBD	O	conceive	_	0	SENT_264	[p5l1874t532r2019b555],
5	and	CC	O	and	_	0	SENT_264	[p5l2033t532r2086b555],
6	designed	VBD	O	design	conj_and	4	SENT_264	[p5l2100t532r2227b563],
7	the	DT	O	the	det	8	SENT_264	[p5l2243t532r2286b555],
8	experiments	NNS	O	experiment	dobj	4	SENT_264	[p5l1276t568r1456b599],
9	and	CC	O	and	_	0	SENT_264	[p5l1477t568r1530b591],
10	provided	VBN	O	provide	conj_and	4	SENT_264	[p5l1551t568r1681b599],
11	overall	JJ	O	overall	amod	13	SENT_264	[p5l1701t568r1798b591],
12	project	NN	O	project	nn	13	SENT_264	[p5l1820t568r1923b599],
13	oversight	NN	O	oversight	dobj	10	SENT_264	[p5l1944t568r2083b599],
14	.	.	O	.	_	0	SENT_264	[p5l1944t568r2083b599],

1	SP	NN	O	sp	nsubj	4	SENT_265	[p5l2104t568r2139b591],
2	and	CC	O	and	_	0	SENT_265	[p5l2161t568r2213b591],
3	AW	NN	O	aw	conj_and	1	SENT_265	[p5l2233t568r2287b591],
4	performed	VBD	O	perform	_	0	SENT_265	[p5l1277t603r1432b634],
5	the	DT	O	the	det	6	SENT_265	[p5l1446t603r1490b626],
6	experiments	NNS	O	experiment	dobj	4	SENT_265	[p5l1503t603r1690b634],
7	.	.	O	.	_	0	SENT_265	[p5l1503t603r1690b634],

1	FM	NNP	O	FM	nn	7	SENT_266	[p5l1704t604r1756b630],
2	,	,	O	,	_	0	SENT_266	[p5l1704t604r1756b630],
3	MSK	NNP	O	MSK	appos	7	SENT_266	[p5l1771t603r1845b630],
4	,	,	O	,	_	0	SENT_266	[p5l1771t603r1845b630],
5	AW	NNP	O	AW	appos	7	SENT_266	[p5l1858t603r1919b630],
6	,	,	O	,	_	0	SENT_266	[p5l1858t603r1919b630],
7	JMC	NNP	O	JMC	nsubj	11	SENT_266	[p5l1927t603r2000b634],
8	,	,	O	,	_	0	SENT_266	[p5l1927t603r2000b634],
9	and	CC	O	and	_	0	SENT_266	[p5l2015t603r2067b626],
10	JWM	NN	O	jwm	nsubj	11	SENT_266	[p5l2075t604r2149b634],
11	analyzed	VBD	O	analyze	_	0	SENT_266	[p5l2163t603r2287b634],
12	the	DT	O	the	det	13	SENT_266	[p5l1277t638r1321b661],
13	data	NNS	O	datum	dobj	11	SENT_266	[p5l1337t638r1405b661],
14	.	.	O	.	_	0	SENT_266	[p5l1337t638r1405b661],

1	RTD	NNP	ORGANIZATION	RTD	nsubj	13	SENT_267	[p5l1421t639r1495b665],
2	,	,	O	,	_	0	SENT_267	[p5l1421t639r1495b665],
3	JAM	NNP	O	JAM	conj_and	1	SENT_267	[p5l1506t638r1579b669],
4	,	,	O	,	_	0	SENT_267	[p5l1506t638r1579b669],
5	CR	NN	O	cr	conj_and	1	SENT_267	[p5l1596t638r1645b665],
6	,	,	O	,	_	0	SENT_267	[p5l1596t638r1645b665],
7	SCB	NN	ORGANIZATION	scb	conj_and	1	SENT_267	[p5l1662t638r1729b665],
8	,	,	O	,	_	0	SENT_267	[p5l1662t638r1729b665],
9	GJH	NN	O	gjh	conj_and	1	SENT_267	[p5l1745t638r1813b669],
10	,	,	O	,	_	0	SENT_267	[p5l1745t638r1813b669],
11	and	CC	O	and	_	0	SENT_267	[p5l1829t638r1882b661],
12	DJK	NNP	O	DJK	conj_and	1	SENT_267	[p5l1897t639r1955b669],
13	contributed	VBD	O	contribute	_	0	SENT_267	[p5l1970t638r2142b661],
14	reagentsl	NN	O	reagentsl	nn	16	SENT_267	[p5l2159t638r2288b669],
15	materials/analysis	NN	O	materials/analysis	nn	16	SENT_267	[p5l1277t673r1528b704],
16	tools	NNS	O	tool	dobj	13	SENT_267	[p5l1539t673r1614b696],
17	.	.	O	.	_	0	SENT_267	[p5l1539t673r1614b696],

1	FM	NNP	O	FM	nn	7	SENT_268	[p5l1625t674r1677b700],
2	,	,	O	,	_	0	SENT_268	[p5l1625t674r1677b700],
3	MSK	NNP	ORGANIZATION	MSK	appos	7	SENT_268	[p5l1688t673r1841b704],
4	,	,	O	,	_	0	SENT_268	[p5l1688t673r1841b704],
5	JMC	NNP	ORGANIZATION	JMC	appos	7	SENT_268	[p5l1688t673r1841b704],
6	,	,	O	,	_	0	SENT_268	[p5l1688t673r1841b704],
7	andJWM	NNP	O	andJWM	nsubj	8	SENT_268	[p5l1852t673r1983b704],
8	wrote	VBD	O	write	_	0	SENT_268	[p5l1993t678r2075b696],
9	the	DT	O	the	det	10	SENT_268	[p5l2086t673r2129b696],
10	paper	NN	O	paper	dobj	8	SENT_268	[p5l2140t681r2231b704],
11	.	.	O	.	_	0	SENT_268	[p5l2140t681r2231b704],

1	FM	NNP	O	FM	nsubj	2	SENT_269	[p5l2242t674r2286b695],
2	provided	VBD	O	provide	_	0	SENT_269	[p5l1277t709r1406b740],
3	patient	NN	O	patient	nn	5	SENT_269	[p5l1429t709r1532b740],
4	care	NN	O	care	nn	5	SENT_269	[p5l1554t717r1614b732],
5	oversight	NN	O	oversight	dobj	2	SENT_269	[p5l1636t709r1769b740],
6	and	CC	O	and	_	0	SENT_269	[p5l1791t709r1843b732],
7	managed	VBD	O	manage	conj_and	2	SENT_269	[p5l1866t709r1996b740],
8	regulatory	JJ	O	regulatory	amod	9	SENT_269	[p5l2019t709r2168b740],
9	affairs	NNS	O	affair	dobj	7	SENT_269	[p5l2190t709r2286b732],
10	.	.	O	.	_	0	SENT_269	[p5l2190t709r2286b732],

1	MAP	NN	O	map	nn	9	SENT_270	[p5l1277t744r1483b775],
2	,	,	O	,	_	0	SENT_270	[p5l1277t744r1483b775],
3	JM	NN	O	jm	dep	9	SENT_270	[p5l1277t744r1483b775],
4	,	,	O	,	_	0	SENT_270	[p5l1277t744r1483b775],
5	JAK	NN	O	jak	dep	9	SENT_270	[p5l1277t744r1483b775],
6	,	,	O	,	_	0	SENT_270	[p5l1277t744r1483b775],
7	RTD	NN	ORGANIZATION	rtd	dep	9	SENT_270	[p5l1494t745r1568b771],
8	,	,	O	,	_	0	SENT_270	[p5l1494t745r1568b771],
9	DRK	NN	O	drk	nsubj	13	SENT_270	[p5l1579t745r1654b771],
10	,	,	O	,	_	0	SENT_270	[p5l1579t745r1654b771],
11	and	CC	O	and	_	0	SENT_270	[p5l1665t744r1717b767],
12	SL	NNP	O	SL	conj_and	9	SENT_270	[p5l1728t744r1765b767],
13	provided	VBD	O	provide	_	0	SENT_270	[p5l1775t744r1905b775],
14	patient	NN	O	patient	nn	15	SENT_270	[p5l1915t744r2019b775],
15	care	NN	O	care	dobj	13	SENT_270	[p5l2029t752r2088b767],
16	and	CC	O	and	_	0	SENT_270	[p5l2100t744r2152b767],
17	protocol	NN	O	protocol	nn	18	SENT_270	[p5l2163t744r2286b775],
18	oversight	NN	O	oversight	conj_and	15	SENT_270	[p5l1276t779r1415b810],
19	.	.	O	.	_	0	SENT_270	[p5l1276t779r1415b810],

1	JAM	NN	O	jam	nsubj	2	SENT_271	[p5l1432t779r1498b810],
2	provided	VBD	O	provide	_	0	SENT_271	[p5l1520t779r1650b810],
3	protocol	NN	O	protocol	nn	4	SENT_271	[p5l1671t779r1795b810],
4	oversight	NN	O	oversight	dobj	2	SENT_271	[p5l1816t779r1955b810],
5	.	.	O	.	_	0	SENT_271	[p5l1816t779r1955b810],

1	SCB	NN	ORGANIZATION	scb	nsubj	7	SENT_272	[p5l1977t779r2044b806],
2	,	,	O	,	_	0	SENT_272	[p5l1977t779r2044b806],
3	GJH	NN	O	gjh	conj_and	1	SENT_272	[p5l2066t779r2134b810],
4	,	,	O	,	_	0	SENT_272	[p5l2066t779r2134b810],
5	and	CC	O	and	_	0	SENT_272	[p5l2156t779r2208b802],
6	DJK	NNP	O	DJK	nsubj	7	SENT_272	[p5l2229t780r2287b810],
7	provided	VBD	O	provide	_	0	SENT_272	[p5l1277t815r1406b846],
8	data	NN	O	datum	nn	9	SENT_272	[p5l1420t815r1481b838],
9	analysis	NN	O	analysis	dobj	7	SENT_272	[p5l1494t815r1603b846],
10	and	CC	O	and	_	0	SENT_272	[p5l1617t815r1669b838],
11	clinical	JJ	O	clinical	amod	13	SENT_272	[p5l1683t815r1786b838],
12	trial	NN	O	trial	nn	13	SENT_272	[p5l1800t815r1858b838],
13	oversight	NN	O	oversight	dobj	7	SENT_272	[p5l1871t815r2010b846],
14	.	.	O	.	_	0	SENT_272	[p5l1871t815r2010b846],

1	Funding	NNP	O	Funding	_	0	SENT_273	[p5l1313t854r1441b885],
2	.	.	O	.	_	0	SENT_273	[p5l1313t854r1441b885],

1	The	DT	O	the	det	2	SENT_274	[p5l1455t854r1511b877],
2	authors	NNS	O	author	nsubj	3	SENT_274	[p5l1524t854r1633b877],
3	received	VBD	O	receive	_	0	SENT_274	[p5l1647t854r1767b877],
4	no	DT	O	no	det	6	SENT_274	[p5l1781t862r1815b876],
5	speciﬁc	NN	O	speciﬁc	nn	6	SENT_274	[p5l1829t854r1935b885],
6	funding	NN	O	funding	dobj	3	SENT_274	[p5l1949t854r2063b885],
7	for	IN	O	for	_	0	SENT_274	[p5l2075t854r2119b876],
8	this	DT	O	this	det	9	SENT_274	[p5l2132t854r2181b877],
9	study	NN	O	study	prep_for	3	SENT_274	[p5l2195t854r2277b885],
10	.	.	O	.	_	0	SENT_274	[p5l2195t854r2277b885],

1	Competing	VBG	O	compete	_	0	SENT_275	[p5l1314t893r1474b924],
2	interests	NNS	O	interest	dep	1	SENT_275	[p5l1488t893r1620b916],
3	.	.	O	.	_	0	SENT_275	[p5l1488t893r1620b916],

1	MSK	NNP	O	MSK	nn	5	SENT_276	[p5l1637t893r1711b920],
2	,	,	O	,	_	0	SENT_276	[p5l1637t893r1711b920],
3	SCB	NNP	ORGANIZATION	SCB	appos	5	SENT_276	[p5l1727t893r1794b920],
4	,	,	O	,	_	0	SENT_276	[p5l1727t893r1794b920],
5	GJH	NNP	O	GJH	nsubj	10	SENT_276	[p5l1810t893r1878b924],
6	,	,	O	,	_	0	SENT_276	[p5l1810t893r1878b924],
7	and	CC	O	and	_	0	SENT_276	[p5l1893t893r1946b916],
8	DJK	NNP	O	DJK	nsubj	10	SENT_276	[p5l1961t894r2019b924],
9	are	VBP	O	be	cop	10	SENT_276	[p5l2034t901r2078b916],
10	employees	NNS	O	employee	_	0	SENT_276	[p5l2093t893r2243b924],
11	of	IN	O	of	_	0	SENT_276	[p5l2259t893r2290b915],
12	Abbott	NNP	ORGANIZATION	Abbott	nn	13	SENT_276	[p5l1276t929r1377b952],
13	Laboratories	NNP	ORGANIZATION	Laboratories	prep_of	10	SENT_276	[p5l1397t929r1589b952],
14	.	.	O	.	_	0	SENT_276	[p5l1397t929r1589b952],

1	JWM	NN	O	jwm	nsubj	4	SENT_277	[p5l1606t930r1680b960],
2	is	VBZ	O	be	cop	4	SENT_277	[p5l1702t929r1721b952],
3	a	DT	O	a	det	4	SENT_277	[p5l1742t937r1756b952],
4	member	NN	O	member	_	0	SENT_277	[p5l1777t929r1898b952],
5	of	IN	O	of	_	0	SENT_277	[p5l1917t929r1948b951],
6	the	DT	O	the	det	10	SENT_277	[p5l1966t929r2010b952],
7	Abbott	NNP	ORGANIZATION	Abbott	nn	10	SENT_277	[p5l2030t929r2132b952],
8	Scientiﬁc	NNP	ORGANIZATION	Scientiﬁc	nn	10	SENT_277	[p5l2153t929r2286b952],
9	Advisory	NNP	ORGANIZATION	Advisory	nn	10	SENT_277	[p5l1276t964r1403b995],
10	Committee	NNP	ORGANIZATION	Committee	prep_of	4	SENT_277	[p5l1416t964r1578b987],
11	for	IN	O	for	_	0	SENT_277	[p5l1590t964r1634b986],
12	HIV	NN	O	hiv	nn	17	SENT_277	[p5l1646t965r1706b987],
13	and	CC	O	and	_	0	SENT_277	[p5l1720t964r1772b987],
14	hepatitis	NN	O	hepatitis	conj_and	12	SENT_277	[p5l1785t964r1910b995],
15	C	NN	O	c	nn	17	SENT_277	[p5l1923t964r1943b987],
16	virus	NN	O	virus	nn	17	SENT_277	[p5l1956t964r2025b987],
17	therapeutics	NNS	O	therapeutics	prep_for	4	SENT_277	[p5l2040t964r2225b995],
18	.	.	O	.	_	0	SENT_277	[p5l2040t964r2225b995],

1	infected	JJ	O	infected	amod	2	SENT_278	[p5l1327t1075r1429b1094],
2	individuals	NNS	O	individual	nsubj	13	SENT_278	[p5l1450t1075r1587b1094],
3	receiving	VBG	O	receive	partmod	2	SENT_278	[p5l1608t1075r1724b1102],
4	effective	JJ	O	effective	amod	6	SENT_278	[p5l1743t1075r1850b1094],
5	antiviral	JJ	O	antiviral	amod	6	SENT_278	[p5l1871t1075r1975b1094],
6	therapy	NN	O	therapy	dobj	3	SENT_278	[p5l1997t1075r2093b1102],
7	for	IN	O	for	_	0	SENT_278	[p5l2113t1075r2150b1094],
8	extended	JJ	O	extended	amod	9	SENT_278	[p5l2170t1075r2286b1094],
9	periods	NNS	O	period	prep_for	6	SENT_278	[p5l1326t1109r1420b1136],
10	of	IN	O	of	_	0	SENT_278	[p5l1430t1109r1457b1128],
11	time	NN	O	time	prep_of	9	SENT_278	[p5l1465t1109r1520b1128],
12	continually	RB	O	continually	advmod	3	SENT_278	[p5l1530t1109r1672b1136],
13	replenish	VB	O	replenish	_	0	SENT_278	[p5l1682t1109r1799b1136],
14	their	PRP$	O	they	poss	16	SENT_278	[p5l1810t1109r1870b1128],
15	viral	JJ	O	viral	amod	16	SENT_278	[p5l1878t1109r1933b1128],
16	reservoir	NN	O	reservoir	dobj	13	SENT_278	[p5l1944t1109r2081b1136],
17	.	.	O	.	_	0	SENT_278	[p5l1944t1109r2081b1136],

1	J	NN	O	j	nn	3	SENT_279	[p5l1944t1109r2081b1136],
2	Clin	NNP	O	Clin	nn	3	SENT_279	[p5l2091t1109r2142b1129],
3	Invest	NNP	O	Invest	_	0	SENT_279	[p5l2152t1109r2227b1128],
4	115	CD	NUMBER	115	num	3	SENT_279	[p5l2239t1109r2286b1128],
5	:	:	O	:	_	0	SENT_279	[p5l2239t1109r2286b1128],
6	3250-3255	CD	DURATION	3250-3255	dep	3	SENT_279	[p5l1326t1143r1466b1163],
7	.	.	O	.	_	0	SENT_279	[p5l1326t1143r1466b1163],

1	Kieffer	NNP	PERSON	Kieffer	nn	2	SENT_280	[p5l1326t1177r1415b1196],
2	TL	NNP	O	TL	nsubj	38	SENT_280	[p5l1424t1177r1466b1200],
3	,	,	O	,	_	0	SENT_280	[p5l1424t1177r1466b1200],
4	Finucane	NNP	PERSON	Finucane	nn	5	SENT_280	[p5l1477t1177r1593b1196],
5	l\/IM	NNP	O	l\/IM	appos	2	SENT_280	[p5l1604t1177r1658b1200],
6	,	,	O	,	_	0	SENT_280	[p5l1604t1177r1658b1200],
7	Nettles	NNP	PERSON	Nettles	nn	8	SENT_280	[p5l1669t1177r1757b1197],
8	RE	NNP	O	RE	appos	2	SENT_280	[p5l1767t1177r1808b1200],
9	,	,	O	,	_	0	SENT_280	[p5l1767t1177r1808b1200],
10	Quinn	NNP	ORGANIZATION	Quinn	nn	11	SENT_280	[p5l1819t1177r1900b1203],
11	TC	NNP	ORGANIZATION	TC	appos	2	SENT_280	[p5l1911t1177r1954b1200],
12	,	,	O	,	_	0	SENT_280	[p5l1911t1177r1954b1200],
13	Broman	NNP	PERSON	Broman	nn	14	SENT_280	[p5l1965t1177r2067b1196],
14	KW	NNP	O	KW	appos	2	SENT_280	[p5l2078t1177r2129b1200],
15	,	,	O	,	_	0	SENT_280	[p5l2078t1177r2129b1200],
16	et	FW	O	et	dep	22	SENT_280	[p5l2140t1181r2163b1196],
17	al.	FW	O	al.	nn	18	SENT_280	[p5l2173t1177r2199b1196],
18	(	FW	O	(	dep	16	SENT_280	[p5l2211t1177r2286b1202],
19	2004	CD	DATE	2004	dep	22	SENT_280	[p5l2211t1177r2286b1202],
20	)	CD	NUMBER	)	num	22	SENT_280	[p5l2211t1177r2286b1202],
21	Genotypic	JJ	O	genotypic	amod	22	SENT_280	[p5l1326t1211r1456b1238],
22	analysis	NN	O	analysis	dep	38	SENT_280	[p5l1467t1211r1563b1238],
23	of	IN	O	of	_	0	SENT_280	[p5l1573t1211r1600b1230],
24	HIV-1	NN	MISC	hiv-1	nn	26	SENT_280	[p5l1608t1211r1683b1231],
25	drug	NN	O	drug	nn	26	SENT_280	[p5l1695t1211r1754b1238],
26	resistance	NN	O	resistance	prep_of	22	SENT_280	[p5l1764t1211r1888b1230],
27	at	IN	O	at	_	0	SENT_280	[p5l1898t1215r1921b1230],
28	the	DT	O	the	det	29	SENT_280	[p5l1931t1211r1969b1230],
29	limit	NN	O	limit	prep_at	26	SENT_280	[p5l1980t1211r2039b1230],
30	of	IN	O	of	_	0	SENT_280	[p5l2049t1211r2076b1230],
31	detection	NN	O	detection	prep_of	29	SENT_280	[p5l2083t1211r2208b1230],
32	:	:	O	:	_	0	SENT_280	[p5l2083t1211r2208b1230],
33	Virus	NN	O	virus	nn	34	SENT_280	[p5l2218t1211r2286b1231],
34	production	NN	O	production	npadvmod	37	SENT_280	[p5l1326t1245r1469b1272],
35	without	IN	O	without	_	0	SENT_280	[p5l1487t1245r1584b1264],
36	evolution	NN	O	evolution	prep_without	34	SENT_280	[p5l1602t1245r1721b1264],
37	in	IN	O	in	advmod	38	SENT_280	[p5l1740t1245r1763b1264],
38	treated	VBN	O	treat	_	0	SENT_280	[p5l1781t1245r1871b1264],
39	adults	NNS	O	adult	dobj	38	SENT_280	[p5l1889t1245r1963b1264],
40	with	IN	O	with	_	0	SENT_280	[p5l1981t1245r2034b1264],
41	undetectable	JJ	O	undetectable	amod	43	SENT_280	[p5l2052t1245r2216b1264],
42	HIV	NN	O	hiv	nn	43	SENT_280	[p5l2234t1245r2287b1264],
43	1oads	NNS	O	1oad	prep_with	39	SENT_280	[p5l1326t1278r1417b1305],
44	.	.	O	.	_	0	SENT_280	[p5l1326t1278r1417b1305],

1	J	NNP	O	J	nn	3	SENT_281	[p5l1326t1278r1417b1305],
2	Infect	NNP	O	Infect	nn	3	SENT_281	[p5l1428t1278r1502b1297],
3	Dis	NNP	O	Dis	_	0	SENT_281	[p5l1514t1278r1553b1297],
4	189	CD	NUMBER	189	num	3	SENT_281	[p5l1567t1278r1614b1297],
5	:	:	O	:	_	0	SENT_281	[p5l1567t1278r1614b1297],
6	1452-1465	CD	DATE	1452-1465	dep	3	SENT_281	[p5l1629t1278r1767b1298],
7	.	.	O	.	_	0	SENT_281	[p5l1629t1278r1767b1298],

1	Hermankova	NN	O	hermankova	nn	2	SENT_282	[p5l1326t1313r1490b1332],
2	M	NN	O	m	_	0	SENT_282	[p5l1503t1313r1532b1336],
3	,	,	O	,	_	0	SENT_282	[p5l1503t1313r1532b1336],
4	Ray	NNP	PERSON	Ray	nn	5	SENT_282	[p5l1545t1313r1590b1340],
5	SC	NNP	PERSON	SC	appos	2	SENT_282	[p5l1603t1313r1643b1336],
6	,	,	O	,	_	0	SENT_282	[p5l1603t1313r1643b1336],
7	Ruff	NNP	PERSON	Ruff	nn	8	SENT_282	[p5l1656t1313r1713b1332],
8	C	NNP	O	C	appos	2	SENT_282	[p5l1723t1313r1747b1336],
9	,	,	O	,	_	0	SENT_282	[p5l1723t1313r1747b1336],
10	Powell-Davis	NNP	O	Powell-Davis	nn	11	SENT_282	[p5l1760t1313r1921b1332],
11	M	NNP	O	M	appos	2	SENT_282	[p5l1934t1313r1963b1336],
12	,	,	O	,	_	0	SENT_282	[p5l1934t1313r1963b1336],
13	Ingersoll	NNP	ORGANIZATION	Ingersoll	nn	14	SENT_282	[p5l1976t1313r2086b1340],
14	R	NNP	ORGANIZATION	R	appos	2	SENT_282	[p5l2099t1313r2122b1336],
15	,	,	O	,	_	0	SENT_282	[p5l2099t1313r2122b1336],
16	et	FW	O	et	dep	2	SENT_282	[p5l2136t1317r2158b1332],
17	al.	FW	O	al.	nn	18	SENT_282	[p5l2171t1313r2197b1332],
18	(	FW	O	(	dep	2	SENT_282	[p5l2211t1313r2286b1338],
19	2001	CD	DATE	2001	dep	18	SENT_282	[p5l2211t1313r2286b1338],
20	)	CD	NUMBER	)	num	24	SENT_282	[p5l2211t1313r2286b1338],
21	HIV-1	NN	O	hiv-1	nn	24	SENT_282	[p5l1326t1346r1401b1366],
22	drug	NN	O	drug	nn	24	SENT_282	[p5l1413t1346r1472b1373],
23	resistance	NN	O	resistance	nn	24	SENT_282	[p5l1482t1346r1606b1365],
24	proﬁles	NNS	O	proﬁles	dep	18	SENT_282	[p5l1616t1346r1710b1373],
25	in	IN	O	in	_	0	SENT_282	[p5l1721t1346r1744b1365],
26	children	NNS	O	child	prep_in	24	SENT_282	[p5l1754t1346r1859b1365],
27	and	CC	O	and	_	0	SENT_282	[p5l1869t1346r1915b1365],
28	adults	NNS	O	adult	conj_and	2	SENT_282	[p5l1925t1346r1999b1365],
29	with	IN	O	with	_	0	SENT_282	[p5l2009t1346r2062b1365],
30	viral	JJ	O	viral	amod	31	SENT_282	[p5l2072t1346r2127b1365],
31	load	NN	O	load	prep_with	28	SENT_282	[p5l2137t1346r2191b1365],
32	of	IN	O	of	_	0	SENT_282	[p5l2200t1346r2227b1365],
33	<	JJR	O	<	prep_of	31	SENT_282	[p5l2235t1346r2286b1365],
34	50	CD	NUMBER	50	num	35	SENT_282	[p5l2235t1346r2286b1365],
35	copies/ml	NN	O	copies/ml	dep	33	SENT_282	[p5l1326t1380r1444b1407],
36	receiving	VBG	O	receive	partmod	2	SENT_282	[p5l1457t1380r1573b1407],
37	combination	NN	O	combination	nn	38	SENT_282	[p5l1584t1380r1746b1399],
38	therapy	NN	O	therapy	dobj	36	SENT_282	[p5l1759t1380r1948b1407],
39	.	.	O	.	_	0	SENT_282	[p5l1759t1380r1948b1407],

1	JAMA	NN	O	jama	_	0	SENT_283	[p5l1759t1380r1948b1407],
2	286	CD	NUMBER	286	num	1	SENT_283	[p5l1960t1380r2008b1400],
3	:	:	O	:	_	0	SENT_283	[p5l1960t1380r2008b1400],
4	196-207	CD	NUMBER	196-207	dep	1	SENT_283	[p5l2023t1378r2131b1400],
5	.	.	O	.	_	0	SENT_283	[p5l2023t1378r2131b1400],

1	BaileyJR	NNP	O	BaileyJR	nsubjpass	34	SENT_284	[p5l1326t1414r1445b1441],
2	,	,	O	,	_	0	SENT_284	[p5l1326t1414r1445b1441],
3	Sedaghat	NNP	ORGANIZATION	Sedaghat	nn	4	SENT_284	[p5l1456t1414r1570b1441],
4	AR	NNS	ORGANIZATION	ar	appos	1	SENT_284	[p5l1579t1414r1624b1437],
5	,	,	O	,	_	0	SENT_284	[p5l1579t1414r1624b1437],
6	Kieffer	NN	PERSON	kieffer	nn	7	SENT_284	[p5l1634t1414r1723b1433],
7	T	NN	PERSON	t	appos	1	SENT_284	[p5l1732t1414r1755b1437],
8	,	,	O	,	_	0	SENT_284	[p5l1732t1414r1755b1437],
9	Brennan	NNP	ORGANIZATION	Brennan	nn	10	SENT_284	[p5l1765t1414r1875b1433],
10	T	NN	ORGANIZATION	t	appos	1	SENT_284	[p5l1884t1414r1908b1437],
11	,	,	O	,	_	0	SENT_284	[p5l1884t1414r1908b1437],
12	Lee	NNP	PERSON	Lee	nn	13	SENT_284	[p5l1918t1414r1962b1433],
13	PK	NNP	O	PK	appos	1	SENT_284	[p5l1973t1414r2015b1437],
14	,	,	O	,	_	0	SENT_284	[p5l1973t1414r2015b1437],
15	et	FW	O	et	nn	17	SENT_284	[p5l2025t1418r2047b1433],
16	al.	FW	O	al.	nn	17	SENT_284	[p5l2057t1414r2083b1433],
17	(	FW	O	(	dep	34	SENT_284	[p5l2094t1414r2169b1439],
18	2006	CD	DATE	2006	number	19	SENT_284	[p5l2094t1414r2169b1439],
19	)	CD	NUMBER	)	num	26	SENT_284	[p5l2094t1414r2169b1439],
20	Residual	JJ	O	residual	amod	26	SENT_284	[p5l2180t1414r2286b1433],
21	human	JJ	O	human	amod	26	SENT_284	[p5l1326t1448r1413b1467],
22	immunodeﬁciency	NN	O	immunodeﬁciency	nn	26	SENT_284	[p5l1436t1448r1671b1475],
23	virus	NN	O	virus	nn	26	SENT_284	[p5l1693t1448r1753b1467],
24	type	NN	O	type	amod	26	SENT_284	[p5l1776t1452r1828b1475],
25	1	CD	NUMBER	1	number	24	SENT_284	[p5l1852t1448r1860b1467],
26	viremia	NN	O	viremia	dobj	17	SENT_284	[p5l1884t1448r1979b1467],
27	in	IN	O	in	_	0	SENT_284	[p5l2001t1448r2024b1467],
28	some	DT	O	some	det	29	SENT_284	[p5l2046t1454r2110b1467],
29	patients	NNS	O	patient	prep_in	26	SENT_284	[p5l2132t1448r2233b1475],
30	on	IN	O	on	_	0	SENT_284	[p5l2255t1455r2286b1467],
31	antiretroviral	JJ	O	antiretroviral	prep_on	17	SENT_284	[p5l1326t1482r1497b1501],
32	therapy	NN	O	therapy	nsubjpass	34	SENT_284	[p5l1510t1482r1606b1509],
33	is	VBZ	O	be	auxpass	34	SENT_284	[p5l1618t1482r1635b1501],
34	dominated	VBN	O	dominate	_	0	SENT_284	[p5l1647t1482r1784b1501],
35	by	IN	O	by	_	0	SENT_284	[p5l1795t1482r1823b1509],
36	a	DT	O	a	det	38	SENT_284	[p5l1835t1489r1847b1501],
37	small	JJ	O	small	amod	38	SENT_284	[p5l1859t1482r1922b1501],
38	number	NN	O	number	agent	34	SENT_284	[p5l1935t1482r2035b1501],
39	of	IN	O	of	_	0	SENT_284	[p5l2046t1482r2073b1501],
40	invariant	JJ	O	invariant	amod	41	SENT_284	[p5l2082t1482r2197b1501],
41	clones	NNS	O	clone	prep_of	38	SENT_284	[p5l2208t1482r2286b1501],
42	rarely	RB	O	rarely	advmod	43	SENT_284	[p5l1326t1516r1399b1543],
43	found	VBN	O	find	partmod	41	SENT_284	[p5l1411t1516r1486b1535],
44	in	IN	O	in	_	0	SENT_284	[p5l1498t1516r1521b1535],
45	circulating	VBG	O	circulate	prepc_in	43	SENT_284	[p5l1533t1516r1670b1543],
46	CD4	NN	O	cd4	dobj	45	SENT_284	[p5l1682t1516r1755b1537],
47	+	CC	O	+	_	0	SENT_284	[p5l1682t1516r1755b1537],
48	T	NN	O	t	nn	49	SENT_284	[p5l1764t1516r1782b1535],
49	cells	NNS	O	cell	dobj	45	SENT_284	[p5l1794t1516r1873b1543],
50	.	.	O	.	_	0	SENT_284	[p5l1794t1516r1873b1543],

1	J	NNP	O	J	nn	2	SENT_285	[p5l1794t1516r1873b1543],
2	Virol	NNP	O	Virol	_	0	SENT_285	[p5l1884t1516r1949b1536],
3	80	CD	NUMBER	80	num	2	SENT_285	[p5l1961t1516r1995b1535],
4	:	:	O	:	_	0	SENT_285	[p5l1961t1516r1995b1535],
5	6441-6457	CD	DURATION	6441-6457	dep	2	SENT_285	[p5l2008t1514r2148b1535],
6	.	.	O	.	_	0	SENT_285	[p5l2008t1514r2148b1535],

1	Havlir	NNP	PERSON	Havlir	nn	2	SENT_286	[p5l1326t1550r1406b1569],
2	DV	NNP	O	DV	nsubj	23	SENT_286	[p5l1420t1550r1467b1573],
3	,	,	O	,	_	0	SENT_286	[p5l1420t1550r1467b1573],
4	Strain	NNP	O	Strain	nn	5	SENT_286	[p5l1483t1550r1559b1570],
5	MC	NNP	O	MC	appos	2	SENT_286	[p5l1576t1550r1625b1573],
6	,	,	O	,	_	0	SENT_286	[p5l1576t1550r1625b1573],
7	Clerici	NNP	ORGANIZATION	Clerici	nn	8	SENT_286	[p5l1641t1550r1724b1570],
8	M	NNP	ORGANIZATION	M	appos	2	SENT_286	[p5l1741t1550r1769b1573],
9	,	,	O	,	_	0	SENT_286	[p5l1741t1550r1769b1573],
10	Ignacio	NNP	PERSON	Ignacio	nn	11	SENT_286	[p5l1785t1550r1878b1577],
11	C	NNP	PERSON	C	appos	2	SENT_286	[p5l1895t1550r1919b1573],
12	,	,	O	,	_	0	SENT_286	[p5l1895t1550r1919b1573],
13	Trabattoni	NNP	O	Trabattoni	nn	14	SENT_286	[p5l1934t1550r2072b1569],
14	D	NNP	O	D	appos	2	SENT_286	[p5l2088t1550r2114b1573],
15	,	,	O	,	_	0	SENT_286	[p5l2088t1550r2114b1573],
16	et	FW	O	et	appos	2	SENT_286	[p5l2130t1554r2152b1569],
17	al.	FW	O	al.	nn	18	SENT_286	[p5l2168t1550r2194b1569],
18	(	FW	O	(	dep	16	SENT_286	[p5l2211t1550r2286b1575],
19	2003	CD	DATE	2003	number	20	SENT_286	[p5l2211t1550r2286b1575],
20	)	CD	NUMBER	)	num	22	SENT_286	[p5l2211t1550r2286b1575],
21	Productive	JJ	O	productive	amod	22	SENT_286	[p5l1326t1584r1464b1603],
22	infection	NN	O	infection	dep	18	SENT_286	[p5l1477t1584r1590b1603],
23	maintains	VBZ	O	maintain	_	0	SENT_286	[p5l1603t1584r1727b1603],
24	a	DT	O	a	det	27	SENT_286	[p5l1740t1591r1752b1603],
25	dynamic	JJ	O	dynamic	amod	27	SENT_286	[p5l1764t1584r1870b1611],
26	steady	JJ	O	steady	amod	27	SENT_286	[p5l1883t1584r1961b1611],
27	state	NN	O	state	dobj	23	SENT_286	[p5l1973t1588r2031b1603],
28	of	IN	O	of	_	0	SENT_286	[p5l2043t1584r2070b1603],
29	residual	JJ	O	residual	amod	30	SENT_286	[p5l2080t1584r2179b1603],
30	viremia	NN	O	viremia	prep_of	27	SENT_286	[p5l2191t1584r2286b1603],
31	in	IN	O	in	_	0	SENT_286	[p5l1327t1618r1350b1637],
32	human	JJ	O	human	amod	37	SENT_286	[p5l1366t1618r1454b1637],
33	immunodeﬁciency	NN	O	immunodeﬁciency	nn	37	SENT_286	[p5l1471t1618r1706b1645],
34	virus	NN	O	virus	nn	37	SENT_286	[p5l1722t1618r1782b1637],
35	type	NN	O	type	nn	37	SENT_286	[p5l1799t1622r1852b1645],
36	1-infected	JJ	O	1-infected	amod	37	SENT_286	[p5l1871t1618r1996b1637],
37	persons	NNS	O	person	prep_in	30	SENT_286	[p5l2013t1624r2110b1645],
38	treated	VBN	O	treat	partmod	30	SENT_286	[p5l2127t1618r2217b1637],
39	with	IN	O	with	_	0	SENT_286	[p5l2232t1618r2286b1637],
40	suppressive	JJ	O	suppressive	amod	42	SENT_286	[p5l1326t1651r1471b1678],
41	antiretroviral	JJ	O	antiretroviral	amod	42	SENT_286	[p5l1483t1651r1654b1670],
42	therapy	NN	O	therapy	prep_with	38	SENT_286	[p5l1667t1651r1763b1678],
43	for	IN	O	for	_	0	SENT_286	[p5l1775t1651r1812b1670],
44	ﬁve	NN	O	ﬁve	nn	45	SENT_286	[p5l1823t1651r1866b1670],
45	years	NNS	DURATION	year	prep_for	42	SENT_286	[p5l1878t1657r1947b1678],
46	.	.	O	.	_	0	SENT_286	[p5l1878t1657r1947b1678],

1	J	NNP	O	J	nn	2	SENT_287	[p5l1955t1651r1968b1678],
2	Virol	NNP	O	Virol	_	0	SENT_287	[p5l1979t1651r2043b1671],
3	77	CD	NUMBER	77	num	2	SENT_287	[p5l2057t1649r2090b1670],
4	:	:	O	:	_	0	SENT_287	[p5l2057t1649r2090b1670],
5	1121241219	CD	NUMBER	1121241219	dep	2	SENT_287	[p5l2105t1651r2273b1671],
6	.	.	O	.	_	0	SENT_287	[p5l2105t1651r2273b1671],

1	Ramratnam	NN	MISC	ramratnam	nn	2	SENT_288	[p5l1326t1686r1477b1705],
2	B	NN	O	b	_	0	SENT_288	[p5l1499t1686r1523b1709],
3	,	,	O	,	_	0	SENT_288	[p5l1499t1686r1523b1709],
4	Ribeiro	NNP	PERSON	Ribeiro	nn	5	SENT_288	[p5l1545t1686r1640b1705],
5	R	NNP	PERSON	R	appos	2	SENT_288	[p5l1662t1686r1686b1709],
6	,	,	O	,	_	0	SENT_288	[p5l1662t1686r1686b1709],
7	He	PRP	O	he	dep	8	SENT_288	[p5l1709t1686r1744b1705],
8	T	NN	O	t	appos	2	SENT_288	[p5l1766t1686r1790b1709],
9	,	,	O	,	_	0	SENT_288	[p5l1766t1686r1790b1709],
10	Chung	NNP	PERSON	Chung	nn	11	SENT_288	[p5l1812t1686r1897b1713],
11	C	NNP	PERSON	C	appos	2	SENT_288	[p5l1918t1686r1942b1709],
12	,	,	O	,	_	0	SENT_288	[p5l1918t1686r1942b1709],
13	Simon	NNP	PERSON	Simon	nn	14	SENT_288	[p5l1965t1686r2046b1706],
14	V	NNP	PERSON	V	appos	2	SENT_288	[p5l2067t1686r2093b1709],
15	,	,	O	,	_	0	SENT_288	[p5l2067t1686r2093b1709],
16	et	FW	O	et	appos	2	SENT_288	[p5l2116t1690r2138b1705],
17	al.	FW	O	al.	nn	18	SENT_288	[p5l2161t1686r2187b1705],
18	(	FW	O	(	dep	16	SENT_288	[p5l2210t1686r2286b1711],
19	2004	CD	DATE	2004	num	21	SENT_288	[p5l2210t1686r2286b1711],
20	)	CD	NUMBER	)	num	21	SENT_288	[p5l2210t1686r2286b1711],
21	Intensiﬁcation	NN	O	intensiﬁcation	nsubj	25	SENT_288	[p5l1326t1719r1511b1738],
22	of	IN	O	of	_	0	SENT_288	[p5l1523t1719r1550b1738],
23	antiretroviral	JJ	O	antiretroviral	amod	24	SENT_288	[p5l1560t1719r1731b1738],
24	therapy	NN	O	therapy	prep_of	21	SENT_288	[p5l1744t1719r1840b1746],
25	accelerates	VBZ	O	accelerate	rcmod	2	SENT_288	[p5l1853t1719r1990b1738],
26	the	DT	O	the	det	27	SENT_288	[p5l2003t1719r2041b1738],
27	decay	NN	O	decay	dobj	25	SENT_288	[p5l2054t1719r2124b1746],
28	of	IN	O	of	_	0	SENT_288	[p5l2136t1719r2164b1738],
29	the	DT	O	the	det	32	SENT_288	[p5l2173t1719r2211b1738],
30	HIV1	NN	O	hiv1	nn	32	SENT_288	[p5l2224t1719r2286b1739, p5l1328t1753r1337b1772],
31	latent	JJ	O	latent	amod	32	SENT_288	[p5l1356t1753r1428b1772],
32	reservoir	NN	O	reservoir	prep_of	27	SENT_288	[p5l1446t1753r1559b1772],
33	and	CC	O	and	_	0	SENT_288	[p5l1576t1753r1621b1772],
34	decreases	VBZ	O	decrease	conj_and	25	SENT_288	[p5l1638t1753r1764b1776],
35	,	,	O	,	_	0	SENT_288	[p5l1638t1753r1764b1776],
36	but	CC	O	but	_	0	SENT_288	[p5l1781t1753r1822b1772],
37	does	VBZ	O	do	aux	39	SENT_288	[p5l1839t1753r1895b1772],
38	not	RB	O	not	neg	39	SENT_288	[p5l1912t1757r1954b1772],
39	eliminate	VB	O	eliminate	rcmod	2	SENT_288	[p5l1971t1753r2089b1772],
40	ongoing	JJ	O	ongoing	amod	42	SENT_288	[p5l2106t1753r2210b1780],
41	virus	NN	O	virus	nn	42	SENT_288	[p5l2226t1753r2286b1772],
42	replication	NN	O	replication	dobj	39	SENT_288	[p5l1326t1787r1492b1814],
43	.	.	O	.	_	0	SENT_288	[p5l1326t1787r1492b1814],

1	J	NNP	O	J	nn	5	SENT_289	[p5l1326t1787r1492b1814],
2	Acquir	NNP	MISC	Acquir	nn	5	SENT_289	[p5l1503t1787r1591b1814],
3	Immune	NNP	MISC	Immune	nn	5	SENT_289	[p5l1602t1787r1707b1806],
4	Deﬁc	NNP	MISC	Deﬁc	nn	5	SENT_289	[p5l1720t1787r1783b1806],
5	Syndr	NNP	MISC	Syndr	_	0	SENT_289	[p5l1796t1787r1871b1814],
6	35	CD	NUMBER	35	num	5	SENT_289	[p5l1882t1787r1916b1806],
7	:	:	O	:	_	0	SENT_289	[p5l1882t1787r1916b1806],
8	33-37	CD	NUMBER	33-37	dep	5	SENT_289	[p5l1929t1785r2008b1806],
9	.	.	O	.	_	0	SENT_289	[p5l1929t1785r2008b1806],

1	Kempf	NNP	PERSON	Kempf	nn	2	SENT_290	[p5l1326t1821r1414b1848],
2	DJ	NNP	O	DJ	_	0	SENT_290	[p5l1428t1821r1464b1848],
3	,	,	O	,	_	0	SENT_290	[p5l1428t1821r1464b1848],
4	King	NNP	O	King	nn	5	SENT_290	[p5l1482t1821r1542b1848],
5	MS	NN	O	m	appos	2	SENT_290	[p5l1558t1821r1603b1844],
6	,	,	O	,	_	0	SENT_290	[p5l1558t1821r1603b1844],
7	Bernstein	NNP	PERSON	Bernstein	nn	8	SENT_290	[p5l1621t1821r1742b1840],
8	B	NNP	PERSON	B	appos	2	SENT_290	[p5l1760t1821r1783b1844],
9	,	,	O	,	_	0	SENT_290	[p5l1760t1821r1783b1844],
10	Cernohous	NNP	O	Cernohous	nn	11	SENT_290	[p5l1801t1821r1939b1841],
11	P	NN	O	p	appos	2	SENT_290	[p5l1957t1821r1978b1844],
12	,	,	O	,	_	0	SENT_290	[p5l1957t1821r1978b1844],
13	Bauer	NNP	PERSON	Bauer	nn	14	SENT_290	[p5l1996t1821r2071b1840],
14	E	NNP	O	E	appos	2	SENT_290	[p5l2087t1821r2109b1844],
15	,	,	O	,	_	0	SENT_290	[p5l2087t1821r2109b1844],
16	et	FW	O	et	nn	18	SENT_290	[p5l2126t1825r2149b1840],
17	al.	FW	O	al.	nn	18	SENT_290	[p5l2166t1821r2192b1840],
18	(	FW	O	(	rcmod	14	SENT_290	[p5l2211t1821r2286b1846],
19	2004	CD	DATE	2004	num	21	SENT_290	[p5l2211t1821r2286b1846],
20	)	CD	NUMBER	)	num	21	SENT_290	[p5l2211t1821r2286b1846],
21	Incidence	NN	O	incidence	dobj	18	SENT_290	[p5l1326t1855r1450b1874],
22	of	IN	O	of	_	0	SENT_290	[p5l1470t1855r1497b1874],
23	resistance	NN	O	resistance	prep_of	21	SENT_290	[p5l1515t1855r1640b1874],
24	in	IN	O	in	_	0	SENT_290	[p5l1661t1855r1684b1874],
25	a	DT	O	a	det	27	SENT_290	[p5l1705t1862r1716b1874],
26	double-blind	JJ	O	double-blind	amod	27	SENT_290	[p5l1737t1855r1900b1874],
27	study	NN	O	study	prep_in	18	SENT_290	[p5l1921t1855r1987b1882],
28	comparing	VBG	O	compare	partmod	2	SENT_290	[p5l2007t1855r2145b1882],
29	lopinavirl	NN	O	lopinavirl	nn	30	SENT_290	[p5l2165t1855r2288b1882],
30	ritonavir	NN	O	ritonavir	dobj	28	SENT_290	[p5l1326t1889r1439b1908],
31	plus	CC	O	plus	prep	30	SENT_290	[p5l1452t1889r1503b1916],
32	stavudine	NN	O	stavudine	dep	31	SENT_290	[p5l1517t1889r1638b1908],
33	and	CC	O	and	_	0	SENT_290	[p5l1652t1889r1698b1908],
34	lamivudine	NN	O	lamivudine	dep	31	SENT_290	[p5l1712t1889r1853b1908],
35	to	TO	O	to	_	0	SENT_290	[p5l1868t1893r1891b1908],
36	nelﬁnavir	NN	O	nelﬁnavir	prep_to	28	SENT_290	[p5l1906t1889r2028b1908],
37	plus	CC	O	plus	prep	36	SENT_290	[p5l2041t1889r2091b1916],
38	stavudine	NN	O	stavudine	dep	37	SENT_290	[p5l2106t1889r2226b1908],
39	and	CC	O	and	_	0	SENT_290	[p5l2241t1889r2286b1908],
40	lamivudine	NN	O	lamivudine	dep	37	SENT_290	[p5l1326t1922r1494b1949],
41	.	.	O	.	_	0	SENT_290	[p5l1326t1922r1494b1949],

1	J	NNP	O	J	nn	3	SENT_291	[p5l1326t1922r1494b1949],
2	Infect	NNP	O	Infect	nn	3	SENT_291	[p5l1505t1922r1579b1941],
3	Dis	NNP	O	Dis	_	0	SENT_291	[p5l1591t1922r1630b1941],
4	189	CD	NUMBER	189	num	3	SENT_291	[p5l1644t1922r1691b1941],
5	:	:	O	:	_	0	SENT_291	[p5l1644t1922r1691b1941],
6	51-60	CD	NUMBER	51-60	dep	3	SENT_291	[p5l1704t1922r1783b1941],
7	.	.	O	.	_	0	SENT_291	[p5l1704t1922r1783b1941],

1	King	NNP	O	King	nn	2	SENT_292	[p5l1326t1957r1386b1984],
2	MS	NN	O	m	nsubj	29	SENT_292	[p5l1400t1957r1444b1980],
3	,	,	O	,	_	0	SENT_292	[p5l1400t1957r1444b1980],
4	Bernstein	NNP	PERSON	Bernstein	nn	5	SENT_292	[p5l1459t1957r1580b1976],
5	BM	NN	O	bm	appos	2	SENT_292	[p5l1595t1957r1643b1980],
6	,	,	O	,	_	0	SENT_292	[p5l1595t1957r1643b1980],
7	Walmsley	NNP	ORGANIZATION	Walmsley	nn	8	SENT_292	[p5l1657t1957r1777b1984],
8	SL	NNP	ORGANIZATION	SL	appos	5	SENT_292	[p5l1791t1957r1828b1980],
9	,	,	O	,	_	0	SENT_292	[p5l1791t1957r1828b1980],
10	Sherer	NNP	PERSON	Sherer	nn	11	SENT_292	[p5l1843t1957r1927b1977],
11	R	NNP	PERSON	R	appos	5	SENT_292	[p5l1941t1957r1964b1980],
12	,	,	O	,	_	0	SENT_292	[p5l1941t1957r1964b1980],
13	Feinberg	NNP	PERSON	Feinberg	nn	14	SENT_292	[p5l1978t1957r2091b1984],
14	J	NNP	PERSON	J	appos	5	SENT_292	[p5l2100t1957r2118b1984],
15	,	,	O	,	_	0	SENT_292	[p5l2100t1957r2118b1984],
16	et	FW	O	et	dep	5	SENT_292	[p5l2133t1961r2156b1976],
17	al.	FW	O	al.	nn	18	SENT_292	[p5l2170t1957r2196b1976],
18	(	FW	O	(	dep	5	SENT_292	[p5l2211t1957r2286b1982],
19	2004	CD	DATE	2004	number	20	SENT_292	[p5l2211t1957r2286b1982],
20	)	CD	NUMBER	)	num	24	SENT_292	[p5l2211t1957r2286b1982],
21	Baseline	NN	O	baseline	nn	24	SENT_292	[p5l1326t1991r1430b2010],
22	HIV-1	NN	O	hiv-1	nn	24	SENT_292	[p5l1448t1991r1523b2011],
23	RNA	NN	MISC	rna	nn	24	SENT_292	[p5l1543t1991r1603b2011],
24	level	NN	O	level	dep	18	SENT_292	[p5l1620t1991r1676b2010],
25	and	CC	O	and	_	0	SENT_292	[p5l1694t1991r1740b2010],
26	CD4	NN	O	cd4	nn	28	SENT_292	[p5l1757t1991r1812b2011],
27	cell	NN	O	cell	nn	28	SENT_292	[p5l1829t1991r1870b2010],
28	count	NN	O	count	appos	2	SENT_292	[p5l1888t1995r1960b2010],
29	predict	VBP	O	predict	_	0	SENT_292	[p5l1978t1991r2069b2018],
30	time	NN	O	time	dobj	29	SENT_292	[p5l2086t1991r2142b2010],
31	to	TO	O	to	_	0	SENT_292	[p5l2160t1995r2183b2010],
32	loss	NN	O	loss	prep_to	29	SENT_292	[p5l2201t1991r2245b2010],
33	of	IN	O	of	_	0	SENT_292	[p5l2262t1991r2289b2010],
34	virologic	JJ	O	virologic	amod	35	SENT_292	[p5l1326t2024r1436b2051],
35	response	NN	O	response	prep_of	32	SENT_292	[p5l1451t2030r1562b2051],
36	to	TO	O	to	_	0	SENT_292	[p5l1577t2028r1600b2043],
37	nelﬁnavir	NN	O	nelﬁnavir	prep_to	29	SENT_292	[p5l1615t2024r1742b2047],
38	,	,	O	,	_	0	SENT_292	[p5l1615t2024r1742b2047],
39	but	CC	O	but	_	0	SENT_292	[p5l1757t2024r1798b2043],
40	not	RB	O	not	_	0	SENT_292	[p5l1812t2028r1854b2043],
41	lopinavir/ritonavir	NN	O	lopinavir/ritonavir	conj_negcc	37	SENT_292	[p5l1868t2024r2110b2051],
42	,	,	O	,	_	0	SENT_292	[p5l1868t2024r2110b2051],
43	in	IN	O	in	_	0	SENT_292	[p5l2125t2024r2148b2043],
44	antiretroviral	JJ	O	antiretroviral	amod	46	SENT_292	[p5l2163t2024r2286b2043, p5l1326t2058r1381b2077],
45	therapy-naive	JJ	O	therapy-naive	amod	46	SENT_292	[p5l1394t2058r1567b2085],
46	patients	NNS	O	patient	prep_in	37	SENT_292	[p5l1580t2058r1707b2085],
47	.	.	O	.	_	0	SENT_292	[p5l1580t2058r1707b2085],

1	J	NNP	O	J	nn	3	SENT_293	[p5l1580t2058r1707b2085],
2	Infect	NNP	O	Infect	nn	3	SENT_293	[p5l1719t2058r1793b2077],
3	Dis	NNP	O	Dis	_	0	SENT_293	[p5l1804t2058r1844b2077],
4	190	CD	NUMBER	190	num	3	SENT_293	[p5l1858t2058r1905b2077],
5	:	:	O	:	_	0	SENT_293	[p5l1858t2058r1905b2077],
6	280-284	CD	NUMBER	280-284	dep	3	SENT_293	[p5l1918t2058r2027b2078],
7	.	.	O	.	_	0	SENT_293	[p5l1918t2058r2027b2078],

1	King	NNP	O	King	nn	2	SENT_294	[p5l1326t2092r1386b2119],
2	MS	NN	O	m	_	0	SENT_294	[p5l1397t2092r1442b2115],
3	,	,	O	,	_	0	SENT_294	[p5l1397t2092r1442b2115],
4	Brun	NNP	PERSON	Brun	nn	5	SENT_294	[p5l1454t2092r1517b2111],
5	SC	NNP	O	SC	conj_and	2	SENT_294	[p5l1530t2092r1569b2115],
6	,	,	O	,	_	0	SENT_294	[p5l1530t2092r1569b2115],
7	Kempf	NNP	PERSON	Kempf	nn	9	SENT_294	[p5l1582t2092r1669b2119],
8	DJ	NNP	O	DJ	nn	9	SENT_294	[p5l1678t2092r1708b2119],
9	(	NNP	O	(	conj_and	2	SENT_294	[p5l1721t2092r1796b2117],
10	2005	CD	DATE	2005	num	12	SENT_294	[p5l1721t2092r1796b2117],
11	)	CD	NUMBER	)	num	12	SENT_294	[p5l1721t2092r1796b2117],
12	Relationship	NN	O	relationship	dep	9	SENT_294	[p5l1808t2092r1968b2119],
13	between	IN	O	between	_	0	SENT_294	[p5l1980t2092r2084b2111],
14	adherence	NN	O	adherence	prep_between	12	SENT_294	[p5l2097t2092r2228b2111],
15	and	CC	O	and	_	0	SENT_294	[p5l2241t2092r2286b2111],
16	the	DT	O	the	det	17	SENT_294	[p5l1327t2126r1365b2145],
17	development	NN	O	development	conj_and	2	SENT_294	[p5l1387t2126r1553b2153],
18	of	IN	O	of	_	0	SENT_294	[p5l1575t2126r1602b2145],
19	resistance	NN	O	resistance	prep_of	17	SENT_294	[p5l1621t2126r1746b2145],
20	in	IN	O	in	_	0	SENT_294	[p5l1768t2126r1791b2145],
21	antiretroviral-naive	JJ	O	antiretroviral-naive	amod	24	SENT_294	[p5l1814t2126r2071b2149],
22	,	,	O	,	_	0	SENT_294	[p5l1814t2126r2071b2149],
23	HIV-1-infected	JJ	O	hiv-1-infected	amod	24	SENT_294	[p5l2093t2126r2286b2146],
24	patients	NNS	O	patient	prep_in	19	SENT_294	[p5l1326t2160r1427b2187],
25	receiving	VBG	O	receive	partmod	2	SENT_294	[p5l1440t2160r1556b2187],
26	lopinavir/ritonavir	NN	O	lopinavir/ritonavir	dobj	25	SENT_294	[p5l1567t2160r1803b2187],
27	or	CC	O	or	_	0	SENT_294	[p5l1815t2166r1842b2179],
28	nelﬁnavir	NN	O	nelﬁnavir	conj_or	26	SENT_294	[p5l1854t2160r1981b2179],
29	.	.	O	.	_	0	SENT_294	[p5l1854t2160r1981b2179],

1	J	NNP	O	J	nn	3	SENT_295	[p5l1989t2160r2002b2187],
2	Infect	NNP	O	Infect	nn	3	SENT_295	[p5l2014t2160r2087b2179],
3	Dis	NNP	O	Dis	_	0	SENT_295	[p5l2099t2160r2138b2179],
4	191	CD	NUMBER	191	num	3	SENT_295	[p5l2153t2160r2200b2179],
5	:	:	O	:	_	0	SENT_295	[p5l2153t2160r2200b2179],
6	20462052	CD	NUMBER	20462052	dep	3	SENT_295	[p5l2213t2160r2286b2179, p5l1327t2194r1390b2214],
7	.	.	O	.	_	0	SENT_295	[p5l2213t2160r2286b2179, p5l1327t2194r1390b2214],

1	Bonhoeffer	NNP	PERSON	Bonhoeffer	nn	8	SENT_296	[p5l1326t2228r1471b2247],
2	S	NNP	O	S	nn	8	SENT_296	[p5l1479t2228r1499b2251],
3	,	,	O	,	_	0	SENT_296	[p5l1479t2228r1499b2251],
4	CofﬁnJM	NNP	O	CofﬁnJM	appos	8	SENT_296	[p5l1509t2228r1636b2255],
5	,	,	O	,	_	0	SENT_296	[p5l1509t2228r1636b2255],
6	Nowak	NNP	PERSON	Nowak	appos	8	SENT_296	[p5l1645t2228r1731b2248],
7	MA	NNP	PERSON	MA	nn	8	SENT_296	[p5l1740t2228r1783b2247],
8	(	NNP	O	(	_	0	SENT_296	[p5l1793t2226r1868b2253],
9	1997	CD	DATE	1997	num	10	SENT_296	[p5l1793t2226r1868b2253],
10	)	CD	NUMBER	)	dep	8	SENT_296	[p5l1793t2226r1868b2253],
11	Human	JJ	O	human	amod	15	SENT_296	[p5l1878t2228r1972b2247],
12	immunodeﬁciency	NN	O	immunodeﬁciency	nn	15	SENT_296	[p5l1982t2228r2217b2255],
13	virus	NN	O	virus	nn	15	SENT_296	[p5l2226t2228r2286b2247],
14	drug	NN	O	drug	nn	15	SENT_296	[p5l1326t2262r1385b2289],
15	therapy	NN	O	therapy	dep	10	SENT_296	[p5l1397t2262r1493b2289],
16	and	CC	O	and	_	0	SENT_296	[p5l1505t2262r1551b2281],
17	virus	NN	O	virus	nn	18	SENT_296	[p5l1562t2262r1622b2281],
18	load	NN	O	load	dep	10	SENT_296	[p5l1635t2262r1694b2281],
19	.	.	O	.	_	0	SENT_296	[p5l1635t2262r1694b2281],

1	J	NNP	O	J	nn	2	SENT_297	[p5l1702t2262r1715b2289],
2	Virol	NNP	O	Virol	_	0	SENT_297	[p5l1725t2262r1790b2281],
3	71	CD	NUMBER	71	num	2	SENT_297	[p5l1803t2260r1836b2281],
4	:	:	O	:	_	0	SENT_297	[p5l1803t2260r1836b2281],
5	3275-3278	CD	DURATION	3275-3278	dep	2	SENT_297	[p5l1849t2260r1989b2282],
6	.	.	O	.	_	0	SENT_297	[p5l1849t2260r1989b2282],

1	Patick	NNP	O	Patick	nn	2	SENT_298	[p5l1326t2296r1403b2315],
2	AK	NNP	O	AK	nsubj	35	SENT_298	[p5l1413t2296r1459b2319],
3	,	,	O	,	_	0	SENT_298	[p5l1413t2296r1459b2319],
4	Duran	NNP	PERSON	Duran	nn	5	SENT_298	[p5l1470t2296r1550b2315],
5	M	NNP	PERSON	M	appos	2	SENT_298	[p5l1562t2296r1590b2319],
6	,	,	O	,	_	0	SENT_298	[p5l1562t2296r1590b2319],
7	Cao	NNP	O	Cao	nn	8	SENT_298	[p5l1602t2296r1650b2316],
8	Y	NN	O	y	appos	2	SENT_298	[p5l1660t2296r1684b2319],
9	,	,	O	,	_	0	SENT_298	[p5l1660t2296r1684b2319],
10	Shugarts	NN	O	shugart	nn	11	SENT_298	[p5l1695t2296r1804b2323],
11	D	NN	O	d	appos	2	SENT_298	[p5l1815t2296r1840b2319],
12	,	,	O	,	_	0	SENT_298	[p5l1815t2296r1840b2319],
13	Keller	NNP	PERSON	Keller	nn	14	SENT_298	[p5l1852t2296r1928b2315],
14	MR	NN	PERSON	mr	appos	2	SENT_298	[p5l1938t2296r1987b2319],
15	,	,	O	,	_	0	SENT_298	[p5l1938t2296r1987b2319],
16	et	FW	O	et	dep	2	SENT_298	[p5l1998t2300r2020b2315],
17	al.	FW	O	al.	nn	18	SENT_298	[p5l2032t2296r2057b2315],
18	(	FW	O	(	dep	2	SENT_298	[p5l2070t2296r2145b2321],
19	1998	CD	DATE	1998	number	20	SENT_298	[p5l2070t2296r2145b2321],
20	)	CD	NUMBER	)	num	21	SENT_298	[p5l2070t2296r2145b2321],
21	Genotypic	JJ	O	genotypic	dep	18	SENT_298	[p5l2156t2296r2286b2323],
22	and	CC	O	and	_	0	SENT_298	[p5l1326t2329r1372b2348],
23	phenotypic	JJ	O	phenotypic	amod	24	SENT_298	[p5l1384t2329r1526b2356],
24	characterization	NN	O	characterization	nsubj	35	SENT_298	[p5l1538t2329r1745b2348],
25	of	IN	O	of	_	0	SENT_298	[p5l1756t2329r1783b2348],
26	human	JJ	O	human	amod	29	SENT_298	[p5l1792t2329r1879b2348],
27	immunodeﬁciency	NN	O	immunodeﬁciency	nn	29	SENT_298	[p5l1891t2329r2127b2356],
28	virus	NN	O	virus	nn	29	SENT_298	[p5l2137t2329r2198b2348],
29	type	NN	O	type	prep_of	24	SENT_298	[p5l2210t2333r2262b2356],
30	1	CD	NUMBER	1	num	31	SENT_298	[p5l2276t2329r2284b2348],
31	variants	NNS	O	variant	dep	32	SENT_298	[p5l1326t2363r1428b2382],
32	isolated	VBN	O	isolate	amod	2	SENT_298	[p5l1451t2363r1551b2382],
33	from	IN	O	from	_	0	SENT_298	[p5l1573t2363r1635b2382],
34	patients	NNS	O	patient	prep_from	32	SENT_298	[p5l1658t2363r1761b2390],
35	treated	VBN	O	treat	_	0	SENT_298	[p5l1784t2363r1876b2382],
36	with	IN	O	with	_	0	SENT_298	[p5l1898t2363r1953b2382],
37	the	DT	O	the	det	40	SENT_298	[p5l1976t2363r2015b2382],
38	protease	NN	O	protease	nn	40	SENT_298	[p5l2038t2367r2148b2390],
39	inhibitor	NN	O	inhibitor	nn	40	SENT_298	[p5l2171t2363r2287b2382],
40	nelﬁnavir	NN	O	nelﬁnavir	prep_with	35	SENT_298	[p5l1326t2397r1453b2416],
41	.	.	O	.	_	0	SENT_298	[p5l1326t2397r1453b2416],

1	Antimicrob	NNP	O	Antimicrob	nn	3	SENT_299	[p5l1465t2397r1612b2416],
2	Agents	NNPS	O	Agents	nn	3	SENT_299	[p5l1624t2397r1710b2424],
3	Chemother	NNP	O	Chemother	_	0	SENT_299	[p5l1723t2397r1867b2417],
4	42	CD	NUMBER	42	num	6	SENT_299	[p5l1878t2397r1912b2417],
5	:	:	O	:	_	0	SENT_299	[p5l1878t2397r1912b2417],
6	2637-2644	CD	DATE	2637-2644	dep	3	SENT_299	[p5l1925t2395r2065b2417],
7	.	.	O	.	_	0	SENT_299	[p5l1925t2395r2065b2417],

1	Perrin	NNP	O	Perrin	nn	2	SENT_300	[p5l1326t2431r1406b2450],
2	V	NNP	O	V	_	0	SENT_300	[p5l1415t2431r1440b2454],
3	,	,	O	,	_	0	SENT_300	[p5l1415t2431r1440b2454],
4	Mammano	NNP	PERSON	Mammano	nn	5	SENT_300	[p5l1450t2431r1584b2450],
5	F	NN	O	f	appos	2	SENT_300	[p5l1593t2431r1608b2450],
6	(	CD	NUMBER	(	num	9	SENT_300	[p5l1618t2431r1693b2456],
7	2003	CD	DATE	2003	num	9	SENT_300	[p5l1618t2431r1693b2456],
8	)	CD	NUMBER	)	num	9	SENT_300	[p5l1618t2431r1693b2456],
9	Parameters	NNS	O	parameter	dep	5	SENT_300	[p5l1702t2431r1845b2450],
10	driving	VBG	O	drive	partmod	2	SENT_300	[p5l1854t2431r1945b2458],
11	the	DT	O	the	det	12	SENT_300	[p5l1954t2431r1992b2450],
12	selection	NN	O	selection	dobj	10	SENT_300	[p5l2001t2431r2113b2450],
13	of	IN	O	of	_	0	SENT_300	[p5l2122t2431r2149b2450],
14	nelﬁnavirresistant	JJ	O	nelﬁnavirresistant	amod	18	SENT_300	[p5l2156t2431r2286b2450, p5l1326t2465r1434b2484],
15	human	JJ	O	human	amod	18	SENT_300	[p5l1443t2465r1530b2484],
16	immunodeﬁciency	NN	O	immunodeﬁciency	nn	18	SENT_300	[p5l1542t2465r1777b2492],
17	virus	NN	O	virus	nn	18	SENT_300	[p5l1787t2465r1847b2484],
18	type	NN	O	type	prep_of	12	SENT_300	[p5l1858t2469r1911b2492],
19	1	CD	NUMBER	1	num	20	SENT_300	[p5l1923t2465r1932b2484],
20	variants	NNS	O	variant	dep	12	SENT_300	[p5l1944t2465r2069b2492],
21	.	.	O	.	_	0	SENT_300	[p5l1944t2465r2069b2492],

1	J	NNP	O	J	nn	2	SENT_301	[p5l1944t2465r2069b2492],
2	Virol	NNP	O	Virol	_	0	SENT_301	[p5l2078t2465r2142b2485],
3	77	CD	NUMBER	77	num	2	SENT_301	[p5l2154t2463r2187b2484],
4	:	:	O	:	_	0	SENT_301	[p5l2154t2463r2187b2484],
5	1017210175	CD	NUMBER	1017210175	dep	2	SENT_301	[p5l2200t2463r2286b2485, p5l1328t2497r1405b2518],
6	.	.	O	.	_	0	SENT_301	[p5l2200t2463r2286b2485, p5l1328t2497r1405b2518],

1	Hughes	NNP	ORGANIZATION	Hughes	nn	2	SENT_302	[p5l1326t2533r1420b2560],
2	SH	NNP	ORGANIZATION	SH	nsubj	17	SENT_302	[p5l1439t2533r1482b2556],
3	,	,	O	,	_	0	SENT_302	[p5l1439t2533r1482b2556],
4	Greenhouse	NNP	PERSON	Greenhouse	nn	5	SENT_302	[p5l1501t2533r1653b2553],
5	JJ	NN	PERSON	jj	appos	2	SENT_302	[p5l1667t2533r1696b2560],
6	,	,	O	,	_	0	SENT_302	[p5l1667t2533r1696b2560],
7	Petropoulos	NNP	PERSON	Petropoulos	nn	8	SENT_302	[p5l1715t2533r1868b2560],
8	CJ	NNP	O	CJ	appos	2	SENT_302	[p5l1887t2533r1921b2560],
9	,	,	O	,	_	0	SENT_302	[p5l1887t2533r1921b2560],
10	Sutrave	NNP	O	Sutrave	nn	11	SENT_302	[p5l1940t2533r2034b2553],
11	P	NN	O	p	appos	2	SENT_302	[p5l2053t2533r2068b2552],
12	(	CD	NUMBER	(	num	16	SENT_302	[p5l2087t2531r2162b2558],
13	1987	CD	DATE	1987	num	16	SENT_302	[p5l2087t2531r2162b2558],
14	)	NN	O	)	nn	16	SENT_302	[p5l2087t2531r2162b2558],
15	Adaptor	NN	O	adaptor	nn	16	SENT_302	[p5l2180t2533r2287b2560],
16	plasmids	NNS	O	plasmid	dep	11	SENT_302	[p5l1326t2567r1436b2594],
17	simplify	VBP	O	simplify	_	0	SENT_302	[p5l1450t2567r1550b2594],
18	the	DT	O	the	det	19	SENT_302	[p5l1565t2567r1603b2586],
19	insertion	NN	O	insertion	dobj	17	SENT_302	[p5l1618t2567r1731b2586],
20	of	IN	O	of	_	0	SENT_302	[p5l1746t2567r1773b2586],
21	foreign	JJ	O	foreign	amod	22	SENT_302	[p5l1784t2567r1876b2594],
22	DNA	NN	O	dna	prep_of	19	SENT_302	[p5l1890t2567r1952b2587],
23	into	IN	O	into	_	0	SENT_302	[p5l1967t2567r2017b2586],
24	helper-independent	JJ	O	helper-independent	amod	26	SENT_302	[p5l2031t2567r2286b2594],
25	retroviral	JJ	O	retroviral	amod	26	SENT_302	[p5l1326t2601r1447b2620],
26	vectors	NNS	O	vector	prep_into	17	SENT_302	[p5l1458t2605r1554b2620],
27	.	.	O	.	_	0	SENT_302	[p5l1458t2605r1554b2620],

1	J	NNP	O	J	nn	2	SENT_303	[p5l1562t2601r1575b2628],
2	Virol	NNP	O	Virol	_	0	SENT_303	[p5l1586t2601r1650b2621],
3	61	CD	NUMBER	61	num	2	SENT_303	[p5l1663t2601r1697b2620],
4	:	:	O	:	_	0	SENT_303	[p5l1663t2601r1697b2620],
5	3004-3012	CD	DURATION	3004-3012	dep	2	SENT_303	[p5l1709t2601r1849b2621],
6	.	.	O	.	_	0	SENT_303	[p5l1709t2601r1849b2621],

1	Elbeik	NNP	ORGANIZATION	Elbeik	_	0	SENT_304	[p5l1326t2635r1405b2654],
2	T	NN	ORGANIZATION	t	dep	1	SENT_304	[p5l1426t2635r1450b2658],
3	,	,	O	,	_	0	SENT_304	[p5l1426t2635r1450b2658],
4	Charlebois	NNP	PERSON	Charlebois	nn	5	SENT_304	[p5l1472t2635r1609b2655],
5	E	NNP	PERSON	E	appos	2	SENT_304	[p5l1631t2635r1652b2658],
6	,	,	O	,	_	0	SENT_304	[p5l1631t2635r1652b2658],
7	Nassos	NNP	ORGANIZATION	Nassos	nn	8	SENT_304	[p5l1675t2635r1759b2655],
8	P	NN	ORGANIZATION	p	appos	2	SENT_304	[p5l1781t2635r1802b2658],
9	,	,	O	,	_	0	SENT_304	[p5l1781t2635r1802b2658],
10	Kahn	NNP	PERSON	Kahn	nn	11	SENT_304	[p5l1825t2635r1891b2654],
11	J	NNP	PERSON	J	appos	2	SENT_304	[p5l1908t2635r1927b2662],
12	,	,	O	,	_	0	SENT_304	[p5l1908t2635r1927b2662],
13	Hecht	NNP	PERSON	Hecht	nn	14	SENT_304	[p5l1950t2635r2027b2654],
14	FM	NNP	O	FM	appos	2	SENT_304	[p5l2048t2635r2094b2658],
15	,	,	O	,	_	0	SENT_304	[p5l2048t2635r2094b2658],
16	et	FW	O	et	appos	2	SENT_304	[p5l2117t2639r2139b2654],
17	al.	FW	O	al.	nn	18	SENT_304	[p5l2161t2635r2187b2654],
18	(	FW	O	(	dep	1	SENT_304	[p5l2211t2635r2286b2660],
19	2000	CD	DATE	2000	num	20	SENT_304	[p5l2211t2635r2286b2660],
20	)	CD	NUMBER	)	dep	18	SENT_304	[p5l2211t2635r2286b2660],
21	Quantitative	JJ	O	quantitative	amod	24	SENT_304	[p5l1326t2669r1486b2695],
22	and	CC	O	and	_	0	SENT_304	[p5l1502t2669r1548b2688],
23	cost	NN	O	cost	conj_and	21	SENT_304	[p5l1564t2673r1613b2688],
24	comparison	NN	O	comparison	dep	1	SENT_304	[p5l1629t2669r1778b2696],
25	of	IN	O	of	_	0	SENT_304	[p5l1794t2669r1821b2688],
26	ultrasensitive	JJ	O	ultrasensitive	amod	30	SENT_304	[p5l1834t2669r2002b2688],
27	human	JJ	O	human	amod	30	SENT_304	[p5l2018t2669r2106b2688],
28	immunodeﬁciency	NN	O	immunodeﬁciency	nn	30	SENT_304	[p5l2122t2669r2286b2688, p5l1326t2702r1405b2729],
29	virus	NN	O	virus	nn	30	SENT_304	[p5l1416t2702r1476b2721],
30	type	NN	O	type	prep_of	24	SENT_304	[p5l1488t2706r1540b2729],
31	1	CD	NUMBER	1	num	32	SENT_304	[p5l1553t2702r1562b2721],
32	RNA	NN	O	rna	dep	1	SENT_304	[p5l1575t2702r1635b2721],
33	viral	JJ	O	viral	amod	35	SENT_304	[p5l1645t2702r1700b2721],
34	load	NN	O	load	nn	35	SENT_304	[p5l1712t2702r1765b2721],
35	assays	NNS	O	assay	dep	32	SENT_304	[p5l1776t2708r1854b2729],
36	:	:	O	:	_	0	SENT_304	[p5l1776t2708r1854b2729],
37	Bayer	NNP	ORGANIZATION	Bayer	nn	38	SENT_304	[p5l1866t2702r1938b2729],
38	bDNA	NNP	O	bDNA	dep	32	SENT_304	[p5l1947t2702r2026b2721],
39	quantiplex	JJ	O	quantiplex	amod	40	SENT_304	[p5l2037t2702r2173b2729],
40	versions	NNS	O	version	dep	38	SENT_304	[p5l2184t2702r2286b2721],
41	3.0	CD	NUMBER	3.0	dep	1	SENT_304	[p5l1326t2736r1360b2755],
42	and	CC	O	and	_	0	SENT_304	[p5l1372t2736r1417b2755],
43	2.0	CD	NUMBER	2.0	dep	1	SENT_304	[p5l1428t2736r1462b2755],
44	and	CC	O	and	_	0	SENT_304	[p5l1473t2736r1519b2755],
45	Roche	NNP	O	Roche	nn	46	SENT_304	[p5l1529t2736r1607b2755],
46	PCR	NN	O	pcr	dep	1	SENT_304	[p5l1618t2736r1673b2756],
47	Amplicor	JJ	O	amplicor	amod	49	SENT_304	[p5l1682t2736r1804b2763],
48	monitor	NN	O	monitor	nn	49	SENT_304	[p5l1814t2736r1918b2755],
49	version	NN	O	version	dep	1	SENT_304	[p5l1928t2736r2019b2755],
50	1.5	CD	NUMBER	1.5	dep	49	SENT_304	[p5l2032t2736r2090b2763],
51	.	.	O	.	_	0	SENT_304	[p5l2032t2736r2090b2763],

1	J	NNP	O	J	nn	3	SENT_305	[p5l2032t2736r2090b2763],
2	Clin	NNP	PERSON	Clin	nn	3	SENT_305	[p5l2100t2736r2152b2756],
3	Microbiol	NNP	PERSON	Microbiol	_	0	SENT_305	[p5l2163t2736r2286b2755],
4	38	CD	NUMBER	38	num	3	SENT_305	[p5l1326t2770r1360b2789],
5	:	:	O	:	_	0	SENT_305	[p5l1326t2770r1360b2789],
6	1113-1120	CD	DATE	1113-1120	dep	3	SENT_305	[p5l1375t2770r1513b2790],
7	.	.	O	.	_	0	SENT_305	[p5l1375t2770r1513b2790],

1	Highbarger	NNP	O	Highbarger	nn	2	SENT_306	[p5l1326t2804r1473b2831],
2	HC	NNP	O	HC	_	0	SENT_306	[p5l1485t2804r1533b2827],
3	,	,	O	,	_	0	SENT_306	[p5l1485t2804r1533b2827],
4	Alvord	NNP	PERSON	Alvord	nn	5	SENT_306	[p5l1546t2804r1632b2823],
5	WG	NNP	O	WG	appos	2	SENT_306	[p5l1645t2804r1698b2827],
6	,	,	O	,	_	0	SENT_306	[p5l1645t2804r1698b2827],
7	Jiang	NNP	PERSON	Jiang	nn	8	SENT_306	[p5l1707t2804r1775b2831],
8	MK	NNP	O	MK	appos	2	SENT_306	[p5l1788t2804r1837b2827],
9	,	,	O	,	_	0	SENT_306	[p5l1788t2804r1837b2827],
10	Shah	NNP	PERSON	Shah	nn	11	SENT_306	[p5l1851t2804r1912b2824],
11	AS	NNP	O	AS	appos	2	SENT_306	[p5l1925t2804r1966b2827],
12	,	,	O	,	_	0	SENT_306	[p5l1925t2804r1966b2827],
13	Metca1fJA	NN	O	metca1fja	appos	2	SENT_306	[p5l1980t2804r2121b2831],
14	,	,	O	,	_	0	SENT_306	[p5l1980t2804r2121b2831],
15	et	FW	O	et	dep	2	SENT_306	[p5l2135t2808r2157b2823],
16	al.	FW	O	al.	nn	17	SENT_306	[p5l2171t2804r2197b2823],
17	(	FW	O	(	dep	2	SENT_306	[p5l2211t2804r2286b2829],
18	1999	CD	DATE	1999	num	20	SENT_306	[p5l2211t2804r2286b2829],
19	)	CD	NUMBER	)	num	20	SENT_306	[p5l2211t2804r2286b2829],
20	Comparison	NN	O	comparison	dep	17	SENT_306	[p5l1326t2838r1482b2865],
21	of	IN	O	of	_	0	SENT_306	[p5l1493t2838r1520b2857],
22	the	DT	O	the	det	26	SENT_306	[p5l1529t2838r1567b2857],
23	Quantiplex	JJ	O	quantiplex	amod	26	SENT_306	[p5l1578t2838r1722b2865],
24	version	NN	O	version	nn	26	SENT_306	[p5l1733t2838r1824b2857],
25	3.0	CD	NUMBER	3.0	num	26	SENT_306	[p5l1836t2838r1870b2857],
26	assay	NN	O	assay	prep_of	20	SENT_306	[p5l1881t2844r1943b2865],
27	and	CC	O	and	_	0	SENT_306	[p5l1954t2838r2000b2857],
28	a	DT	O	a	conj_and	2	SENT_306	[p5l2011t2845r2023b2857],
29	sensitized	VBN	O	sensitize	partmod	2	SENT_306	[p5l2034t2838r2156b2857],
30	Amplicor	NN	MISC	amplicor	nn	32	SENT_306	[p5l2166t2838r2287b2865],
31	monitor	NN	O	monitor	nn	32	SENT_306	[p5l1326t2872r1431b2891],
32	assay	NN	O	assay	dobj	29	SENT_306	[p5l1443t2878r1504b2899],
33	for	IN	O	for	_	0	SENT_306	[p5l1517t2872r1554b2891],
34	measurement	NN	O	measurement	prep_for	32	SENT_306	[p5l1566t2876r1738b2891],
35	of	IN	O	of	_	0	SENT_306	[p5l1750t2872r1777b2891],
36	human	JJ	O	human	amod	42	SENT_306	[p5l1787t2872r1874b2891],
37	immunodeﬁciency	NN	O	immunodeﬁciency	nn	42	SENT_306	[p5l1887t2872r2123b2899],
38	virus	NN	O	virus	nn	42	SENT_306	[p5l2135t2872r2195b2891],
39	type	NN	O	type	nn	42	SENT_306	[p5l2208t2876r2261b2899],
40	1	CD	NUMBER	1	num	42	SENT_306	[p5l2276t2872r2284b2891],
41	RNA	NN	O	rna	nn	42	SENT_306	[p5l1326t2906r1386b2925],
42	levels	NNS	O	level	prep_of	34	SENT_306	[p5l1398t2906r1465b2925],
43	in	IN	O	in	_	0	SENT_306	[p5l1478t2906r1501b2925],
44	plasma	NN	O	plasma	nn	45	SENT_306	[p5l1513t2906r1600b2933],
45	samples	NNS	O	sample	prep_in	29	SENT_306	[p5l1612t2906r1737b2933],
46	.	.	O	.	_	0	SENT_306	[p5l1612t2906r1737b2933],

1	J	NNP	O	J	nn	3	SENT_307	[p5l1612t2906r1737b2933],
2	Clin	NNP	PERSON	Clin	nn	3	SENT_307	[p5l1749t2906r1800b2926],
3	Microbiol	NNP	PERSON	Microbiol	_	0	SENT_307	[p5l1813t2906r1936b2925],
4	37	CD	NUMBER	37	num	3	SENT_307	[p5l1949t2904r1983b2925],
5	:	:	O	:	_	0	SENT_307	[p5l1949t2904r1983b2925],
6	3612-3614	CD	DURATION	3612-3614	dep	3	SENT_307	[p5l1995t2906r2135b2926],
7	.	.	O	.	_	0	SENT_307	[p5l1995t2906r2135b2926],

1	20	CD	NUMBER	20	_	0	SENT_308	[p5l1277t1177r1310b1197],
2	.	.	O	.	_	0	SENT_308	[p5l1277t1177r1310b1197],

1	April	NNP	DATE	April	_	0	SENT_309	[p5l1772t3092r1834b3123],
2	2007	CD	DATE	2007	num	1	SENT_309	[p5l1849t3094r1914b3116],
3	|	NNP	O	|	dep	1	SENT_309	[p5l1929t3091r1931b3124],
4	Volume	NN	O	volume	nn	7	SENT_309	[p5l1945t3092r2051b3116],
5	3	CD	NUMBER	3	num	7	SENT_309	[p5l2064t3094r2078b3116],
6	|	NN	O	|	nn	7	SENT_309	[p5l2093t3091r2096b3124],
7	Issue	NN	O	issue	dep	3	SENT_309	[p5l2112t3093r2178b3116],
8	4	CD	NUMBER	4	num	10	SENT_309	[p5l2190t3094r2206b3116],
9	|	NN	O	|	nn	10	SENT_309	[p5l2221t3091r2223b3124],
10	e46	NN	O	e46	dep	1	SENT_309	[p5l2238t3094r2287b3116],

